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Abstract 
The development of tritopic azole ligands tethered to the cyclotriveratrylene (CTV) 
molecular host is described within this thesis. The assembly of tripodal pyridyl-CTV 
ligands with metal precursors has led to the discovery of a diverse range of 
metallo-supramolecular assemblies, but comparable ligands incorporating 
five-membered ring counterparts are considerably less developed. New azole ligands 
could potentially coordinate to metals at different bite angles compared to the 
established pyridyl systems, leading to the assembly of previously inaccessible 
architectures. Furthermore, azoles, in particular 1,3-diazoles, are precursors to 
organometallic N-heterocyclic carbene (NHC) complexes. The fusion of NHC 
ligands and CTV cavitands has not previously been investigated. 
 A tritopic benzimidazole ligand was prepared, which assembles with 
[Pd(Cl)2(MeCN)2] to yield a rare trans-linked metallocryptophane as an alternative 
to the more commonly encountered architectures requiring a cis-protected Pd(II) 
precursor. Additionally, the coordination of an oxazole ligand was investigated, 
leading to the assembly of 1D polymer chains. 
 The assembly of a 4-thiazolyl ligand with AgBF4 and AgReO4 led to the 
assembly of the first CTV-type coordination cubes, with chiral self sorting upon 
coordination to Ag(I) and spontaneous resolution of crystals being exhibited. In 
addition to cubic cages, 2D and 3D coordination polymers were also accessible upon 
coordination to Ag(I). 
 The first metal-NHC complexes on a CTV scaffold were also prepared, with 
Ir(III) and Ru(II) complexes being examined as catalysts in the transfer 
hydrogenation of acetophenone, suggesting that in the case of Ru(II), intermolecular 
cooperativity may be exhibited. 
 Trinuclear Pd(II)-NHC complexes were targeted, and examined as catalysts 
in the regioselective Suzuki-Miyaura reaction of 2,4-dibromopyridine and 
4-methoxybenzeneboronic acid. Catalysts displayed high activities over a short 
period of time, preparing traces of the ‘favoured’ o-coupled product and significant 
quantities of para- and bis-coupled products, potentially via two pathways.  
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Chapter 1  
Introduction 
1.1 Supramolecular Chemistry 
The term ‘supramolecular chemistry’ was first coined by Johannes Diederick van 
der Waals in 1873, when he proposed molecules close in space must interact with 
one another.1 In 1894, Fished suggested the lock and key mechanism when 
researching the enzymatic cleavage of polysaccharides.2 The lock and key 
mechanism involves the selective fitting of a guest within the active site of a 
biological host molecule, often an enzyme, which were later understood to be 
through intermolecular interactions such as hydrogen bonding and π-π stacking. 
The field of supramolecular chemistry focuses on ‘chemistry beyond the 
molecule’, a term coined by Jean-Marie Lehn, a recipient of the 1987 Nobel Prize in 
chemistry.3 The basis of supramolecular chemistry is molecular self-assembly, 
which involves the spontaneous arrangement of covalently bound molecular 
subunits into ordered arrays through reversible interactions, such as hydrogen 
bonding, halogen bonding and metal coordination. Self-assembly is a dynamic 
process and in equilibrium, allowing systems to self-correct as the thermodynamic 
minimum is reached, which is not an instantaneous process. Supramolecular 
chemistry has since developed into a multidisciplinary field, hugely impacting both 
biological and physical sciences. Life itself cannot function without supramolecular 
chemistry, with examples including the complementary hydrogen bonds between 
DNA nucleotides,4 facilitating the assembly of the double helix structure, and the 
folding of enzymes through hydrogen bonding, and π-π stacking and disulfide links 
formed between cysteine residues. The extent of supramolecular interactions in 
biological systems led to Nadrian Seeman inventing the field of DNA 
nanotechnology.5 The development and influence of supramolecular chemistry have 
developed in tandem with the establishment and improvement of analytical 
instrumentation, for example synchrotron sources for X-ray diffraction, which have 
led to a number of critical discoveries.  
 Research on macrocycles by Lehn, Cram and Pedersen directed the field of 
supramolecular chemistry, with Pedersen discovering the cation-templated synthesis 
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of crown ethers.6, 7 Changing the metal cation selected based on ionic radii led to the 
templation of different sized crown-ethers through the Williamson ether synthesis. 
Addition of Li+ led to the smaller 12-crown-4 being isolated, whilst K+ templates the 
cyclisation of 18-crown-6. Crown ethers are also excellent receptors for cationic 
species, with oxygen atoms of the macrocycle coordinating to the relevant cation. 
The recognition properties of crown ethers and the 3D cryptand hosts developed by 
Lehn and co-workers have greatly influenced the field of metallo-supramolecular 
chemistry.8, 9 
1.1.1 Metallo-supramolecular chemistry 
Metal coordination to multitopic ligands is a powerful tool for supramolecular 
chemists, and well-defined polyhedra. The combination of a transition metal centre, 
whose geometries are often well-defined by crystal field effects, and a carefully 
designed multitopic ligand can lead to the assembly of architectures with high 
fidelity. Lehn and co-workers have demonstrated this by combining 
poly-2,2’-bipyridine ligands with Cu(I), which has a propensity to yield tetrahedral 
complexes. This particular combination led to the assembly of a dinuclear [Cu2L2]
2+ 
double helicate complex.10 Additionally, coordination of octahedral Ni(II) cations to 
similar poly-2,2’-bipyridine ligands led to the assembly of triple helicates.11 
Self-recognition properties of helicates were demonstrated in the same article, and 
upon employing poly-2,2’bipyridines of different lengths, alongside both Cu(I) and 
Ni(II) salts, only the homoleptic, homonuclear double or triple helicates were 
observed as products. The same ligand class assembled with FeCl2 to surprisingly 
yield a [Fe5L5(Cl)]
9+ circular helicate ensemble whose assembly was 
anion-templated.12 Using modern-day organometallic chemistry, Leigh and 
co-workers used alkene metathesis chemistry to link a circular helicate analogue into 
a pentafoil knot (figure 1.1, right).13 
Employing two ditopic units with specific geometries allows for the 
assembly of 2D shapes.14 A key example is Fujita’s archetypal [Pd4L4]
8+ molecular 
square (figure 1.1, left), which combined a cis-protected Pd(II) subunit and the rigid 
ditopic ligand 4,4’-bipyridine.15 The ethylenediamine ligand forced the incoming 
4,4’-bipyridine ligands to coordinate cis- with respect to one another, leading to the 
assembly of a square as the thermodynamic product. By changing the geometry of 
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the ligand and/or metal subunits, shapes such as triangles16 and hexagons17 can also 
be accessed. 
  
Figure 1.1 Left: Fujita's molecular square. Right: Leigh's pentafoil knot.13, 15 
The combination of ditopic and tritopic components leads to the assembly of 3D 
polyhedra. Raymond and co-workers have prepared [Ga4L6(NEt4
+)]11- and the 
analogous Fe3+ tetrahedra from linear bis-catecholate and octahedral Ga3+ cations 
(figure 1.2, left).18 The same class of complex is capable of encapsulating highly 
reactive cationic phosphine-acetone adducts in aqueous media.19 Nitschke and 
co-workers have prepared a family of cationic [M4L6]
n+ tetrahedra, which can be 
prepared in a one-pot synthesis through subcomponent self-assembly.20 Many 
ligands prepared in this group revolve around the condensation of 2-formylpyridine 
and amines in the presence of a metal centre, yielding a bidentate pyridylimine 
ligand.21 The same group demonstrated the encapsulation of white phosphorus 
within a tetrahedral cage, rendering it indefinitely stable in aqueous media (figure 
1.2, right).22 The authors stated that P4 was unable to be oxidised because the 
products were too large to fit within the cavity. The addition of benzene led to the 
release of white phosphorus from the cage. The encapsulation of white phosphorus, 
and yellow arsenic (As4) has also recently been achieved by Wu and co-workers 
within an anionic tetrahedral cage.23  
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Figure 1.2 Left: Raymond's [Ga4L6]11- tetrahedron.18 Triethylammonium guest is shown in 
green. Right: Nitschke's [Fe4L6]8+ tetrahedron encapsulating white phosphorus.22 
 One position of the P4 guest is shown as space-filling and only the S of SO3  
 groups shown for clarity. 
Larger platonic solids are also accessible, such as metallo-cubes, which typically 
arise through the edge-directed assembly of a facially-protected octahedral metal 
with linear linkers such as 4,4’-bipyridine, as demonstrated by Thomas and 
co-workers when reporting a [Ru8L12] cube.
24 Nitschke and co-workers intricately 
prepared a [Fe8Pt6L24]
28+ heterobimetallic cube by combining subcomponent 
self-assembly with molecular panelling.25, 26 Square-planar Pt(II) ions reside in the 
centre of each face coordinated to four ligands, making a square-shaped [PdL4] 
fragment. Bidentate pyridylimine groups terminate each of the ligands coordinating 
to Pt2+, and concomitantly, three coordinate to octahedral Fe(II) centres on each 
vertex of the cube (figure 1.3, left). 
Molecular panelling is an approach Fujita and co-workers have made great 
strides in, and assemblies are face-directed.27 By treating ligands as 2D geometric 
panels such as triangles or squares, they can be linked together roughly orthogonally 
by square planar metals to give rise to 3D polyhedra. The first example reported in 
this group was the assembly of a triangular ligand with a cis-protected Pd(II) tecton 
into a [Pd6L4]
12+ octahedron.28 The precursor [Pd(en)(NO3)2] was employed as a 
tecton because it possesses a bidentate ethylenediamine (en) ligand which forces two 
oncoming ligands to coordinate cis- to one another about the square planar Pd(II) 
centre. Alternating faces of the octahedron were occupied by ligands, and the cage 
behaved as a receptor to adamantanecarboxylates (figure 1.3, right). Derivatives of 
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Fujita’s octahedral cages have proven to be effective host molecules towards a range 
of substrates, including tetrabenzylsilane29 and cis-azobenzene, with no evidence of 
the azobenzene moiety isomerising to yield the trans-isomer in solution.30 
 
Figure 1.3 Left: Nitschke's [Fe8Pt6L24]28+ cube.26 Right: Fujita's catalytically active [Pd6L4]12+ 
octahedron.31 Adamantanecarboxylate guests shown in space-filling. 
In contrast to Platonic solids, which are regular polyhedra with congruent faces, 
Archimedean solids are semi-regular 3D polyhedra, and contain two or more 
polygons as faces in the assembly. Archimedean solids are much rarer than their 
Platonic counterparts. Fujita has more recently reported the assembly of much larger 
Archimedean solids by employing [Pd(MeCN)4](BF4)2 and slightly bent ditopic 
ligands. The unprotected Pd(II) centre can coordinate to four ligands, facilitating the 
assembly of 3D polyhedra with bent ligand systems. Fujita has elegantly 
demonstrated that slightly altering the bite angle between the m-pyridyl donors of 
his ligand, by substituting the phenyl group of 1,3-di(4-pyridyl)benzene for 
2,5-furan, 2,5-thiophene or 2,5-selenophene interior can drastically alter the 
polyhedron obtained post-assembly, accessing M12L24 cuboctahedra (figure 1.4, 
left),32 M24L48 rhombicuboctahedra,
33, M30L60 icosidodecahedra,
34 with the largest 
assembly to date in his group being a M48L96 polyhedron comprising of trigonal and 
tetragonal faces.35 In addition to Fujita’s Archimedean assemblies, Stang,14, 17, 36 
Newkome37 (figure 1.4, right) and Ward38 have made invaluable contributions with 
their discoveries of truncated tetrahedra, cuboctahedra and truncated octahedra 
through metal coordination and hydrogen bonds. 
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Figure 1.4 Left: Fujita's cuboctahedron. Right: Newkome's cuboctahedron.32, 37 
1.1.2 Cavitands 
A number of bowl-shaped molecules with internal cavities exist, and have been 
coined as cavitands by Cram.39 The most commonly encountered cavitands are 
derivatives of calix[4]arene. A common precursor in calix[4]arene chemistry is 
tbutylcalix[4]arene, whose synthesis is straightforward upon condensation of 
4-tbutylphenol and formaldehyde under basic conditions.40-42 Removal of the 
tert-butyl group under Lewis acidic conditions is facile, and replacement with a 
range of ligand groups is possible. The hydroxyl groups on the lower-rim partake in 
hydrogen bonding interactions with one another, thus adopting a cone conformation, 
although introducing steric bulk to the methylene bridges can disrupt and overcome 
the propensity to form hydrogen bonds, leading to partial cone conformations 
prevailing.43 
 Calix[n]arenes display rich and varied coordination chemistry. Coordination 
of metals to the lower-rim hydroxyl groups is established,44, 45 as well as through 
ligand functionality introduced to the calix[4]arene upper-rim. Key assemblies 
include Kobayashi and Fukazawa’s [M4L2] cages bearing pyridyl donors
46, 47 and de 
Mendoza’s carboxylate-functionalised calix[4]arene and calix[5]arene scaffolds, 
which coordinate equatorially around uranyl cations with hexagonal bipyramidal 
geometries, affording [(UO2)8(L)6]
8- octahedral and [(UO2)20(L)12]
20- icosahedral 
cages respectively (figure 1.5).48 
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Figure 1.5 De Mendoza's [(UO2)20(L)12]20- icosoahedron.48 
1.1.3 Cyclotriveratrylene 
Cyclotriveratrylene (CTV) is a rigid C3-symmetric cavitand with a shallow 
hydrophobic cavity (figure 1.6, left). The interior of the bowl is electron-rich and 
CTV has been utilised as a molecular host to fullerenes.49, 50 The structure of CTV 
was realised in 1965 by Lindsey,51 but first discovered by Robinson in 1915 who 
mistook it for the dimer.52 A number of CTV derivatives are known, including the 
hexakis-hydroxyl derivative cyclotricatechylene (CTC), which is accessible via the 
complete demethylation of CTV. Robson and co-workers elegantly demonstrated the 
ability of CTC to form clam-like structures and encapsulate anions of different sizes 
within the electron-rich cavity by dissociation of hydrogen bonds about the dimer.53 
CTC has also been employed as a C3-symmetric dioxolene ligand,
54 and also as a 
portion of the monomer in a polymer of intrinsic microporosity.55 Arguably the most 
synthetically useful derivative is the tris-hydroxyl analogue cyclotriguaiacylene 
(CTG) (figure 1.6, right), which can be functionalised through straightforward 
means by reaction with an alkyl halide or acid halide under basic conditions to give 
rise to a range of compounds bearing ligand groups for metal coordination56 or for 
applications such as Hg(II) detection in aqueous media.57 
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Figure 1.6 Left: Cyclotriveratrylene (CTV). Right: helical enantiomers of cyclotriguaiacylene 
(CTG). 
Like all CTV derivatives, CTG exists predominantly in the crown-conformation. 
Additionally, CTG possesses helical chirality about the upper-rim and enantiomers 
can be separated through chiral HPLC techniques. Racemisation occurs after ca. one 
month at 20 ºC, via the unfavourable saddle conformation, although this is 
accelerated at higher temperatures and varies depending on functionality introduced 
to the cavitand (figure 1.7).58, 59 Interconversion between enantiomers is slow and 
cannot be measured on the NMR timescale due to the high energy barrier for 
inversion via the saddle conformation. Chiral self-sorting can occur upon metal 
coordination.60 The favourable crown-conformation contains two doublets 
corresponding to the endo- and exo- protons of the lower rim at δ = 5.0-4.6 and 
3.9-3.6 ppm, with geminal coupling between the two doublets observed at roughly 
14 Hz. 
Figure 1.7 Racemisation of CTG via the saddle conformation. 
The concave nature of the CTV bowl makes it an ideal capping group for molecular 
cages, the simplest of which are known as cryptophanes, where two CTV units 
typically adopt a head-to-head arrangement and are linked together by a range of 
spacer units.8, 61 Both CTV units in a cryptophane possess helical chirality, therefore 
the cryptophanes are typically isolated as diastereomers, termed the 
syn-diastereomer and anti-diastereomer which are of different symmetries.62, 63 The 
syn-cryptophane comprises two CTV units of opposite handedness, whereas the 
anti-cryptophanes contain two CTV units of the same handedness and are therefore 
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chiral. Whilst the vast majority of cryptophanes have the ‘out-out’ conformation, 
Holman and co-workers isolated a rare example of an ‘imploded’ cryptophane upon 
thermal release of guest, led to one CTV cap taking up the unfavourable saddle 
conformation and the capsule collapsing.64 Addition of THF guest reinflates the 
cryptophane.  
Cryptophanes have proven to behave as reversible hosts to a range of small 
neutral molecules including bromochlorofluoromethane,65 methane,66 aminoxy 
radicals,67 ammonium cations68 and also xenon (figure 1.8, left).69, 70 The 
electron-rich nature of the CTV-bowl leads to cryptophanes being poor receptors for 
anions. Holman and co-workers have however addressed this by furnishing each 
CTV arene face with d6 metal arene and Cp complexes (Fe(II), Ru(II) and Ir(III)) in 
a sandwich motif, causing a significant increase in π-acidity within the cavity and 
facilitating the binding of anions within the CTV core and also cryptophanes.71-74 
 In addition to cryptophanes bearing organic linkers, coordination chemistry 
can be utilised to link two derivatised CTV-type ligands through three metal centres. 
This was first demonstrated by Shinkai and co-workers in 2001, who assembled a 
C3-symmetric pyridyl CTV ligand with cis-protected Pd(II) tectons to yield chiral 
anti-metallo-cryptophanes.75 Further investigations by Chambron and co-workers 
led to the stereoselective assembly of chiral anti-isomers.76 The same group also 
employed a mixture of two CTV-type ligands and self-recognition led to only 
homoleptic cryptophanes being isolated. Hardie and co-workers have extensively 
studied cis-protected metallo-cryptophanes, reporting chiral Ir(III) isomers,77 in 
addition to achiral [Pd3(bis-NHC)3(L)2] syn-cryptophane cages (figure 1.8, right).
78 
Further investigations into metallated cryptophanes have notably revealed the 
assembly of a catenated metallo-cryptophane,79 and a soft coordination polymer 
derived from organic cryptophanes bearing a carboxylic acid ligand on the equator.80  
As well as metallo-cryptophanes, a host of larger cages have been reported. 
Upon mixing Pd(NO3)2 and the tris-isonicotinoylcyclotriveratrylene ligand, a 
[Pd6L8]
12+ stellated octahedron assembles (figure 1.9, left). Each CTV ligand 
occupies one face of an octahedron and the CTV lower-rim stellates from the centre 
of each face.82 The same cages have been proven to encapsulate sodium alkyl 
sulfates in solution,83 and can be disassembled and reassembled in solution.84 In 
addition to using [Pd(NO3)2] as a precursor for the assembly of stellated octahedra, 
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Hardie and co-workers reacted the chelating [Pd(en)(NO3)2] with the same 
isonicotinoyl ligand, and a [Pd3(en)3(L)2] metallo-cryptophane was the initial 
product. However, this proved to be metastable and rearranged in solution to yield 
the [Pd6L8]
12+ stellated octahedron and [Pd(en)2]
2+ as byproduct.78  
 
Figure 1.8 Left: Holman's organic cryptophane bearing a Xe guest molecule (pink sphere).81 
Right: Hardie's [Pd3(L)2(bis-NHC)3]6+ metallo-cryptophane.78 
Further examples of CTV-type metallo-cages include tetrahedral assemblies. Hardie 
and co-workers have reported two different types of [Ag4L4]
4+ tetrahedra. One is 
built upon the amino- derivative of cyclotriguaiacylene, the base of each bowl 
behaves as the cornerpiece of the assembly and each Ag(I) centre is tetrahedral, 
interacting with three ligands and one acetonitrile molecule.85-87 The second class of 
reported [Ag4L4]
4+ tetrahedron is based on a quinoline-functionalised CTV ligand, 
one arm on each host is non-coordinating, and the Ag(I) centres are linear 
2-coordinate.88 Robson and co-workers have reported the assembly of 
[Cu6(CTC)4]
12- and [(VO)6(CTC)4]
12- tetrahedral cages with the closely related 
hexakis-hydroxyl CTC (figure 1.9, right).89, 90 Both tetrahedral assemblies are 
structurally similar, with the cavitand bowl behaving as cornerpieces in the 
tetrahedron and the six metal centres reside on the edges. The Cu(II) centres possess 
square-planar geometry, whilst vanadyl unit is square pyramidal, with the 
oxo-ligand pointing outwards of the capsule, perpendicular to the CTC ligands. 
CTV-derived ligands have proven capable of assembling with metal centres 
to yield platonic solids, and also topologically complex architectures. A key 
example is a [Pd4L4]
8+ Solomon cube.91 The assembly comprises of two [M2L2] 
metallacycles which form a Solomon-like link – two interwoven rings with four 
crossing points, but the two interlocked metallacycles are linked by Pd(II) centres. 
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The assembly also contains eight vertices, each of which is triple-connecting, 
rendering it a cube. A CTV-type ligand has also assembled with Cu(II) to yield 
[Cu6L6] metallacycles, which form an infinite Borromean network, with each ring 
forming a network with six nearest neighbours.92 Borromean rings are Brunnian 
links containing (at least) three overlapping, but non-interlocking rings. Removal of 
one ring from the architecture leads to the collapse of the structure. 
 
Figure 1.9 Left: Hardie's [Pd6L8]12+ stellated octahedron. Right: Robson's [(VO)6(CTC)4] 
tetrahedron.82, 90 
1.1.4 Metallo-supramolecular assemblies in catalysis 
Utilising supramolecular systems in catalytic transformations, as catalysts 
themselves or reaction vessels to either initiate or accelerate a reaction is an 
emerging and significant field. Many examples stem from confining a substrate 
within a cage, facilitating a reaction and then releasing the cargo, in a similar 
method to enzymatic transformations within biological systems. Catalysis within a 
cage is antithetical to the inhibition of P4 oxidation observed by Nitschke and 
co-workers,22 but the principles and reasoning behind the transformations is the 
same. 
 An early example of a supramolecular system influencing reactivity was 
reported by Breslow in 1971 when investigating the chlorination of anisole.93 Upon 
reaction of anisole with hypochlorous acid, o- and p-chlorination is observed. 
Breslow added α-cyclodextrin to the reaction mixture, which formed a 1:1 complex 
with anisole, protecting the o- and m-positions of anisole within the cyclodextrin 
cavity, and therefore rendering them inaccessible to reactivity. Only a slight increase 
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in rate was observed, but Breslow’s findings gave early insight into how 
supramolecular complexation can affect regioselectivity and reactivity.  
The Diels-Alder reaction has been well-studied within supramolecular hosts. 
A study by Sanders and co-workers in 1993 first demonstrating this when carrying 
out a [4 + 2] cycloaddition between pyridine-containing diene and dienophiles 
within a Zn-porphyrin trimer.94 A 200-fold increase in rate was observed upon 
addition of the molecular host, alongside selective exo-cyclisation. The authors 
proposed a Zn-templated transition-state through coordination of the pyridyl diene to 
explain the regioselectivity. Rebek and co-workers have employed a deep vase-like 
cavitand as a catalyst for the Diels-Alder cycloaddition of 
9-(hydroxymethyl)anthracene and adamantyl maleimide. The interior of the cavitand 
is hydrophobic, whilst the upper-rim contains hydrogen-bonding units, giving the 
maleimide dienophile a strong binding affinity for the cavitand. The confined 
dienophile readily partook in the expected 9-10 Diels-Alder cycloaddition.95 Fujita 
and co-workers employed the [M6L4] octahedron shown in figure 1.3 as a reaction 
vessel to catalyse the same reaction.31 In this case, the unusual 1,4-Diels Alder 
product was observed, with the authors proposing π-π interactions between the 
central anthracene ring and maleimide were too restricted within the cage, leading to 
selective 1,4-cyclisation. (scheme 1.1). Fujita also prepared a [Pd6L4] open bowl, 
which selectively catalysed the conventional 9,10-cycloaddition. Introducing 
chirality into the cis-protecting tecton of the octahedron, Fujita has since carried out 
asymmetric [2 + 2] and [2 + 4] Diels-Alder cyclisations with ee (enantiomeric 
excess) reaching 50%.96 The octahedron itself does not contain chiral centres, but 
the walls of the cage distort slightly. 
Scheme 1.1 Right: Fujita's 1,4-cycloaddition mediated within a cage. Left: The commonly 
observed 9,10-cycloaddition product isolated in the absence of a cage catalyst.31 
Nitschke and co-workers have employed a tetrahedral cage as a catalyst for the 
hydrolysis of the insecticide dichlorovos, which is chemically similar to chemical 
warfare agents, by accelerating its decomposition.97 The recognition may be 
mediated by hydroxyl groups exo- to the cages rather than within the cavity. Ward 
and co-workers have more recently prepared a [Co8L12]
16+ capable of catalysing the 
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Kemp elimination of benzisoxazole to 2-cyanophenolate within the cubic cavity, in 
aqueous media (scheme 1.2, top).98 A 2 × 105-fold increase in rate was observed, 
and was proposed to occur within the cavity, whilst assisted by hydrogen bonding 
interactions with hydroxyl groups on the cube edges.  
Raymond’s anionic [Ga4L6]
11- tetrahedral cages have proven to be excellent 
catalysts across a range of reactions, displaying >800-fold rate accelerations in a 
number of cases. The clusters have a high affinity for cationic species, and can 
efficiently catalyse the Aza-Cope rearrangements of enammonium cations within the 
cavity, forcing the reactive groups in close proximity of one another. After 
cyclisation, [NMe4]
+ displays a greater affinity for the cage, outcompeting the 
rearrangement product, which becomes hydrolysed, neutral and hence 
non-competitive with the [NMe4]
+ guest.99-101 In addition to the aza-Cope 
rearrangement, the same class of cages can catalyse the Nazarov cyclisation of 
pentamethylpentadienol, yielding pentamethylcyclopentadiene (Cp*H) with a rate 
acceleration of 2.1 × 106 (kcat/kuncat).102 
 As an extension to confining a guest within the anionic cages, Raymond has 
encapsulated cationic (pre)catalysts such as [Ir(Cp*)(PMe3)(CH3)(C2H4)]
+ and 
[Rh(COD)(PMe3)2]
+ species within tetrahedral cages, which display size- and 
shape-selectivities in the C-H activation of ketones and ethers, and isomerisation of 
allylic alcohols respectively.103, 104  
Reek and co-workers have prepared a number of cage molecules 
encapsulating organometallic catalysts and delivering an increase in rate. An early 
key example was a Rh(I) organometallic complex bearing a tris-4-pyridylphosphine 
ligand. The nitrogen atoms of the pyridines coordinated to a Zn porphyrin leading to 
a twofold increase in activity for the hydroformylation of 1-octene compared to in 
the absence of porphyrins.105 By taking advantage of the pyridyl-Zn interaction 
within a porphyrin-containing scaffold, Reek and co-workers have encapsulated a 
Rh(I) complex bearing a pyridine-grafted BINAP 
(2,2’bisdiphenylphosphino-1,1’-binaphthyl) ligand within a Zn-porphyrinic cage, 
and witnessed a marked increase in rate, alongside ee of 79% in the enantioselective 
hydroformylation of styrene.106 
Resorcinarenes often form hydrogen-bonded hexameric cages in solution.107 
Reek has encapsulated the Au(I)-NHC catalyst [Au(IPr)(OTf)] within the cage, 
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leading to remarkably different reactivity with 4-phenylbutyne in water-saturated 
benzene (scheme 1.2, bottom).108 The free catalyst hydrates the triple bond, leading 
to the ketone being formed as the Markovnikov product, with quantitative 
conversions observed after 30 mins. The encapsulated complex displays much lower 
selectivity, and was a less active catalyst (28% conversion after 400 min). The 
Markovnikov product was observed in a 12% conversion, the anti-Markovnikov 
aldehyde (4%) and unusually, an intramolecular-cyclised product (12%), which only 
exists in the absence of water, and the authors stated was present due to the 
incapability of water to penetrate the cage. 
 
Scheme 1.2 Top: Ward's Kemp elimination of 2-cyanophenolate within a cubic cage.98 Bottom: 
Reek's alkyne hydration and cyclisation catalysed by an Au(I)-NHC complex 
encapsulated within the resorcin[4]arene hexamer.108 
A class of supramolecular cage regularly employed in catalysis within the CTV 
family is the hemicryptophane. In contrast to cryptophanes which possess two CTV 
units linked together in a head-to-head fashion, hemicryptophanes are heterotopic, 
possessing one CTV-terminus and a different C3-symmetric capping unit, such as 
tris(2-aminoethyl)amine (tren).109 Despite requiring extensive, multi-step syntheses, 
the capping group and linkers of hemicryptophanes can be relatively easily tuned for 
a range of applications, including primary ammonium encapsulation, with the NH3 
moiety forming hydrogen-bond interactions with an aza-crown capping unit, and the 
hydrophobic CTV bowl encasing an alkyl chain, as elegantly demonstrated by Lehn 
and co-workers in 1982.8 Hemicryptophane complexes have more recently been 
trialled as tuneable catalysts. The south capping unit can often be a group such as 
tren, which strongly bind to metals. The first example was reported by Dutasta in 
2009, who endohedrally coordinated a {VO}3+ moiety within a trialkanolamine 
capped hemicryptophane in a trigonal bipyramidal geometry (figure 1.10). The 
encaged vanadium complex proved to be an excellent catalyst for the oxidation of 
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sulfides to sulfoxides, outcompeting a bowl-shaped catalyst.110, 111 By incorporating 
BINOL (1,1’-bi-2-naphthol) groups into the walls of the hemicryptophane, Martinez 
and co-workers increased the hydrophobicity of the cage, which accelerated 
catalysis to give turnover numbers of up to 10000 per catalyst.112 The tren-capped 
hemicryptophanes have proven a versatile host to endohedrally coordinated metals. 
Makita and co-workers coordinated Zn(II) within the south capping unit of a 
hemicryptophane, which led to a twofold rate increase compared to a Zn-tren 
catalyst.113, 114 Makita also demonstrated a RuCl2 hemicryptophane was capable of 
oxidising primary alcohols, selectively trapping the aldehyde, whereas a free Ru-tren 
catalyst displayed little discrimination between the aldehyde and carboxylic acid.115 
Cu(II)-hemicryptophanes developed by Dutasta and Martinez have proven capable 
of oxidising cycloalkanes, whilst partly discriminating between cyclohexane, 
cyclooctane and adamantane, suggesting catalysis was occurring within the 
cavity.116 C-H activation of alkanes remains a highly challenging reaction. 
 
Figure 1.10 Dutasta's hemicryptophane possessing an endohedrally coordinated vanadium 
moiety.110, 112 
1.2 Carbene ligands 
1.2.1 Introduction to carbenes 
Carbene ligands are two-electron donor ligands in organometallic chemistry, and 
bear six valence electrons and no formal charge.117 Carbenes can be referred to as 
singlet or triplet, depending on the electronic nature of the centre. In singlet 
carbenes, the bonding orbital obtains some s character, stabilising the orbital by 
lowering its energy in its free form, whereas the pz orbital remains unchanged. The 
pairing energy of electrons is also lower than the band gap between sp2 and pz 
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orbitals. In the bent triplet state, the energy gap between sp2 and p orbitals is less 
than the electron pairing energy. Triplet carbenes can also be considered to be 
diradicals, hence can be observed using EPR spectroscopy. In an extreme case, 
triplet carbenes can be considered as sp3 hybridised, with singly occupied molecular 
orbitals being degenerate. 
 
Figure 1.11 Frontier orbital diagrams of left: bent singlet and right: bent triplet carbenes of sp2 
multiplicity.  
Carbenes were first reported as organometallic ligands in the mid-20th century, with 
Fischer carbenes the primary carbenes to emerge.118 Fischer carbenes have singlet 
multiplicity prior to metal coordination and are both strong σ-donor ligands and 
π-acceptors, hence primarily are found coordinating to low oxidation state, electron 
rich metal centres. In 1974, Schrock carbenes emerged.119 Contrary to Fischer 
carbenes, the Schrock variety are triplet in nature, in the free state, are dianionic and 
prefer metals in higher oxidation states. 
 Electronic effects of the α-substituent strongly dictate the multiplicity of the 
carbene. Strongly Strongly π-donating groups, such as -NR2 donate electron density 
into the pz orbital, destabilising it and in turn increasing the sp
2 – p energy difference 
(figure 1.12, left). On the other hand, triplet carbenes can be promoted by 
π-withdrawing groups stabilising the pz orbital, leading to a smaller sp
2 – p energy 
difference. Strong σ-donating α-substituents can also destabilise the sp2 energy 
level, decreasing the sp2 – p energy difference (figure 1.12, right). 
 
Figure 1.12 Relative orbital energies for left: singlet and right: bent sp2 hybridised carbenes.   
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1.2.2 N-Heterocyclic carbenes 
A third class of carbene is the N-heterocyclic carbene (NHC). NHCs are constrained 
in a five-membered ring system, which in addition to mesomeric effects caused by 
π-donation from α-nitrogen atoms into the empty pz orbital, as well as σ-induction 
from the divalent carbon towards the more electronegative α-nitrogen atoms renders 
NHCs as bent, singlet carbenes. Cyclic NHCs are also 6π systems obeying Hückel’s 
rules of aromaticity. Whilst this affords a secondary stabilisation factor, this is not as 
prominent as anticipated.120 NHCs share similarities with Fischer carbenes, but the 
extent of π-donation from α-nitrogen atoms to the empty pz orbital negates 
backbonding from taking place (figure 1.13). M-C bonds are noticeably longer when 
employing NHC ligands compared to Fischer carbenes because of the lack of back-
donation from the metal centre into the pπ orbital of the carbene. Unlike Fischer and 
Schrock carbenes, NHC ligands can coordinate to metal cations in both high and low 
oxidation states because the absence of back-donation from the metal centre does 
not hamper metal coordination. However, when considering hard soft acid and base 
(HSAB) theory, NHCs are soft donors, therefore coordination to lower oxidation 
state metals is more straightforward. The NHC motif is often seen as analogous to 
phosphines by virtue of being strong σ-donors. The key difference between 
phosphines and NHCs involve back-bonding metrics, where it is much more 
pronounced between metal and phosphine. Phosphines are considerably more labile, 
whereas NHCs are persistent ligands.  
 A major advantage of NHC ligands is that the parent imidazolium salts are 
indefinitely stable, whereas phosphines slowly oxidise over time, which could easily 




Figure 1.13 Frontier orbital diagram of an N-heterocyclic carbene. 
NHCs were first hypothesised as early as 1957 by Breslow as an intermediate in the 
catalytic cycle of the thiazolium containing vitamin B1 when rapid H-D exchange of 
the NCHS proton of the thiazolium ring was observed in NMR studies.122 In 1962, 
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Wanzlick tried to prepare a free carbene by elimination of chloroform from 
2-(trichloromethyl)-1,3-(diphenyl)imidazolinium salts, but instead observed 
dimerisation of two carbene equivalents.123 
 The first metal-NHC complexes reported were by Wanzlick and Öfele in 
1968 (scheme 1.3).124, 125 Wanzlick employed the basic metal precursor, mercury(II) 
acetate to simultaneously deprotonate and coordinate to Hg(II) in a concerted, 
one-step mechanism. On the other hand, Öfele reported the rearrangement of an 
imidazolium pentacarbonylhydridochromium salt at elevated temperatures to yield a 
Cr(0)-NHC complex.  
 
Scheme 1.3 Top: Wanzlick’s synthesis of a Hg(II) NHC complex124. Bottom: Öfele’s Cr(0) NHC 
preparation via a redistribution pathway.125 
Few examples of N-heterocyclic carbene complexes were reported for over two 
decades, before Arduengo reported the isolation of the first stable free carbene in 
1991 (scheme 1.4).126 The field has rapidly expanded since Arduengo’s discovery, 
and NHC chemistry has developed remarkably over a short space of time, where 
they are now considered a ligand at the frontier of organometallic chemistry.  
 
Scheme 1.4 Arduengo's isolation of a free carbene.126 
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1.2.3 Synthesis of metal-NHC complexes 
1.2.3.1 The free carbene method 
A commonly employed method in the synthesis of metal-NHC complexes follows 
on from Arduengo’s pioneering work, and employs a strong base such as nBuLi or 
NaH to deprotonate the imidazolium salt, liberating a highly reactive free carbene, 
which can be isolated and characterised. Introduction of the free carbene to a metal 
precursor leads to metal-ligand interaction and preparation of a (typically) stable 
complex. The groups of Grubbs and Nolan have both reacted 
1,3-bis(2,4,6-trimethylphenyl)imidazole-2-ylidene (IMes) with Grubbs’ 1st 
generation catalyst and one phosphine ligand was displaced by the NHC, leading to 
the isolation of the more active 2nd generation catalyst (scheme 1.5).127, 128 The same 
group have also prepared Au(I)-NHC complexes via addition of the free carbene to a 
metal precursor, albeit more effective methodologies to prepare this class of 
complex have since been reported.129 
 
Scheme 1.5 Nolan's synthesis of Au(I) and Ru(II)-NHC complexes via a free carbene.127, 129 
The free carbene route towards preparing metal-NHC complexes is commonly used, 
with little prerequisite regarding the metal precursors employed, but there are a 
number of disadvantages to this methodology. Isolation of highly air- and 
moisture-sensitive free carbenes is necessary, which is highly challenging. 
Additionally, the substrate scope for free carbene generation is somewhat limited. 
The use of strong bases prevents any imidazolium salt bearing base-sensitive 
N-substituents, including, but not limited to picolyl, carboxylate and a number of 
methylene-bearing precursors.130 A wide range of synthetic protocols have been 
documented, which bypass the need to liberate free carbenes.  
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1.2.3.2 In situ deprotonation and metallation, basic metal precursors and 
transmetallation routes 
 
Scheme 1.6 Metal-NHC coordination via (a) in situ deprotonation and metallation,131 (b) 
addition of a basic metal precursor,132 (c) Ag(I)-NHC generation and  
 transmetallation pathways.133 
The in situ deprotonation of an imidazolium salt bypasses the need to isolate the 
reactive carbenic species, and is compatible with a variety of transition metal 
precursors (scheme 1.6). The need for strong bases is also diminished, and a number 
of reported examples employ weaker bases, such as potassium carbonate.  
A commonly encountered class of complex whose synthesis employs this 
strategy are the PEPPSI™ complexes pioneered by Organ and co-workers (scheme 
1.6(a)).131 PEPPSI stands for pyridine enhanced precatalyst preparation stabilisation 
and initiation. Complexes are straightforward to prepare, giving near-quantitative 
yields under aerobic conditions. PEPPSI™ complexes are known for catalysing a 
range of transformations, including both C-C134-139 and C-heteroatom140-143 coupling 
with a vast substrate scope. This class of complex have proven to catalyse 
cross-coupling reactions regioselectively,144 and when incorporating chiral groups 
into the NHC scaffold, Kündig and co-workers have demonstrated PEPPSI™ 
complexes can mediate asymmetric Suzuki-Miyaura reactions.145 
An alternative to addition of both a base and metal precursor is to employ a 
basic metal precursor, such as an acetate, oxide or amide. Synergic pathways often 
dominate, where simultaneous deprotonation and metallation occur in a single 
transition step. Wanzlick’s Hg(II)-NHC complex (scheme 1.3) was the first example 
of a metal-NHC complex prepared via this route.124 Palladium(II) acetate is a 
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popular precursor in the preparation of Pd(II)-NHC complexes, where the acetate 
ligand mediates both deprotonation and coordination in a concerted single 
step.146, 147 Ni(II) complexes derived from nickelocene are also well-established, and 
can be prepared following a similar mechanism (scheme 1.6(b)).131, 148-150 
Nickelocene is a 20-electron complex and is also highly basic. It is one of the few 
reported complexes which readily loses a cyclopentadienyl ligand upon reaction 
with an imidazolium halide.131 A subsequent concerted deprotonation and 
metallation occurs, liberating the volatile protonated cyclopentadiene, and 
coordination of both the carbene and halide, with the formation of an 18-electron 
complex an additional driving force.  
A somewhat popular approach to metal-NHC complexes is via Ag(I)-NHC 
transfer (scheme 1.6(c)). Ag(I) carbenes are straightforward to prepare using the 
basic metal precursor Ag2O. In 1993, Arduengo reported the first example of an 
Ag(I)-NHC complex,151 but their transmetallation capabilities were not realised until 
1998 upon discovery by Lin and co-workers,152 who upon deprotonating an 
imidazolium salt with Ag2O in the presence of Pd(II) or Au(I) precursors, reported 
the Ag(I) carbene transfer in high yields, with significant AgCl precipitation as a 
by-product. In the absence of Pd(II) or Au(I), Ag(I)-NHC complexes can be 
isolated, whereas the reaction does not proceed in the absence of Ag2O. 
Transmetallation primarily occurs because of the high lattice enthalpy associated 
with silver halide formation.153 The low Ag-C bond strength also contributes but is a 
secondary force compared to the formation of AgX. Similar to the first three 
methods introduced, poor tolerance of basic groups on the carbene wingtips is a 
potential pitfall.130 
1.2.4 NHC ligands in supramolecular chemistry 
The implementation of multimetallic NHC complexes is an emerging topic in 
organometallic and supramolecular chemistry. Systems can have disadvantages 
commonly encountered when discussing the synthesis of metal-NHC complexes, for 
example, many cavitands bear base-sensitive groups, which significantly limit the 
methodologies that can be employed. Additionally incorporating multiple 
imidazolium moieties onto an often aromatic scaffold can lead to solubility 
problems, which can further restrict the synthetic strategies that can be employed. 
Despite these disadvantages, the strong metal-NHC interactions allow for more 
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facile postsynthetic modification, which can be challenging on a number of 
metallo-supramolecular assemblies, due to the labile nature of M-N bonds in many 
complexes. 
 Hahn has led the field of poly-NHC ligands in metallo-supramolecular 
chemistry.154 This work stemmed from the assembly of a molecular rectangle in 
2008 by reaction of a dinuclear Ni(II)-NHC with 4,4-bipyridine in the presence of 
AgBF4
155 (figure 1.14). Peris has recently prepared slightly larger Ni4L4 rectangles 
as receptors for polyaromatic hydrocarbons.156 The employment of the piano stool 
motif as cornerpieces in polyhedra has been utilised on multiple occasions (mainly 
Rh or Ir-Cp* derived), but architectures directed by Werner-type ligands have 
dominated the field.157 Carbon coordination has generally been through C-H 
activation-directed assembly rather than carbene coordination.158 Hahn and 
co-workers coordinated the same bis-carbene ligand to Au(I), and upon ligand 
exchange with dppe in the presence of AgBF4 yielded a much narrower 
[Au4(dppe)2(NHC)2] with carbene units undergoing π-π stacking arrangements with 
one another.159 
 
Figure 1.14 Left: Hahn’s molecular rectangle. Right: Peris’s rectangle encapsulating one 
pyrene guest. Only the first carbon of the N-butyl chains is shown for clarity.155, 156 
Since this discovery, Hahn and co-workers have prepared purely organometallic 
squares and rectangles, initially through stepwise syntheses by preforming the 
architecture bearing ditopic o-siloxyisocyanate ligands, before a subsequent 
acid-mediated deprotection and carbene generation, liberating protic NHC 
complexes (scheme 1.7). This has been demonstrated in a homoleptic fashion, by 
generating a Ir(III) square linked by isocyanate ligands,160 or heteroleptic, by 
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preforming a dinuclear Pt(II)-NHC complex and interacting with the same 
isocyanate ligand.161 
 
Scheme 1.7 Hahn's synthesis of a homoleptic molecular square.160 
More recently, the same group have reported the one-step synthesis of homoleptic 
[M4L4]
n+(PF6)n molecular squares with Pd
II-allyl or IrI-COD cornerpieces,162 in a 
straightforward manner similar to Fujita’s pioneering work in 1990.15 The 
realisation that simple 2D shapes can be assembled through metal-carbene 
interactions under facile conditions may lead to the one-pot assembly of 3D 
polyhedra which have previously been thought of as inaccessible. 
 In addition to [M4L4]
n+ molecular squares and rectangles, Hahn and 
co-workers have also extensively investigated bis- and poly-NHC complexes of 
coinage metals (Cu, Ag, Au) for the preparation [M2L2]
2+ rectangles and 3D 
containers, preparing carbene ligands on a tris-1,3,5-imidazolylbenzene scaffold, 
similar to those reported by Kaim in the early 2000s.163, 164 Divergent 
bis-imidazolium salts are well documented for their propensity to form dinuclear 
[AgNHC2]2
+ complexes when employed as a salt of a non-coordinating anion.153, 165-
167 Hahn and co-workers prepared a series of [M2L2]
2+ complexes incorporating 
functionality into the NHC scaffold, with reactive handles for postsynthetic 
modifications. A bis-imidazolium salt incorporating a trans-stilbene moiety was 
coordinated to Ag(I), yielding a [M2L2]
2+ 2PF6
¯ rectangle, which upon irradiation at 
λ = 365 nm, a [2 + 2] cycloaddition occurred, yielding a cyclobutane (scheme 1.8). 
By constraining the two alkene groups so they are parallel to one another, this 
facilitates the [2 + 2] cycloaddition which would not occur should the two olefin 
units not be aligned in this manner. Treatment of the Ag(I)-NHC complexes with 
NH4Cl reprotonated the carbene.
168 Instead of an internal stilbene-derived ligand, the 
same group prepared a bis-imidazolium salt with pendant coumarin groups, which 
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was coordinated to Ag(I), Au(I) and Cu(I).169 Upon radiation with UV light at 
λ = 365 nm, a [2 + 2] cycloaddition of coumarin groups was initiated. The authors 
state that photodimerisation of coumarin typically yields four isomers, the syn-HH, 
anti-HH, syn-HT and anti-HT (H = head, T = tail). In the case of the molecular 
rectangles, only the syn-HH isomer was observed. Furthermore, irradiation of the 
photodimerised Au(I) complex at λ = 365 nm led to the reversible photocleavage of 
the cyclobutane groups, and regeneration of the coumarin-terminated rectangle. 
Recently, Hahn and co-workers have extended photocyclisation to [M3L2]
3+ 
molecular containers for the templation of 3D hexakis-imidazolium cages.170 Huynh 
and co-workers have also utilised the [Au2L2] rectangle motif using a more flexible 
ligand scaffold, bearing a pincer in the centre of the ligand scaffolds and behaves as 
a host to the BF4 anion.
171 Upon the addition of CoCl2·6H2O, the flexible interior of 
the complex folds, leading to the formation of a heterobimetallic helicate.  
 
Scheme 1.8 Hahn's [2+2] cycloaddition of stilbene within a dinuclear metal-NHC complex.168  
In 2002, Meyer and co-workers prepared the tris-imidazolium precursor 
1,1,1-[tris-3-(methylimidazolium-1-yl)methyl]ethane tribromide, which upon 
coordination to Ag(I) after salt metathesis to the hexafluorophosphate salt, yielded a 
[Ag3L2](PF6)3 complex, seen as the first three-dimensional carbene complex.
172 By 
preparing imidazolium derivatives of similar systems to Kaim’s disc shaped 
ligands,163, 164 the preparation of organometallic cylinder-shaped assemblies has 
become possible by reaction of 1,3,5-tris-imidazolium-1-ylbenzene and 
1,2,4,5-tetrakis-imidazolium-1-ylbenzene salts with Ag2O. The first M3L2 and M4L2 
hexacarbene and octacarbene cylinders were prepared by Hahn and co-workers in 
2010, and their transmetallation onto Au(I) and Cu(I) investigated, whilst retaining 
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the cage topology (figure 1.15, left).173, 174 In addition to cage synthesis by reaction 
of the imidazolium hexafluorophosphate with Hg(OAc)2 or [PdCl(allyl)]2 under 
basic conditions.175, 176 A sterically crowded [Ag6L2] cylinder was prepared with six 
imidazolium units bonded to a benzene core, and its transmetallation onto Au(I) was 
successful.170 The aromatic core of tris-imidazolium salts can be further extended 
and coordination to Ag(I) remains successful, yielding nanometre-sized cylinders.177 
Transmetallation onto Au(I) or Cu(I) was again successful, with Au···Au 
separations of 1.1-1.4 nm. Peris and co-workers extended investigations by 
preparing a mesionic carbene-coordinated [Ag3L2]
3+ cylinder.178 A 1:1 mixture of 
both Peris and Hahn’s cylinders was dissolved in methanol, with the expectation of a 
statistical mixture of homoleptic and heteroleptic cages to be observed, but only the 
mixed ligand system was detected. Albrecht and co-workers also reported similar 
redistribution of ligands in Au(I)-mesionic carbene complexes in a similar fashion to 
that observed by Peris and co-workers in the presence of AgBF4 during an Au(I) 
catalysed aldol condensation, caused by an Ag(I) carbene transfer and Au(I) 
dissociation.179 These NHC and MIC ligands have since been coordinated to Ni(II), 
Ir(I), Rh(I), Pd(II) and Ir(III) as a flat disk-type complexes, and in the case of Pd(II) 
and Ir(III), were generally slightly better catalysts than monometallic analogues, as 
reported by Sarkar and co-workers (figure 1.15, right).180-182 
 
Figure 1.15 Left: Hahn's [Ag3L2]3+ molecular container.173 Right: Sarkar's Pd(II)-abnormal 
NHC complex bearing a C3-symmetric disk-shaped ligand.182 
A recent study by Hahn and co-workers contrasts the results published by Peris et 
al., Ag2O was added to a 1:1:1 ratio of three imidazolium salts with identical 
coordination modes, but different size arene spacers between them, and only 
homoleptic Ag3L2 cylinders were observed by HRMS and 
1H NMR spectroscopy.183 
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Furthermore, the transmetallation of the homoleptic cages onto Au(I) was carried 
with retention of architectures. 
Narcissistic self-sorting was also observed in a similar reaction between 
Ag2O and a 1:1 ratio of similarly sized tris- and tetrakis-imidazolium salts, and 
again only homoleptic complexes were obtained with high fidelity. Narcissistic 
self-sorting is a phenomenon in supramolecular chemistry that has primarily been 
observed for Werner-type systems, such as Lehn’s helicates,10 which are able to 
self-correct if the thermodynamic product does not form initially. Narcissistic 
self-sorting of M-C bonds had not previously been studied, mainly because the vast 
majority of organometallic interactions are non-reversible and therefore unable to 
correct. Labile Ag-NHC interactions are an exception to this and have led to their 
implementation as supramolecular building blocks, elegantly combining 
organometallic chemistry and self-assembly. 
One method to access poly-NHC complexes is to employ flat, polyaromatic 
imidazolium salts as ligands. Peris and co-workers have used 
triphenylene-functionalised imidazolium salts to prepare C3-symmetric Pd(II) and 
Au(I) complexes, which have proven to be highly active in catalytic reactions, and 
more so than monometallic analogs.184 However, electrochemical and DFT 
calculations on Rh(I) complexes using the same ligand set suggested electronic 
communication between metals is negligible, and stereoelectronic properties are 
comparable to a monometallic benzimidazol-2-ylidene complex.185 Catalytic 
enhancement may instead be through metal centres being closer in proximity due to 
extensive π-π stacking interactions between complexes.186 More recent 
developments have been in the extension of the π system, both through increased 
conjugation and the incorporation of nitrogen atoms in a hexaazatriphenylene 
system.187  
In addition to C3v-symmetric flat carbene complexes, Peris and co-workers 
have also studied Pd(II) and Au(I) complexes of a D3h-symmetric triptycene-fused 
tris-carbene, which was crystallographically elucidated by Bielawski and 
co-workers in 2010.184, 188 In collaboration with Kuck, Peris prepared a 
tribenzotriquinacene-fused (TBTQ) carbene complex of Rh(I) (the crystal structure 
or the imidazolium salt is displayed in figure 1.16).189 TBTQ is a fused 
C3-symmetric cavitand closely related to cyclotriveratrylene. The authors stated that 
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due to high steric repulsion, different Rh(I) local environments existed and free 
rotation about the Rh(I) centre was unlikely. This was backed up by 13C{1H} NMR 
spectroscopy. 
 
Figure 1.16 Kuck's TBTQ-annulated imidazolium salt.189 
Employing calixarenes and resorcinarenes as a wingtip for NHC ligands has 
extensively been studied throughout the past ten years, with most examples 
involving Pd(II). First investigating phosphine derivatives, Matt and Brenner 
prepared a calix[4]arene monophosphine, which behaved as a ligand towards Pd(II) 
as a precatalyst. This phosphine complex could catalyse the Suzuki-Miyaura 
reaction with TOF values often >200,000 in a number of screens.190 Later studies 
focused on extending the family from phosphines to NHC ligands. A family of 
calix[4]arenylimidazolium salts were prepared, and their coordination to Pd(II) 
investigated. Mono-NHC complexes with similar coordination modes to the PEPPSI 
family and [Pd(NHC)2(Br)2] complexes have also been investigated as catalysts.
191 
Complexes were still highly active at catalysing the Suzuki-Miyaura reaction, with 
quantitative results at 0.1 mol% loading. Bis-NHC complexes bridging across the 
upper-rim of the same cavitand were also targeted and still displayed ‘breathing’ of 
the calixarene backbone, but were poorly active, presumably because of a reduced 
disposition to reductively eliminate substrates during catalysis when the two NHC 
ligands coordinated trans with respect to one another. The phosphine complexes did 
display supramolecular enhancement to catalysis, with much higher activities 
displayed than small phosphines, whereas the NHC complexes in this case displayed 
similar activities to much smaller analogues, suggesting the calixarene was not 
behaving as a receptor, and simply performing as a bulky ligand. 
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Figure 1.17 Matt and Toupet's calix[4]arene-NHC complex.191 
Willans and co-workers have also investigated Pd(II)-NHC complexes incorporating 
calix[4]arene groups, on this occasion focusing on tetranuclear complexes.192 
Decreasing the catalyst loading led to increased turnover numbers (TON) in the 
Suzuki-Miyaura reaction of 4-bromotoluene and phenylboronic acid. This behaviour 
has been coined as homeopathic by de Vries and co-workers.193 As well as 
calixarenes, Pd(II), Ni(II) and Cu(I) resorcin[4]arene derivatives, both tethered with 
phosphines194 and imidazolium species,195-199 have also been studied in a range of 
catalytic reactions with similar results. Chianese has prepared an Ir(I)-NHC 
complex, with the NHC wingtip being dendritic side groups which form a bowl-
shaped assembly.200 The Ir(I)-NHC complex displayed shape-selectivity when 
carrying out the hydrosilylation on a mixture of ketones. 
 The fusion of NHC ligands and rigid cavitands in the CTV family are limited 
to Kuck and Peris’ Rh(I) complex fused onto the TBTQ scaffold,189 and Hardie’s 
metallo-cryptophanes decorated with bis-NHC ligands (figure 1.8). Employment of 
alternative cis-protecting units such as ethylenediamines led to rearrangement of the 
M3L2 metallo-cryptophane to M6L8 stellated octahedral assemblies (figure 1.9).
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 NHCs have also been incorporated into rotaxane systems. Huynh and 
co-workers have studied the reactivity of bridged Pd(II)-NHC dimers, in particular 
their reactivity towards nucleophiles, and in catalysis.201 Upon reaction with ditopic 
bis-pyridines, the Pd(II) dimer can be split, leading to the formation of a dinuclear 
complex terminated by a Pd(II)-NHC. The same bis-pyridine chain can behave as an 
axle in [2]-pseudorotaxane formation, and upon reaction with the Pd(II) dimer, cap 
the pyridyl termini and construct a [2]-rotaxane.202 
 In 2015, Pöthig and co-workers reported the synthesis of the macrocycle 
calix[4]imidazolium[2]pyrazole, bearing four imidazolium units and two pyrazoles 
linked by methylene spacers, along with its coordination to Ni(II), yielding a 
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dinuclear saddle-shaped complex.203 Upon addition of a halide source, the Ni(II) 
complex encapsulates one halide ion, forming a capsoplex by encompassing one 
guest within two saddle-shaped molecules which assemble in a tennis-ball motif.204 
Upon reaction of the macrocycle with Ag2O, an [Ag8L2]
8+ complex assembles, 
coined as a pillarplex, bearing eight Ag-NHC interactions and eight Ag-pyrazole 
links.205 Pillarplexes are highly functional materials and upon anion exchange can be 
tuned to exhibit aqueous or organic solubility. In addition, the octanuclear carbene 
complex was successfully transmetallated onto Au(I), with the Au(I)-pillarplex 
being luminescent.205 This class of cavitand behaves as a host towards linear guests 
such as 1,8-diaminooctane in aqueous media. A more recent study into the Ag(I) 
pillarplex involved the preparation of an organometallic [2]-rotaxane in excellent 
yield by threading a longer alkyl chain and capping.206 Upon altering the pH of the 
system, it is possible to cycle between an organometallic [2]-rotaxane and organic 
[3]-rotaxane by repeatedly regenerating the imidazolium salt and subsequent 
deprotonations (scheme 1.9).  
 
Scheme 1.9 Pothig's organometallic [2]-rotaxane (left) and organic [3]-rotaxane (right) after 
treatment with acid.206 
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1.3 Project outline 
This project deals with preparing new azole-functionalised cyclotriveratrylenes. The 
vast majority of literature precedent involving metallo-supramolecular architectures 
built upon CTV scaffolds deal with pyridyl donor systems, and save Ag(I) 
assemblies, the rationale behind their assembly with well-defined metal centres and 
prediction of topology is becoming better understood. Five-membered ring systems 
offer the potential to coordinate to metals at different angles to their pyridyl 
counterparts, with respect to the CTV bowl, which in turn could allow accessibility 
towards larger metallo-supramolecular cages currently not attainable using the 
pyridyl ligands.  
 Furthermore, azoles are precursors to NHC ligands. The use of hybrid 
carbene-cavitand systems has, in a number of cases, led to extremely active 
complexes in catalytic transformations, namely Pd(II) or Ni(II) catalysed 
cross-coupling reactions.191, 194-199 The flexible calix[4]arene and resorcin[4]arene 
scaffolds have dominated this field, whereas use of the rigid CTV cavitand has not 
been previously reported beyond a C1 imidazolium salt used as an organocatalyst in 
Michael additions.207 A number of multimetallic complexes using disk-shaped 
ligands have been reported, and their behaviour as catalysts compared to 
monometallic analogues, but comparative studies investigating cavitand complexes 
are limited to conformationally flexible hosts. Therefore, it would be of interest to 
investigate whether CTV-functionalised carbene complexes are superior catalysts to 
monometallic analogues, and if so, rationalise reasoning behind this and whether 
supramolecular factors regarding either (a) the cavitand or (b) communication 
between metal centres can enhance catalysis in such cases. 
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Chapter 2  
Synthesis, characterisation and self-assembly of tripodal 
benzimidazole and oxazole ligands 
This chapter highlights the preparation of benzimidazole and oxazole-appended 
cyclotriveratrylene ligands, and their metal-mediated assembly yielding 
metallo-cryptophanes and coordination polymers respectively. A number of novel 
cyclotriveratrylenes were also reported, but their coordination to defined metal 
centres proved unsuccessful. 
2.1 Introduction 
Imidazole is a five-membered ring containing nitrogen atoms in the 1- and 
3-positions. Five membered diazoles are aromatic systems, obeying Hückel’s 4n+2 
rule, and the nitrogen atom displaying protic character donates two electrons into the 
π-system. The second nitrogen atom has a basic lone pair associated, and can be 
compared to that in pyridine as it also contributes just one electron to the π-cloud 
(figure 2.1). 
 
Figure 2.1 Frontier orbital diagram of imidazole. Blue orbitals represent the nitrogen atoms. 
Imidazole is thus amphoteric, displaying both acid and base character. The protic 
nitrogen (N1) displays acidic character, whilst N3 is more basic than pyridine, and 
behaves in the same manner. Nucleophilic aromatic substitution can occur at C2, 
which is electron deficient as this site is between by two electronegative nitrogen 
atoms. 
 Imidazoles are widespread throughout nature, and found in a diverse range of 
biologically significant molecules, including vitamin B-12 whose structure was 
realised crystallographically by Hodgkin,1 and the purine nucleotides comprised 
within the scaffold of DNA and RNA.2 Imidazole-containing compounds have a rich 
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coordination chemistry, spanning diverse materials such as complexes bearing 
N-coordination similar to pyridyl complexes,3 zeolitic imidazolate frameworks 
(ZIFs)4 and N-heterocyclic carbene complexes.5, 6 In 2002, Kaim and co-workers 
prepared a number of M3L2 cages incorporating 
tris-1,3,5-(1-methylbenzimidazoyl)mesitylene, by taking advantage of the linear 
binding mode of the group ten metals silver and copper. In the case of Ag(I), a BF4
¯ 
anion is encapsulated within the cage, whereas the Cu(I) system with CuI starting 
material interestingly encapsulated a [CuI3]
2- anion.7 
The same group also prepared ditopic bis-benzimidazolyl ligands on a 
4,6-dimethylbenzene scaffold, and upon altering stoichiometries of Ag(I):ligand, 
M2L2 rectangles were accessible, whereby benzimidazole moieties π-π stack with 
one another (figure 2.2).8 By simply introducing an additional methyl group to the 
arene spacer, a different M2L2 rectangle assembles. In this case, the arene groups sit 
flat at the top and bottom of the rectangle, and anionic guests reside within the 
cavity. Such small rectangular targets are rarer than 3D trigonal-bipyramidal or 
tetrahedral cages.9 Upon altering the position, and/or number of benzimidazolyl 
substituents on the arene, the number of and position of methyl groups, and also the 
metal used, a library of C2, C3 and C4 symmetric cages could be targeted using a 
simple ligand system. 
 
Figure 2.2 An Ag2L2 rectangle reported by Kaim and co-workers.8 
2.2 Imidazolyl ligand syntheses 
Cyclotriguaiacylene (CTG) 2.3 was prepared in a three-step synthesis according to 
previous methodologies (scheme 2.1).10, 11 The phenolic allyl-protection of 
4-hydroxy-3-methoxybenzyl alcohol was achieved quantitatively to yield 2.1, 
followed by an acid-catalysed trimerisation as a dry melt, precipitating 2.2 in a 62% 
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yield. Reactions can be limited by stirrer capability, caused by reaction solidification 
due to precipitation of 2.2. A Pd-catalysed reductive deallylation of 2.2 afforded 2.3 
in a 69% yield (scheme 2.1). The 1H NMR spectrum of CTG contains the two 
characteristic doublets at 4.71 and 3.50 ppm, corresponding to the endo- and 
exo- protons of the CTG methylene bridge. The endo- proton resonance appears 
further downfield because it undergoes steric compression with neighbouring 
endo- protons associated with the tribenzo[a,d,g]cyclononatriene core, as a 
consequence of being within ca. 2 Å, of one another.12  
 
Scheme 2.1 Synthesis of CTG 2.3. 
 
Figure 2.3 1H NMR spectrum (293 K, 300 MHz, CDCl3) of CTG 2.3. Inset: Molecular structure 
of 2.3. 
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A racemic mixture of CTG 2.3 was employed for all manipulations. As introduced 
in Chapter 1, CTG displays helical chirality about the upper rim, and there is a route 
for interconversion between enantiomers via the saddle confirmation. Whilst 
separation of enantiomers is possible using chiral HPLC methods, such a method is 
highly challenging and racemisation occurs over time.13  
 
Scheme 2.2 Synthesis of imidazole 2.4. 
Imidazole 2.4 was prepared according to previous methodology by reaction of CTG 
with 1-(chloromethyl)imidazole hydrochloride under basic conditions, displayed in 
scheme 2.2.14 The synthesis proved unreliable due to the instability of precursor 
1-(chloromethyl)imidazole hydrochloride (2.6, whose synthesis is shown in scheme 
2.3), and repeatability was low. The electron-withdrawing nature of both the 
imidazole moiety and chloride lead to an activated methylene group, which was 
highly susceptible to nucleophilic attack and self-condensation reactions owing to 
the nucleophilicity of imidazole. Reactions to prepare ligand 2.4 were carried out on 
a small scale in anhydrous, anoxic DMF, a polar aprotic solvent, using NaH as base, 
but this was not always successful. Utilisation of weaker bases led to increased 
reaction times, and significantly more polymer formation. In addition to high 
reactivity in solution, precursor 2.6 proved extremely hygroscopic and deliquescent, 
turning from a white solid, to a thick gel, to an aqueous solution within seconds of 
exposure to air. When 2.6 was worked up using Schlenk techniques and stored in a 
glove box, the deliquescence could be suppressed, although upon dissolution for 
installation onto CTG, polymerisation in solution occurred and outcompeted the 
desired reaction. 
 
Scheme 2.3 Synthesis of imidazole precursor 2.6. 
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The 1H NMR spectrum of 2.4 contains the diagnostic endo- and exo- protons at 4.59 
and 3.39 ppm respectively, and the presence of only two doublets diagnostic for a 
C3-symmetric CTV derivative. N-functionalised imidazoles typically contain three 
resonances, the furthest downfield being the proton residing between nitrogen 
atoms, and the two backbone protons upshifted by ca. 0.5 ppm. H4 has split into a 
pseudo-quartet due to the diastereotopicity at this site, and appears somewhat 
downfield compared to methylene spacers on other ether-linked CTG ligands, owing 
to the neighbouring electronegative atoms.14, 15  
 
Figure 2.4 1H NMR spectrum (293 K, 300 MHz, CDCl3) of ligand 2.4. Inset: Molecular 
structure of 2.4. 
The problematic 1-(chloromethyl)imidazole·HCl caused inconsistencies in the 
preparation of ligand 2.4. When the ligand was successfully prepared, previous 
results in the Hardie group showed the assembly of 2.4 with AgReO4 led to the 
growth of 1D coordination polymer crystals, displaying the dimeric handshake 
motif, where a reciprocal host-guest relationship between CTV bowl and 
neighbouring ligand arm was observed.14 
 
 
Figure 2.5 An Ag(I) imidazolyl coordination polymer reported by Hardie and co-workers.14 
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The unreliable synthesis of 2.4 led to alternative ligand sets being desired, despite 
the obvious appeal of an imidazolyl ligand. 
2.2.1 Ethyl-tethered imidazole ligand 
Extending the alkyl spacer between CTG and imidazole was a route considered, in 
order to give a more stable ligand without the issues of a highly active electrophilic 
centre. The nucleophilic substitution of 1-(chloromethyl)imidazole could proceed 
via SN1 or SN2 pathways due to resonance stabilisation of the generated carbocation 
upon loss of chloride. Utilising an ethyl spacer would prevent such a pathway from 
occurring, thus promoting the direct SN2 reaction with trianionic CTG. 
Haloethylimidazoles would likely be more straightforward to prepare than the 
challenging (bromoethyl)CTV.  
The commercially available 2-(hydroxyethyl)imidazole was chlorinated 
using thionyl chloride, affording 2-(chloroethyl)imidazole hydrochloride as a 
non-hygroscopic solid. Unfortunately, no reaction ensued when added to a DMF 
solution of CTG over NaH, so a better leaving group was required. By using thionyl 
bromide instead, bromo-derivative 2.7 could be prepared, as shown in scheme 2.4.16   
 
Scheme 2.4 Synthesis of imidazole 2.8. 
Imidazole 2.7 only proved hygroscopic when isolated as a powder. When allowed to 
crystallise by standing at -20 ºC for 48 h in a 1:1 methanol: diethyl ether solution, 
orange crystals were isolated, which were stable and easy to handle under ambient 
conditions. Upon scale-up, difficulties were encountered with oligomerisation. 
Reactions were only possible on a small scale. The preparation of derived CTG 2.8 
was low yielding and again reproducibility was erratic. The 1H NMR spectrum of 
ligand 2.8 (figure 2.6) displayed the characteristic endo- and exo- doublets 
associated with the CTV-methylene bridge at 4.66 and 3.47 ppm. Two CH2 groups 
assigned using HMQC and DEPT-135 spectroscopy were reported as multiplets at 
4.28 and 4.17 ppm. HRMS comprised of peaks {M+H}+ and {M+H2}
2+ with m/z 
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299.1395 (2+) and 596.2718 (1+) attributed to bis-functionalised CTG and 346.1668 
(2+) and 691.3257 (1+) corroborating with the tris-substituted compound, but the 
presence of one set of doublets attributed to H12 suggests ionisation of one ligand 
arm was responsible for this. 
 
Figure 2.6 1H NMR spectrum (293 K, 300 MHz, DMSO-d6) of 2.8. Inset: Molecular structure of 
2.8. 
Crystals of ligand 2.8 suitable for diffraction using synchrotron radiation were 
grown from the diffusion of diethyl ether and acetone vapours into a DMSO solution 
of 2.8. Compound 2.8 crystallised in the trigonal P3 space group. The asymmetric 
unit comprised of one third of 2.8, with the whole ligand possessing strict C3 
symmetry. The imidazole ring is disordered over two positions. 
 
Figure 2.7 Asymmetric unit of 2.8, ellipsoids are shown at the 50% probability. 
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Crystals of 2.8 were racemic, with bowl-in-bowl stacks comprising of the same 
enantiomer (figure 2.8) and with centroid-centroid separations of ca. 4.68 Å, and 
therefore not interacting through π-π stacking arrangements. Bowl-in-bowl stacking 
arrangements are a well-known packing motif in CTV chemistry.15 Stacks 
constituting opposite enantiomers were antiparallel with respect to one another. In 
both cases, the imidazole arms align perfectly. Methoxy groups of neighbouring 
cavitands are relatively close in proximity, with CMe···O separations of ca. 3.29 Å. 
  
 
Figure 2.8 Left: Packing diagram of 2.8. Right: enantiomeric bowl-in-bowls. Bottom: space-
filling model of packing motif. One imidazole position has been omitted for clarity. 
The low yields, small scales and requirement of further steps associated with the 
ethyl-tethered ligand, 2.8, mean alternative imidazole targets were sought. One route 
considered would be to use a backbone-functionalised azole. Rather than 
N-haloalkylimidazoles, derivatising the backbone could yield a more stable 
precursor that is less prone to oligomerisation, and this approach could lead to better 
yields. This strategy would however be limited to azoles with only one nitrogen 
atom present, such as oxazole. The protic nature of imidazole is anticipated to be 
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troublesome, an average proton population of 50:50 at both nitrogens. A 1:1 ratio of 
tautomers exists, which are inseparable, and relevant when using unsymmetrical 
imidazoles. Additional steps would be required with the need to protect and 
deprotect a nitrogen atom. Furthermore, multiple isomers would be anticipated 
because of the potential for both tautomers of the imidazole to be present on a CTV 
scaffold. The tautomers are displayed in figure 2.9. Alterations to the imidazole 
scaffold were therefore required. 
 
Figure 2.9 Tautomers of a backbone-functionalised imidazole. 
2.3 Benzimidazole-functionalised CTG 
One selected method to improve yields and increase precursor stability would be to 
prepare a 1-(methyl)benzimidazolyl ligand. The presence of a hydrophobic 
benzo-backbone should lower the affinity of such a system towards water, reducing 
hygroscopicity and deliquescent behaviour. Benzimidazole is slightly less basic than 
imidazole because of further conjugation into the arene system. Incorporating the 
aryl backbone of benzimidazoles could also afford the potential for π-π stacking 
interactions with another benzimidazole group, or the CTG arene faces, which could 
promote crystallisation of ligands and complexes. 
Kaim and co-workers employed planar, tripodal benzimidazolyl ligands as 
ligands for metallo-supramolecular cages7, 8 The benzimidazole motif has also found 
use in rotaxane synthesis, both as an effective receptor for the axle17 and as a stopper 
group.18  
 Benzimidazole, 2.11 was a previously unpublished, but known problematic 
compound in the Hardie group.19 The formerly-used synthetic route employed 8 eq. 
of 1-(chloromethyl)benzimidazole hydrochloride, 2.10 as the electrophile, which 
dimerised to form 1,1’-methylenebisimidazole as a by-product. Such dimerisation 
had previously been reported by Mokhtari and co-workers when reacting 
1-(chloromethyl)benzimidazole·HCl with guaiacol (2-methoxyphenol) under similar 
conditions.20 The by-product also proved difficult to remove using chromatographic 
methods, and displayed a higher affinity for DCM than water during extractions. To 
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circumvent dimerisation of 2.10, the number of equivalents of 2.10 was lowered 
from 8 to 3.4 in the preparation of 2.11. This both suppresses the dimerisation of 
2.10, and also reduces reaction times by over half. The extraction step was also 
modified. Most alkyl halides used in the preparation of CTV-type ligands are water 
soluble, and can easily be removed by simple extraction methods. Neutralised salt 
2.10 (and any dimerised by-product if prepared in trace quantities) have inherently 
poorer aqueous solubility. By simultaneously quenching sodium hydride and 
precipitating 2.11 upon addition of water to the reaction, and filtering the precipitate, 
the by-products can be removed via much simpler means. The by-product and 
starting electrophile remained in solution at this stage, and could easily be discarded  
rather than carrying out a chromatographic separation.  
 
Scheme 2.5 Synthesis of benzimidazole 2.11. 
Compound 2.9 was prepared by formaldehyde-mediated hydroxymethylation of 
benzimidazole. An aqueous formaldehyde solution was selected rather than the dry 
melt method using paraformaldehyde described in the synthesis of precursor 2.5 due 
to the much higher melting point of benzimidazole (170 ºC compared to 88 ºC for 
imidazole). The chlorination of 2.9 was carried out in neat thionyl chloride due to its 
insolubility in chlorinated solvents. Salt 2.10 was prepared as a non-hygroscopic 
solid, which is also indefinitely stable under ambient conditions. Ligand 2.11 was 
prepared in good yields overnight, and fully characterised using 2D NMR methods 
alongside mass spectrometry, microanalysis and infrared spectroscopy. NMR 
spectra were assigned in DMSO-d6, despite the high solubility of 2.11 in 
chloroform, because this would give direct comparisons to benzimidazolium salts 
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discussed in Chapter 4. Additionally, the 1H NMR spectrum in CDCl3 contained a 
triplet at 7.27 ppm, which overlapped with the residual chloroform peak. 
As expected, H1 was the furthest downfield proton at 8.34 ppm. The 
characteristic doublets of the tribenzo[a,d,g]cyclononatriene core appeared at 4.69 
and 3.47 ppm. The H8 resonances at 6.16 ppm are diastereotopic, and thus display 
subtle splitting. The HRMS spectrum contained a single peak at 821.3065 
corresponding to {M+Na}+ (calculated 821.3059). 
 
Figure 2.10 1H NMR spectrum (293 K, 300 MHz, DMSO-d6) of benzimidazole 2.11. Inset: 
Molecular structure of 2.11 and 7.7-6.8 ppm. 
Crystals of 2.11 were grown from the slow evaporation of an acetone solution. The 
ligand crystallised in the triclinic P1̅ space group. The asymmetric unit comprises of 
one molecule of 2.11 (figure 2.11). The three benzimidazole groups are oriented 
towards the centre of the CTG cavitand, with each arm being of different orientation 
CArene-O-C-Nbenzimidazole torsion angles were measured as 70.0, 85.1 and 63.6°. This 
motif effectively blocks the bowl from behaving as a molecular host. 
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Figure 2.11 Asymmetric unit of 2.11, ellipsoids are shown at the 50% probability.  
Weak intramolecular C-H···N interactions exist between the benzimidazolyl groups 
of 2.11, the closest having a C···N separation of ca. 3.51 Å. Of the three 
inward-folded benzimidazole groups, two of the imidazole moieties point towards 
the centre of the bowl, whereas one points outwards, and partakes in a weak 
C-H···O interaction with a neighbouring methoxy group at C···O separation of ca. 
3.25 Å. The ab plane comprises of primitive layers of 2.11, whilst in the c direction, 
enantiomeric layers stack in inverted orientations. 
 
Figure 2.12 Unit cell of 2.11, as shown in the crystallographic a axis.  
Co-crystals of 2.11·CTG were also grown from the slow evaporation of an acetone 
solution. A small crop of crystals were initially grown by David Martin (MChem 
student) when attempting to crystallise 2.11 which was contaminated by trace 
quantities of 2.3 (CTG), but it has since been proven that the same crystals grow 
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from an acetone solution of 2.11 and 2.3 in a 1:1 ratio. Co-crystals crystallised in the 
trigonal P3c1 space group, and the asymmetric unit comprised of one third of both 
components (figure 2.13). 
 
Figure 2.13 Asymmetric unit of 2.11·CTG. Ellipsoids are drawn at the 50% probability. 
The co-crystals assembled into a 2D hydrogen-bonding network with O-H···N 
interactions between hydroxyl group of CTG and benzimidazole nitrogen atoms at 
O···N separation of ca. 2.79 Å (figure 2.14). Each CTG molecule hydrogen bonds to 
three neighbouring benzimidazole units in a 63 topology. The CTG and 2.11 
molecules in one network are of opposite enantiomers. Both components of the 
co-crystal engage in bowl-in-bowl stacking interactions with the opposite 
enantiomer, rendering hydrogen-bonded layers as homochiral, whilst the crystal 
itself is racemic. Bowl-in-bowl stacking is well documented for 
cyclotriveratrylene,21, 22 but less commonly encountered for ligand derivatives.23-26 
 
Figure 2.14 Left: Hydrogen bonded network, H-bond shown in red. Right: bowl-in-bowl 
stacking exhibited in 2.11·CTG.  
- 52 - 
A powder pattern of the bulk material is a good match to the simulated spectrum 
derived from the crystal, with a number of overlapping peaks implying the 
crystalline material is phase pure (figure 2.15). 
 
Figure 2.15 Powder X-Ray diffraction pattern of 2.11·CTG. Simulated (red trace) (100 K) and 
observed data (blue trace) (293 K). 
2.4 Assembly of a neutral metallo-cryptophane 
The assembly of ligand 2.11 with a range of metals (M = Co(II), Ni(II), Cu(I), 
Cu(II), Zn(II), Pd(II), Ag(I)) with counterions including halides, nitrates and 
non-coordinating anions such as BF4
¯ and PF6
¯ was investigated, but in most cases 
proved unsuccessful. After stirring a DMF solution of 2.11 with 1.5 eq. 
[Pd(Cl)2(MeCN)2] for 24 h, as shown in scheme 2.6, before diffusing diethyl ether 
vapours into the vial, a pale yellow powder initially precipitated after 7 days, which 
proved highly insoluble once formed. After three months, a small crop of pale 
yellow crystals grew, the single crystal data confirmed the structure of 2.12 as 
[Pd3Cl6(2.11)3∙(H2O)]∙1.5H2O∙3DMF. Crystals proved insoluble when isolated 
Capsule 2.12 is a rare example of a trans-linked metallo-cryptophane, a motif 
previously only observed with d10 Ag(I) and Cu(II).26 trans-Coordination of Pd(II) is 
known in calix[4]arene chemistry; Tsuji and co-workers reported the assembly of a 
neutral [Pd2L2Cl4] capsule.
27 In order to prepare a metallo-cryptophane using a 
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a bis-phosphine or bis-NHC typically has to be adopted, forcing the two incoming 
donors to coordinate cis- with respect to one another.26, 28-32 
 
Scheme 2.6 Synthesis of metallo-cryptophane 2.12. 
Metallo-cryptophane 2.12 crystallised in the cubic P𝑎3  space group. The 
asymmetric unit comprises of two one-third components of the CTV-type ligand, 
one Pd(II) centre, one DMF and two water molecules, of which one is of half 
occupancy and shown in figure 2.16. The two chloride ligands coordinate trans with 
respect to one another with Pd-Cl bond lengths of 2.2747(15) and 2.2944(15) Å with 
a Cl-Pd-Cl angle of 177.77º. The Pd-N benzimidazole distances are 2.012(4) and 
2.013(5) Å with a N-Pd-N angle of 179.01º, with the Pd centre displaying 
near-square planar geometry. Both benzimidazole groups are crystallographically 
inequivalent and not coplanar with respect to the palladium centre, and a torsion 
angle of 53º between the planes. The Pd(II) centres are buried within the core of the 
assembly, with Pd∙∙∙Pd separations ca. 5.74 Å forming a trigonal node at a much 
closer distance than in cis-protected Pd(II) cryptophanes, which were reported as 
16.29 Å in bis-NHC protected cryptophanes.29 The benzo-backbones of 
benzimidazoles reside exo-to the cage, with imidazole NCHN pointing towards the 
centre of the capsule. The azole groups π-π stack with one another at separation of 
ca. 3.47 Å, stabilising the strained Carene-O-C-Nimid torsion angles of 66.3 and 73.4°. 
The space-filling diagram shows the pinched nature of Pd(II) nodes limit any guest 
encapsulation in the cryptophane by covering the windows of the architecture 
(figure 2.17). One water guest molecule is trapped within the core of the 
cryptophane, which was likely present in the DMF solvent during reaction. The 
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water molecule has a nearest contact to an imidazole NCHN moiety, at O···C 
separation of ca. 2.57 Å. DMF molecules reside above the external enclosed 
windows of the cryptophane. 
 
Figure 2.16 Asymmetric unit of [Pd3(2.11)2Cl6]. Ellipsoids are drawn at the 50% probability. 
 
Figure 2.17 Left: space filling diagram of [Pd3(2.11)2Cl6]. Right ellipsoid diagram of 
cryptophane [Pd3(2.11)2Cl6]. 
Both 2.11 ligands in cryptophane 2.12 are of the same enantiomer, rendering this an 
anti-metallo-cryptophane. The crystals however, are racemic, with opposite 
enantiomers of cryptophane packing in a checkerboard-like conformation (figure 
2.18, left). The unit cell comprises of eight cryptophanes in a 2 x 2 x 2 cube motif 
within the cell and displayed in figure 2.18, right. 
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Figure 2.18 Left: checkerboard motif of cryptophane enantiomers. Right: unit cell diagram 
looking down the crystallographic a axis. 
Solution studies performed in conjunction with David Martin confirms the presence 
of cryptophane in DMF and DMSO, but a number of components were also 
detected, indicating assembly took place over a long period of time, backed up by 
the duration of crystallisation. The HRMS spectrum (figure 2.19) was dominated by 
{Pd(2.11)Cl}+ at m/z 941.1833, with a small product peak of 
{Pd3(2.11)2Cl5(MeCN)}
+ present at m/z 2134.2070, which was an excellent match to 
the simulated isotopic pattern. The small peak m/z at 1916.3352 matched the 
cryptophane less one Pd(II) centre.  
 
Figure 2.19 HRMS of 2.12. 
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Figure 2.20 Observed (top) vs simulated (bottom) isotope pattern for [Pd3(2.11)2(Cl)5(MeCN)]+ 
(m/z = 2134.2070). 
1H NMR spectroscopy also backed up the notion that more than one species was 
present in solution. HRMS obtained in DMSO also contained 2.12 as a trace peak, 
so studies in DMSO-d6 (figure 2.21) and DMF-d7 (figure 2.22) were carried out. In 
both cases, very weak spectra with numerous peaks were present, suggesting 
multiple species in solution. Both spectra contained significant liberated free MeCN 
(denoted by *), suggesting this was being displaced by benzimidazolyl ligands. 
 
Figure 2.21 1H NMR spectrum (293 K, 300 MHz, DMSO-d6) of 2.11 (top), 2.11 + 
[Pd(Cl)2(MeCN)2] after 24 h (bottom). Liberated acetonitrile denoted by *. 
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The 1H NMR spectrum was also obtained in DMF-d7, and once again significant 
free acetonitrile was liberated indicating coordination of benzimidazole groups to 
Pd(II), but similarly, the sheer number of peaks indicates numerous species in 
solution. 
 
Figure 2.22 1H NMR spectrum (293 K, 300 MHz, DMF-d7) of 2.11 + [Pd(Cl)2(MeCN)2] after 24 
h. Liberated MeCN denoted by *. 
Powder X-ray diffraction was carried out on the pale yellow solid, but it was evident 
the powder was amorphous in nature. An insufficient quantity of crystals was grown 
to yield a powder pattern of sufficient quality. 
 The precipitation of a pale yellow powder was observed in all cases during 
the attempted crystallisation of 2.11 with a range of other Pd(II) salts including 
[Pd(MeCN)4](BF4)2, [Pd(dppe)2(Cl)2], Pd(OTf)2, and Pd(NO3)2, but crystals only 
grew when using [Pd(Cl)2(MeCN)2].  
2.5 A benzotriazole substituted CTV 
Another class of azole considered were 1,2,3-triazole-based compounds. 
1,2,3-triazoles can readily be prepared in a Cu-catalysed click reaction between 
organic azides and alkynes.33, 34 Benzotriazole is commercially available, but can be 
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prepared by the monodiazotisation of o-phenylenediamine, followed by spontaneous 
cyclisation. The employment of benzotriazoles avoids the use of potentially 
explosive azides, and can also give rise to a rich coordination chemistry. The main 
limitation of benzotriazole compared to benzimidazole within the scope of this 
project is that it cannot be used to prepare NHC complexes.  
 
Figure 2.23 Resonance forms of benzotriazole. 
Regarding metal coordination and functionalisation, N3 is the most Lewis-basic, so 
most commonly partakes in reactivity, but consideration for N2 (central nitrogen) 
competing must be taken, and reactions at this centre are known, albeit rarer and 
historically challenging to control.35 Similarly to benzimidazoles, the protic nitrogen 
(N1 in major isomers) donates two electrons into the π-cloud, hence is typically 
much less basic and can only be functionalised upon deprotonation. Breit and co-
workers have designed different Rh(I) catalysts which can be used to functionalise 
either N1 or N2 with high selectivities.36 
 
Scheme 2.7 Synthesis of benzotriazole 2.15. 
The synthesis of the novel benzotriazole 2.15 mirrored that selected to prepare 
benzimidazole 2.11 and is shown in scheme 2.7. Compound 2.13 was prepared 
according to previous methodologies.37 The 1H NMR spectrum gave no evidence to 
suggest N2 functionalisation under the above conditions. Similarly to 
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1-(hydroxymethyl)benzimidazole, benzotriazole derivative 2.13 proved insoluble in 
chlorinated solvents, so neat thionyl chloride was employed when preparing 2.14. 
Compound 2.15 was prepared employing the same conditions as 2.11, and 
consideration for potential dimerisation of 2.14 in a manner similar to benzimidazole 
2.10 led to only a slight excess of electrophile being added. Benzotriazole 2.15 was 
prepared in good yields overnight and fully characterised using NMR and mass 
spectrometry. The HRMS spectrum (figure 2.24) comprised of a single peak at 
824.2933 (calculated 824.2916) corresponding to {M+Na}+. 
 
Figure 2.24 HRMS of 2.15. 
The 1H NMR spectrum contained the characteristic doublets corresponding to the 
CTG endo- and exo-protons (H15). The presence of two doublets confirming the 
preparation of a single C3-symmetric product. H
7 splits into two doublets due to 
diastereotopicity at this site. No protons reside on the azole ring, therefore no peaks 
further downfield than those associated with the benzo-backbone were detected in 
the 1H NMR spectrum (figure 2.25). 
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Figure 2.25 1H NMR spectrum (293 K, 300 MHz, CDCl3) of 2.15. Inset: Molecular structure of 
2.15. 
The coordination chemistry of 2.15 was investigated, but crystals could not be 
grown from a range of solvent systems, and no concrete evidence of metal 
coordination could be ascertained. Similarly to benzimidazole 2.11, assemblies with 
Pd(II) precursors led to the precipitation of an insoluble pale-yellow solid after ca. 
one week, but in this case, no crystals grew after a prolonged period of time. 
2.6 Oxazole-furnished CTG ligand 
A concept explored in 2.2.1 was to incorporate an aprotic azole moiety as a ligand 
group. Oxazoles were selected for this purpose. Ethyl oxazole-5-carboxylate is a 
commercially available starting material, whereby the ester group is connected to the 
backbone carbon adjacent to the oxygen atom of the oxazole ring. 
 
Scheme 2.8 Synthesis of oxazole 2.18. 
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The preparation of alcohol 2.16 proved to be low yielding, but gave sufficient 
material to carry forward (scheme 2.8). Ester reductions typically require lithium 
aluminium hydride as a reducing agent due to the weaker Al-H bond than that in a 
borohydride counterpart. The reduction carried out to prepare 2.16 involved the 
in-situ preparation of LiBH4, which is a stronger reducing agent than its sodium 
counterpart. Borohydride-mediated reductions are generally carried out in protic 
solvent, but by using a mixture of THF and methanol, the scope of reducible 
carbonyl compounds is increased and includes esters. This system allows for 
reduction of more challenging substrates, whilst avoiding the handling issues 
associated with LiAlH4 and stronger reducing agents. A number of theories for this 
have been postulated, including the in situ generation of the highly reducing 
trimethoxyborohydride anion.38, 39 The THF solvent could also form a Lewis adduct 
with neutral group 13 species by coordinating into the unoccupied p-orbital of the 
boron atom, in the same manner that BH3·THF can reduce esters to the 
corresponding alcohol.40 A simple thionyl chloride-mediated chlorination to prepare 
2.17 as the hydrochloride salt was then carried out. Reaction of 
5-(chloromethyl)oxazole·HCl with CTG under basic conditions was unsuccessful, 
presumably due to deprotonation of the oxazole hydrochloride outcompeting 
deprotonation of CTG. Oxazoles are weakly basic azoles, with inductive effects 
associated with the electronegative oxygen atom stabilising the protic oxazolium 
form.41 It was therefore necessary to neutralise 2.17 in aqueous sodium hydrogen 
carbonate, extract into DCM and add the neutral electrophile to a DMF solution of 
CTG and Cs2CO3. 2.18 was isolated as a sandy-brown solid in good yield.  
 The 1H NMR spectrum contains the characteristic endo- and exo- doublets 
at 4.73 and 3.53 ppm (figure 2.26). The methylene bridge, H4 displays subtle 
splitting due to diastereotopicity at this site. These protons are further upfield by ca. 
1.4 ppm compared to that observed in the nitrogen-appended ligands such as 2.15 
because of lower inductive effects at this position. The most acidic proton, H1, was 
located at 7.87 ppm.  
- 62 - 
 
Figure 2.26 1H NMR spectrum (293 K, 300 MHz, CDCl3) of 2.18. Inset: Molecular structure of 
2.18. 
The 13C{1H} NMR spectrum (figure 2.27) contained comparatively fewer peaks 
than benzimidazole 2.11 due to four less benzo-backbone resonances. As seen for 
other azole ligands prepared, C6, the aromatic carbon adjacent to methoxy group is 
the furthest downfield carbon centre. DEPT-135, HMQC and HMBC spectra aided 
full assignment of all carbon atoms (see Appendix). 
 
Figure 2.27 13C{1H} NMR spectrum (293 K, 75 MHz, CDCl3) of 2.18. Inset: Molecular structure 
of 2.18. 
The mass spectrum (figure 2.28) contained two dominant molecular ion peaks 
{M+H}+ (calculated 652.2290) and {M+Cs}+ (calculated 784.1266). The lack of 
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mono- or bis-oxazolyl peaks confirmed the tris-substituted ligand as the desired 
product. 
 
Figure 2.28 HRMS of 2.18. 
Single crystals suitable for X-ray diffraction could be isolated by diffusing diethyl 
ether vapours into a DMF solution of 2.18. (2.18)4·H2O crystallised in the hexagonal 
P63 space group. The asymmetric unit comprises of one and a third ligands (figure 
2.29). Both crystallographically independent 2.18 molecules were of the same 
enantiomer and note P63 is a chiral space group. Hence, each crystal contains only 
one enantiomer of ligand. A material comprising of a single enantiomer is known as 
a conglomerate. The three oxazole groups of the full CTV ligand in the asymmetric 
units are of different orientations, with one oxazole oxygen atoms pointing towards 
the centre of the bowl, one almost in-line with the CTV-arene faces, and one 
pointing outwards. Bowl-in-bowl stacks were observed, but rather than the 
commonly found α-stacking motif, where tribenzo[a,d,g]cyclononatriene bowls are 
parallel to neighbours in that column, β-stacks instead formed.42 One methylene 
group of tribenzo[a,d,g]cyclononatriene cores points into the centre of the below 
bowl, giving rise to every other molecule being of like-orientation. Stacks are also 
antiparallel, with alternating columns running in the opposite orientation. A partially 
occupied water molecule resides within the asymmetric unit. Isomorphic 
nitromethane-solvate crystals could also be grown, but data were of poor quality. 
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Figure 2.29 Top: Asymmetric unit of (2.18)4·H2O, ellipsoids are drawn at the 50% probability. 
Bottom left: β-bowl-in-bowl stacking. Bottom right: unit cell as shown down the 
crystallographic c-axis. 
2.7 Assembly of Co(II) coordination polymers 
The coordinative properties of oxazole 2.18 were trialled with a range of transition 
metal precursors covering Co(II) to Zn(II), Pd(II), and Ag(I) halides and 
non-coordinating anions. It was envisaged that a similar metallo-cryptophane to 2.12 
could assemble, minus the π-π stacking interactions of the benzimidazole 
backbones, but crystals could not be grown, and only intractable yellow solid 
isolated. No evidence of crystalline material, or coordination could be attained in 
most reactions.  
Diffusion of diethyl ether vapours into a DMF solution of 2.18 and 
CoCl2·6H2O in 1:1 proportions gave a mixture of two crystalline products 
[Co(Cl)2(2.18)2]n, 2.19a and [Co(Cl)2(2.18)]n, 2.19b. 
Polymer 2.19a crystallised in the P1 space group. Each octahedral Co(II) centre 
coordinates axially to two chloride ligands at distances of 2.4608(12) Å, and four 
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equatorial oxazolyl moieties with Co-N bond lengths of 2.146(3) and 2.151(3) Å. 
The asymmetric unit comprised of one whole ligand unit, one Co atom of half 
occupancy on the unit cell vertex, one Cl atom, three DMF molecules, one 
disordered over two positions and three water molecules (figure 2.30). 
 
Figure 2.30 Asymmetric unit of 2.19a. Ellipsoids are drawn at the 50% probability 
Crystals could only be grown at low-ambient temperatures (ca. 6 ºC). Attempts to 
regrow crystals above and below this temperature were ultimately unsuccessful and 
oils were obtained. Crystallisations in the fridge also failed, likely caused by too 
cold an environment, and/or increased humidity. 
Near-diamond-shaped channels arise throughout the polymer chains with a 
Co-CTVcentroid-Co angle of ca. 85.5º. One oxazolyl moiety per cavitand is 
non-coordinating, and interdigitates with a neighbouring polymer chain, facilitated 
by π-π stacking of one non-coordinating and one ligated oxazole at separation of ca. 
3.49 Å (figure 2.31), effectively filling the channels of the doubly bridged chest 
structure.   
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Figure 2.31 Top left: 1D chain of 2.19a. Top right: three interwoven polymer chains. Bottom: 
space filling model of chains. 
A second composite of polymer (2.19b) of composition [Co(Cl)2(2.18)]n·3H2O was 
also grown from the same batch and the structure obtained using synchrotron 
radiation. The asymmetric unit comprised of one [Co(Cl)2(2.18)] unit and three 
water solvent molecules (figure 2.32). 
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Figure 2.32 Asymmetric unit of 2.19b. Ellipsoids are drawn at the 50% probability. 
Crystal data were of poor redundancy. Polymer 2.19b assembled as a ladder-like 
polymorph with rungs running between two parallel chains of ligand. The Co(II) 
centres here were contorted-trigonal bipyramidal, with oxazole ligands occupying 
the two axial sites and one equatorial position. The two chloride ligands were also 
equatorial. The two Co-Nax bond lengths were 1.994(9) and 2.016(7) Å, and a 
Co-Nequatorial bond length of 2.211(9) Å. The Co-Cl bond lengths were 2.270(3) and 
2.316(2) Å. The Nax-Co-Nax bond angle was near-linear at 178.6(3)º, with significant 
distortion around the equator, with a Cl-Co-Cl angle of 145.01(15)º and Cl-Co-Neq 
angles of 108.4(2)º and 106.5(2)º. In contrast to 2.19a, interdigitation between 
polymers was not observed in the case of 2.19b. Instead, π-π stacking interactions 
between arene faces of the CTV core were observed, at a distance of ca. 3.62 Å 
measured between arene centroids (figure 2.33). There are well-defined pores within 
each polymer chain, however, the orientation of neighbouring chains does block 
them from passing through the whole structure. 
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Figure 2.33 Left: Stick model of 2.19b. Centre: Space filling of two front-on chains. Right: two 
side-on chains. 
Crystals were also grown from a vial containing Co(NO3)2 and ligand 2.18 from the 
diffusion of diethyl ether into an N-methylpyrrolidone (NMP) solution. SCXRD 
analysis using synchrotron radiation proved a polymer with composition 
[Co(NO3)2(2.18)2]n, complex 2.20. The unit cell parameters of 2.19a and 2.20 were 
similar, with the major differences in 2.20 being with two NMP molecules in the 
asymmetric unit rather than DMF, and trans-nitrate anions as opposed to chlorides 
(figure 2.34).  
 
Figure 2.34 Asymmetric unit of 2.20. Ellipsoids are drawn at the 50% probability. 
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All four oxazole groups are equatorial about the octahedral Co(II) centre with Co-N 
bond lengths of 2.1256(12) and 2.1507(13) Å. The Co-O bond length was measured 
at 2.1254(13) Å, shorter than that noted for the chloride ligand by 0.2 Å. The same 
oxazole-oxazole π-π stacking between overlapping chains is also observed at 
centroid-centroid separation of ca. 3.67 Å. 
 
Figure 2.35 Left: three repeating units of 2.20. Right: exert showing capsular aggregation. 
The observed powder pattern for bulk material related to 2.19a and 2.19b is 
indicative of a mixture of components (figures 2.36 and 2.37). Whilst there is peak 
overlap with the simulated X-ray spectra for 2.19a and 2.19b, it is not clear whether 
crystals of other composites were present in the bulk material. A number of crystals 
were screened, however only crystals with the same unit cell as 2.19 were found. 
Multiple composites of polymers are not uncommon because of the low 
thermodynamic driving force to induce polymerisation. Coordination polymer 2.20 
displayed similar results, with peak overlap between the bulk material and simulated 
pattern for the single crystal studied, but it is unclear whether multiple composites 
were present in the bulk material. Crystals with the same unit cell parameters as 2.20 
could only be found during screening. 
 It is worth noting that the experimental powder pattern was obtained at room 
temperature, whereas the simulated pattern was derived from data collected at 
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100-120 K, therefore peak intensities and also slight variations in angles are likely to 
occur. 
 
Figure 2.36 Powder pattern for 2.19a and 2.19b. Simulated data from crystal structures (100 K) 
of polymer 2.19a (blue trace) and 2.19b (red trace). Observed data from bulk material 
(rt) (black trace). 
 
Figure 2.37 Powder pattern for 2.20. Simulated spectrum from crystal structure (100 K) (red 
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2.8 Conclusions and future work 
Two imidazole-functionalised cyclotriguaiacylene ligands were prepared, but scale 
up and reproducibility were challenging because of the instability of precursors. 
Therefore, benzimidazole 2.11 was prepared and fully characterised and upon 
optimisation of synthetic protocol, overcame problems associated with the imidazole 
counterparts. Ligand 2.11 assembled with [Pd(Cl)2(MeCN)2] to yield 
anti-metallo-cryptophane 2.12, and crystals of composition 
[Pd3Cl6(2.11)3∙(H2O)]∙1.5H2O∙3DMF. Both ligands in cryptophane 2.12 were of the 
same enantiomer, with crystals being racemic overall. Complex 2.12 was a rare 
example of a trans-linked metallo-cryptophane. Most examples of 
metallo-cryptophanes incorporating Pd(II) require cis-protecting groups such as a 
bis-NHC, forcing incoming cavitand ligands to coordinate cis- with respect to one 
another. These cryptophanes are typically also charged species. 
 Benzotriazolyl ligand 2.15 was also prepared in good yield, but its assembly 
with a range of metal precursors was unsuccessful. One azole not furnished on a 
CTV scaffold during this project was the 1,2,3-triazole derivative. 1,2,3-triazoles are 
straightforward to prepare using click chemistry, and have been appended onto CTV 
in a three-step synthesis to prepare dendrimer-functionalised cyclotriveratrylenes,43 
but coordination chemistry of this group tethered onto CTV remains untrialled. 
A 5-oxazolyl ligand was also synthesised, and assembled with two Co(II) 
salts to yield 1D coordination polymers. Single-crystal and powder X-ray diffraction 
revealed the presence of (at least) two composites. Total yields were low, and 
crystals could only be grown at low ambient temperatures. 
Future work could involve investigating the assembly of ligands 2.11, 2.15 and 
2.18 with the cis-protecting Pd(II)-bis-NHC tectons. It would be anticipated that 
they could assemble into anti-metallo-cryptophanes, with the bite angle of donor 
atoms relative to CTV reasonably similar to the pyridyl donors previously 
employed. 
2.9 Experimental section 
Unless stated in the experimental section, chemicals were bought from commercial 
suppliers (Sigma Aldrich, Fisher Scientific, Alfa Aesar, Fluorochem) and used 
without further purification. Reactions performed under an atmosphere of dry 
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nitrogen were carried out using standard Schlenk and glovebox procedures. Nitrogen 
gas was dried by passing through a twin column of 4 Å molecular sieves and P2O5. 
Anhydrous solvents (THF, DCM, CHCl3, MeCN) were dried by passing through a 
column of activated alumina, degassed via the freeze-pump-thaw method prior to 
use and stored over 4 Å molecular sieves. Anhydrous DMF was bought from 
commercial suppliers, and both further dried and stored over 4 Å molecular sieves, 
and subsequently degassed via the freeze-pump-thaw method prior to use. 
1H, 13C{1H}, 19F and 31P NMR spectra were obtained using either a Bruker 
DPX 300 MHz spectrometer, Bruker Avance III HD-400 400 MHz spectrometer, or 
a Bruker Avance 500 MHz spectrometer. Full characterisation of novel compounds 
by 1H and 13C{1H} NMR spectroscopy was aided by 1H-1H COSY, DEPT-135, 
HMBC and HMQC experiments. Electrospray mass spectra were obtained using a 
Bruker microTOF-Q spectrometer. FT-IR spectra were obtained using a 
Perkin-Elmer Spectrum One spectrophotometer. Elemental analyses were performed 
by Mrs. Tanya Marinko-Covell of the University of Leeds analytical service, or Mr. 
Stephen Boyer of the London Metropolitan University. Crystal structures were 
obtained using either synchrotron radiation from beamline I19 at the Diamond light 
source, or an Agilent SuperNova single crystal X-ray diffractometer.  
Synthesis of 3-methoxy-4-(propenyloxy)benzyl alcohol, 2.1 
4-Hydroxy-3-methoxybenzyl alcohol (30.74 g, 195.0 mmol), 
potassium carbonate (27.26 g, 197.0 mmol) and allyl bromide 
(19.10 mL, 216.0 mmol) were added to acetone and the 
solution heated to reflux under Ar for 24 h. The solvent was 
removed in vacuo and residue washed with DCM and water, the layers were 
separated and the organic layer dried with MgSO4, DCM was removed in vacuo, 
affording 2.1 as a white solid. Yield 37.62 g, 193.7 mmol, 99%. 1H NMR (300 
MHz, CDCl3) δ (ppm) 6.94 (s, 1H, H
7), 6.86 (s, 2H, H8, H6), 6.09 (m, 1H, H3), 5.40 
(dq, 1H, J = 17.2, 1.5 Hz, trans-H
2), 5.28 (dd, 1H, J = 10.6, 1.3 Hz, cis-H2), 4.61 (m, 
4H, H9, H4), 3.29 (s, 3H, H1) 13C{1H} NMR (75 MHz, CDCl3) δ (ppm) 150.0 (C5), 
148.0 (C11), 134.4  (C3), 133.7 (C11), 119.7 (C2), 118.4 (C7), 113.8 (C8), 111.3 (C6), 
70.4 (C4), 65.7 (C9), 56.3 (C1). All data are consistent with those reported in the 
literature.11 
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 Synthesis of (±)-2,7,12-trimethoxy-3,8,13-tris-(propenyloxy)-10,15-dihydro-5H-
tribenzo[a,d,g]-cyclononene, 2.2 
3-Methoxy-4-(propenyloxy)benzyl alcohol (37.16 
g, 193.1 mmol) was melted at 70 ºC and phosphoric 
acid (spatula tip) added. The reaction was stirred for 
24 h until it solidified. The resulting solid was 
triturated in methanol (400 mL) before being 
filtered and dried in vacuo, affording 2.2 as a white solid. Yield 21.34 g, 40.0 mmol, 
63%. 1H NMR (300 MHz, CDCl3) δ (ppm) 6.86 (s, 3H, H
5), 6.81 (s, 3H, H4), 6.07 
(m, 3H, H2), 5.38 (dd, 3H, J = 17.3, 1.4 Hz, trans-H1), 5.26 (dd, 3H, J = 10.5, 1.2 
Hz, cis-H1), 4.75 (d, 3H, J = 13.79 Hz, endo-H6), 4.60 (m, 6H, H3), 3.84 (s, 9H, H7), 
3.53 (d, 3H, J = 14.2 Hz, exo-H6); 13C{1H} NMR (75 MHz, CDCl3) δ (ppm) 148.2, 
(C11) 146.1 (C10), 133.7 (C2), 132.4 (C8), 131.7 (C9), 117.5 (C1), 115.6 (C5), 113.6 




tribenzo[a,d,g]-cyclononene (CTG), 2.3 
(±)-2,7,12-Trimethoxy-3,8,13-tris-(propenyloxy)-10,15-
dihydro-5H-tribenzo[a,d,g]-cyclononene (10.30 g, 19.4 
mmol) was added to a mixture of anhydrous THF (250 
mL), diethylamine (91 mL) and water (90 mL), the 
reaction mixture degassed and backfilled with N2, and heated to 80 ºC under Ar for 
3 h. Palladium acetate (0.32 g, 1.4 mmol) and triphenylphosphine (0.95 g, 3.6 mmol) 
were added and the black solution held at reflux overnight. The mixture was filtered 
through celite, giving an orange solution. The solvents were removed in vacuo and 
the residue triturated in methanol, affording 2.3 as an off-white solid. Yield: 5.50 g, 
13.5 mmol, 69%; 1H NMR (300 MHz, CDCl3) δ (ppm) 6.89 (s, 3H, H
2), 6.80 (s, 3H, 
H3), 4.72 (d, 3H, J = 13.6 Hz, endo-H4), 3.86 (s, 9H, H1), 3.51 (d, 3H, J = 13.8 Hz, 
CTG exo-H4); 13C NMR (75 MHz, DMSO-d6) δ (ppm) 145.96, 144.87, 132.57, 
130.42, 116.78, 113.97, 55.97, 35.02. All data are consistent with those reported in 
the literature.11 
 




CTG (200 mg, 0.5 mmol) was added to a 
suspension of sodium hydride (118 mg, 4.9 
mmol) in anhydrous, degassed DMF (10 mL) 
and stirred for 30 mins. 1-
(chloromethyl)imidazole·HCl (0.48 g, 3.2 
mmol) was added and the mixture stirred at 
room temperature under N2 for 72 h. The mixture was extracted with water (500 
mL) and dichloromethane (3 x 300 mL). The organic layers were washed with 
water, (100 mL) and dried with MgSO4, DCM was removed in vacuo and the 
product extracted from residual DMF with Et2O, affording the title compound as a 
white solid. Yield 176 mg, 0.3 mmol, 55%. LC-MS (ESI)+ m/z 649.3, Calcd. for 
C36H37N6O6 649.2775; 
1H NMR (300 MHz, CDCl3) δ (ppm) 7.52 (s, 3H, H
1), 7.02 
(s, 3H, H3), 6.98 (s, 3H, H2), 6.68 (s, 3H, H8), 6.62 (s, 3H, H9), 5.73 (m, 6H, H4), 
4.59 (d, 3H, J = 13.9 Hz, endo-H12), 3.84 (s, 9H, H5), 3.39 (d, J = 13.8 Hz, exo-H12); 
13C {1H} NMR (75 MHz, CDCl3) δ 150.18, 143.39, 137.78, 136.59, 131.68, 129.88, 
123.25, 119.32, 114.10, 76.66, 56.20, 36.37. All data are consistent with those 
reported in the literature.14  
 
Synthesis of 1-(hydroxymethyl)imidazole, 2.5 
Imidazole (10.00 g, 147.1 mmol) and paraformaldehyde (4.30 g, 143.1 
mmol) were heated in a dry melt at 110 ºC for 1 h and the liquid 
solidified upon cooling. The solid residue was triturated in ethyl 
acetate, affording the title compound as a free-flowing white solid. Yield 10.49 g, 
106.9 mmol, 76%. HRMS (ESI)+ m/z 99.0552 Calcd. for {C4H7N2O}
+ 99.0558; 1H 
NMR (300 MHz, CDCl3) δ (ppm) 7.30 (s, 1H, H
1), 7.10 (s, 1H, H3), 6.98 (s, 1H, 
H2), 5.41 (s, 2H, H4); m.p. 37-39 ºC (lit. 36-38 ºC); 13C{1H} NMR (75 MHz, CDCl3) 
δ (ppm) 136.29 (C1), 128.60 (C2), 118.88 (C3), 70.41 (C4) All data are consistent 
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Synthesis of 1-(chloromethyl)imidazole hydrochloride, 2.6 
1-(Hydroxymethyl)imidazole (1.0 g, 10 mmol) was dissolved in 
dry dichloromethane (30 mL) at 0 ºC and thionyl chloride (3 mL) 
added. The mixture was warmed to room temperature and stirred under argon 
overnight. Solvent and excess thionyl chloride were removed in vacuo and the 
residue washed with acetonitrile, affording the title compound as a hygroscopic 
white solid. Yield 0.87 g, 7.5 mmol, 73.5%. 1H NMR (300 MHz, D2O) δ (ppm) 9.09 
(s, 1H, H1), 7.77 (s, 1H, H3), 7.57 (s, 1H, H2), 6.09 (s, 2H, H4); 13C {1H} NMR (75 
MHz, DMSO-d6) δ (ppm) 138.11 (C
1), 129.20 (C2), 119.91 (C3), 68.14 (C4). All data 
are consistent with those reported in the literature.37 
 
Synthesis of 1-(2-bromoethyl)imidazole hydrobromide, 2.7 
Thionyl bromide (2.21 mL, 28.6 mmol) was added dropwise to a 
Schlenk flask containing 1-(2-hydroxyethyl)imidazole (1.07 g, 
9.5 mmol) in anhydrous DCM (40 mL) at 0 ºC. The solution held at 0 ºC for 20 mins 
before warming to rt and stirred overnight. Solvent and excess thionyl bromide were 
removed in vacuo, affording a red oil which was dissolved in water and neutralised 
with saturated sodium carbonate. The product was extracted in chloroform and 
solvent removed in vacuo, affording the title compound as an orange solid. Yield 
1.10 g, 6.6 mmol, 71%. 1H NMR (300 MHz, CDCl3) δ (ppm) 7.63 (s, 1H, H
1), 7.11 
(s, 1H, H3), 6.99 (s. 1H, H2), 4.37 (t. 2H, J = 6.4 Hz, H4), 3.60 (t, 2H, J = 6.4 Hz, 
H5); 13C{1H} NMR (75 MHz, CDCl3) δ (ppm) 137.41, 129.93, 118.85, 48.54, 30.46. 





CTG (200 mg, 0.49 mmol) was added to a 
suspension of sodium hydride (118 mg, 4.9 mmol) 
in anhydrous, degassed DMF (10 mL) at room 
temperature and stirred for 30 mins. 1-
(bromoethyl)imidazole·HCl (0.8 g, 3.2 mmol) was 
added in portions and the reaction mixture stirred 
for 96 h under N2. The solution was extracted with water (500 mL) and 
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dichloromethane (3 x 300 mL). The organic layers were combined, washed with 
water (200 mL) and dried with MgSO4. DCM was removed in vacuo and the 
product extracted from residual DMF with Et2O, affording the title compound as a 






+, Calcd. for 299.1390, 346.1656, 597.2708, 691.3239 respectively; 
1H NMR (300 MHz, DMSO-d6) δ (ppm) 7.65 (s, 3H, H
1), 7.21 (s, 3H, H3), 7.06 (s, 
3H, H9), 7.04 (s, 3H, H8), 6.86 (s, 3H, H2), 4.66 (d, 3H, J = 13.3 Hz, endo-H12), 
4.28, (m, 6H, H4), 4.17 (m, 6H, H5), 3.69 (s, 9H, H13), 3.47 (d, 3H, J = 13.3 Hz, exo-
H12); 13C {1H} NMR (75 MHz, DMSO-d6) δ (ppm) 147.70 (C
7), 145.92 (C8), 137.58 
(C1), 132.94 (C10), 132.05 (C9), 128.20 (C2), 119.67 (C3), 115.66 (C9), 114.19 (C8), 
68.56 (C5), 56.06 (C13), 45.64 (C4), 34.93 (C12); FTIR ν (cm-1) 2917, 2846, 1669, 
1607, 1509, 1260. 
 
Synthesis of 1-(hydroxymethyl)benzimidazole, 2.9 
Benzimidazole (1.57 g, 13 mmol) was dissolved in THF (40 mL) 
and formaldehyde (1 mL, 13 mmol, 37% in H2O) was added 
slowly. The pale yellow solution was stirred for 1 h under ambient 
conditions. Solvents were removed in vacuo, affording a white 
solid as the title compound with no need to purify. Yield 1.78 g, 12.2 mmol, 90%. 
HRMS (ESI+) 149.0705, Calcd. for C8H9N2O 149.0709; 
1H NMR (501 MHz, 
DMSO-d6) δ (ppm) 8.25 (s, 1H, H
1), 7.65 (d, 2H, J = 8.9 Hz, H3, H6), 7.27 (t, 1H, J 
= 8.0 Hz, H4), 7.22 (t, 1H, J = 8.0 Hz, H5), 6. (t, 1H, J = 7.0 Hz, H9), 5.60 (d, 2H, 
J = 6.8 Hz, H8); 13C{1H} NMR (126 MHz, DMSO-d6) δ (ppm) 143.44, 141.51, 
133.14, 122.06, 121.40, 119.10, 110.54, 67.21. All other data are consistent with 
those reported in the literature.37 
 
Synthesis of 1-(chloromethyl)benzimidazole hydrochloride, 2.10 
1-(Hydroxymethyl)benzimidazole (2.32 g, 15.7 mmol) was stirred in 
thionyl chloride (15 mL, 200.0 mmol) at room temperature under 
argon overnight. Thionyl chloride was removed in vacuo and the 
residue recrystallised from MeOH and Et2O, affording a white solid 
as the title compound. Yield 2.37 g, 11.7 mmol, 75%. HRMS (ESI+) 167.0368, 
Calcd. for {C8H8ClN2}
+ 167.0371; 1H NMR (300 MHz, CD3OD) δ (ppm) 9.74 (s, 
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1H, H1), 8.11-8.05 (m, 1H, H3), 7.96-7.89 (m, 1H, H6), 7.81-7.71 (m, 2H, H4, H5), 
6.50 (s, 2H, H8); 13C{1H} NMR (75 MHz, CD3OD) δ 143.28, 132.46, 131.42, 




tribenzo[a,d,g]cyclononene, 2.11  
CTG (400 mg, 1.0 mmol) was added to a suspension of NaH (60% dispersion in 
mineral oil) (0.84 g, 20.8 mmol) in anhydrous, 
degassed DMF (10 mL) under an N2 atmosphere at 
room temperature, and stirred for 30 mins. 1-
(Chloromethyl)benzimidazole hydrochloride (694 
mg, 3.4 mmol) was added in portions and the 
mixture stirred for 16 h. Water (100 mL) was added 
and the resulting grey precipitate filtered. The grey 
residue was re-dissolved in dichloromethane (60 mL), dried over MgSO4, and 
solvents removed in vacuo. The residue was sonicated in diethyl ether (50 mL), 
affording the title compound as a white solid. Yield 0.58 g, 0.73 mmol, 75%; HRMS 
(ESI+) 821.3065 {MNa}+, calculated for {C48H42N6NaO6}
+ 821.3059; 1H NMR (300 
MHz, DMSO-d6) δ (ppm) 8.35 (s, 3H, H
1), 7.65 (dd, 3H, J = 6.1, 2.9 Hz, H6) , 7.59-
7.55 (m, 3H, H3), 7.25-7.20 (m, 6H, H4, H5), 7.18 (s, 3H, H10), 7.04 (s, 3H, H11), 
6.20-6.10 (m, 6H, H8), 4.69 (d, 3H, J = 13.5 Hz, endo-H16), 3.67 (s, 9H, H9), 3.47 (d, 
3H, J = 13.6 Hz, exo-H16); 13C{1H} NMR (75 MHz, DMSO-d6) δ (ppm) 148.76 
(C13), 144.34 (C1), 143.50 (C2), 143.46 (C7), 134.88 (C15), 133.47 (C12), 131.79 
(C14), 122.90 (C5), 122.21 (C4), 119.51 (C6), 119.01 (C10), 114.34 (C11), 110.76 (C3), 
73.03 (C8), 55.93 (C9), 35.06 (C16); Elemental analysis for C48H42N6O6∙1.5(H2O) 
Calcd. C 69.79, H 5.50, N 10.18; Found: C 69.82, H 5.01, N 10.32; FT-IR (cm-1) 
3092, 2958, 2926, 1611, 1452, 1273, 1198, 970, 745. 
 
[Pd3Cl6(L2)2] metallo-cryptophane, 2.12  
A solution of L2 (7 mg, 8 μmol) and [PdCl2(MeCN)2] (3.4 mg, 13 μmol) in DMF (1 
mL) was stirred for 24 h. Two drops were taken for HRMS characterisation, and the 
rest set up as a vapour diffusion with diethyl ether anti-solvent. A pale yellow solid 
precipitated after one week, and small number of pale yellow blocks grew after three 
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months. HRMS (ESI+) m/z 941.1833 for species {PdCl(L2)}+, 2134.21 
{Pd6Cl5L2(MeCN)}
+; FT-IR (cm-1) 1611, 1508, 1264, 1182, 1141, 1066, 1025, 742. 
Satisfactory microanalysis was not obtained from powdered material which is likely 
a mixture of cage and PdCl2: Found C 47.39 H 3.41 N 7.73 % Calcd. for 
[Pd3Cl6(L2)2] C 54.12, H 3.98, N 7.89; for [Pd3Cl6(L2)2].PdCl2 C 49.96, H 3.67, N 
7.29. 
 
Synthesis of 1-(hydroxymethyl)benzotriazole, 2.13  
Benzotriazole (5 g, 41.9 mmol) was dissolved in THF (60 mL) and 
formaldehyde (37% in H2O) (3.4 mL, 41.9 mmol) added. The 
colourless solution was stirred for 1 h, solvent removed in vacuo 
and the residue washed with methanol, affording the title compound as a white solid. 
Yield (4.92 g, 33.0 mmol, 79%). 1H NMR (300 MHz, DMSO-d6) δ (ppm) 8.06 (d, J 
= 8.4 Hz, H2), 7.91 (d, 1H, J = 9.1 Hz, H5), 7.64-7.52 (m, 1H, H4), 7.43 (m, 1H, H3), 
7.19 (t, 1H, J = 7.7 Hz, H8), 6.02 (d, 2H, J = 7.6 Hz, H7) 13C{1H} NMR (75 MHz, 
DMSO-d6) δ (ppm) 146.38 (C
1), 133.14 (C6) 127.34 (C4), 124.08 (C3), 119.04 (C2), 
110.92 (C5), 70.20 (C7). All data are consistent with those reported in the literature.46 
 
Synthesis of 1-(chloromethyl)benzotriazole·HCl, 2.14 
1-(Hydroxymethyl)benzotriazole (2.0 g, 13.4 mmol) was stirred 
in thionyl chloride (10 mL) at room temperature under a N2 
atmosphere overnight. Solvents were removed in vacuo, and the 
residue recrystallised from MeOH/Et2O in the freezer, affording the title compound 
as a colourless crystalline solid (2.2 g, 10.8 mmol, 80%). HRMS (ESI+) 168.0321, 
Calcd. for {MH: C7H7ClN3}
+ 168.0323; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.14-
8.09 (m, 1H, H2), 7.68 (dt, 1H, J = 8.3, 1.0 Hz, H5), 7.64-7.57 (m, 1H, H4), 7.46 
(ddd, 1H, J = 8.1, 6.9, 1.1 Hz, H3), 6.41 (s, 2H, H7); 13C{1H} NMR (75 MHz, 
CDCl3) δ (ppm) 142.67 (C
1), 133.08 (C6), 128.77 (C4), 125.06 (C3), 120.75 (C2), 









CTG (100 mg, 0.2 mmol) and NaH (60% 
dispersion) (220 mg, 5.5 mmol) were dissolved in 
anhydrous, degassed DMF (5 mL) and stirred for 
30 mins at rt under an atmosphere of N2. 1-
(chloromethyl)benzotriazole·HCl (226 mg, 1.1 
mmol) was added and the reaction stirred at rt 
overnight. Water (20 mL) was added to the burgundy solution and a pale pink solid 
precipitated. The solid was filtered under reduced pressure, and washed with water 
(5 mL), MeOH (5 mL) and diethyl ether (5 mL), affording 2.15 as a pale pink solid. 
Yield 180 mg, 0.2 mmol, 94%. HRMS (ESI+) 824.2933, Calcd. for {MNa: 
C45H39N9NaO6}
+ 824.2916; 1H NMR (300 MHz, CDCl3) δ (ppm) 7.98-7.89 (m, 3H, 
H4), 7.44-7.35 (m, 3H, H3), 7.20-7.12 (m, 6H, H2, H5), 6.82 (s, 3H, H10), 6.65 (s, 3H, 
H13), 6.52 (d, 3H, J = 11.3 Hz, H7), 6.39 (d, 3H, J = 11.3 Hz, H7), 4.50 (d, 3H, J = 
13.7 Hz, endo-H15), 3.85 (s, 9H, H14), 3.32 (d, 3H, J = 13.9 Hz, exo-H15); 13C{1H} 
NMR (75 MHz, CDCl3) δ (ppm) 149.45 (C
9), 146.20 (C1), 144.20 (C8), 135.84 
(C11), 133.18 (C6), 131.56 (C12), 128.03 (C5), 124.42 (C2), 120.54 (C10), 119.81 (C4), 
113.81 (C13), 109.97 (C3), 76.66 (C7), 56.32 (C14), 36.28 (C15). Elemental analysis 
for C45H39N9O6 Calcd. C 67.40, H 4.90, N 15.72; Found: C 67.28, H 5.09, N 15.57. 
 
Synthesis of 5-hydroxymethyloxazole, 2.16 
Ethyl oxazole-5-carboxylate (3 mL, 25.0 mmol) and lithium chloride (6.37 
g, 150.0 mmol) were dissolved in anhydrous THF (50 mL) and methanol 
(100 mL) under a N2 atmosphere and cooled to 0 ºC. Sodium borohydride 
(5.67 g, 150.0 mmol) was added in small portions over a 30 min period, 
warmed to rt and stirred for 24 h. Water (100 mL) was added and the product 
extracted into ethyl acetate (3 x 150 mL) and DCM (3 x 50 mL). The organic layers 
were combined, dried over MgSO4, filtered and solvents removed in vacuo, 
affording the title compound as an orange oil. Yield 1.40 g, 14.1 mmol, 56%. 1H 
NMR (300 MHz, CDCl3) δ (ppm) 7.85 (s, 1H, H
1), 7.01 (s, 1H, H2), 4.69 (s, 2H, 
H3), 2.61 (s, 1H, H4); 13C {1H} NMR (75 MHz, DMSO-d6) δ (ppm) 151.74, 151.56, 
123.98, 55.34. All data were consistent with those reported in the literature.48 
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Synthesis of 5-Chloromethyloxazole, 2.17 
2.16 (1.4 g, 14.1 mmol) was dissolved in anhydrous DCM (5 mL) and 
anhydrous hexane (5 mL) under a N2 atmosphere and cooled to 0 ºC. Thionyl 
chloride (5 mL) was added and the reaction mixture gradually heated to 
reflux over a 1 h period and stirred for 16 h. The reaction was cooled and quenched 
with H2O (15 mL), sat. NaHCO3 (20 mL) and extracted into Et2O (3 x 30 mL). The 
organic layers were combined, dried over MgSO4, filtered and solvents removed in 
vacuo, affording the title compound as a pale yellow oil. Yield 0.71 g, 6.0 mmol, 
43%. 1H NMR (300 MHz, CDCl3) δ (ppm) 7.89 (s, 1H, H
1), 7.10 (s, 1H, H2), 4.62 
(s, 2H, H3) 13C {1H} NMR (75 MHz, DMSO-d6) δ (ppm) 153.31, 148.22, 128.23, 





CTG (100 mg, 0.2 mmol) and caesium carbonate 
(797 mg, 2.4 mmol) were dissolved in DMF (5 
mL) and heated to 100 ºC for 1 h. 
5-(Chloromethyl)oxazole (200 mg, 1.7 mmol) 
was added and the reaction stirred at 100 ºC for 
16 h, during which the reaction mixture turned 
brown. Water was added and the brown residue was filtered, washed with water (5 
mL), methanol (5 mL) and diethyl ether (10 mL), affording the title compound as a 
tan solid. Yield (113 mg, 17.3 mmol, 72%). HRMS (ESI+) 784.1275, Calcd. for 
{M+Cs: C36H33N3O9}
+ 784.1266; 1H NMR (300 MHz, CDCl3) δ (ppm) 7.87 (s, 3H, 
H1), 7.11 (s, 3H, H2), 6.94 (s, 3H H7), 6.83 (s, 3H, H10), 5.06 (s, 6H, H4), 4.73 (d, 
3H, J = 13.0 Hz, endo-H12), 3.83 (s, 9H, H11), 3.53 (d, 3H, J = 13.7 Hz, exo-H12); 
13C{1H} NMR (75 MHz, CDCl3) δ (ppm) 151.67 (C
1), 149.31 (C6), 148.27 (C3), 
146.29 (C5), 134.28 (C8), 131.95 (C9), 126.35 (C2), 118.52 (C7), 114.40 (C10), 62.28 
(C4), 56.47 (C11), 36.62 (C12). Elemental analysis for C36H33N2O9∙(H2O) Calcd. C 
64.57, H 5.27, N 6.45; Found: C 64.43, H 5.52, N 6.26. 
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Synthesis of polymers 2.19a and 2.19b 
2.18 (5.0 mg, 0.007 mmol), CoCl2·6H2O (1.8 mg, 0.007 mmol) and DMF (1 mL) 
were added to a vial and stirred for 5 min. Diethyl ether vapours were diffused into 
the vial and pale blue blocks grew after ca. 3 weeks. Total yield 2.1 mg, 31%.  
Insufficient material led to only single crystal and powder X-ray diffraction analysis 
being attainable. Crystal growth was very sensitive towards ambient temperature, 
and could only be grown between ca. 5-8 ºC. 
 
Synthesis of polymer 2.20 
2.18 (5.0 mg, 0.007 mmol), Co(NO3)2·6H2O (2.2 mg, 0.007 mmol) and NMP (1 
mL) were added to a vial and stirred for 5 min. Diethyl ether vapours were diffused 
into the vial and pale pink blocks grew after ca. 3 weeks. Yield 1.8 mg, 0.002 mmol, 
25%.  
Insufficient material led to only single crystal and powder X-ray diffraction analysis 
being attainable. Crystal growth was very sensitive towards ambient temperature, 
and could only be grown between ca. 5-8 ºC. 
 
2.10 Supplementary crystallography information 
Crystals were mounted under inert oil on a MiTeGen tip and flash frozen using an 
OxfordCryosystems low temperature device. X-ray diffraction data were collected 
using CuK radiation (λ = 1.54184 Å) or MoK (λ = 0.71073 Å) using an Agilent 
Supernova dual-source diffractometer with Atlas S2 CCD detector and fine-focus 
sealed tube generator, or using synchrotron radiation (λ = 0.6889 Å) at Beamline I19 
at the Diamond light source. Data were corrected for Lorenztian and polarization 
effects and absorption corrections were applied using multi-scan methods. The 
structures were solved by direct methods using SHELXS-97 and refined by full-
matrix on F2 using SHELXL-97.49 Unless otherwise specified, all non-hydrogen 
atoms were refined as anisotropic, and hydrogen positions were included at 
geometrically estimated positions. 
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2.10.1 Additional crystallographic details 
2.8 
The imidazole ring was disordered over two positions, each with 50% occupancy. 
(2.11)∙(2.3) 
The crystal data were of poor quality with poor internal consistency, and did not 
diffract to high angles, even when using synchrotron radiation. 
[2.12∙(H2O)]∙1.5H2O∙3DMF 
Water and DMF molecules were refined isotropically, one guest water molecule 
displayed threefold site-symmetry, and another was at 50% occupancy. Hydrogen 
positions for water molecules were not included. 
(2.18)4·H2O  
The water molecule was refined as isotropic and the hydrogen positions not 
included. 
2.19a 
All DMF solvent molecules were refined as isotropic, one was disordered over two 
positions with a 1:1 distribution of electron-density between the sites. C41 was split 
between both positions, behaving as both the carbonyl carbon and a N-methyl 
carbon in separate symmetry partners. Water molecules were refined as isotropic 
and hydrogen positions not included. 
2.19b 
Data were of low redundancy due to the small size of the dataset. Attempts to find 
this crystal composite in further grown batches was unsuccessful for better quality 
data collection were unsuccessful. Three water molecules observed in the 
asymmetric unit were refined as isotropic and hydrogen positions not included. 
2.20 
One NMP solvent molecule was disordered over two positions and of 0.5 
occupancy. The NMP solvent molecule displaying site-symmetry was refined as 
isotropic. 
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Compound 2.8b 2.11a (2.11)∙(2.3)b [2.12∙(H2O)]∙1.5H2O∙3DMF
a (2.18)4·H2O
a 
Formula C39H42N6O6 C48H42N6O6 C72H66N6O12 C105H110Cl6N15O17.5Pd3 C144H119N12O37 
Mr 690.79 798.88 1207.31 2393.98 2609.50 
Crystal size 0.15 x 0.08x0.08 0.31 x 0.05 x 0.05 0.05 x 0.02 x 0.02 0.07 x 0.06 x 0.05 0.05 x 0.09 x 0.18 
Crystal system Trigonal (hexagonal axes) Triclinic Trigonal Cubic Hexagonal 
Space group 𝑃3̅   𝑃1̅   Pc31   𝑃𝑎3̅   P63 
a (Å) 20.9167(6) 10.7347(5) 19.4199(10) 27.7884(3) 27.8461(4) 
b (Å) 20.9167(6) 12.6277(4) 19.4119(10) 27.7884(3) 27.8461(4) 
c (Å) 4.6836(2) 14.8026(6) 9.0953(8) 27.7884(3) 9.89520(10) 
α (0) 90 83.722(3) 90 90 90 
β (0) 90 86.985(4) 90 90 90 
γ (0) 120 79.149(3) 120 90 120 
V (Å3) 1774.58(13) 1957.81(14) 2968.1(4) 21458.1(4) 6644.8(2) 
Z 2 2 2 8 2 
ρcalc (g.cm
-3) 1.293 1.355 1.351 1.482 1.304 
θ range (0) 1.329- 33.041 3.58-73.75 2.10-20.81 3.18-73.79 3.174- 74.345 
No. data collected 17698 15677 23054 19190 44555 
No. unique data 2683 7391 2079 7084 8533 
Rint 0.0750 0.0281 0.1652 0.0430 0.0606 
No. obs. Data (I  >  2σ(I)) 1793 6235 1967 5598 7363 
No. parameters 155 544 274 414 582 
No. restraints 0 0 1 0 1 
R1 (obs data) 0.0939 0.0375 0.0762 0.0675 0.0572 
wR2 (all data) 0.3210 0.0927 0.1936 0.1994 0.1673 
S 1.099 1.022 1.124 1.040 1.089 
Max. shift/esd 0.001 0.001 0.000 0.001 0.000 
Largest difference peak and hole/ (e Å3) 1.431,  -0.379 0.205,  -0.219 0.248,  -0.215 2.155,  -1.143 1.257,  -0.563 
Table 2.1 data. a = CuKα radiation, b = synchrotron radiation 
 
- 84 - 
 
 
Compound 2.19aa 2.19bb 2.20b 
Formula C87H107Cl2CoN11O26 C36H32Cl2CoN3O12 C97H102CoN12O29 
Mr 1852.67 828.47 1958.83 
Crystal size 0.17 x 0.21 x 0.33 0.08 x 0.10 x 0.11 0.11 x 0.12 x 0.14 
Crystal system Triclinic Triclinic Triclinic 
Space group 𝑃1̅ 𝑃1̅ 𝑃1̅ 
a (Å) 11.8619(5) 10.68120(10) 11.97940(10) 
b (Å) 15.3330(5) 16.5920(2) 14.98320(10) 
c (Å) 16.0976(7) 17.0517(2) 15.91110(10) 
α (0) 110.509(3) 102.1580(10) 115.25 
β (0) 100.788(3) 105.3480(10) 98.9990(10) 
γ (0) 105.274(3) 99.0730(10) 105.5150(10) 
V (Å3) 2515.64(17) 2774.83(6) 2365.97(3) 
Z 1 2 1 
ρcalc (g.cm
-3) 1.223 0.992 1.375 
θ range (0) 3.08- 73.85 1.977- 25.068 1.522- 29.477 
No. data collected 21162 5923 40329 
No. unique data 9487 4633 14188 
Rint 0.0277 0.0191 0.0422 
No. obs. Data (I > 2σ(I)) 7839 4379 12279 
No. parameters 547 475 634 
No. restraints 4 0 1 
R1 (obs data) 0.1113 0.1456 0.0582 
wR2 (all data) 0.3398 0.4529 0.1798 
S 1.444 2.423 1.070 
Max. shift/esd 0.001 0.001 0.000 
Largest difference peak and hole/ (e Å3) 1.714,  -0.665 1.964,  -0.753 1.352,  -0.536 
Table 2.2 Crystallographic data. a = CuKα radiation, b = synchrotron radiation 
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Chapter 3  
Synthesis and structural variation of Ag(I) thiazolyl metallo-
supramolecular assemblies 
This chapter focuses on the preparation of a novel tripodal thiazolyl ligand and its 
assembly with Ag(I) salts, giving rise to a range of assemblies, including the first 
cyclotriveratrylene-based coordination cubes, and a diverse array of coordination 
polymers of complex connectivity. 
3.1 Introduction 
3.1.1 The thiazole motif in metallo-supramolecular chemistry 
Thiazoles are somewhat chemically similar to oxazoles, simply possessing a 
different chalcogen atom in sulfur rather than oxygen. Thiazoles are slightly stronger 
bases than oxazoles, and the mesomeric effects observed with oxazole systems are 
effectively suppressed because of the lower electronegativity of sulfur compared to 
oxygen.1 In contrast to oxazoles, which are not particularly abundant in biological 
systems, thiazoles are more commonly observed, with key biologically-relevant 
thiazole containing compounds including thiamine (vitamin B1)
2 and the 
bioluminescent firefly luciferin.3 
 Coordination complexes incorporating thiazole ligands have been 
extensively studied, with thiazoles being integrated into both monodentate and 
multidentate systems. The nitrogen-coordinating motif is ubiquitous in thiazole 
coordination chemistry. A key example includes Andersson’s Ir(I) complexes, 
which were capable of quantitatively catalysing asymmetric hydrogenations of 
trisubstituted alkenes, favouring the S enantiomer in >99% ee when using a 
cycloheptene-fused thiazole ligand (figure 3.1).4 The authors stated 
olefin-coordination at Ir(I) was only possible on the re face of the alkene, which 
exposed the si face, allowing asymmetric hydrogenation to take place. 
 
Figure 3.1 Andersson’s Ir(I)-thiazolyl cationic complex.3 The [BArF]¯ anion is omitted. 
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The thiazole motif has found use in metallo-supramolecular chemistry. Early work 
by Rice and co-workers incorporated pyridylthiazoles as ligand systems in double 
and triple Cu(II) helicates.5 Through assembly of two disk-shaped thiazolyl ligands 
at Ag(I), Shionoya and co-workers assembled [Ag3L2]
3+ complexes which 
assembled in a helical manner. The M and P enantiomers were observed at 298 K in 
a 1:1 ratio and crystals grown were of the racemate.6 Heating solutions of helicates 
to 328 K led to coalescence of signals, which upon taking advantage of the labile 
Ag-N interactions led to flipping between the P and M enantiomers at elevated 
temperatures (figure 3.2, left). A further study by the same group investigated a 
heteroleptic analogue possessing a hexathiazolylbenzene ligand.7 The [M3L
1L2]3+ 
complex assembled quantitatively through heterotopic recognition. VT NMR 
spectroscopy revealed that molecular motion was being exhibited by association and 
dissociation of the thiazole groups on the hexathiazolyl disk. A more recent example 
by Leigh and co-workers incorporated a thiazolo[5,4-d]thiazole unit into a ligand 
scaffold to prepare an interwoven 2 x 2 molecular grid (figure 3.2, right). After 
closing the grid using alkene metathesis chemistry, an interwoven Solomon link was 
isolated.8 
 
Figure 3.2 Left: Shiyonoya’s molecular gear, solvents and anions are omitted for clarity. Right: 
Leigh’s molecular grid. Isopentyl groups and anions are omitted for clarity. 
Assemblies of coordination polymers from thiazolyl ligands are somewhat scarcer 
than discrete complexes, and only a handful have been reported.9 A Cu(II)-MOF 
reported by zur Loye and co-workers incorporated a 
2-(4-pyridyl)thiazole-4-carboxylate scaffold, and assembled into a moganite 
topology.10 The authors remarked that the moganite topology is rarely seen, but is 
similar to the quartz topology. Aside from zur Loye’s MOF, examples are limited to 
coordination polymers incorporating non-coordinating thiazole spacers,11 or grown 
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solvothermally from a thiazole solution with metals bearing coordinating solvent 
molecules.12 
3.1.2 Ag(I) assemblies of CTV ligands 
Metal ions with predictable geometries due to crystal field effects can assemble with 
CTV ligands to yield well-defined architectures. For example, when furnished with 
cis-protecting ligands, the square-planar Pd(II) ion assembles with CTV-ligands to 
yield metallo-cryptophanes.13-16 If cis-protecting ligands are not employed, or the 
bidentate ligand is not a sufficiently strong σ-donor, the predicted stella octangula 
assembles with high fidelity.17, 18 In a contrasting manner, Ag(I) cations 
predominantly adopt linear and tetrahedral coordination modes, but trigonal planar 
and T-shaped geometries can also be observed. The lack of crystal field effects 
associated with Ag(I) means predicting the coordination mode and conformation of 
assemblies, and also the network topology of polymeric material is much more 
challenging, especially when ligands have a degree of flexibility associated. An 
incredibly diverse library of Ag(I) assemblies with CTV-ligands have been 
published, including mechanically interlocked cryptophanes19 (figure 3.3, left), 
tetrahedra (figure 3.3, right),20, 21 and a number of 1D,22, 23 2D23-27 and 3D 
coordination polymers.24, 25, 28 The applications of Ag(I) assemblies can be limited 
by their stability, owing to the high lability of Ag(I) complexes, which can 
dissociate when dissolved in coordinating solvent, in addition to photosensitivity. 
 
Figure 3.3 Left: Hardie's catenated metallo-cryptophane. Right: Hardie’s Ag4L4 tetrahedron. 
Solvent molecules and anions are omitted for clarity. 
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3.2 Synthesis of a thiazole-appended CTV ligand 
In a similar fashion to oxazole ligand 2.18, a thiazole ligand group was desired 
because of the poor stability of the imidazole precursor and problems encountered 
upon scale-up (Chapter 2). As ligands, thiazoles display a somewhat similar binding 
motif to imidazoles, where the nitrogen atom is Lewis basic, and the sulfur seldom 
partakes in coordination chemistry in the same way the protic nitrogen atom of 
imidazole does not. C-S bonds are the longest on the diazole due to a poorer orbital 
overlap between carbon and sulfur atoms, and the C-S-C portion of the ring becomes 
puckered as a result. Thiazolium salts can also be targeted, and M-NHC complexes 
bearing thiazolium-derived ligands have been previously reported, including a 
thiazolium derivative of Grubbs’ second generation catalyst as a key example.29 The 
major disadvantage of thiazol-2-ylidene ligands is that they afford complexes of 
lower stability than imidazolyl counterparts because the sulfur atom cannot be 
functionalised, leading to no steric protection of the metal from one side of the 
carbene, in addition to poorer π-overlap of sulfur p-orbitals with the carbenic pz 
orbital, and diminished σ-withdrawal compared to imidazol-2-ylidene systems.  
CTG 2.3 was furnished with thiazolyl groups upon reaction with the 
commercially available 4-(chloromethyl)thiazole hydrochloride, affording 
(±)-4,4',4''-(((3,8,13-trimethoxy-10,15-dihydro-5H-tribenzo[a,d,g][9]annulene-
2,7,12-triyl)tris(oxy))tris(methylene))trithiazole, 3.1 in good yields when employing 
caesium carbonate as the base, as shown in scheme 3.1. Upon the slow addition of 
water to the reaction mixture, 3.1 precipitated as a spectroscopically pure compound. 
Microanalysis suggested 3.1 was isolated as a hydrochloride salt, displaying a good 
match to 3.1·(HCl)·0.5(H2O).  
The 1H NMR spectrum of 3.1 (figure 3.4) suggested the successful synthesis 
of a C3-symmetric CTV ligand, with endo- and exo- doublets of H
12 sited at 4.71 and 
3.49 ppm. The methylene bridge between azole and CTV was observed at 5.30 ppm, 
considerably further upfield than the N-substituted benzimidazole (2.11) due to the 
decreased acidity of the methylene bridge located from 6.20-6.10 ppm. The two 
azolyl resonances, H1 and H2 were assigned at 8.81 and 7.38 ppm, considerably 
downfield compared to oxazole ligand 2.18, whose azolyl resonances were sited at 
7.87 and 7.11 ppm, presumably due to the more polarised H1 compared to the 
analogous proton in 2.18. Ligand 3.1·HCl can easily be neutralised by washing a 
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DCM solution of ligand with aqueous NaHCO3, before passing the organic phase 
through a silica plug. 
 
Scheme 3.1 Synthesis of thiazole ligand 3.1. 
 
Figure 3.4 1H NMR spectrum (300 MHz, 293 K, CDCl3) of 3.1. 
Assignment of the 13C{1H} NMR spectrum was aided by HMQC and HMBC 
experiments. The two CH2 groups, C
4 and C12 assigned as 67.82 and 36.62 ppm 
respectively, with the HMQC NMR spectrum displaying 1J coupling between the 
two endo- and exo- protons of the CTV bowl and the carbon environment at 36.62 
ppm. 13C{1H} NMR and DEPT-135 spectra are displayed in figure 3.5. 
The HRMS spectrum (figure 3.6) was also diagnostic, containing three 
molecular ion fragments assigned as {M+H}+ (m/z 700.1623), {M+Na}+ (m/z 
722.1414) and {M2+H}
+ (m/z 1399.3143) peaks (calculated at m/z 700.1605, 
722.1424 and 1399.3136 respectively). When monitoring reactions, the {MCs}+ 
fragment dominates. 
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Figure 3.5 13C{1H} NMR spectrum (75 MHz, 293 K, CDCl3) of 3.1 (top, black trace) with 117.0-
114.5 inset. DEPT-135 spectrum (bottom, blue trace). 
The HRMS spectrum (figure 3.6) was also diagnostic, containing three 
molecular ion fragments assigned as {M+H}+ (m/z 700.1623), {M+Na}+ (m/z 
722.1414) and {M2+H}
+ (m/z 1399.3143) peaks (calculated at m/z 700.1605, 
722.1424 and 1399.3136 respectively). When monitoring reactions, the {MCs}+ 
fragment dominates. 
 
Figure 3.6 HRMS (ESI+) of 3.1. 
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Crystals of 3.1·4(H2O) were grown by Dr. Flora Thorp-Greenwood, by standing 3.1 
in a mixture of DMF and H2O. Clathrate 3.1·4(H2O) crystallised in the chiral, 
hexagonal P63 space group. The asymmetric unit comprises of one third of a CTG 
bowl and two crystallographically distinct water molecules (figure 3.7, left). 
Spontaneous resolution upon crystallisation occurred, with a single enantiomer of 
ligand observed in a particular crystal. Conglomerate 3.1·4(H2O) exhibits 
bowl-in-bowl stacking, with a CTG centroid separations of 5.135 Å, which is a 
considerably longer distance than a number of previous example ligands.30 The 
ligands do not quite sit flush, with each bowl rotated about 60º throughout the stack 
in an ABAB arrangement (figure 3.7, right). The ligand arms are extended outwards, 
and align in the plane of the arene groups of the CTG bowl. The Cthiazole-C-O-Carene 
torsion angle is near-linear at -179.3º, with the thiazole sulfur atom sitting furthest 
away from the CTG bowl, and the nitrogen atom aligned towards the methoxy 
group. 
 
Figure 3.7 Left: Asymmetric unit of 3.1·4H2O. Ellipsoids are drawn at the 50% probability. 
Right: Bowl-in-bowl stacks of 3.1 ligands. 
Four waters of crystallisation reside within the pores of the crystal lattice and form a 
2D hydrogen-bonding network with thiazole nitrogen atoms at a N…O separation of 
2.895 Å (figure 3.8, top). The crystallographically distinct water within the tetramer 
is separated from neighbouring oxygen atoms by O…O distances of 2.915 Å. The 
hydrogen bonding network forms a 63 network topology with a honeycomb 
structure, as shown in figure 3.8. 
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Figure 3.8 Top: 63 topological 2D-hydrogen bonding network, Bottom left: 63 topology of 2D 
sheets in ABAB array with individual sheets shown in red and blue. Bottom right: 
  A single hexagonal layer. 
A second conglomerate of thiazole ligand crystals, in the form of 3.1·3(MeNO2) 
were grown by diffusing diethyl ether vapours into a solution of 3.1 in nitromethane. 
Clathrate 3.1·3(MeNO2) crystallised in the hexagonal 𝑅3̅ space group, with the 
asymmetric unit comprising of one third of 3.1 and a fully occupied nitromethane 
solvate molecule (Figure 3.9). Similarly to 3.1·4(H2O), nitromethane clathrate 3.1 
displayed chiral self-sorting, A Cthiazole-C-O-Carene torsion angle of 178.9º was noted, 
which once again is near-linear, but the thiazole groups in both structures have 
distinct rotations. In the 3.1·3(MeNO2) case, the thiazole nitrogen atom is pointing 
away from the methoxy group as opposed to being of opposite orientation in 
3.1·4(H2O). 
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Figure 3.9 Asymmetric unit of 3.1·3MeNO2. Ellipsoids are drawn at the 50% probability. 
Both 3.1·4(H2O) and 3.1·3(MeNO2) display bowl-in-bowl stacking, in the 
nitromethane clathrate case, at a separation of 4.4 Å, a considerably shorter distance 
than the hydrogen-bonding network. Channels run down the crystallographic c axis 
of 3.1·3(MeNO2), containing three crystallographically identical MeNO2 molecules, 
as shown in figure 3.10. The stacks are also perfectly aligned in 3.1·3(MeNO2). The 
thiazole nitrogen atoms are directed towards the nitromethane-filled pores, the 
methyl groups of MeNO2 align themselves within the hydrophobic pocket of the 
CTV outer-rim at a CMeNO2···COMe separation of 3.645 Å. Nthiazole···NMeNO2 and 
O···O distances between nitromethane guests of 3.645 Å and 3.818 Å respectively 
exist in the clathrate. 
 
Figure 3.10 Packing diagram of 3.1·3MeNO2 looking down the crystallographic c axis. 
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Both enantiomers of ligand crystallised. Fortuitously, the studied crystal of 
3.1·4(H2O) was of the P-enantiomer of ligand, whereas 3.1·3(MeNO2) comprised of 
the M-enantiomer. 
3.3 Metallo-cube assembly 
Drawing inspiration from cryptophane 2.12, linear trans-coordinating metals were 
desired, and initially, coordination studies with Pd(II) sources including 
[Pd(Cl)2(MeCN)2] which offer this geometry were targeted. Within ca. 7 days, a 
pale yellow solid precipitated, and HRMS of the mother liquor revealed no evidence 
of Pd(II) coordination. The common linear 2-coordinate geometry exhibited by 
Ag(I) would allow for 3.1 to use the same binding mode. Attempts to assemble 
ligand 3.1 with Co(II), Ni(II), Cu(I), Cu(II), Zn(II) and Pd(II) were unsuccessful, 
with no solution-state evidence implying complexes had assembled. It was 
intriguing that only Ag(I) salts yielded crystalline coordination complexes with 
ligand 3.1. 
 
Figure 3.11 Crystal structure images of 3.2. 
Diffusion of diethyl ether vapours into mixtures of 1.5 eq. of AgBF4 or AgReO4, and 
3.1·HCl in DMF, which were kept in the dark led to the assembly of isostructural 
[Ag12L8]12X
¯ metallo-cubes (X = ReO4
¯ = 3.2, X = BF4
¯ = 3.3), which crystallised 
as pale orange cube-shaped crystals within a week (figure 3.11). A powdered 
contaminant also appeared in the vial, assumed to be AgCl. Crystals initially grew 
on the base of the vial where AgCl resided, behaving as a nucleation bed. Cube 
crystals did still grow after neutralisation of ligand, but crystal growth required 
much longer durations, was much lower yielding and side-reactivity occurred (see 
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Section 3.4). Cube crystals grown after neutralising the ligand were also orange, 
although much paler in colour. The unit cell parameters were identical in all cases. 
Crystals of 3.2 and 3.3 also be grown from DMAC and NMP solutions, 
which bore the same unit cell parameters as their counterparts grown in DMF. 
Studies in this chapter only involved complex grown from DMF. EDX 
(energy-dispersive X-ray spectroscopy) analysis of cube crystals grown confirmed 
the only heavy elements present were Ag, S, and Re for 3.2 and Ag, S, and F for 3.3. 
No chlorine was detected, so it is unlikely AgCl templated assembly of metallo-
cubes. 
The asymmetric unit of 3.2, [Ag12(3.1)8]12(ReO4)·n(DMF) comprises of a 
third of a ligand, one silver ion, and fragments of two perrhenate anions, one of 
which is external to the cubic core, and an internal perrhenate anion of low 
occupancy, which resides on a four-fold symmetry axis and is therefore subjected to 
symmetry-induced disorder (figure 3.12, left). Metallo-cubes 3.2 and 3.3, 
[Ag12(3.1)8]12(BF4)·n(DMF), both crystallised in the chiral, cubic F432 space group 
and are isostructural. The asymmetric unit of 3.3 comprises of a third of a ligand and 
one Ag(I) ion (figure 3.12, right). Neither anions nor solvent in the structure of 
complex 3.3 could be located within the difference map, therefore the SQUEEZE 
function of PLATON was employed on this structure.31 
 
Figure 3.12 Left: Asymmetric unit of 3.2. Right: Asymmetric unit of 3.3. Ellipsoids are drawn 
at the 50% probability. 
Only nitrogen atoms coordinated to Ag(I) cations in 3.2, with a Ag-N bond length of 
2.151(15) Å. Near-linear coordination of thiazoles was exhibited, with N-Ag-N 
bond angles 175.9(8)º. The thiazolyl ligands were askew from a plane, with a 
C-N-N-C torsion angle of -31.9º. A weak H-bonding interaction between the NCHS 
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thiazolyl proton and partially occupied internal perrhenate anion was measured, with 
a C···O separation of 3.30 Å.  
 The ligands in 3.2 and 3.3 adopt threefold symmetry. Each CTV ligand 
behaves as a cornerpiece, and is connected to three nearest neighbours through 
coordination to Ag(I), which in turn connect two ligands in an M12L8 fashion. Rather 
than the anticipated scenario of Ag(I) cations residing on the cube edges, the 
thiazolyl group adopts a Cthiazole-C-O-Carene torsion angle of -83.6º and fold inwards 
above the bowl, as opposed to residing in the plane of the cavitand benzo-groups. 
This folding motif buries the Ag(I) cations within the interior of the cube, preventing 
exo-coordination (figure 4.14, bottom), and they also cannot be observed in the 
space-filling model (figure 3.13, right)). The thiazole sulfur atom is orientated on the 
external face of the cube, with the coordinating nitrogen internally.  
 
Figure 3.13 Top left: Metallo-cube 3.2 looking down a face one vertex. Top right: Space-filling 
diagram displaying sulfur-edged windows. Bottom: Ag(I)-connectivity between 3.1 
ligands. 
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Small windows exist on each face of the cube (figure 3.12), at S···S diameters of 
6.00 Å, and the overall diameter of the cube measured from the centroids of 
tribenzo[a,d,g]-cyclononatriene ligand core was 14.7 Å, and 25.4 Å across the 
diagonal body. Separations of 8.71 Å were measured between Ag(I) cations, and the 
internal volume of M12L8 cubes was measured as ca. 5000 Å
3 excluding anions 
when using a 1.2 Å probe. 
Extensive π-π stacking interactions were observed at the vertices, between 
arene faces of tribenzo[a,d,g]-cyclononatriene cores at separation of 3.81 Å. 3.2 and 
3.3 both engage in cubic close packing arrays. One cube complex interacts with 
twelve neighbouring cubes in a close cubic packing array, with π-stacking occurring 
on the cube edges (figure 3.14). 
 
Figure 3.14 Edge-directed π-π stacking of metallo-cubes. 
Homochiral recognition is also observed in 3.2 and 3.3 crystals, and all eight ligands 
in a single cube complex are the same enantiomer. Examples of racemic ligands 
undergoing homochiral self-sorting upon metal-directed assembly are known,32, 33 
including cages34-38 and a number of CTV-systems.15, 17, 39, 40 Complexes 3.2 and 3.3 
both display a further level of homochirality, with spontaneous resolution occurring 
and crystallisation as conglomerates; only one ligand enantiomer is seen in a single 
crystal of 3.2 or 3.3. Spontaneous resolution of both cages and the bulk mixture is 
known, but a much rarer phenomenon than just the former. Examples include a cage 
reported by Rissanen and co-workers,41 and CTV derivatives including a 
hemicryptophane42 and organic cryptophanes.43, 44 For a timely review on chiral 
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metallo-supramolecular assemblies, see Shiyonoya et al.45 The bulk sample 
contained both enantiomers of cube complexes, and fortuitously, the crystals of 3.2 
and 3.3 studied in single crystal X-ray diffraction were of opposite handedness. The 
unit cell of both 3.2 and 3.3 reveal face-centred cubic packing, as shown in figure 
3.14. 
 
Figure 3.15 Left: Unit cell diagram of 3.2. Right: Unit cell of 3.3, both display the FCC motif. 
Very high symmetry is associated with 3.2, with a Russian Doll arrangement of 
components observed, as shown in figure 3.16. The six internal perrhenate anions 
sited behind each S4 window on each face of a cube formed an octahedron, which 
were surrounded by a cuboctahedron of Ag(I) cations, encompassed within the cube 
of ligand centroids, which were all inside a rhombicuboctahedron comprising of the 
external perrhenate anions. 
 
Figure 3.16 Matryoshka diagrams of 3.2. Internal anion connectivity shown in light blue, Ag(I) 
connectivity in black, CTV centroids in red and external anions in blue. 
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FTIR spectra of 3.2 and 3.3 both contain the relevant B-F and Re-O stretches at 
1046 and 903 cm-1 respectively. PXRD patterns for both 3.2 (figure 3.17) and 3.3 
(figure 3.18) are a good match to the simulated spectra obtained from the .res files 
associated with studied crystals, suggesting the bulk crystalline material is 
phase-pure. 
 
Figure 3.17 PXRD spectrum of 3.2. Simulated data from crystal structure (100 K, blue), 
Observed data from bulk material (rt, red). 
 
Figure 3.18 PXRD spectrum of 3.3. Simulated data from crystal structure (100 K, black), 
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Cube-shaped crystals grew within ca. 7 days of initial reaction. Naturally, the longer 
the crystals were untouched, the larger growth, and it was not uncommon to observe 
crystals >400 μm in diameter if vials were stored in the dark for 3-4 weeks. SEM 
and optical microscopy imaging revealed cube crystals to have a regular truncated 
cube shape (SEM figure 3.18 top left, and optical microscopy figure 3.19 bottom). 
Defects did begin to appear when drying crystals in vacuo, and surface cracks were 
evident (figure 3.19 top right). Whilst samples were always stored in darkness when 
not studied as a precaution to the known photosensitivity of silver, a crop of 3.2 
deliberately exposed to light for 24 h showed no obvious signs of decomposition. 
SEM and optical microscopy experiments were performed by Dr. Alex Kulak. 
 
 
Figure 3.19 SEM image of a single cube crystal of 3.3 (top left) and a crop of 3.3 crystals (top 
right). Bottom: Optical microscopy image of a crystal of 3.3. 
3.2 and 3.3 are rare examples of metallo-cubes bearing ligand-residing vertices of 
M12L8 stoichiometry. Robson and co-workers reported the first example of a Cu12L8 
metallo-cube of such nature in 1999, whilst Li and co-workers have prepared rigid 
tritopic terpyridyl ligands which behaved as cornerpieces in the edge-directed 
assembly of platonic cubes.46, 47 Metallo-cubes are more commonly the inverse, with 
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the metal residing on the corner in an edge-directed M8L12 assembly
48 or a 
face-directed M8L6 fashion.
49 
 CTV offers itself as an ideal cornerpiece for a cube, with all three hydroxyl 
groups roughly orthogonal to one another with respect to the centroid of the 
cyclononatriene core, assembly of coordination cubes were previously elusive. 
Organic derivatives were however known; Warmuth and co-workers reported an 
organic cube assembling through edge-directed dynamic covalent chemistry, by 
reacting an aldehyde-functionalised CTV with p-phenylenediamine.50 Kuck,51 
Beuerle52 more recently Mastalerz53 have reported organic supramolecular cubes 
assembling through similar means using vertices based on the closely related 
tribenzotriquinacene (TBTQ) motif.  
Despite the organic precedent, edge-directed metallo-supramolecular cubes 
bearing CTV-derived ligands had previously not been reported. Instead, an 
assortment of 3D assemblies, with the thermodynamically favourable cryptophanes 
being most dominant.13, 19 Stellated octahedra17, 18, 40 and a Pd4L4 topologically 
complex Solomon cube40 were the closest examples to M12L8 cubes, prior to their 
discovery. 
3.3.1 Solution state studies of 3.2 and 3.3 
Crystals could be redissolved in polar aprotic solvents such as DMF and DMSO, but 
evidence suggested dissociation of the labile Ag-N bonds in solution was occurring, 
and that both 3.2 and 3.3 were not remaining intact upon dissolution. The 1H NMR 
spectrum of a mixture of 3.1 and AgBF4 in DMF-d7 after 24 h was very broad 
(figure 3.20), whilst the HRMS of 3.2 dissolved in DMF contained peaks 
corroborating [AgL]+ (808.0561) and [AgL2]
+ (1507.2125), calculated 808.0574 and 
1507.2015 respectively, as shown in figure 3.21. Metal coordination is occurring in 
solution, although the labile Ag-N bonds in 3.2 and 3.3 are appearing to dissociate, 
therefore solution state data is unlikely to be reflective of [M12L8]
12+ metallo-cubes. 
The high resolution mass spectrum of 3.2 was obtained by Dr. Stuart Warriner using 
direct injection techniques. 
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Figure 3.20 1H NMR spectrum (300 MHz, 293 K, DMF-d7) of AgBF4 and 3.1 after 24 h. 
 
Figure 3.21 HRMS of complex 3.2. 
3.3.2 Investigations into applications of metallo-cubes 
A number of studies on 3.2 and 3.3 were carried out, with guest-binding and 
post-synthetic modification the primary targets. Assessment of their material 
properties was then carried out. Powder XRD suggested the 3.2 and 3.3 were 
phase-pure (figures 3.17 and 3.18). Crystals of 3.2 and 3.3 were then activated by 
soaking in DCM for 48 h before vacuum filtration and drying. The diffraction 
pattern obtained for DCM-soaked crystals of 3.3 is less distinct (figure 3.22), 
possibly indicating a deterioration of crystallinity in the sample. 
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Figure 3.22 PXRD spectrum of 3.3·nDMF (blue trace) and 3.3 after soaking in DCM and 
drying in vacuo (red trace). 
A number of strategies for post-synthetic modifications were carried out, many 
revolved around the notion of imparting reactivity at the Ag(I) centres, and/or 
transmetallating onto other substrates. Iodine uptake was attempted, both through 
diffusion of vapours into a vial of crystals, and soaking crystals in an ethereal 
solution of iodine, but was unsuccessful. A white powder appeared instead, and it 
may be possible that redox activity ensued. Ag(I) reactions with elemental iodine is 
a primary method to prepare the I+ cation. No evidence of transmetallation onto I+ 
yielding a halogen-bonded adduct was observed. Taking this on board, 
transmetallation onto other linear, d10 metals was also attempted, including reactions 
with solutions of [Cu(MeCN)4]BF4, [Au(nbe)3]BF4 (nbe = norbornene), and 
Zn(BF4)·XH2O, but were to no avail. 
 The only access to the internal cavity is through the small 6 Å windows of 
the cube faces, therefore any potential guest species must be able to thread through 
the small openings of the assembly. Linear dinitriles were targeted as they may be 
able to permeate the windows of the cube, in addition to internally coordinating to 
Ag(I), skewing the coordination geometry of the metal, and potentially altering the 
size and shape of the architecture. A range of chain lengths were trialled, ranging 
from malononitrile (NC(CH2)CN) to sebaconitrile (NC(CH2)8CN). FTIR would 
provide a strong handle for encapsulation studies, with the target 
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cm-1. There was however no evidence of coordination or uptake of dinitriles into the 
cubic lattice. Hardie and co-workers have previously coordinated dintriles to linear 
Ag(I) salts, leading to the assembly of coordination polymers assembled about 
tetrahedral Ag(I).54 
 A BET isotherm was obtained on a 50 mg sample of 3.3, to determine the 
ability of metallo-cubes adsorbing N2 onto the internal and external surface of 
metallo-cubes. An extremely low BET surface area was, however, calculated of 
3.3769 ± 0.6444 m2g-1, so further studies into gas sorption were not carried out. The 
isotherm gave a linear positive gradient, perhaps suggesting a non-porous material. 
A calixarene coordination cage has a calculated surface area of 558 m2g-1 displaying 
hysteresis in the BET isotherm,55 which is considerably less than Farha’s MOF, 
possessing a calculated surface area of ca. 7560 m2g-1.56 
3.4 Assembly of complexes after neutralising ligand 3.1  
Examples of slight contaminants such as HCl encouraging crystallisations have been 
documented in the Hardie group, so it was of interest to investigate both 
coordination when using 3.1·HCl, and neutral 3.1 obtained by washing a DCM 
solution with aq. NaHCO3, and passing the DCM (5% MeOH) solution through a 
silica plug (scheme 3.2). When assembling 3.1 with AgBF4, the powdered 
contaminant presumed to be AgCl was absent, and crystal growth took considerably 
longer than the week reported previously. A smaller crop of cube crystals grew after 
one month. Additionally, a small number of colourless rods (ca. 10% of the bulk) 
also grew in the vial. Separation of rods and cubes was difficult because rod and 
cube crystals grew within close proximity of one another. Single crystal XRD on the 
rod-shaped crystals confirmed the structure as a 3D coordination polymer of 
complex topology. 
 
Scheme 3.2 Neutralisation of ligand 3.1. 
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Crystals of ([Ag83.16](BF4)8)n, 3.4, were obtained as a minor impurity from 
cube assembly from the diffusion of diethyl ether vapours into a DMF solution of 
AgBF4 and 3.1. Coordination polymer 3.4 crystallised in the hexagonal R3 space 
group with an asymmetric unit comprising of eight Ag(I) ions and six 3.1 ligands 
(figure 3.23). The unit cell size was extremely large and measured as 76.13(12) x 
76.13(12) x 16.27(3) Å, with a cell volume of 81,651(3) Å3. Attempts to solve the 
structure after indexing to a smaller unit cell were unsuccessful. The polymer was of 
high symmetry, with the smallest repeating unit being [Ag8L6]. A full complement 
of anions and solvent molecules could not be located within the difference map, 
therefore the SQUEEZE routine of PLATON was employed.31 The six inequivalent 
ligands have been labelled a-f to allow for more straightforward rationalisation.  
 
Figure 3.23 Asymmetric unit of [Ag8(3.1)6](BF4)8]n. Ellipsoids are drawn at the 50% 
probability. The thiazolyl unit on ligand a denoted by * coordinates to Ag6  
 rendering 3.4 3D in nature. 
Unlike 3.2 and 3.3, both enantiomers of ligand were observed in the asymmetric unit 
in a 50:50 ratio. The two-coordinate Ag(I) cations were linked by one M- and one 
P-enantiomer of 3.1. The varying coordination modes of Ag(I) centres gave 
coordination polymer 3.4 high complexity. Of the eight Ag(I) cations, five (Ag1, 
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Ag3, Ag4, Ag5 and Ag8) were 2-coordinate, with Ag-N bond lengths ranging 
between 2.056(16) Å (Ag3-N7) and 2.212(17) Å (Ag6-N13) and all 2-coordinate 
N-Ag-N bond angles near-linear from 178.3(6)º (Ag8) to 167.4(6)º. The three 
remaining Ag(I) centres in the asymmetric unit were 3-coordinate, displaying 
considerably different coordination modes to one another. Ag2 and Ag7 are 
coordinated to two thiazolyl units and a DMF solvent molecule, with Ag-N bonds of 
2.090(13) Å and 2.167(16) Å (Ag2), and 2.153(14) Å and 2.171(14) Å (Ag7), and 
longer Ag-O lengths of 2.502(17) Å (Ag2) and 2.464(17) Å (Ag7). The N-Ag-N 
angle about Ag2 was 159.1(6)º and N-Ag-O angles measured at 85.7(6)º and 
114.3(6)º. For Ag7, the analogous bond angles were 154.2(6), 84.3(6) and 120.6(6)º 
respectively. The bond angles of these centres give rise to distorted T-shape 
geometries. Ag6 was also 3-coordinate, displaying a coordination mode more typical 
of an offset trigonal planar Ag(I) centre and coordinates to three thiazolyl moieties, 
with N-Ag-N bond angles of 106.7(6), 119.1(7) and 130.9(6)º. Two thiazolyl units 
are in the ASU, with Ag-N bond lengths measured as 2.194(15) and 2.212(17) Å, 
whilst the third Ag-N bond length was elongated at 2.330(18) Å, and was identified 
as belonging to ligand a. The Carene-O-C-Cthiazole torsion angle of this thiazolyl group 
is markedly different to the rest in the structure, and was measured as 103(2)º. This 
third thiazolyl moiety links layers of the polymer, and forms helical chains through 
the c-direction. The handedness of the polymeric helicate renders the crystals chiral. 
The CTV-bowl donating this thiazolyl group to Ag(I) exhibits bowl-in-bowl 
stacking with a ligand of the same handedness at a centroid-centroid separation of 
4.819 Å. Save the aforementioned Carene-O-C-Cthiazole torsion angle, the rest of the 
comparable angles in 3.4 remain within 20o of plane of the CTV arene face, 
typically with values between -169 -179o, and 162-174o. One thiazolyl unit of the 
eighteen in the asymmetric unit is non-coordinating, and leads to the hexagonal 
metallacycles not all being fully connected (figure 3.24). 
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Figure 3.24 An M6L6 metallacycle (highlighted in blue box) surrounded by three hexagonal 
helical arrays in 3.4. 
As expected for a material of high complexity, a number of inter-layer interactions 
were observed, including bowl-in-bowl stacking at centroid-centroid separations 
between 4.63 and 4.93 Å. CTV bowls in these stacks align near-perfectly. 
Bowl-in-bowl stacking between two offset cavitands at 6.82 Å were also measured. 
The non-coordinating thiazole of ligand f resides 3.58 Å above Ag3, but the thiazole 
π-cloud is perpendicular to the Ag(I) cation. A thiazolyl sulfur of ligand b resides 
3.297 Å above Ag4, undertaking a weak cation-π interaction.  
Expanding 3.4 along the crystallographic c axis revealed a topologically 
complex polymer, displaying much more intricate connectivity than the space filling 
diagram in figure 3.25 suggests. By joining 3-coordinate sites in the network as 
shown in figure 3.26 (ligand bowl centroids dark blue, Ag6 light blue), a highly 
complicated helicated array was observed, with both M and P helices observed 
within the crystal structure. Each helix comprised of five ligand centroids and one 
Ag6 equivalent, and did not form a six-membered ring. Furthermore, fully 
connected hexagons of six ligand centroids were observed on each layer furthest 
away from Ag6 equivalents. Significant channels were observed in the structure of 
3.4 (figure 3.26), with a volume measured at ca. 28,000 Å3 using a 1.2 Å probe.31 
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Figure 3.25 Space filling diagram of polymer 3.4 observed down the crystallographic c axis. 
 
Figure 3.26 Left: 3-fold connectivity of polymer 3.4, displaying helical behaviour. Right: 
hexagonal L6 channels (right). Connectivity between CTV centroids shown in  
 dark blue and connectivity to Ag6 shown in light blue. 
Attempts to increase the ratio of polymer crystals relative to cubes were carried out 
including decreasing the assembly temperature to -20 ºC, but this inhibited 
crystallisation. Difficulties separating the small quantity of polymer crystals, and 
increasing ratios of polymer grown meant further analysis beyond screening a 
number of crystals was too problematic. 
3.4.1 Ag(I)-thiazolyl assemblies of non-tetrahedral anions 
When using 3.1·HCl, cube crystals formed with tetrahedral anions (BF4
¯, ReO4
¯) 
subject to symmetry-induced disorder. Crystallisations of the reaction of 3.1·HCl 
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with AgPF6 were set up, but crystalline material was not obtained. 
Post-neutralisation gave different results altogether. Colourless cube-shaped crystals 
of 3.5 with composition [Ag12L8]12(PF6)·5(H2O) with the same cube motif as 3.2 
and 3.3 could be grown over a 4-6 week period, with unit cell parameters near 
identical to those of 3.2 and 3.3, table 3.2. Crystals were also obtained in lower 
yields, consistent with the assembly of 3.2 and 3.3 when using neutral 3.1 as a 
precursor. The structure of complex 3.5 was solved in the F432 space group with the 
asymmetric unit comprising of one third of a CTV unit, two anions, one internal to 
the cube of low occupancy and two water molecules, one of full occupancy exo to 
the cube, and one guest of low occupancy residing above the cavitand within the 
interior of the cube (figure 3.27). The Ag-N bond length was measured as 2.14(2) Å, 
near-identical to those in 3.2 and 3.3. 
 
Figure 3.27 Top: Asymmetric unit of [Ag12(3.1)8](PF6)12·3.66H2O, 3.5. Ellipsoids are drawn at 
the 50% probability. Bottom: Fully grown complex of 3.5. External anions and water 
molecules are omitted for clarity. 
In addition to cube crystals, a very small crop of colourless rods were grown in the 
same vial with hexagonal unit cell parameters of a = b = 76.868(4) Å, c = 
16.1769(7) Å, the same dimensions as 3.4. Crystals were of too poor resolution to 
obtain a full dataset. In addition to AgPF6, a propensity to grow colourless 
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cube-crystals when employing AgOTf was also exhibited. The unit cell parameters 
measured in this case during crystal screening were cubic a = b = c = 35.6991(3) Å, 
consistent with the formation of the Ag12L8 cube. No rod-shaped crystals were 
visible in this reaction vessel. 
 One silver salt previously employed in the Hardie group is silver 
cobalticarborane Ag[CoCb2], a bis-carbollide species containing a Co(III) cation 
sandwiched between two nido-carborane units. 3.1·HCl and 1.5 eq. AgCoCb2 were 
dissolved in DMF and diethyl ether vapours diffused into the vial. 
Hexagonal-shaped plates were grown with unit cell parameters of a = 47.561(2) b = 
27.0856(13) c = 35.7374(14), α = γ = 90º β = 105.639(4)º. Crystals were extremely 
thin in one plane, which led to poor resolution and no diffraction beyond 1.7 Å. 
However, after neutralising 3.1, diffusing diethyl ether into a DMF solution of 3.1 
and 1 eq. AgCoCb2, a small crop of pale yellow blocks grew after ca. one month 
which were different to the plates obtained when using 3.1·HCl. SCXRD revealed 
the 2D coordination polymer, [Ag33.13](CoCb2)3(C3H7NO)5)n, complex 3.6. Crystals 
were solved in the 𝑃1̅ space group, with the asymmetric unit comprising of three 
ligand molecules, three Ag(I) cations, three cobalt bis-carbollide anions and five 
DMF solvent molecules (figure 3.28). 
 
Figure 3.28 Asymmetric unit of [Ag3(3.1)3][Co(C2B9H11)2]3·5DMF, 3.6. Ellipsoids are drawn at 
the 50% probability. 
- 113 - 
The two P-enantiomers of ligand 3.1 partake in bowl-in-bowl stacking at a 
centroid-centroid separation of 4.394 Å, significantly shorter than the bowl-in-bowl 
stacks observed in polymer 3.4. Two thiazolyl moieties from both ligands in the 
stack interact with 3-coordinate Ag(I) centres. The third Ag(I) ion displays 
near-linear 2-coordinate geometry. The Ag-N bond lengths around 3-coordinate 
centres range between 2.210(5) (Ag2-N1) and 2.403(7) Å (Ag1-N4), with the 
longest Ag-N bond being longer than the similar 3-coordinate Ag(I) centre in 3.4. 
N-Ag-N bond angles about Ag1 were measured as 85.0(2), 135.3(2) and 139.1(2)º, 
and 90.72(19), 132.65(18) and 136.04(19)º about Ag2, being heavily distorted from 
both trigonal planar and T-shaped geometries. The near-linear Ag(I) centre featured 
an N-Ag-N of 175.0(2)º, almost identical to the angles featured in cube 3.2. Bond 
lengths of 2.128(5) Å and 2.136(5) Å were also much shorter than measured about 
the 3-coordinate Ag(I) centres in 3.6. Carene-O-C-Cthiazole torsion angles displayed on 
thiazoles bridged by 2-coordinate Ag(I) centres were both near anti-periplanar, 
measured as -179.178 and 167.092º. The M-enantiomer of ligand displayed dihedral 
angles associated with the same group of 163.860 and 177.329º, both of which 
coordinated to 3-coordinate Ag(I). Torsion angles associated with the same group on 
uppermost P-enantiomer in the stack were in plane with the CTV-arene faces, 
measured as -179.4 and 178.0º. More strain was exhibited on the torsion angles on 
the bottom P-enantiomer in the stack, whose torsion angles towards 3-coordinate 
Ag(I) centres, were measured as -132.867 and -132.254º, ca. 30º less than the 
strained group coordinating to a similar Ag(I) centre in polymer 3.4. In a manner 
comparable to polymer 3.4, one thiazolyl unit remains non-coordinated and is 
located on the lowest P-enantiomer in the stack. The nitrogen atom of this unit was 
measured as 3.39 Å from the nearest Ag(I) ion, but is both perpendicular and 
considerably offset from the metal centre.  
Extending the structure reveals hexagonal channels are distributed throughout 
the polymer, but are filled with cobalticarborane anions and DMF solvent 
molecules, rendering the polymer non-porous and potentially templating polymer 
assembly (figure 3.29). Extensive bowl-in-bowl stacking was exhibited by 3.6, with 
stacks comprising of only one enantiomer. Bowl-in-bowl stacking between polymer 
sheets were measured at 4.854 Å, slightly longer than between the two stacking in 
the same polymer unit. Crystals overall were racemic, with alternating sheets 
comprising of a 2:1 ratio with opposite enantiomers forming the majority. Each 
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sheet displays a 63 topology, with hexagonal channels arising and each CTV ligand 
connecting to three neighbouring units (figure 3.30). Homochiral recognition was 
observed in 3.6, with a 2:1 ratio of P:M enantiomers of ligand observed in the 
asymmetric unit, which was consistent throughout that 2D sheet, alongside 
homochiral bowl-in-bowl stacks. Overall, T symmetry renders the crystals racemic, 
with alternating 2D sheets comprising of ligand ratios P2M and M2P.  
 
Figure 3.29 Packing diagram of 3.6 looking down the crystallographic c axis. 
 
Figure 3.30 63 Network topology exhibited by polymer 3.6. 
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A PXRD spectrum (figure 3.31) was obtained for the bulk material isolated for 3.6. 
Key low-angle peaks do overlap. Very few peaks were observed at 2θ > 20º, and it 
is unclear whether the bulk material is phase pure. 
 
Figure 3.31 PXRD spectrum of polymer 3.6. Simulated pattern (black, 100 K), experimental 
data (red, rt). 
3.5 Synthesis of an ester-linked thiazole ligand 
The two major methods used to functionalise CTG 2.3 are through the SN2 reaction 
with an alkyl halide, cf. 2.4, 2.11, 2.18, 3.1. The other method not explored yet is 
through reaction of CTG with an acid chloride. Ester-linked ligands are much more 
rigid, which can aid crystallisation of metallo-supramolecular assemblies. The 
archetypal isonicotinoyl ligand has been used to generate a diverse array of 
materials, including Borromean chainmail57 and metallo-cryptophanes.14, 17 
Ester-linked analogues of N-functionalised benzimidazole 2.11 were avoided 
because of the arising carbamate group, which would likely hydrolyse under basic 
conditions, but remain an option for backbone-functionalised azole ligands. The 
major disadvantage of ester groups on a ligand scaffold is their base-sensitive 
nature. This would make them unviable materials for the synthesis of metal-NHC 
complexes desired in this project, so therefore were only used for assembly 
purposes.  
(±)-3,8,13-Trimethoxy-10,15-dihydro-5H-tribenzo[a,d,g][9]annulene-2,7,12-
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chloride and CTG under weakly basic conditions (scheme 3.3). The reactive nature 
of acyl chlorides via hydrolytic means led to the treatment of thiazole-4-carbonyl 
chloride as a reaction intermediate. Thiazole-4-carbonyl chloride prepared by 
heating a solution of carboxylic acid in neat SOCl2 at reflux. SOCl2 was removed in 
vacuo and replaced with THF. The acyl chloride solution subsequently was added to 
a basic CTG solution in THF.  
Scheme 3.3 Synthesis of ester-linked ligand 3.7.  
Ligand 3.7 displayed poorer solubility than the ether-linked 3.1, which is a common 
observation in CTV chemistry because of fewer degrees of rotational freedom 
associated with the ester group. The 1H NMR spectrum of 3.7 (figure 3.32) was 
diagnostic for an ester-linked CTV ligand. The two thiazole resonances were 
significantly further downfield than CTV aromatics at 9.25 and 8.83 ppm. No 
ethereal CH2 group was present, therefore no resonances were observed in the 2.5 
ppm window between the CTV-endo protons and the arene groups. The doublet 
associated with the endo-H12 proton at 4.89 ppm is diagnostic for a C3-symmetric 
CTV ligand. COSY and HMQC NMR spectroscopy confirmed the exo-resonance 
was hidden under the methoxy group. 
 
Figure 3.32 1H NMR spectrum (300 MHz, 298 K, DMSO-d6) of 3.7. 
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The 13C{1H} NMR spectrum (figure 3.33) also displayed a good match to 3.7. The 
furthest downfield carbon was assigned as the carbonyl carbon, C4 at 158.77 ppm, 
and no HMBC couples were observed at this site. C12 appeared at 34.97 ppm, 
comparable to benzimidazole 2.11, whose analogous carbon resonance appeared at 
37.07 in the same NMR solvent.  
 
Figure 3.33 13C{1H} NMR spectrum (75 MHz, 298 K, DMSO-d6) of 3.7. 
The high-resolution mass spectrum of 3.7 (figure 3.34) displayed an excellent match 
to the desired product, with the {M+H}+ peak dominating the spectrum with 
m/z = 742.0979 (calculated 742.0982). An FTIR spectrum was also obtained, with a 
strong absorption observed at 1737.41 cm-1, diagnostic for the C=O stretching 
frequency in a ester group. 
 
Figure 3.34 HRMS of ligand 3.7. 
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Single crystals of composition 3.7·C4H10O·H2O suitable for diffraction were grown 
from the diffusion of diethyl ether into an acetonitrile solution of ligand. The 
structure was solved in the hexagonal 𝑃3̅ space group, and the asymmetric unit 
comprised of one third of 3.7, a partially-occupied diethyl ether molecule and two 
half-occupied water molecules, as displayed in figure 3.35. The ligand equivalent 
possesses strict C3 symmetry. A Carene-O-C-Cthiazole torsion angle of -167.789º is 
slightly out of plane compared to the aqueous and nitromethane solvates of 3.1, 
which are much closer to 180º. The azole group is also of a unique rotation, and is 
orthogonal to the CTV bowl, rather than near parallel to the CTV-arene rim as 
observed in the structures of 3.1.  
 
Figure 3.35 Asymmetric unit of 3.7·(C4H10O)·1.5(H2O). 
Unlike both structures of 3.1, 3.7·C4H10O·1.5(H2O) crystals are racemic. 
Enantiomers are close in proximity to one another, and weak hydrogen bonding 
interactions between ester carbonyl and thiazolyl H5 proton, at C···O separation of 
3.216 Å were measured. Ligand stacking was exhibited (figure 3.36), however CTV 
units were measured as 8.7 Å apart between cyclononatriene centroids, rather than 
the much more commonly encountered ca. 4.6 Å. A diethyl ether molecule residing 
on a 3-fold symmetry axis was trapped between cavitands at separation of 3.21 Å 
and could not be refined anisotropically.  
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Figure 3.36 Stacking of 3.7 with a three-fold symmetry disordered diethyl ether trapped 
between cavitands. 
3.5.1 Reactivity of ligand 3.7 with metal precursors 
In the same fashion as with ligand 3.1, diffusion of diethyl ether vapours into DMF, 
DMSO, NMP or MeNO2 solutions of 3.7 with varying stoichiometries of metal 
precursors was performed. Metals employed included Co-Zn(II), Cu(I), Pd(II) and 
Ag(I), bearing Cl¯, Br¯, NO2
¯, OTf¯, BF4
¯ and PF6
¯ anions. In all cases where Ag(I) 
was employed, a black precipitate was observed at the bottom of vials, and Pd(II) 
saw pale yellow precipitates form over a week, but no crystals were observed in all 
cases. A vial containing 1.5 eq. CuCl2·2H2O and 3.7 did yield a crop of blue 
crystals, which SCXRD revealed as the decomposition product 
[Cu(Cl)(DMF)(H2O)(4-thiazolecarboxylate)], 3.8. The driving force in this reaction 
was the formation of a 5-membered metallacycle. HRMS of the mother liquor did 
not reveal the fate of the remaining portion of CTV.  
The asymmetric unit was comprised of one unit of 
[Cu(Cl)(DMF)(H2O)(4-thiazolecarboxylate)] (figure 3.37). The Cu(II) centre 
revealed a square pyramidal geometry with the water ligand (O3) at the apex. The 
N2-Cu1-O1 angle was measured as 170.32(9)º, whereas O2-Cu1-O3, O2-Cu1-Cl1 
and O3-Cu1-Cl1 angles measured as 98.73(8), 104.67(6) and 156.52(6)º 
respectively. Decarboxylation of ester-linked CTV ligands has previously been 
observed but not published in the Hardie group, and reported in the thesis of 
Christopher Carruthers when o-linked pyridyl ligands were introduced to Cu(II) or 
Zn(II).58 
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Figure 3.37 Left: Asymmetric unit of 3.8. Ellipsoids are drawn at the 50% probability. Right: 
2D sheet of 3.8 displaying hydrogen bonding interactions. 
Table 3.1 Selected bond lengths (Å) and angles (º) for 3.8 
Cu1-N2 1.962(2) N2-Cu1-Cl1 94.23(7) 
Cu1-O1 1.9428(19) O1-Cu1-O2 85.68(8) 
Cu1-O2 2.232(2) O1-Cu1-O3 88.70(8) 
Cu1-O3 2.027(2) O2-Cu1-O3 98.73(8) 
Cu1-Cl1 2.2764(7) O1-Cu1-Cl1 94.93(6) 
N2-Cu1-O1 170.32(9) O2-Cu1-Cl1 104.67(6) 
N2-Cu1-O2 95.02(9) O3-Cu1-Cl1 156.52(6) 
N2-Cu1-O3 81.65(9)   
 
The extended structure of [Cu(Cl)(DMF)(H2O)(4-thiazolecarboxylate)] revealed a 
2D hydrogen bonded network focused about the water ligand, as shown in figure 
3.37. Both water hydrogen atoms donated to neighbouring carboxylate groups, with 
both the coordinating and non-coordinating oxygen atoms of the carboxylate taking 
part at O···O separations of 2.841 and 2.832 Å respectively. 
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3.6 Conclusions and future work 
A novel 4-thiazolyl ligand, 3.1·HCl was prepared and fully characterised. Its 
assembly with a range of metals investigated. Crude 3.1 displayed a high affinity 
towards Ag(I), yielding the first examples of coordination cubes derived from a 
CTV ligand, 3.2 and 3.3. Cube crystals displayed dual chiral resolution, with all 
cubes within a single crystal being of a single enantiomer of ligand. The reactivity of 
metallo-cubes and also their viability as molecular hosts was probed, however these 
proved to be unsuccessful. 
 Furthermore, after neutralising 3.1, cube crystals of 3.3 grew after ca. one 
month rather than one week. In addition, minor side-products were observed in the 
form of a 3D coordination polymer, 3.4, which bore considerable pores throughout 
its structure. Attempts to increase the ratio of polymer:cube crystals were 
unsuccessful. 
 Ligand 3.1 also assembled with silver cobalticarborane, which yielded a 2D 
coordination polymer of 63 topology. The hydrochloride salt of 3.1 led to crystal 
growth of a different morphology, although crystals were too poorly diffracting to 
obtain meaningful data.  
An ester-linked 4-thiazoloyl ligand was also successfully prepared. No 
evidence of coordination to Ag(I) could be attained. Coordination at Cu(II) led to 
decarboxylation of 3.6, and crystals of [Cu(Cl)(H2O)(DMF)(thiazole-4-carboxylate)] 
grew as a 2D hydrogen-bonded network. 
Future work involving 3.2 and 3.3 could involve trying to incorporate donor 
groups within the sulfur-edged windows of cubes. Whilst seldom coordinating, the 
positioning of these groups around the windows could facilitate a soft d8 transition 
metal such as Rh(I) or Ir(I) to coordinate, which could be a method of trapping metal 
ions that are air-sensitive in the absence of chelating olefin ligands. Weak hydrogen-
bonding interactions could also be targeted at this position, for example, targeting 
substrates such as H2S. 
Additionally, investigating the assembly of metallo-cubes with Ag(I) salts of 
large anions, such as [BArF4] could yield interesting results. If Ag[BAr
F
4] could 
yield cubes, the bulky, internal anions would be within close proximity of one 
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another and undergo unwanted reactivity caused by confinement. Conversely, an 
altogether new assembly could be achieved, in the same manner as cobalticarborane. 
The tetrafluoroborate and hexafluorophosphate 3D coordination polymers 
could be viable materials to accommodate large guest species. A reproducible 
method of preparing these polymers in a good ratio would however be paramount to 
this application. 
3.7 Experimental section 
Unless stated in the experimental section, chemicals were bought from commercial 
suppliers and used without further purification. Unless stated, all reactions were 
carried out under aerobic conditions. Reactions performed under an atmosphere of 
dry nitrogen were carried out using standard Schlenk and Glovebox procedures, with 
solvents dried and degassed using the same methodology described in Section 2.9. 




(±)-Cyclotriguaiacylene (100 mg, 0.24 mmol) 
and Cs2CO3 (800 mg, 2.35 mmol) were dissolved 
in DMF (5 mL) and stirred at rt for 30 mins. 4-
(Chloromethyl)thiazole·HCl (134 mg 1.60 
mmol) was added and the brown solution stirred 
at 100 ºC overnight. The dark brown mixture 
was cooled, water (10 mL) was added and the 
resultant grey precipitate filtered and washed with Et2O, affording the title 
compound as a cream solid. Yield 135 mg, 0.19 mmol, 80%. HRMS (ESI+) 
700.1621 {M+H: C36H34N3O6S3}
+, 1399.3143 {M2+H: C72H67N6O12S6}
+ Calcd. for 
700.1605 and 1399.3136 respectively; 1H NMR (300 MHz, CDCl3) δ (ppm) 8.81 (d, 
3H, J = 2.1 Hz , H1), 7.38 (s, 3H, H2), 6.94 (s, 3H, H7), 6.77 (s, 3H, H10), 5.30 (s, 
6H, H4), 4.71 (d, 3H, J = 13.6 Hz, endo-H12), 3.81 (s, 9H, H11), 3.49 (d, 3H J = 13.5 
Hz, exo-H12); 13C{1H} NMR (75 MHz, CDCl3) 154.02 (C
3), 153.12 (C1), 148.52 
(C6), 146.73 (C5), 133.05 (C8), 131.94 (C9), 116.31 (C2), 116.23 (C7), 114.14 (C10), 
67.82 (C4), 56.51 (C11), 36.62 (C12); IR ν (cm-1) 3500, 3404 (broad), 3087, 2920, 
1659 (sharp), 1512 (sharp), 1262 (sharp); Elemental analysis Calcd. for 
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3.1.(HCl).0.5(H2O) C 58.01, H 4.73, N 5.64 Found C 58.30, H 4.50, N 5.50; 
Elemental analysis Calcd. for 3.1: C 61.78, H 4.75, N 6.00 Found: C 61.69, H 4.51, 
N 6.14. X-ray quality crystals were obtained from a saturated DMF:water solution, 
and the diffusion of diethyl ether vapours into a nitromethane solution of 3.1. 
 
Ligand 3.1 was isolated as a monohydrochloride salt. Dissolving 3.1·HCl in DCM 
and washing with aq. NaHCO3 prior to filtering through silica led to neutralisation 
of the ligand. 
 
Synthesis of [Ag12(3.1)8](ReO4)12 , 3.2  
Crude 3.1·HCl (7 mg, 0.01 mmol) and AgReO4 (4.6 mg, 0.015 mmol) were 
dissolved in DMF (1 mL), kept in the dark, and diethyl ether vapours were diffused 
into the reaction vial, affording cubic crystals of 3.1, [Ag12L8]∙(ReO4)12∙(DMF)10, 
along with a small amount of powdered contaminant likely to be AgCl. Yield 6.1 
mg, 49%. FTIR ν (cm-1) 3090, 1653 (DMF C=O), 1508 (sharp), 1260 (sharp), 1086 
(sharp), 903 (Re-O). Satisfactory elemental analysis could not be obtained due to 
high levels of solvation and the presence of minor inorganic impurities. pXRD 
indicates the crystalline material is phase pure. [Ag12L8](ReO4)12∙10(DMF) calcd. C 
35.94, H 3.17, N 4.48, found C 32.74, H 2.26, N 3.59%. HRMS (ESI+) 808.0561 
{AgL}+, 1507.2125 {AgL2}
+, calcd. 808.0574 and 1507.2106 respectively. 
 
Synthesis of [Ag12(3.1)8](BF4)12, 3.3  
Crude 3.1·HCl (7 mg, 0.01 mmol) and AgBF4 (2.9 mg, 0.015 mmol) were dissolved 
in DMF (1 mL), kept in the dark, and diethyl ether vapours were diffused into the 
reaction vial, affording cubic crystals of complex 3.3, [Ag12L8]∙(BF4)12∙(DMF)12, 
along with a small amount of powdered contaminant likely to be AgCl. Yield 7.5 
mg, 76%. FTIR ν (cm-1) 3098, 1656 (DMF C=O), 1510 (sharp), 1256 (sharp), 1149 
(sharp), 1046 (B-F). Satisfactory elemental analysis could not be obtained due to 
high levels of solvation and the presence of minor inorganic impurities. pXRD 
indicates the crystalline material is phase pure. [Ag12L8](BF4)12∙12(DMF) calcd. C 
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Synthesis of ([Ag8(3.1)6]8(BF4))n, 3.4 
Neutralised 3.1 (7 mg, 0.01 mmol) and AgBF4 (2.9 mg, 0.015 mmol) were dissolved 
in DMF (1 mL), kept in the dark, and diethyl ether vapours were diffused into the 
reaction vial. A small crop of crystals (2.2 mg) was isolated which were mostly pale 
orange blocks, alongside a small quantity of colourless needles. Did not grow phase 
pure so microanalysis was not undertaken. 
 
Synthesis of [Ag12(3.1)8](PF6)12.3.66H2O, 3.5 
Neutralised, 3.1 (7 mg, 0.01 mmol) and AgPF6 (3.4 mg, 0.015 mmol) were dissolved 
in DMF (1 mL), kept in the dark, and diethyl ether vapours were diffused into the 
reaction vial. A small crop of colourless crystals (2.8 mg) was isolated. Did not 
grow phase pure so microanalysis was not undertaken. 
 
Synthesis of ([Ag3(3.1]3][CoCb2]3·5(DMF)n 3.6  
Neutral (±)-tris-(4-methylthiazolyl)cyclotriguaiacylene, 3.1 (7 mg, 0.01 mmol) and 
Ag[CoCb2] (5.5 mg, 0.01 mmol) were dissolved in DMF (1 mL), kept in the dark, 
and diethyl ether vapours were diffused into the reaction vial. A small crop of pale 
yellow crystals (3.1 mg) was isolated by filtration and washing with DCM (2 mL). 
FTIR ν (cm-1) 2927, 2859, 2531 (B-H), 1650, 1258, 1085. Satisfactory elemental 
analysis could not be obtained due to high levels of solvent. Calculated for 
[Ag3(3.1]3]n[CoCb2]3·10(C3H7NO)·7(CH2Cl2) C 39.95, H 5.32, N 5.64; Found C 
39.72, H 5.33, N 5.64. PXRD indicated the crystalline material was phase pure. 
 
Synthesis of (±)-3,8,13-trimethoxy-10,15-dihydro-5H-
tribenzo[a,d,g][9]annulene-2,7,12-triyl tris(thiazole-4-carboxylate), 3.7 
 4-Thiazolecarboxylic acid (0.31 g, 2.40 mmol) was 
dissolved in thionyl chloride (5 mL) and heated to 
reflux for 16 h under a N2 atmosphere. Thionyl 
chloride was removed in vacuo, affording 
4-thiazolecarbonyl chloride, which was not 
characterised and treated as an intermediate and assumed to have been prepared 
quantitatively. 
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CTG (200 mg, 0.49 mmol) was dissolved in anhydrous THF (15 mL) under a N2 
atmosphere and cooled to 0 ºC. Triethylamine (1.03 mL, 7.35 mmol) was added and 
the reaction mixture stirred for 30 mins. A solution of 4-thiazolecarbonyl chloride (5 
eq.) in THF (15 mL) was added via cannula transfer and the reaction mixture stirred 
at 0 ºC for 120 mins, before warming to rt and stirring for 24 h. Volatiles were 
removed in vacuo and the orange residue triturated in EtOH (50 mL). A cream solid 
was isolated, washed with MeOH (3 x 20 mL) and Et2O (3 x 10 mL), affording 3.7 
as a cream coloured solid (298 mg, 0.40 mmol, 82%). HRMS (ESI+) 360.5264 
742.0979 (calculated 742.0982); 1H NMR (300 MHz, DMSO-d6) δ (ppm) 9.25 (s, 
3H, H1), 8.83 (s, 3H, H2), 7.53 (s, 3H, H7), 7.32 (s, 3H, H10), 4.88 (d, 3H, J = 14.0 
Hz, endo-H12), 3.72 (s, 4H, H11, exo-H12); 13C{1H} NMR (75 MHz, DMSO-d6) δ 
(ppm) 158.77 (C4), 155.96 (C1), 149.38 (C6), 145.67 (C3), 138.67 (C9), 137.58 
(C8), 131.92 (C5), 131.08 (C2), 124.15 (C7), 114.55 (C19), 56.19 (C11), 34.97 
(C12); IR ν (cm-1) 3088, 1737 (C=O), 1543, 1249, 1165; Elemental analysis for 
3.7·3.5(HCl) Calcd.: C 49.73, H 3.54, N 4.83; Found: C 50.10, H 2.99, N 5.03 
3.8 Supplementary crystallographic information 
Crystals were mounted under inert oil on a MiTeGen tip and flash frozen using an 
OxfordCryosystems low temperature device. X-ray diffraction data were collected 
using CuK radiation (λ = 1.54184 Å) or MoK (λ = 0.71073 Å) using an Agilent 
Supernova dual-source diffractometer with Atlas S2 CCD detector and fine-focus 
sealed tube generator, or using synchrotron radiation (λ = 0.6889 Å) at Beamline I19 
at the Diamond light source. Data were corrected for Lorenztian and polarization 
effects and absorption corrections were applied using multi-scan methods. The 
structures were solved by direct methods using SHELXS-97 and refined by 
full-matrix on F2 using SHELXL-97. Unless otherwise specified, all non-hydrogen 
atoms were refined as anisotropic, and hydrogen positions were included at 
geometrically estimated positions. 
3.8.1 Additional crystallographic details 
3.2 
Oxygen atoms of perrhenate anions were refined as isotropic and Re-O bond lengths 
restrained to be chemically reasonable. One anion was refined with group Uiso for 
the O sites. One ReO4 was sited on a 4-fold axis, displaying symmetry-induced 
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disorder. This ReO4 was of low occupancy for charge balance. The highest residual 
peak was a Fourier ripple measured 0.24 Å from Re1. 
3.3 
The SQUEEZE routine of PLATON was employed30 because anions could not be 
located in the difference map, and a void space of ca. 45% of the unit cell volume 
was calculated. Residual electron density could not be meaningfully refined as 
anions or solvents. Global restraints were placed on the anisotropic displacement 
parameters. 
3.4 
Anions could not be located in the difference map, therefore, the SQUEEZE routine 
of PLATON was employed30, which calculated a void space of ca. 48% of the unit 
cell volume. 
3.6 
The highest residual peak was a Fourier ripple measured 1.07 Å from Ag1. 
3.7 
The diethyl ether molecule was sited on 3-fold symmetry axis, displaying 
symmetry-induced disorder. The C-O bond in diethyl ether was restrained to be 
chemically reasonable. The diethyl ether molecule was refined as isotropic. 




Compound 3.1∙4(H2O)a 3.1∙3(MeNO2)a 3.2a 3.3a 




Mr 771.9 882.97 9895.52 7934.84 
Crystal colour and shape Yellow, needle Colourless, rod Pale orange, block Pale orange, block 
Crystal size (mm) 0.15 x 0.05 x 0.02 0.20 x 0.03 x 0.02 0.15 x 0.10 x 0.10 0.15 x 0.12 x 0.07 




Space group P63 R3 F432 F432 
a (Å) 14.5223(19) 28.138(3) 35.7237(4) 35.4548(7) 
b (Å) 14.5223(19) 28.138(3) 35.7237(4) 35.4548(7) 
c (Å) 10.2701(12) 4.4445(5) 35.7237(4) 35.4548(7) 
α (0) 90 90 90 90 
β (0) 90 90 90 90 
γ (0) 120 120 90 90 
V (Å3) 1875.8(4) 3047.4(5) 45590.0(9) 44568.2(15) 
Z 2 3 4 4 
T/K 110(1) 120(1) 120(1) 120(1) 
ρcalc (g.cm-3) 1.367 1.443 1.442 1.183 
θ range (0) 3.51 – 73.42 5.45 – 73.82 3.50-73.74 3.53–73.63 
No. data collected 4447 4449 9948 4858 
No. unique data 2239 2150 3794 2572 
Rint 0.0604 0.0786 0.0341 0.0286 
No. obs. Data (I > 2σ(I)) 1394 1635 2667 1639 
No. parameters 158 183 168 152 
No. restraints 1 1 4 42 
R1 (obs data) 0.0886 0.0719 0.0847 0.0718 
wR2 (all data) 0.2598 0.1873 0.2886 0.2256 
Flack parameter -0.07(7) 0.08(5) 0.03(4) 0.15(3) 
S 0.996 1.052 1.036 1.042 
Max. shift/esd 0.000 0.000 0.001 0.001 
Largest difference peak 
and hole/ (e Å3) 
1.332, -0.326 0.399, -0.315 
 
2.000, -2.126 0.778, -0.479 
Table 3.2 Crystallographic data. a = CuKα radiation, b = synchrotron radiation 
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C267 H393 Ag6B108 Co6 
N27 O45 S18 
C40H37N3O10.75S3 C28H44Cl4Cu4N8O16S4 
Mr 15627.45 8981.36 7446.42 829.42 1272.91 
Crystal colour and shape Colourless, needle Colourless, block Pale orange, block Colourless, block Blue, block 
Crystal size (mm) 0.023 x 0.044 x 0.179 0.088 x 0.101 x 0.144 0.061 x 0.08 x 0.093 0.17 x 0.12 x 0.10 0.31 x 0.28 x 0.26 
Crystal system Trigonal (hexagonal 
axes) 
Cubic Triclinic Trigonal (hexagonal 
axes) 
Orthorhombic 
Space group R3 F432 𝑃1̅ 𝑃3̅ P212121 
a (Å) 76.1229(12) 35.7386(3) 16.9206(2) 16.7381(6) 5.51030(10) 
b (Å) 76.1229(12) 35.7386(3) 25.1781(2) 16.7381(6) 11.4557(2) 
c (Å) 16.2705(3) 35.7386(3) 25.2520(2) 8.7148(4) 18.1230(2) 
α (0) 90 90 119.2780(10) 90.00 90 
β (0) 90 90 104.8890(10) 90.00 90 
γ (0) 120 90 91.4090(10) 120.00 90 
V (Å3) 81651(3) 45647.0(13) 8923.53(17) 2114.46(14) 1144.00(3) 
Z 9 4 1 2 4 
T/K 120(1) 120(2) 120 100(2) 120.01(10) 
ρcalc (g.cm-3) 0.953 1.307 1.386 1.303 1.848 
θ range (0) 3.07-44.49 4.103-73.660 1.114-26.237 5.08-73.76 4.566- 73.368 
No. data collected 61017 11161 87282 5308 2850 
No. unique data 26341 3775 21797 2772 1989 
Rint 0.0504 0.0366 0.0878 0.0358 0.0163 
No. obs. Data (I > 2σ(I)) 22117 2531 18825 2179 1980 
No. parameters 2777 194 2179 171 148 
No. restraints 1 0 0 1 0 
R1 (obs data) 0.0504 0.1226 0.0767 0.0701 0.0214 
wR2 (all data) 0.1320 0.3702 0.2398 0.2186 0.0546 
Flack parameter 0.276(7) -0.225 ( 0.028 )   0.039(12) 
S  1.017 1.339 1.055 1.095 1.120 
Max. shift/esd 0.082 0.001 0.017 0.002 0.001 
Largest difference peak and 
hole/ (e Å3) 
0.863, -0.477 1.508, -1.451 4.123, -1.528 1.444, -0.433 0.229, -0.410 
Table 3.3 Crystallographic data. a = CuKα radiation, b = synchrotron radiation 
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Chapter 4  
Synthesis and characterisation of benzimidazolium salts, and 
targeted group 11 carbene complexes 
 
This chapter focuses on the preparation and characterisation of novel, tripodal 
imidazolium salts, and investigations into their coordination to d10 metals. A new 
class of guaiacol-derived mono-benzimidazolium salts were also prepared which 
are comparable to one-third of the CTV bowl. This ligand-class can potentially both 
enhance species elucidation, and arise as a pathway to compare activities of 
monodentate and tridentate systems in catalysis. 
4.1 Introduction 
Many NHC ligands in organometallic chemistry are derived from N-arylated 
imidazolium salts. These are generally prepared in the Debus-Radziszewski reaction 
by condensation of glyoxal, an aniline and formaldehyde in acidic media (scheme 
4.1). Reactions are facile, but side-reactions such as reverse-aldol condensations also 
arise, whereby one carbonyl of the glyoxal can be regenerated, leading to often 
protracted workups.1 A key example is 1,3-bis-mesitylimidazolium chloride 
(IMes·HCl), (mesityl = 2,4,6-trimethylphenyl), formed when using 
2,4,6-trimethylaniline as the amine source in the synthesis. Additionally, the bulkier 
the aniline, the more challenging (and often unsuccessful) the condensation. 
Arduengo and co-workers developed a modified procedure of the 
Debus_Radziszewski reaction to overcome these issues, whereby a diimine could be 
prepared, before reaction with chloromethyl ethyl ether rather than an aldehyde.2 
This route remains popular for the bulkiest of NHC ligands, including IPr·HCl 
(1,3-bis-(2,6-diisopropylphenyl)imidazolium chloride) and the isopentyl derivative, 
IPent·HCl. In spite of the drawbacks, the Debus-Radziszewski reaction is 
extensively used and a highly popular route to prepare imidazolium salts (or 
substituted imidazoles when ammonia and a secondary amine are used), and is a 
highly scalable reaction. 
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Scheme 4.1 Synthesis of imidazolium salts via the Debus-Radziszewski reaction1, 2 
The tris-imidazolium nature of CTV-type ligands would lead to the 
Debus-Radziszewski route being unviable using suitable cavitands, as the 
by-product issues would be amplified, with the possibility of mixed-arm by-products 
offering a number of additional problems. It was therefore decided that the 
straightforward nucleophilic substitution of an N-derivatised imidazole, such as 
ligand 2.4, with a pertinent electrophile would be the method of choice (scheme 
4.2). The electrophile has to be susceptible to SN2 reactions, otherwise the 
E1-elimination reaction often observed with the tert-butyl cation may well dominate 
proceedings. Whilst an amino CTG precursor is known, and reactivity in the 
Debus-Radziszewski reaction may be possible, the number of potential by-products 
and likely separative problems would be magnified. Furthermore, Brenner and 
co-workers have recently prepared bis-resorcinarenylimidazolium salts to overcome 
cavitand scission reactions when preparing Ni(II) complexes.3-5 This ligand was 
prepared using the Debus-Radziszewski reaction, and gave only a 13% conversion. 
It is worth noting the ligand in question here is monocationic rather than the 
tricationic targets in this project. 
4.2 Imidazolium salts on a CTG scaffold 
Imidazole 2.4, which was reported in section 2.2, could be efficiently alkylated by 
its reaction with methyl iodide. All reactions involving methyl iodide were carried 
out in a sealed J. Youngs ampoule because its high volatility and low boiling point 
led to it evaporating despite the use of condenser tubes (scheme 4.2). 
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Scheme 4.2 Synthesis of imidazolium salts 4.1 and 4.2. 
The 1H NMR spectrum of tris-imidazolium iodide, 4.1 (figure 4.1) was diagnostic, 
with the characteristic downfield shift of imidazolium proton H1 to 9.32 ppm from 
7-8 ppm in imidazoles due to the increased acidity at this site. C3-symmetry was 
retained, evidenced by the two doublets attributed to endo- and exo-H12. 
 
Figure 4.1 1H NMR spectrum (293 K, 300 MHz, DMSO-d6) of ligand 4.1. 
The mass spectrum of ligand 4.1 (figure 4.2) contains major peaks at m/z 410.1258, 
947.1506 and 1092.0957 attributed to imidazolium less two and one iodide anions, 
and also a {M+H}+ species respectively. 
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Figure 4.2 HRMS of imidazolium salt 4.1. 
Salt-metathesis of 4.1 with NH4PF6 yielding hexafluorophosphate 4.2 was facile. 
1H 
NMR spectra of imidazolium halides and hexafluorophosphates often differ slightly. 
The imidazolium NHCN proton in an imidazolium halide is shifted slightly further 
downfield due to being more acidic than when bearing a non-coordinating anion. 
This increase in acidity is caused by a weak hydrogen-bonding interaction between 
the hydrogen atom in question and the halide anion, which can facilitate 
deprotonation. In the case of 4.1 and 4.2, both 1H NMR spectra were identical. 
19F{1H} NMR spectroscopy, along with HRMS confirmed the successful salt 
metathesis of 4.1. The 19F{1H} NMR spectrum contained the characteristic PF6
¯ 
doublet residing at -71.42 ppm (JF-P = 711.54 Hz) (figure 4.3). The HRMS spectrum 
contained peaks less varying numbers of hexafluorophosphate anions. HRMS 
showed no evidence of peaks attributed to iodide-containing fragments, with the 
hexafluorophosphate salt appearing dominant, as shown in figure 4.4. Major peaks 
could be assigned as the +3, +2 and +1 peaks for ligand less the relevant number of 
anions. 
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Figure 4.3 19F{1H} NMR spectrum (293 K, 282 MHz, DMSO-d6) of 4.2. 
 
 
Figure 4.4 HRMS of 4.2. 
Crystals suitable for X-ray diffraction were grown from the diffusion of diethyl ether 
vapours into an acetonitrile solution of 4.2. The asymmetric unit comprises one third 
of the ligand, two anions (which are of half occupancy) and a partially occupied 
acetonitrile molecule (figure 4.5). 
 
Figure 4.5 Asymmetric unit of 4.2·3(MeCN). Ellipsoids are drawn at the 50% probability, with 
hexafluorophosphate anions and acetonitrile refined as isotropic. Each 
hexafluorophosphate anion is of 0.5 occupancy. 
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The ligand has threefold crystallographic symmetry, and the imidazolium arms were 
strained with a Carene-O-C-Nimid torsion angle measured as 77.2º. Salt 4.2·3(MeCN) 
crystallised in the chiral, hexagonal P6 space group as a conglomerate – only one 
enantiomer of the ligand crystallised in each crystal. A number of azole ligands 
crystallised as conglomerates, including solvates of the 4-thiazolyl (3.1) and 
5-oxazolylcyclotriguaiacylene (2.18). Bowl-in-bowl stacking of the 
single-enantiomer is also exhibited (figure 4.7), with a distance of 4.57 Å between 
centroids of cyclononatriene bowls, which is marginally less than 
4-(pyridyl)methylcyclotriguaiacylene (4.68 Å) and a bipyridyl analogue (4.67 Å).6, 7 
Two ligand molecules reside in the unit cell, with twelve hexafluorophosphate 
anions of half-occupancy balancing the charge. Acetonitrile molecules reside on the 
unit cell vertices (figure 4.6). A H···F hydrogen bond is present, with a C-F 




Figure 4.6 Unit cell diagram of 4.2·3(MeCN). 
 
Figure 4.7 Bowl-in-bowl stacking exhibited by conglomerate crystals of 4.2·3(MeCN). 
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Whilst the synthesis of 4.1 and 4.2 were highly successful, reliability issues posed in 
the synthesis of 2.4 mean imidazolium salts 4.1 and 4.2 were prepared to prove 
synthetic methodology, and NHC complexes were not targeted with this system. 
4.3 Synthesis and characterisation of a tricationic benzimidazolium 
salt 
Benzimidazole 2.11 can be furnished with a number of alkyl halides. The most 
straightforward of reactions is that with methyl iodide to afford 1,1',1''-(((3,8,13-
trimethoxy-10,15-dihydro-5H-tribenzo[a,d,g][9]annulene-2,7,12-
triyl)tris(oxy))tris(methylene))tris(3-methyl-1H-benzimidazolium) iodide, 4.3 
(scheme 4.3). 
 
Scheme 4.3 Synthesis of benzimidazolium salt 4.3 
The above salt was prepared in good yield and fully authenticated by 1H (figure 4.8) 
and 13C{1H} NMR spectroscopy (figure 4.9), and mass spectrometry. Peaks in the 
13C{1H} NMR spectrum of 4.3 were assigned using HMQC and HMBC spectra. The 
1H NMR spectrum displays the downfield shift of H1 to 9.89 ppm from 8.35 ppm in 
2.11, which is diagnostic for the formation of a benzimidazolium salt. The H16 
exo-proton peak appears underneath H9 at 3.56 ppm. The integral of this peak 
matched that for the methoxy resonance plus the aforementioned exo-proton. COSY 
and HMQC spectra confirmed this was the case. The COSY NMR spectrum (figure 
4.10) showed the endo-proton coupling to this resonance, and for the HMQC 
spectrum (figure 4.10) coupling to two carbon environments for the proton peak at 
3.58 ppm was observed, which were both confirmed to be C9 and C16. These two 
peaks can both be distinguished in the DEPT-135 NMR spectrum. Asymmetric 
imidazolium species contain three proton resonances, with the two backbone 
resonances found between 7 and 8 ppm. For benzimidazolium systems, the 
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benzo-backbone resonances appear in the aromatic region of the NMR spectrum, 
often occurring as two triplets and two doublets as observed in figure 4.8, although 
these signals overlapping is not uncommon. 
 
Figure 4.8 1H NMR spectrum (293 K, 300 MHz, DMSO-d6) of benzimidazolium salt 4.3. 
 
 
Figure 4.9 13C{1H} NMR spectrum (293 K, 75 MHz, DMSO-d6) of benzimidazolium salt 4.3. 
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Figure 4.10 Top: COSY and bottom: HMQC spectra of 4.3 (293 K, 300 MHz, DMSO-d6). 
The tricationic nature of the benzimidazolium salt leads to a number of product 
peaks in the HRMS spectrum (Figure 4.11), namely {M-3I}3+ (m/z = 281.1484), 
{M-2I}2+ (m/z = 485.1465), {M-I}+ (m/z = 1097.1959) and {M+NH4}
+ (m/z = 
1242.1336). The two peaks at 349.1559 and 825.2148 correspond to one 
imidazolium arm being cleaved in the mass spectrometer. This is a common 
observation with all the imidazolium salts prepared in this project, with the NMR 
data and obvious C3-symmetry suggesting that this is not a contaminant in the 
product.  
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Figure 4.11 HRMS (ESI+) of ligand 4.3. 
Salt metathesis reactions of 4.3 with ammonium hexafluorophosphate and 
hexafluroantimonate sources were carried out with the intention of obtaining crystals 
suitable for structure determination using X-ray diffraction. 19F{1H} and 31P{1H} 
NMR spectroscopy and HRMS indicated successful anion exchange. 1H NMR 
spectroscopy of imidazolium hexafluorophosphate 4.4 revealed a near-identical 
spectrum, with negligible upfield shift of the imidazolium proton by 0.05 ppm. The 
FTIR spectrum also gave good indication that a successful salt metathesis reaction 
had taken place, with a sharp peak appearing at 834 cm-1, strongly suggesting a P-F 
stretch. Colourless needles of 4.4 suitable for X-ray diffraction were grown from the 
diffusion of diethyl ether vapours into an acetonitrile solution of imidazolium salt. 
The X-ray data were collected by Edward Britton using synchrotron radiation. The 
signal-to-noise parameter was low due to crystals being extremely thin in two 
dimensions. 
The crystal structure was solved in the triclinic P1  space group and the 
asymmetric unit comprised of a whole tris-benzimidazolium salt and three 
hexafluorophosphate anions (figure 4.12). 
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Figure 4.12 Asymmetric unit of 4.4. Ellipsoids are drawn at the 50% probability. 
Two benzimidazolium arms were refined as isotropic due to high levels of disorder, 
and one azole moiety was disordered over two positions. A H···F hydrogen bonding 
interaction between an imidazolium proton was observed at C···F separation of 
2.901 Å, supporting the minimal upfield shift in 1H NMR spectrum of 4.4 relative to 
the iodide analogue. A wide variation of Carene-O-C-Nimid torsion angles were 
measured, with the disordered benzimidazole group which intercalates between 
CTV bowls exhibiting near-antiperiplanar angles of -173.2 and 176.4º. Another 
dihedral angle was measured as -143.2º and a third highly strained angle of -64.9º, 
with a H-bonding interaction between the nearest methoxy group and the ether link 
observed with C···O separation of 2.79 Å. The strained benzimidazolium group 
participates in π-π stacking with an equivalent neighbour belonging to a ligand of 
opposite enantiomer, at centroid separation of ca. 3.72 Å. 
Homochiral stacks are formed which are considerably offset, with the centroid of the 
cyclononatriene core of one ligand residing above the methoxy group of a 
neighbouring cavitand of the same handedness, at a distance of ca. 3.7 Å. 
Intercalation of a benzimidazolium group of a neighbouring cavitand of opposite 
handedness between two ligands was exhibited, with the benzo-backbone of the 
benzimidazolium salt engaging in π-π stacking interactions with an internal face of 
the below CTV bowl and exterior of the above cavitand at separation of 3.72 and 
3.99 Å respectively (figure 4.13). Intercalation of an arm in this fashion has been 
observed previously in CTV chemistry, most recently within the crystal structure of 
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a tripodal Re(I) complex, but bowl-in-bowl stacks involving this case were perfectly 
aligned.7 
 
Figure 4.13 Intercalation of M-enantiomer of 4.4 between stacks of P-enantiomers. 
4.4 Synthesis and characterisation of an N-benzyl substituted 
tripodal benzimidazolium salt 
 
Scheme 4.4 Synthesis of benzimidazolium salt 4.5. 
Ligand 4.3 displayed good solubility in DMSO and DMF, and required heat to 
redissolve in acetonitrile, but once dissolved, remained in solution. Whilst a reliable 
ligand preparation, the methyl substituent also provides very little steric bulk on one 
side of the imidazolium salt, and flexible, but also bulkier alternatives were sought. 
Another benzimidazolium salt class considered were those bearing a benzyl 
moiety. Benzyl-tethered carbenes had previously been prepared in the Hardie group 
for stabilisation of metallo-cryptophanes in order to prevent rearrangement into 
larger assemblies.8 N-benzyl ligand 4.5 was prepared overnight in good yield 
(scheme 4.4). The reaction conditions were milder than those used in the preparation 
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of 4.3, with heating to 60 ºC and no need to seal reaction vessels. The tris-cationic 
product precipitated from acetonitrile overnight. The benzyl group can provide steric 
bulk when hinged towards the metal centre, which when part of metal-NHC 
complexes could stabilise low oxidation state metals during catalytic cycles, whilst 
also being capable of folding away from the metal centre, thus not hindering 
substitution reactions about the metal during catalytic cycles. The disadvantage of 
this ligand is solubility; 4.5 is insoluble in DCM and MeCN, two of the more 
feasible solvents for NHC complex synthesis via basic metal precursors or 
transmetallation reactions, preferring solvents such as DMF and DMSO. Whilst 
carbene complexes can be prepared in DMF and DMSO, they are less tolerant of 
strong bases, limiting the methodologies that can be utilised.9 The common Ag(I) 
transmetallation route does not proceed in high yields when using highly polar 
aprotic solvents, presumably due to solubilisation of Ag(I) halide by-products in 
such reaction media, reducing the lattice enthalpy associated with AgX formation.  
The 1H NMR spectrum of 4.5 confirmed the preparation of a C3-symmetric 
imidazolium salt, with the peak for imidazolium H1 residing at 10.18 ppm, as shown 
in figure 4.14. The endo- and exo- protons of the tribenzo[a,d,g]-cyclononatriene 
core (H21) were located at 4.74 and 3.54 ppm. NCH2O protons of methylene bridge 
(H13) split into a pseudo-quartet due to diastereotopicity at this site. The sheer 
number of aromatic protons (associated with benzimidazole, N-benzyl and 
cyclotriveratrylene core) was anticipated to give highly complex NMR spectra with 
large numbers of peaks between 8 and 7 ppm. However, the three N-benzylic 
resonances, and one CTV environment appeared as one broad overlapped peak at 
7.41 ppm. 
The aromatic carbon adjacent to the methoxy group of CTV was once again 
the furthest downfield in the 13C{1H} NMR spectrum (149.17 ppm), as confirmed 
by HMBC NMR spectroscopy. C1 was slightly further upfield in benzimidazole 2.12 
than in benzimidazolium salt 4.5 at 142.98 ppm (figure 4.15). Three CH2 
environments were noted in the DEPT-135 NMR spectrum; C13 at 76.24 ppm, 
characteristic of NCH2O groups on all CTV-furnished benzimidazoles. The two 
protons of the methylene bridge on CTV coupled to one carbon environment at 
34.78 ppm in the HMQC spectrum (figure 4.16). 
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Figure 4.14 1H NMR spectrum (293 K, 300 MHz, DMSO-d6) of 4.5. 
 
 
Figure 4.15 13C{1H} NMR spectrum (293 K, 75 MHz, DMSO-d6) of 4.5. 
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Figure 4.16 HMQC spectrum of 4.5. 
The HRMS (figure 4.17) contained the major ion peak as at m/z 357.1624 
(calculated 357.1698), corresponding to the 3+ peak of 4.5, less three bromide ions. 
The peak at m/z 490.2127 (calculated 490.2125) is a good match to a bis-benzylated 
imidazolium salt. The 1H NMR spectrum displays obvious C3-symmetry with a 
single set of CTV endo- and exo- peaks being present, so this was thought to be an 
ionisation event, rather than unwanted partial reactivity.  
 
Figure 4.17 HRMS (ESI+) of 4.5. 
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4.5 Investigations into the preparation of more soluble 
benzimidazolium salts 
Solubility was a major consideration when selecting potential N-substituents for 
imidazolium salts on a CTV scaffold. Both 4.3 and 4.5 displayed limited solubility 
in solvents that are desirable for metal-NHC coordination, such as DCM. 
Longer alkyl chains such as npropyl were considered, but this synthetic route 
required much harsher reaction conditions (100 ºC in MeCN in a J. Youngs 
ampoule) over a longer period of time. Reproducibility was inconsistent, and 
prolonged reaction times (> 5 days as opposed to 16-18 h for 4.3 and 4.5) meant 
more viable syntheses should be pursued. Picolyl (2-methylpyridyl) moieties were 
also targeted. 2-(Bromomethyl)pyridine hydrobromide is commercially available 
and, upon neutralisation, did slowly react with benzimidazole 2.4 over an extended 
period of time, but the reaction could not effectively be pushed towards completion.  
Allyl substituents both enhance solubility and could potentially stabilise low 
oxidation state metals by means of π-donation. Allyl ligand 4.6·Br was prepared in 
good yield as an oily solid, and displayed high solubility in methanol, a solvent 
medium CTV-based compounds seldom dissolve in. The methanolic solubility of 
this ligand allowed for facile salt metatheses with ammonium or sodium salts of 
non-coordinating anions, facilitating a more straightforward isolation of the 
imidazolium salts.  
 
Scheme 4.5 Synthesis of allylic ligand 4.6. 
- 148 - 
 
Figure 4.18 1H NMR spectrum (293 K, 300 MHz, DMSO-d6) of 4.6. 
HRMS contained a number of peaks confirming the successful preparation of 4.6, 




+ fragments (calculated 307.1441, 
533.1985 and 1211.3618 respectively. Fragments observed with m/z = 375.1682 and 
440.1951 correspond to species losing a benzimidazolium arm from the CTV 
scaffold and a bis-allylated product (calculated m/z = 375.1703 and 440.1969 
respectively), however these are artefacts of ionisation, as confirmed by the C3 
symmetry retained in the 1H NMR spectrum. 
 
Figure 4.19 HRMS (ESI+) of 4.6. 
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Previous work in the Hardie group involved using allylic cavitand 2.2 as a 
coordination ligand to Ag(I), and a range of discrete architectures and 
organometallic coordination polymers were isolated bearing Ag-alkene 




sources were carried out, and their assembly with the relevant Ag(I) salt trialled, but 
crystalline material could not be grown in any case. 
Despite the initial promise shown by allyl ligand 4.6, there was also a major 
disadvantage, as unexpected side-reactivity often occurred which proved difficult to 
control. A second species was observed in the 1H NMR spectrum which bore a new 
imidazolium NCHN peak, the ratio of desired product:impurity did vary from 
reaction to reaction. Whilst still a minor by-product, it would pose problems when 
preparing metal complexes, and could not be controlled. A peak in the HRMS 
spectrum at m/z 460.2125 (calculated 460.2125) was an excellent match to the 
proposed cyclisation product (figure 4.20). Both by-product and 4.6 could not be 
separated using chromatographic techniques or through recrystallization. Similarly 
to ligand 4.3, cleavage of a ligand arm was observed in the HRMS (figure 4.21). 
When the allylic analogue was prepared cleanly, the fragment associated with 
proposed by-product was not observed. The proposed by-product would have a 2+ 
charge, consistent with the HRMS data, and lose HBr with respect to the desired 
product. 
 
Figure 4.20 Proposed by-product formed in preparation of imidazolium salt 4.6·Br. 
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Figure 4.21 HRMS (ESI+) of 4.5 showing side-reactivity at m/z = 460.2125. 
 
Figure 4.22 1H NMR spectrum (293 K, 300 MHz, DMSO-d6) of by-product-containing 
imidazolium salt 4.6·Br. Peak a denotes imidazolium proton of desired product,  
 b denotes imidazolium proton of impurity. 
It would be expected for such a cyclisation to be metal-mediated. No transition 
metals were used in the preparation of allyl 4.6 or 2.4. A Pd(II) catalysed 
deallylation of 2.2 led to the isolation of CTG 2.3, so leaching of Pd may have 
occurred, despite every effort to prevent this by filtration through multiple celite 
pads. Allyl groups are known to participate in rearrangements and cyclisations, with 
well-known examples including the Cope, and Claisen rearrangements.11, 12 
Difficulties controlling the side-reactivity of this ligand led to 4.3 and 4.5 becoming 
the primary ligands employed in this project. 
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4.6 Synthesis of one-third synthons of tripodal benzimidazolium 
salts 
In order to compare trimetallic complexes to smaller, discrete analogues, similar 
ligands with a guaiacol (2-methoxyphenylmethyl-) arm on one side of the 
benzimidazole, as opposed to a cavitand, were prepared. Guaiacol was selected as a 
precursor as it is readily available (extracted from wood creosote and a common 
flavourant in coffee and whiskey), and has the same local environment as the 
benzo-backbone to CTG, minus the methylene bridges of the lower rim. 
Imidazole 4.7 was prepared using a modified procedure to that reported in 
the literature, to suppress the competing dimerisation of 
1-(chloromethyl)benzimidazole·HCl observed by both Mokhtari and co-workers, 
and the Hardie group when initially preparing ligand 2.11 (scheme 4.6).13 
Imidazolium salts were fully characterised using HRMS and multinuclear NMR 
spectroscopy. NMR spectra in general for guaiacol-derived ligands were more 
complex than the cavitand counterparts, mainly due to the guaiacol group 
comprising of four aromatic protons with often more complicated splitting patterns. 
For 4.3 and 4.5, the C3-symmetry and methylene bridges meant only two proton 
environments are located on the CTG ligands, both of which are para- with respect 
to one another, and appear as singlets. 
 
Scheme 4.6 Syntheses of the monopods 4.7-4.9. 
The 1H NMR spectrum (figure 4.23) of imidazolium iodide 4.8 was clean, and the 
acidic NCHN proton characteristically had a chemical shift of 9.87 ppm. There were 
two aromatic resonances attributed with the guaiacol group with integrals of 3:1 
relative to one another. The multiplet at 7.16-7.00 ppm could be assigned as H12, H13 
and H15 because the ddd at 6.88 ppm did not couple to C11, and weakly coupled to 
C10 in the HMBC spectrum HRMS contained a single, dominant peak at m/z 
- 152 - 
269.1246 (Calcd. 269.1285), an excellent match to the cation portion of the 
imidazolium salt. 
 
Figure 4.23 1H NMR spectrum (293 K, 300 MHz, DMSO-d6) of ligand 4.8. 
Crystals of imidazolium salt 4.8 (figure 4.24) grew from the diffusion of diethyl 
ether vapours into an acetonitrile solution of ligand, and the structure was obtained 
using synchrotron radiation at the Diamond Light Source. 
 
Figure 4.24 Left: Asymmetric unit of 4.8, ellipsoids are drawn at the 50% probability. Right: 
Packing diagram of 4.8. 
Benzimidazolium salt 4.8 crystallised in the P1 space group with two molecules 
residing in the asymmetric unit (figure 4.24). There are π-π stacking interactions 
between benzimidazole backbones, at centroid separation of 3.93 Å. The guaiacol 
arene unit and benzimidazolium group within the asymmetric unit are not parallel 
and slightly offset, leading to centroid separations slightly greater than 4 Å, and 
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therefore not π-π stacking. Both benzimidazolium salts in the asymmetric unit have 
differing torsion N-C-O-N torsion angles of -73.4 and 63.3o. 
The 3-benzyl-1-((2-methoxyphenoxy)methyl)-1H-benzimidazolium bromide, 4.9 
could be prepared following a matching procedure to that outlined for ligand 4.5. 
The HRMS spectrum was once again diagnostic, with a single peak at m/z 345.1611 
(calculated 345.1598) displaying an excellent match to the imidazolium cation. 
 The imidazolium proton H1 of 4.9 diagnostically resided at 10.04 ppm in the 
1H NMR spectrum (figure 4.25). The benzylic CH2 group resided in a similar 
position to that observed in CTG ligand 4.5 (5.81 vs 5.80 ppm). Interestingly, the 
NCH2O methylene bridge (H
13) was shifted upfield in the monomer 4.9 by ca. 0.5 
ppm relative to the cavitand complex, indicating the CTV bowl has a deshielding 
effect on the protons at this site. The 13C{1H} NMR spectrum bore similarities to 
that of 4.5, with a number of aromatic carbons present, and the two methylene 
bridges were authenticated by DEPT-135 and HMQC NMR spectroscopy.  
 
Figure 4.25 1H NMR spectrum (293 K, 300 MHz, DMSO-d6) of ligand 4.9. 
4.7 Investigation towards the synthesis of group 11 carbene 
complexes 
4.7.1 Strategies towards the isolation of a trimetallic Ag(I)-NHC complex 
Group 11, d10 NHC complexes are well established, both as precursors and also 
catalysts.14, 15 A common starting point in NHC chemistry is coordination to Ag(I), 
primarily using Ag2O as a reagent. A route first reported in 1998 by Lin and 
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co-workers, these reactions often occur in DCM solvent, and have a strong driving 
force, forming water as a by-product.16 In addition to being used as transmetallating 
agents, Ag(I) carbenes have been trialled as anti-cancer drugs, owing to the 
anti-microbial properties and low-toxicity of silver compounds.17, 18 
The preparation of Ag(I)-NHC complexes from Ag2O (or Cu2O for the Cu(I) 
analogues) are well defined (scheme 4.7). In some cases when using the 
imidazolium halide, ligand scrambling can occur and a cationic bis-NHC complex 
can be isolated, with an [AgX2]
- anion.16, 19, 20 The groups of Hahn and Peris have 
demonstrated the ability of Ag(I)-NHC complexes to be used as supramolecular 
building blocks, successfully preparing M3L2 containers which can both be 
transmetallated onto other transition metals, and also undergo post-synthetic 
modification.21-25 
 
Scheme 4.7 Strategies towards Ag(I)-NHC complexes using Ag2O. 
Ligand 4.3 and silver oxide were heated to 80 ºC in acetonitrile, under a nitrogen 
atmosphere in the dark. After 24 h, the attempted isolation of tripodal NHC 
complexes in this case was unsuccessful, with negligible evidence suggesting 
coordination to Ag(I). The desired product from the reaction of imidazolium salt 4.3 
with Ag2O would be expected to give a sharp 
1H NMR spectrum. The fingerprint of 
such a reaction would be the loss of an imidazolium proton upon coordination to 
Ag(I). After 24 h, an imidazolium peak at 9.51 ppm remained, with the endo- and 
exo- doublets of the CTV bowl indicating the C3-symmetric starting material 
constituted the bulk of the reaction mixture. A number of minor peaks were also 
present, notably upfield of the imidazolium proton, which could be either 
C1-symmetric by-products, or decomposition species (figure 4.26). The high 
resolution mass spectrum was inconclusive, and showed no obvious signs that an 
Ag(I) complex was in solution. 
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Figure 4.26 1H NMR spectrum (293 K, 300 MHz, MeCN-d3) from reaction of 4.3 and Ag2O. 
Despite the attempted isolation of Ag(I) NHC complexes being unsuccessful, in situ 
generation of Ag(I) carbenes as reaction intermediates may be possible. The typical 
driving force for preparing Ag(I)-NHC complexes using Ag2O as the precursor is 
water liberation. For the tripodal imidazolium salts, this may be an insufficient 
driving force, and one-pot syntheses where the in situ generation of an Ag(I)-NHC 
complex before transmetallation onto a defined metal precursor, such as a noble 
metal dimer, are well established.14, 20, 26 This augments the driving force to prepare 
a new metal-NHC complex, and the lattice enthalpy associated with silver halide 
formation drives the reaction.  
 One reliable method to prepare metal NHC complexes is via free carbene 
generation. Free NHCs are strong Lewis bases. The main disadvantage of this route 
is the high air- and moisture-sensitivity of free, divalent carbenes. Whilst 
deprotonation of the imidazolium portion of 4.3, 4.5, 4.8 and 4.9 could be attainable, 
the NCH2O methylene bridge would likely be base-sensitive, and competitive 
reactions would be probable. Additionally, a solvent mismatch would prevent this 
route from being viable; free carbenes are typically generated in THF or toluene, 
which 4.3 and 4.5 proved insoluble in. 
4.7.2 Investigations into the synthesis of Au(I)-NHC complexes 
Au(I)-NHC complexes display rich chemistry, with applications in catalysis and 
luminescence.27-29 Typically, Au(I) NHC complexes are linear, 2-coordinate, so it 
was postulated that the trans-labilisation behaviour displayed by the carbene, in the 
presence of a ditopic ligand, or a second cavitand, could give rise to 
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metallosupramolecular architectures (Scheme 4.8). Halide abstraction from Au(I) 
and replacement with a range of new ligands is well documented; Fairlamb and 
co-workers have exchanged the halide for phthalimide ligands, yielding complexes 
that are active cycloisomerisation catalysts.30 The Au(I)-NHC motif has been 
utilised in metallo-supramolecular chemistry of late, with Nitschke preparing a 
tetrahedron with internally gilded Au(I) NHC moieties.31 Alongside Hahn’s 
[AunL2]
n+ cylinders,22, 24, 32, 33 Pöthig and co-workers have reported an 
Au(I)-pillarplex, a pillar-shaped complex bearing eight equatorial Au(I) ions, all of 
which coordinate to an NHC.34 The pillarplexes have a defined cavity, which can 
encapsulate dibromoalkanes, or when the Ag(I) derivative was prepared, cycle 
between an organometallic [2]-rotaxane or an organic [3]-rotaxane upon alteration 
of pH.35 Simple anion exchange and variation of the imidazolium wingtip has 
enhanced solubility in all the above cases. 
 A number of metallo-cryptophanes previously prepared by Hardie and 
co-workers do suffer from solubility issues.36-39. Incorporation of organometallic 
subcomponents has previously addressed these issues; Holman and co-workers have 
decorated each arene face of an organic cryptophane with Ru(II) moieties bearing a 
second η6-arene group, where each face of the CTV bowls is additionally a 
sandwich complex.40 Hardie and co-workers prepared [Pd3L2]
6+ 
metallo-cryptophanes with bis-NHC tectons at Pd(II), but work to directly affix a 
carbenic centre onto the CTV cavitand has not been previously reported. The 
N-substituent (shown as methyl in scheme 4.8) can easily be tailored, with solubility 
and also additional functionality in mind. 
Au is extremely electronegative for a d-block metal, with an χP value 2.54, 
almost identical to carbon.41 Au is termed as carbophilic, forming very strong bonds 
with carbon, essentially covalent in character, and notoriously stable organometallic 
complexes. 
Imidazolium salts 4.3 and 4.5 proved insoluble in DCM; which is often the 
solvent of choice for group 11 carbene coordination. The tripodal Au(I) NHC 
complex derived from 4.3 proved extremely difficult to prepare, and a number of 
procedures were carried out in acetonitrile, and MeCN:DCM mixtures, both with 
heating and at ambient temperatures. Potassium carbonate and tert-butoxide bases 
were both employed, as well as the in-situ transmetallation using Ag2O, but most 
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reactions gave no trace of complex and turned purple in colour, characteristic of 
AuNP formation.  
 
Scheme 4.8 Targeted Au(I)-NHC complex and strategy towards heteroleptic cages. 
 The reaction of [Au(Cl)(SMe2)] with 4.3 and K2CO3, in MeCN at rt gave a 
promising 1H NMR spectrum (figure 4.27), with no imidazolium proton present, but 
by-product formation was also evident. 
 
Figure 4.27 Crude 1H NMR spectrum (293 K, 300 MHz, CDCl3) of Au(I) NHC reaction 
mixture. Arrows denote desired product peaks. 
The 1H NMR spectrum of crude Au(I) NHC contained a number of diagnostic 
peaks, such as the doublet at 4.5 ppm characteristic of the endo-methylene bridge of 
the CTV bowl. Two doublets between 6.0 and 6.5 ppm are characteristic of the 
diastereotopic N-CH2-O methylene bridge, and two singlets at 6.70 and 6.85 are a 
good match to the CTV arene-faces. Another promising sign is the lack of NCHN 
imidazolium proton, suggestive that an Au(I)-NHC complex is present. There are a 
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number of peaks corresponding to by-products, and also hexane upfield. The HRMS 
(figure 4.28) comprised a number of partial product peaks, and also suspected 
decomposition products (figure 4.29). The in situ salt metathesis to iodo-species was 
anticipated because of the soft nature of both Au(I) and I-. Whilst it is promising that 
an Au(I)-NHC complex can be prepared, the consistent poor yields (<10%), and 
potential for more than one complex to be present led to complexes of other metals 
being sought. 
 
Figure 4.28 HRMS spectrum of Au(I) reaction. 
 
Figure 4.29 By-products in the HRMS spectrum during Au(I)-NHC synthesis. 
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4.7.3 Investigations towards Cu(I)-NHC complexes 
Cu(I) complexes of NHCs are amongst the most well defined of all the 1st row 
transition metals, with complexes such as Cu-IMes becoming key players in a wide 
scope of catalytic transformations.42-44 Cu(I)-NHC complexes are often air-sensitive, 
although when using sterically encumbering ligands, can be rendered stable to 
oxygen and moisture. In the same vein as Ag(I) NHC complexes, the reaction of 4.3 
with Cu2O was attempted, but no evidence of coordination was obtained. 
Furthermore, the reaction of 4.3 with CuI in the presence of base was also 
unsuccessful. 
The procedures outlined so far in this chapter that have been tested for metal-
NHC formation have vast literature precedent, so it was somewhat surprising that all 
attempts using this ligand system were unsuccessful. One possible reason for this 
could be the methylene spacer between benzimidazolium and the cavitand as it 
resides between a nitrogen and an oxygen atom. Inductive effects at this site caused 
by the two electronegative atoms may render the hydrogen atoms of this group 
sensitive to strong bases. The preparation of alternative ligands not possessing a 
methylene spacer between imidazolium moiety and CTV may allow such complexes 
to be accessible, but would require multiple highly challenging steps. 
One way to avoid further steps would be the electrochemical procedure 
introduced by Chen, Willans and co-workers.46, 47 Electrochemical syntheses are 
typically more functional-group tolerant, and the free carbene liberation at the 
cathode is dictated by reduction potential of the imidazolium group, as opposed to 
the pKa. Electrodes of the required metal are inserted into the solution and a voltage 
applied. Oxidation of the metal occurs at the anode, liberating Mn+ in solution. The 
metal cations and carbene combine in solution, yielding a clean metal-NHC 
complex, and the sole by-product is hydrogen gas (scheme 4.9). Willans and 
co-workers have previously demonstrated the successful preparation of a 
tetrakis-Cu(I) complex on a calix[4]arene scaffold.48 
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Scheme 4.9 Electrochemical synthesis of Cu(I)-NHC complexes. 
A major limiting factor associated with 4.3 was its poor conductivity, leading to 
very slow reaction. It is unlikely that all three imidazolium groups would be 
simultaneously reduced at the cathode, therefore multiple products are possible. 
Simple mono-imidazolium salts allow for the charge to be dispersed throughout 
solution, so conduct electricity much more effectively. 
 Allyl ligand 4.6 was trialled in the electrochemical reaction with Cu metal, 
and when used as the hexafluorophosphate salt, was slightly more conducting 
(although still poor overall). Interestingly, HRMS (figure 4.30) indicated that the 
ligand had been digested after 24 h, with a number of product peaks/intermediates 
present (figure 4.31). 
 
Figure 4.30 HRMS of electrochemical reaction mixture of ligand 4.6 with Cu (rt, 50 mA, 24 h). 
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Figure 4.31 Species observed in the HRMS during the electrochemical reaction of 4.3 and Cu 
metal. 
Similarly to when using ligand 4.3, the same reaction with 4.6 could not be pushed 
to completion. Five key peaks were observed in the HRMS, most interestingly, the 
3+ peak at m/z 676.2061. The S-shaped complex would most likely be the final 
product because of other peaks showing a good match to a bis-NHC at Cu(I), and 
preference for imidazolium hexafluorophosphates to prepare [M(NHC)2]PF6
¯ 
species when coordinating to group 10 metals. An S-shaped complex would likely 
be the kinetic product in this reaction. The major peak corresponding to m/z 
811.2620 matches a monometallic complex with one imidazolium arm cleaved 
(figure 4.32). It is unclear whether this was an ionization event, or occurring during 
reaction. Cleavage of an azolium arm was commonly encountered during a number 
of ligand syntheses. The imidazolinone at m/z 997.3345 was taken as indication the 
reaction was still active, as this functional group is the product of reaction between a 
free carbene and oxygen. Despite the promise of being able to observe product peaks 
when carrying out electrochemical procedures, the poor conductivity of tripodal 
imidazolium salts led to extremely slow reactivity that even when left for 24 h, did 
not reach completion. An overpotential was applied to the electrochemical system 
which may have led to decomposition of MeCN solvent. Poor conductivity and 
reactivity towards Cu(I), Ag(I) and Au(I) led to alternative methodologies for the 
preparation of  metal-NHC complexes being pursued. 
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4.8 Conclusions 
A number of benzimidazolium salts were prepared, of which 4.3 and benzyl 4.5 
were selected as the key ligands to carry forward due to their facile syntheses when 
compared to alternative targets such as 4.6 and N-propyl variants. 
 A number of methodologies to prepare group 11 NHC complexes were also 
attempted, but limited success was achieved, with intractable product obtained in 
most cases. 
Future work would involve expanding the library of benzimidazolium salts, and 
investigating those which bear additional ligand groups such as pyridyl or picolyl 
donors. The bidentate nature of these complexes may promote coordination to metal 
ions such as Ni2+ or Fe2+, which have more accessible binding sites than the d10 
metals. For a bidentate pyridylimidazolium salt, it may be necessary to add an 
electron-withdrawing group to the pyridyl group, rendering the 2-halopyridine more 
electron deficient and allowing for a nucleophilic aromatic substitution reaction to 
proceed. 
 Routes towards CTV-NHC complexes without the activated methylene 
bridge would also be viable targets despite the potentially pyrrhic syntheses, this 
could be via coupling measures such as Ullmann or Suzuki reactions. This could 
however, open up avenues such as free carbene generation, which are unfeasible 
using the 1st generation of CTV-imidazolium ligands, and therefore allow a much 
wider scope of metal targets, and new methodologies. 
 The electrochemical syntheses of metal NHC complexes Willans and 
co-workers pioneered has very much focused on systems where monometallic 
complexes have been prepared. It would be thought-provoking to prepare 
multimetallic supramolecular complexes electrochemically. Whilst ligands prepared 
in this project displayed their limitations, the fact a tetrakis-Cu(I) calixarene 
complex could be isolated from an electrochemical procedure suggests there is 
scope for the preparation of hybrid organometallic-supramolecular complexes using 
electrochemical procedures. Possible ligand classes could be those based on a 
1,3,5-tris(1-methylimidazolyl)benzene scaffold, or the divergent azolium salts 
prepared by Hahn and co-workers when preparing molecular rectangles. Solubility 
poses much less of an issue with those systems as opposed to the cyclotriveratrylene 
family. 
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 Additionally, the guaiacol-derived ligands were untested in the 
electrochemical synthesis of NHC complexes. The fact complex peaks were 
observed in the HRMS for CTV complexes is promising, therefore from an 
organometallic aspect, it would be interesting to trial this ligand class in 
electrochemical procedures. It would be expected that the poor conductivity issues 
would not arise for the smaller, more charge dense ligands such as 4.8 and 4.9 with a 
better dispersed charge throughout solutions. 
4.9 Experimental section 
Unless stated in the experimental section, chemicals were bought from commercial 
suppliers and used without further purification. Unless stated, all reactions were 
carried out under aerobic conditions. Reactions performed under an atmosphere of 
dry nitrogen were carried out using standard Schlenk and Glovebox procedures, with 
solvents dried and degassed using the same methodology described in section 2.9. 
All analytical techniques are also consistent with those described in section 2.9. 
Synthesis of 1,1',1''-(((3,8,13-trimethoxy-10,15-dihydro-5H-
tribenzo[a,d,g][9]annulene-2,7,12-triyl)tris(oxy))tris(methylene))tris(3-methyl-
1H-imidazolium) iodide, 4.1 
2.4 (119 mg, 0.18 mmol), methyl iodide 
(0.10 mL, 1.40 mmol) and acetonitrile (5 mL) 
were added to a sealed ampoule and heated at 
80 ºC for 16 h. The reaction mixture was 
cooled and diethyl ether added. A yellow 
solid precipitated from solution. Yield 
148 mg, 0.14 mmol, 75%; HRMS (ESI)+ 
410.1259 {C39H45IN6O6}
2+ 947.1508{C39H45I2N6O6}
+ , 1092.0957 {C39H49I3N7O6}
+, 
Calcd. for 410.1217, 947.1485, 1092.0873 respectively; 1H NMR (300 MHz, 
DMSO-d6) δ (ppm) 9.32 (s, 3H, H
1), 7.86 (s, 3H, H3), 7.75 (s, 3H, H2), 7.32 (s, 3H, 
H8), 7.18 (s, 3H, H9), 6.05 (s, 6H, H4), 4.75 (d, 3H, J = 14.1 Hz, endo-H12), 3.89 (s, 
9H, H13), 3.74 (s, 9H, H5), 3.56 (d, 3H, J = 13.3 Hz, exo-H12);13C {1H} NMR (75 
MHz, DMSO-d6) δ (ppm) 148.70 (C
6), 142.82 (C7), 137.28 (C1), 136.14 (C11), 
132.05 (C10), 123.86 (C2), 122.28 (C3), 119.89 (C8), 114.65 (C9), 77.10 (C4), 56.31 
(C5), 36.06 (C13), 34.81 (C12); Elemental Analysis for C39H45I3N6O6.(3.5 H2O) 
Calcd: C 41.18, H 4.61, N 7.39; Found: C 41.10, H 4.40, N: 7.70. 
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Synthesis of of 1,1',1''-(((3,8,13-trimethoxy-10,15-dihydro-5H-
tribenzo[a,d,g][9]annulene-2,7,12-triyl)tris(oxy))tris(methylene))tris(3-methyl-
1H-imidazolium) hexafluorophosphate 4.2 
4.1 (48 mg, 0.04 mmol) and 
ammonium hexafluorophosphate 
(80 mg, 0.49 mmol) were 
dissolved in acetonitrile (5 mL) 
and methanol (5 mL), and stirred 
for 3 h. Diethyl ether (30 mL) was 
added and the title compound 






+; 1H NMR (501 MHz, DMSO-
d6) δ (ppm) 9.28 (s, 3H, H
1), 7.84 (s, 3H, H3), 7.74 (s, 3H, H2), 7.27 (s, 3H, H9), 7.14 
(s, 3H, H8), 6.02 (s, 6H, H4), 4.74 (d, 3H, J = 13.3 Hz, endo-H12), 3.88 (s, 9H, H13), 
3.73 (s, 9H, H5), 3.53 (d, 3H, J = 13.6 Hz, exo-H12); 13C{1H} NMR (126 MHz, 
DMSO-d6) δ (ppm) 148.73 (C
7), 142.90 (C6), 137.30 (C1), 136.10 (C10), 132.03 
(C11), 123.87 (C2), 122.29 (C3), 119.87 (C9), 114.60 (C8), 77.11 (C4), 56.16 (C5), 
36.00 (C13), 34.87 (C12); 19F NMR (282 MHz, DMSO-d6) δ (ppm) -70.16 (d, JF-P = 
711.5 Hz), -71.42 (PF6); Elemental analysis for C39H45F18N6O6P3.(2H2O) Calcd. C 





methyl-1H-benzimidazolium) iodide, 4.3 
2.11 (102 mg, 0.13 mmol) was dissolved in 
MeCN (5 mL) in a J. Youngs ampoule and 
methyl iodide (0.10 mL, 1.70 mmol) added. 
The ampoule was sealed and heated to 80 
ºC for 18 h and the solution turned orange. Diethyl ether (40 mL) was added 
dropwise and the title compound precipitated from solution as a cream solid. Yield 
117 mg, 0.09 mmol, 74%. HRMS (ESI+) 485.1450 {C51H51IN6O6}
2+ 1097.1956 
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{C51H51I2N6O6}
+, 1242.1345 {C51H55I3N7O6}
+ Calcd. for 485.1452, 1097.1954, 
1242.1342 respectively; 1H NMR (300 MHz, DMSO-d6) δ (ppm) 9.86 (s, 3H, H
1), 
8.04 (d, 3H, J = 8.3 Hz, H6), 7.84 (d, 3H, J = 8.3 Hz, H3), 7.69 (t, 3H, J = 7.4 Hz, 
H4), 7.58 (t, 3H, J = 7.5 Hz, H5), 7.33 (s, 3H, H10), 7.08 (s, 3H, H11), 6.37 (s, 6H, 
H8), 4.73 (d, 3H, J = 13.5 Hz, endo-H16), 4.10 (s, 9H, H17), 3.56 (s, 9H, H9), 3.55 (d, 
3H, J = 23.1 Hz, exo-H16); 13C{1H} (75 MHz, DMSO-d6) δ (ppm) 148.95 (C
13), 
143.24 (C1), 142.90 (C12), 136.43 (C14), 132.19 (C15), 131.78 (C2), 130.43 (C7), 
126.96 (C5), 126.81 (C4), 120.59 (C10), 114.49 (C11), 113.79 (C6), 113.64 (C3), 75.92 
(C8), 56.10 (C9), 34.79 (C16), 33.56 (C17); FTIR ν (cm-1) 2026, 1968, 1509, 1269, 
756; m.p 192-194 ºC (dec.); Elemental analysis for C51H51I3N6O6.2(H2O) Calcd.: 




1H-benzimidazolium) hexafluorophosphate 4.4 
4.3 (50 mg, 0.04 mmol) and ammonium 
hexafluorophosphate (20 mg, 0.12 mmol) 
were dissolved in MeCN (1 mL) and MeOH 
(5 mL). The pale yellow solution was stirred 
for 1 h, during which a white solid 
precipitated, was collected via vacuum 
filtration, washed with methanol (5 mL) and 
diethyl ether (3 x 5 mL), affording the title compound as a white solid. Yield 43 mg, 






Calcd. 281.1285, 349.1547, 494.1751, 1133.3149 respectively; 1H NMR (300 MHz, 
DMSO-d6) δ (ppm) 9.86 (s, 3H, H
1), 8.04 (d, 3H, J = 8.3 Hz, H6), 7.84 (d, 3H, J = 
8.3 Hz, H3), 7.69 (t, 3H, J = 7.4 Hz, H4), 7.58 (t, 3H, J = 7.5 Hz, H5), 7.33 (s, 3H, 
H10), 7.08 (s, 3H, H11), 6.37 (s, 6H, H8), 4.73 (d, 3H, J = 13.5 Hz, endo-H16), 4.10 (s, 
9H, H17), 3.56 (s, 9H, H9), 3.55 (d, 3H, J = 13.1 Hz, exo-H16); 13C{1H} (101 MHz, 
DMSO-d6) δ (ppm) 149.00 (C
13), 143.28 (C1), 142.97 (C12), 136.43 (C14), 132.18 
(C15), 131.80 (C2), 130.45 (C7), 126.96 (C5), 126.82 (C4), 120.62 (C10), 114.45 (C11), 
113.76 (C6), 113.62(C3), 75.91 (C8), 55.96 (C9), 34.86 (C16), 33.47 (C17); 19F{1H} 
NMR (376 MHz, DMSO-d6) δ (ppm) -70.15 (d, JF-P = 711.8 Hz). 
31P{1H} NMR 
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(162 MHz, DMSO-d6) δ (ppm) -144.19 (hept, JP-F = 711.5 Hz); FTIR ν (cm
-1) 834 
(P-F bend), 557; Elemental analysis for C51H51F18N6O6P3 Calcd.: C 47.90, H 4.02, N 




1H-benzimidazolium) bromide, 4.5 
2.11 (100 mg, 0.12 mmol) was dissolved in 
acetonitrile (5 mL) and benzyl bromide (0.06 
mL, 0.54 mmol) was added. The colourless 
solution was heated to 60 ºC for 18 h, during 
which time a white solid precipitated from 
solution. The solid was filtered, washed with 
diethyl ether (20 mL) and dried in air, affording 
4.5 as a white solid. Yield 129 mg, 0.22 mmol, 
82%. HRMS (ESI+) 357.1624 {C69H63N6O6}
3+, 
490.2127 {C62H56N6O6}
2+; calculated 357.1598, 
490.2125; 1H NMR (300 MHz, DMSO-d6) δ (ppm) 10.18 (s, 3H, H
1), 8.00 (d, 3H, J 
= 8.1 Hz, H11), 7.91 (d, 3H, J = 8.1 Hz, H8), 7.61 (m, 6H, H9, H10), 7.40 (bs, 6H, H4, 
H5, H6, H18), 7.09 (s, 3H, H15), 6.43 (m, 6H, H13), 5.81 (s, 6H, H2), 4.74 (d, 3H, J = 
13.6 Hz, endo-H21), 3.54 (d, 3H, J = 13.4 Hz, exo-H21), 3.45 (s, 9H, H20); 13C{1H} 
NMR (75 MHz, DMSO-d6) δ (ppm) 149.17 (C
19), 142.98 (C1), 142.51 (C14), 136.71 
(C17), 133.68 (C3), 132.25 (C16), 130.76 (C12), 130.72 (C7), 129.03 (C5), 128.83 (C6), 
128.17 (C4), 127.09 (C10), 127.02 (C9), 121.18 (C18), 114.57 (C15), 114.11 (C8), 
114.00 (C11), 76.24 (C13), 56.02 (C20), 49.92 (C2), 34.80 (C21); FTIR ν (cm-1) 3432, 
2936, 1511, 1269, 766; Elemental analysis for C69H63Br3N6O6(HBr) Calcd.: C 





benzimidazolium) bromide, 4.6 
2.11 (50 mg, 0.063 mmol), allyl bromide (0.12 mL, 1.3 mmol) and acetonitrile (3 
mL) were stirred at 80 ºC in a sealed J. Youngs ampoule for 16 h. Methanol (5 mL) 
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was added to dissolve the red oil formed, 
and solvents removed in vacuo, affording a 
hygroscopic cream coloured solid. The solid 
was dissolved in methanol (5 mL), NH4PF6 
(50 mg) added and stirred for 30 mins. A 
white solid precipitated, was filtered, and 
washed with methanol (5 mL) and diethyl 
ether (5 mL). The title compound was 










+, Calcd. for 307.1441, 375.1703, 440.1969, 
533.1985, 895.3054, 1025.3585, 1211.3618 respectively; 1H NMR (500 MHz, 
DMSO-d6) δ (ppm) 9.86 (s, 3H, H
4), 8.01 (d, 3H, J = 8.3 Hz, H6), 7.88 (d, 3H, J = 
8.3 Hz, H9), 7.69 (t, 3H. J = 7.8 Hz, H7), 7.61 (t, 3H, J = 7.8 Hz, H8), 7.29 (s, 3H, 
H14), 7.04 (s, 3H, H17), 6.40 – 6.30 (m, 6H, H11), 6.06 (ddt, 3H, J = 16.2, 10.7, 5.8 
Hz, H2), 5.38 (d, 3H, J = 10.2 Hz, cis-H1), 5.32 (d, 3H, J = 17.2 Hz, trans-H1), 5.19 
(d, 6H, J = 5.5 Hz, H3), 4.73 (d, 3H, J = 13.3 Hz, endo-H19), 3.51 (s, 12H, H18, exo-
H19); 13C{1H} NMR (100 MHz, DMSO-d6) δ (ppm) 149.16 (C
13), 142.98 (C3), 
142.84 (C12), 136.66 (C15), 132.21 (C16), 130.93 (C5, C10), 130.72 (C2), 127.08 (C8), 
126.97 (C7), 121.13 (C14), 120.58 (C1), 114.41 (C17), 113.99 (C6), 113.93 (C9), 76.28 
(C11), 55.93 (C18), 48.94 (C3), 34.85 (C19); 19F NMR (376 MHz, DMSO-d6) δ (ppm) 
-70.15 (d, JF-P = 711.4 Hz, PF6); 
31P NMR (162 MHz, DMSO-d6) δ (ppm) -144.18 
(hept, JP-F = 711.2 Hz, PF6); Elemental analysis for C57H57F18N6O6P3 Calcd.: C 





Synthesis of 1-(2-methoxyphenyoxy)methylbenzimidazole, 4.7 
Sodium hydride (60% dispersion, 800 mg, 19.48 mmol) was 
added to anhydrous, degassed DMF (5 mL) under an N2 
atmosphere. Guaiacol (400 mg, 0.36 mL, 3.20 mmol) was 
added dropwise over a period of 
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20 mins. The effervescing solution was stirred at rt for 1 h. 
1-(chloromethyl)benzimidazole hydrochloride (786 mg, 3.2 mmol) was added and 
the solution stirred at rt for 16 h. The reaction was quenched with water and the 
product extracted into dichloromethane (3 x 200 mL). The organic layers were 
combined, washed with brine, and dried over MgSO4. Solvents were removed in 
vacuo, and the residue triturated in petroleum ether (60-80), affording the title 
compound as a white solid Yield 441 mg, 1.90 mmol, 58%. HRMS (ESI+) 255.1136 
{C15H15N2O2}, 277.0949 {C15H14N2NaO2}
+ Calcd. for 255.1129 and 277.0948 
respectively; 1H NMR (300 MHz, CDCl3) δ (ppm) 7.81 (s, 1H, H
1), 7.78 (dd, 1H, J 
= 3.3, 1.2 Hz, H3), 7.52 – 7.47 (m, 1H, H5), 7.35 – 7.27 (m, 2H, H4, H6), 7.10 – 7.02 
(m, 1H, H13), 6.90 (dd, 1H, J = 8.1, 1.5 Hz, H14), 6.75 (td, 1H, J = 7.6, 1.5 Hz, H12), 
6.68 (dd, 1H, J = 7.9, 1.8 Hz, H11), 6.03 (s, 2H, H8), 3.79 (s, 3H, H15); 13C{1H} 
NMR (101 MHz, CDCl3) δ (ppm) 151.74 (C
10), 144.63 (C2), 144.05 (C9), 143.34 
(C1), 133.69 (C7), 125.59 (C13), 123.70 (C4), 122.91 (C6), 121.73 (C11), 121.27 (C12), 
120.52 (C3), 112.58 (C14), 110.33 (C5), 74.91 (C8), 55.81 (C15). All data were 
consistent with those reported in the literature.12 
 
Synthesis of 1-(2-methoxyphenyoxy)methyl-3-methylbenzimidazolium iodide, 
4.8 
4.7 (50 mg, 0.19 mmol) and acetonitrile (2 mL) were added 
to a J. Youngs ampoule. Methyl iodide (0.12 mL, 1.90 
mmol) was added, and the ampoule sealed and the pale 
yellow solution heated to 80 ºC for 16 h. Diethyl ether (20 
mL) was added and a white solid precipitated from solution. 
The powder was filtered and washed with diethyl ether (5 
mL). The title compound was isolated as a white powder. Yield 60 mg, 0.15 mmol, 
84%. HRMS (ESI+) 269.1246 {C16H17N2O2}
+ Calculated 269.1285; 1H NMR (300 
MHz, DMSO-d6) δ (ppm) 9.87 (s, 1H, H
2), 8.11 – 8.01 (m, 1H, H7), 8.00 – 7.92 (m, 
1H, H4), 7.77 – 7.67 (m, 2H, H5, H6), 7.16 – 7.00 (m, 3H, H12, H13, H15), 6.88 (ddd, 
1H, J = 8.3, 7.2, 1.7 Hz, H14), 6.45 (s, 2H, H9), 4.12 (s, 3H, H1), 3.65 (s, 3H, H16); 
13C{1H} NMR (75 MHz, DMSO-d6) δ (ppm) 150.60 (C
11), 144.13 (C10), 143.36 
(C2), 131.82 (C3), 130.48 (C8), 127.10 (C6), 126.83 (C5), 125.17 (C12), 120.84 (C14), 
119.36 (C15), 113.82 (C7), 113.72 (C4), 112.98 (C13), 75.66 (C9), 55.53 (C16), 33.57 
(C1); FTIR ν (cm-1) 1491, 1253, 1124, 1054, 1015, 745; m.p. 145-147 ºC; Elemental 
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analysis for C16H17IN2O2Calcd.: C 48.50, H 4.30, N 7.07; Found C 48.59, H 4.26, N 
7.14. 
 
Synthesis of 1-(2-methoxyphenyoxy)benzyl-3-methylbenzimidazolium bromide, 
4.9 
2-(Methoxyphenoxymethyl)benzimidazole (200 mg, 
0.78 mmol) was dissolved in acetonitrile (10 mL) 
and benzyl bromide (0.92 mL, 7.8 mmol) added. The 
colourless solution was heated to 60 ºC overnight, 
during which a white solid precipitated. The 
precipitate was filtered, washed with diethyl ether (20 mL) and dried, affording 4.9 
as a white solid. Yield 293 mg, 0.68 mmol, 88%. HRMS (ESI+) 345.1611 
{C22H21N2O2}
+ Calculated 345.1598; 1H NMR (300 MHz, DMSO-d6) δ (ppm) 10.04 
(s, 1H, H1) , 8.06-7.95 (m, 2H. H8, H11), 7.77 – 7.60 (m, 2H, H9, H10), 7.39 (s, 5H, 
H4, H5, H6), 7.12 (t, 1H, J = 7.0 Hz, H17), 7.06 – 6.94 (m, 2H, H15, H18), 6.86 (t, 1H, 
J = 7.0 Hz, H16), 6.47 (s, 2H, H14), 5.80 (s, 2H, H2), 3.54 (s, 3H, H20); 13C{1H} 
NMR (101 MHz, DMSO-d6) δ (ppm) 150.84 (C
19), 143.67 (C14), 143.08 (C1), 
133.66 (C3), 130.77 (C7, C12), 129.02 (C5), 128.80 (C6), 128.17 (C4), 127.25 (C10), 
127.06 (C9), 125.47 (C17), 120.89 (C16), 120.02 (C18), 114.14 (C8), 114.04 (C11), 
113.06 (C15), 76.06 (C13), 55.42 (C20), 49.95 (C2); FTIR ν (cm-1) 2900, 1505, 1252, 
1206, 745; Elemental analysis for C22H21BrN2O2 Calcd.: C 62.13, H, 4.98, N, 6.59; 
Found C 61.96, H 4.88, N 6.67 
4.10 Supplementary crystallographic information 
Crystals were mounted under inert oil on a MiTeGen tip and flash frozen using an 
OxfordCryosystems low temperature device. X-ray diffraction data were collected 
using CuK radiation (λ = 1.54184 Å) or MoK (λ = 0.71073 Å) using an Agilent 
Supernova dual-source diffractometer with Atlas S2 CCD detector and fine-focus 
sealed tube generator, or using synchrotron radiation (λ = 0.6889 Å) at Beamline I19 
at the Diamond light source. Data were corrected for Lorenztian and polarization 
effects and absorption corrections were applied using multi-scan methods. The 
structures were solved by direct methods using SHELXS-97 and refined by full-
matrix on F2 using SHELXL-97. Unless otherwise specified, all non-hydrogen 
- 170 - 
atoms were refined as anisotropic, and hydrogen positions were included at 
geometrically estimated positions. 
 
4.10.1 Additional crystallographic details 
(4.2)2.3(MeCN) 
Hexafluorophosphate anions were disordered over two positions at 0.5 occupancy 
and refined as isotropic. Bond lengths and angles restrained to be chemically 
reasonable. The acetonitrile molecule was refined as isotropic, bond lengths 
restrained to be chemically reasonable and hydrogen positions not included. Data 
overall were of poor quality and did not diffract to high angles. 
4.4 
Two benzimidazolium groups were highly disordered and therefore refined as 
isotropic. Bond lengths of both benzo-backbones in question were restrained to be 
chemically reasonable using the AFIX command of SHELX. A portion of one 















Table 4.1 Crystallographic data. a = Cuka radiation, b = synchrotron radiation 
Compound (4.2)2.3(MeCN)
a 4.4b 4.8b 
Formula C79H90F36N12.5O12P6 C102H102F36N12O12P6 C32H34I2N4O4 
Mr 2276.45 2557.78 792.43 
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Crystal size 0.03 x 0.06 x 0.10 0.03 x 0.01 x 0.01 0.12 x 0.12 x 0.15 
Crystal system Hexagonal Triclinic Triclinic 
Space group 𝑃6 𝑃1̅ 𝑃1̅ 
a (Å) 26.355(7) 7.4847(9) 9.81010(10) 
b (Å) 26.355(7) 16.4088(17) 11.69940(10) 
c (Å) 4.5656(18) 22.788(3) 14.63640(10) 
α (0) 90 75.410(11) 83.3170(10) 
β (0) 90 80.946(12) 83.0190(10) 
γ (0) 120 78.773(10) 74.0510(10) 
 
V (Å3) 2746.3(18) 2639.3(6) 1597.15(3) 
Z 2 2 2 
ρcalc (g.cm
-3) 1.376 1.609 1.648 
θ range (0) 3.354-59.971 1.708- 20.148 1.761-25.502 
No. data collected 5103 8730 21318 
No. unique data 2277 5085 6465 
Rint 0.0957 0.0620 0.0317 
No. obs. Data (I > 2σ(I)) 1428 1834 6025 
No. parameters 218 641 383 
No. restraints 39 4 0 
R1 (obs data) 0.1754 0.1137 0.0318 
wR2 (all data) 0.4525 0.3374 0.1231 
S 1.523 0.945 1.051 
Max. shift/esd 0.000 0.001 0.001 
Largest difference peak and hole/ (e Å3) 1.454, -0.523 0.830, -0.356 1.830,-0.850 
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Chapter 5  
Synthesis and characterisation of Ir, Rh and Ru NHC complexes, 
and catalytic evaluation in the transfer hydrogenation of 
acetophenone 
This chapter focuses on the preparation of trimetallic Ir(III), Ir(I), Rh(I) and 
Ru(II)-NHC complexes via the Ag(I) transmetallation route. Appropriate complexes 
were investigated as catalysts for the transfer hydrogenation of acetophenone. 
5.1 Introduction 
A number of major discoveries in organometallic chemistry have revolved around 
complexes of noble metals, with Ir, Rh and Ru being at the forefront of 
breakthroughs since the mid-20th century. In 1961, Vaska’s complex, 
[Ir(Cl)(CO)(PPh3)2] was reported, which can reversibly bind molecular oxygen.
1 In 
the 1970s, Wilkinson and Crabtree reported Rh(I) and Ir(I) complexes which could 
catalyse the hydrogenation of alkenes.2, 3 Grubbs has demonstrated that 
Ru(IV)-phosphine and NHC complexes are capable of catalysing alkene metathesis 
reactions, which has become an invaluable tool in the synthesis of molecular knots.4 
Ir, Rh and Ru complexes are often derived from dimeric μ2-chlorido species bearing 
multihaptic or chelating ligands. The dimeric precursors are readily available, and 
split upon reaction with an incoming ligand. 
 Many key advancements in organometallic chemistry have been in the field 
of catalysis. Ir, Rh and Ru complexes and precursors are very expensive, but their 
cost is offset by low catalyst loading requirements. The transition-metal catalysed 
transfer hydrogenation (TH) of ketones and aldehydes to yield alcohols is a powerful 
tool to replace traditional reductions using reducing agents such as sodium 
borohydride, or carrying out hydrogenations under pressurised H2 environments.
5 
TH reactions take place in protic solvents, commonly isopropanol, and the sole 
by-product is a ketone such as acetone. Clean reactivity is afforded, with a much 
smaller environmental impact, and there is no need to use the high pressures 
required for a direct hydrogenation. Furthermore, if a prochiral precursor were to be 
employed, such as acetophenone, asymmetric TH reactions are possible when using 
chiral catalysts.6, 7 The first key breakthrough in TH chemistry was in 1925 with the 
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discovery of the Meerwein-Pondorf-Verley reaction, an aluminium 
alkoxide-mediated TH process.8 Disadvantages included stoichiometric addition of 
Al and side-reactions occurring. A number of examples of transition metal catalysed 
TH reactions had been reported up until the mid-1990s, but most catalysts lacked 
enantioselectivity, or were poorly active.9-11 In 1997, Noyori made a significant 
breakthrough, preparing chiral Ru(II) complexes which were capable of catalysing 
TH reactions in isopropanol solvent, with excellent ee’s, high conversions and at 
low catalyst loadings (figure 5.1, left).6 NHC complexes have since become valuable 
tools in TH catalysis. A key example being Nolan’s NHC analogues of Crabtree’s 
catalyst (figure 5.2, right).12 A number of Rh13-17, Ir13, 16, 18, 19 and Ru-NHC20-25 
complexes have since been reported to catalyse the TH reaction. Recent efforts have 
gone into employing complexes of cheaper metals in TH catalysis, with a focus on 
Fe. Morris and co-workers have prepared an Fe(II) complex comparably active to 
Noyori’s ground-breaking catalyst, but the benefits are offset by a more challenging 
synthetic protocol.26  
 
Figure 5.1 Left: Noyori's Ru(II) TH catalyst and right: Nolan's Ir(I)-NHC complex.5, 6, 12 
The mechanism for TH reactions can be complex, with the pathway being dependent 
on a number of factors including the metal cation, and also the ligand framework. 
Mechanisms can be classed as inner- or outer-sphere mediated. The inner-sphere TH 
(scheme 5.1, bottom left) involves coordination of the deprotonated alcoholic 
solvent before subsequent ‘oxidation’ of the alkoxide mediated by the migration of 
the β-hydride. Ligand exchange then occurs prior to migratory insertion of the 
hydride ligand, reducing the carbonyl to an alcohol, which is then released from the 
metal upon coordination of solvent. The outer-sphere mechanism (scheme 5.1, 
bottom right) dominates when the ligand bears a Brønsted basic group, such as an 
amine. A pericyclic intermediate is formed through interaction of the alcohol and 
C-H with metal and ligand, oxidising the alcohol and yielding a hydrido complex. A 
second transition-state arises through interaction of the ketone with the hydride 
ligand, and the reduced alcohol is then eliminated.27 This reactivity was pioneered 
by Noyori, whose catalysts often followed this pathway in asymmetric TH 
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reactions.5, 6 Morris has, however, prepared Ru(II)-NHC complexes bearing a 
coordinating aniline pendant, and discovered that an inner-sphere mechanism was 
more favourable in this case.28 Hintermair and Crabtree have observed Cp* loss as a 
pathway when employing [Ir(Cp*)(NHC)2(Cl)]
+ catalysts, but this is mediated by an 
unusual scenario of Cp* being the weakest-bound ligand on intermediates when 
employing their catalysts.29  
 
Scheme 5.1 TopL TH reaction. Bottom left: generally accepted inner-sphere and bottom right: 
outer-sphere mechanisms. 
Kück and Peris have previously reported a trimetallic Rh(I)-NHC complex 
annulated onto the TBTQ scaffold, which is structurally similar to CTG. The 
complex possesses pseudo-C3-symmetry with two NHC environments in the 
13C{1H} NMR spectrum, suggesting there is no rotation about Rh-C bonds in 
[Rh(COD)(NHC)(Cl)] complexes.30 Crabtree has previously demonstrated this is 
general for Rh(I) and Ir(I)-NHC complexes bearing COD ligands, and this remained 
the case on the NMR timescale at 105 ºC.31 Carbonylating the complexes led to 
fluxionality and coalescence of the diastereotopic peaks, suggesting the COD ligand 
conformationally locks the complex. It would be reasonable to predict 
conformational locking is common in most NHC complexes bearing multihaptic 
ligands, such as Cp*. 
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5.2 Preparation of Ir(III) NHC complexes 
The selected route for the preparation of trimetallic NHC complexes tethered to the 
CTV scaffold was the transmetallation from a Ag(I)-NHC transfer agent. It was 
discussed in Chapter 4 how the isolation of Ag(I)-NHC complexes of ligand 4.3 
proved unsuccessful, but widespread literature precedent for transmetallation onto 
noble metals exists, in particular when using dimeric precursors. The additional 
enthalpic driving force of Ag(I) halide precipitation further enhances the yield of 
coordination of carbene to metal. Examples of Ir(III)-NHC synthesis have been 
reported which employ weak alkali metal bases instead of Ag2O, but it was decided 
that the strong driving force associated with AgX precipitation would afford the best 
chance of preparing desired complexes. Typically, the preparation of Ir(III) 
complexes via this methodology is carried out in DCM, with acetonitrile also 
previously being used.32 Tripodal imidazolium salts 4.3 and 4.5 were insoluble in 
chlorinated solvents, therefore reactions were carried out in MeCN. Ligand 4.3 
exhibited solubility in acetonitrile, whereas 4.5 did not, hence ligand 4.3 was 
selected for this investigation. The precursor [Ir(Cp*)(Cl)2]2 is readily available and 
reacts with nucleophiles to yield two equivalents of a piano-stool complex. The 
methyl groups of the Cp* ligand increase the π-donating capabilities of the 
multihaptic ligand, in addition to improving solubility of complexes. 
 
Scheme 5.2 Synthesis of Ir(III)-NHC complexes 5.1 and 5.2. 
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Trimetallic Ir(III) complex 5.1 was successfully prepared following the 
methodology described in scheme 5.2. The orange solid obtained was indefinitely 
stable to air and moisture. Careful stoichiometric control was necessary to prevent 
residual [Ir(Cp*)(Cl)2]2 from remaining, whilst an excess of 4.3 would give 
incomplete reactivity, with mono- or bis-metallated complex present, proving 
difficult to separate. HRMS suggested reactions reached completeness after 18 h, 
and a pale yellow solid precipitated from solution, consistent with AgI formation. 
Ag2O was not observed in the Schlenk flask. Consideration for the photosensitivity 
of Ag(I) species, along with potential air- and moisture sensitivity was paramount, 
so 4 Å molecular sieves were added to reactions and manipulations carried out in the 
dark under an atmosphere of dry nitrogen gas. Reactions were filtered through 
multiple Celite™ pads in an attempt to remove Ag(I) impurities, however, in some 
cases AgI was observed in the product even after multiple filtrations. In order to 
circumvent Ag by-product formation, the synthesis of 5.1 employing Cs2CO3 as 
base was attempted, but gave low yields (<15%). Complex 5.2 could be prepared 
following the same methodology applied to 5.1 by employing ligand 4.8, in addition 
to reducing the stoichiometries of Ag2O and [Ir(Cp*)(Cl)2]2 to 0.5 by virtue of each 
complex molecule only bearing one metal centre. 
 HRMS was an excellent tool for characterising complexes derived from 
noble metal dimers, and diagnostic isotope patterns were observed for complexes 
prepared. The obtained spectrum of 5.1 (figure 5.2) contained a major peak at m/z 
643.1692 {M-3Cl}3+ (calculated 643.1665). Additional peaks with a +4 and +2 
charge for similar species minus relevant number of halide ions were also detected 
at m/z 473.6436 and 982.2344 respectively (calculated as 473.6236 and 982.2345 
respectively).  
 Complex 5.2, η5-1,2,3,4,5-pentamethylcyclopentadienyl dichloro (1-methyl-
3-((2-methoxyphenoxy)methyl)benzimidazol-2-ylidene)iridium(III) followed a 
similar trend, and the major peak observed in the HRMS was {M–Cl}+ with m/z = 
631.1700 (calculated 631.1698) displaying a good match to the simulated isotope 
pattern (figure 5.3). 
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Figure 5.2 HRMS of complex 5.1. Inset: observed (top) vs simulated (bottom) isotope pattern 
for m/z = 643.1692, {M-3Cl}3+. 
 
Figure 5.3 HRMS of complex 5.2. Inset: Observed (top) vs simulated (bottom) isotope pattern 
for m/z 631.1700, {M-Cl}+. 
1H NMR spectroscopy was a less useful tool when interpreting spectra of trimetallic 
complexes. The extremely rigid trimetallic complexes gave highly broadened 
spectra, which often precluded their full assignment. VT NMR spectroscopy was 
carried out in CDCl3 and MeCN-d3 between 223 and 323 K, but no changes to 
spectra were observed. No peaks were observed in the 13C{1H} spectrum of 5.1, 
even after further concentrating the sample. Nonetheless, key peaks including the 
methylene bridge and both CH3 groups could be determined using 2D NMR 
spectroscopy. Heteronuclear 2D experiments were also carried out to ratify the 
relative position of carbon atoms, which proved invaluable in determining the 
- 180 - 
carbenic nature of the complexes. Monometallic complexes afforded a valuable 
NMR tool for understanding the behaviour of CTV-derived complexes in solution, 
with key peaks in mono- and trimetallic complexes appearing at similar chemical 
shifts. 
For complex 5.1, the Cp* methyl resonances surprisingly split into two peaks 
at 1.71 and 1.57 ppm, both of which were observed coupling to a single carbon in 
the HMQC spectrum. The peak at 1.51 ppm does overlap with the chemical shift of 
water in CDCl3, but 2D analysis suggests this peak is related to the bulk complex. 
Significantly, both of these Cp* resonances couple to the carbenic carbon in the 
HMBC spectrum, suggesting they are associated with the sole C3-symmetric NHC 
complex. A single peak at 1.69 ppm in the 1H NMR spectrum was observed of 5.2 
corresponding to the Cp* methyl protons. The protons of the methylene bridge H11 
in 5.2 split into two environments at 5.88 and 7.42-7.27 ppm. This was confirmed 
using COSY and HMQC experiments. Similar coupling was observed in the COSY 
and HMQC spectra of 5.1, with the most upfield peak appearing at ca. 5.3 ppm, 
suggesting shielding of this proton from the magnetic field. Preagostic interactions 
may well offer an explanation for the large splitting between seemingly similar 
protons.33 The deshielded proton interacts with the Ir(III) centre in solution, and 
such splitting is typical for this particular phenomenon.27 For 5.2, the N-methyl and 
methoxy resonances were sited at 4.22 and 3.79 ppm respectively, and significant 
peaks were observed at similar chemical shifts in complex 5.1. A broad doublet at 
4.81 ppm coupled to a second broad peak at 3.59 ppm in the COSY experiment for 
5.1, which are suggestive of the endo- and exo- protons of the CTV lower rim. The 
observation of a doublet, in addition to no further Cp* resonances or no imidazolium 
resonances at >9 ppm, implies that in the case of complex 5.1, a single trimetallic 
complex was prepared. SEM-EDX analysis was also carried out, which eliminated 
the possibility of halide mixing as a consequence of employing the imidazolium 
iodide alongside an iridium chloride precursor. 
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Figure 5.4 1H NMR spectra (300 MHz, 293 K, CDCl3) of 5.1 (top, black trace) and 5.2 (bottom, 
red trace). 
A 13C{1H} NMR spectrum could not be obtained for complex 5.1, even when 
adding 30-40 mg of sample to 0.5 mL of CDCl3. A weak DEPT-135 spectrum was 
obtained (shown as the vertical axis in figure 5.6), which revealed two CH2 
resonances at 77.93 and 34.47 ppm, consistent with the fully formed complex and 
comparable to the NCH2O and CTV lower rim resonances on a number of CTV-type 
complexes. 2D NMR spectroscopy, in particular HMQC and HMBC experiments, 
could be used to suggest relative positions of carbon resonances for comparison with 
5.2. Importantly, coupling between peaks at 4.12 ppm (1H) and 171.37 ppm (13C) in 
the HMBC spectrum was observed, diagnostic for the N-methyl group coupling with 
the divalent carbon of the NHC ligand. The Cp* protons were also observed weakly 
coupling to the carbenic centre. The 13C{1H} NMR spectrum of 5.2 (figure 5.5) 
contained a carbenic resonance (C3) in 5.2 at 173.05 ppm, comparable to that 
observed in the HMBC spectrum of 5.1. A single CH2 resonance at 77.71 ppm was 
observed in the DEPT-135 experiment. The Cp* methyl protons of 5.2 coupled to a 
carbon at 90.31 ppm in the HMBC spectrum, confirmed as the cyclopentadienyl 
carbons (C2). 
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Figure 5.5 13C{1H} NMR spectrum of 5.2 (top) with DEPT-135 spectrum (bottom). Inset: 
HMBC spectrum. 
 
Figure 5.6 HMBC spectrum of 5.1 with DEPT-135 NMR spectrum shown on vertical axis. 
1H-1H NOESY NMR spectroscopy was a valuable tool for confirming the highly 
restricted rotation associated with complex 5.1. The Cp* protons weakly interacted 
with the N-methyl group of the carbene and more weakly with the furthest 
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downfield NCH2O proton (figure 5.7). This was compared to the 
1H-1H NOESY 
spectrum of 5.2 (figure 5.8), which revealed through-space interactions between the 
Cp* and N-methyl protons, in addition to the Cp* protons interacting with both 
NCH2O resonances, the methoxy group and also one of the guaiacol protons. The 
above data suggest that 5.1 is rotationally locked, whereas 5.2 displays many more 
degrees of rotational freedom, which perhaps explains the broad nature of NMR 
spectra for the trimetallic complex. 
 
Figure 5.7 NOESY spectrum of 5.1. Through space coupling shown in red. 
 
Figure 5.8 NOESY spectrum of 5.2. Through-space interactions shown in red. 
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Pale yellow rhombohedral crystals of complex 5.1 suitable for diffraction were 
grown from the diffusion of diethyl ether vapours into an acetonitrile solution of the 
complex after ca. one week. Complex 5.1 crystallised in the hexagonal R3𝑐 space 
group. The asymmetric unit (figure 5.9) comprised of one-third of the complex, with 
5.1 possessing strict crystallographic C3 symmetry. A crystal structure could be 
obtained when collecting data using CuKα radiation, which revealed poorly resolved 
acetonitrile solvent molecules in the asymmetric unit, but the data was of poor 
quality due to strongly absorbing heavy atoms. Collecting data using MoKα 
radiation did resolve the absorption problems caused by the Ir atoms when using 
CuKα radiation, but the acetonitrile molecules could not be located within the 
difference map due to poor high angle diffraction, therefore the SQUEEZE routine 
using PLATON was applied.34  
 
Figure 5.9 Left: Asymmetric unit of 5.1. Ellipsoids are drawn at the 50% probability. Right: 
Stick model of trimetallic 5.1. 
The Ir-CNHC bond length was measured as 2.073(11) Å, comparable to previously 
reported Ir(III)-NHC complexes.32 Ir-Cl bond lengths were 2.421(3) and 2.422(3) Å, 
and an Ir-Cp* centroid distance of 1.810 Å calculated. A Carene-O-C-NNHC torsion 
angle of 168.9º was measured, with the NHC nitrogen atom lying close to the plane 
of the CTV arene faces. The Ir(III) centre is pointed away from the CTV bowl, in 
the direction of the lower rim. The outer rim of the cavitand shields one face of the 
Ir(III) centre, exerting significant bulk on the system. Only part of the 
benz-backbone of the NHC lies in the plane of the CTV arenes. Hydrogen bonding 
interactions between chloride ligands and hydrogen atoms from the N-methyl group  
and a hydrogen atom from the NCH2O methylene bridge may have arisen, with 
C···Cl separations of 3.318 Å and 3.191 Å respectively. Preagostic interactions 
between a calculated methylene bridge proton and Ir(III) centres may be present, at a 
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calculated Ir···H separation of 2.886 Å, with a C-H-Ir angle of 117.53º, obeying the 
rules proposed by Ellman.33 Neutron diffraction would confirm preagostic 
interactions by locating the hydrogen atoms, as opposed to using calculated 
positions. 
Complex 5.1 crystallised as a head-to-head dimer (figure 5.10, left), with π-π 
stacking interactions between benzo-backbones of the NHC at centroid separation of 
3.69 Å. The dimers comprised of a single enantiomer of 5.1, whilst crystals overall 
were racemic. The three Ir(III) centres are peripheral to the CTV bowl at Ir···Ir 
separation of 14.171 Å, ca. 3 Å less than that reported for an emissive 
metallo-cryptophane, although the coordination mode about the Ir(III) centre and the 
ligand groups on the CTV bowl in both cases are considerably different because the 
Ir(III) centres were sited on equatorial positions of the capsule.35 The space filling 
diagram (figure 5.10, right) also shows the ligand buttressing encases Ir(III) centres 
(light blue) with high efficiency, and are only slightly exposed above the two 
chloride ligands. This may have implications from a catalytic point of view, 
however, it is worth noting that the halides are displaced in catalytic transformations 
involving Ir(III), and some flexibility will exist in this system, so may not suppress 
the catalytic viability of 5.1.  
 
Figure 5.10 Left: dimeric aggregation of 5.1. Right: space-filling model of dimer. 
Complementary close packing of Cp* ligands with a neighbouring CTV-arene face 
were observed, with closest contacts of 3.632 Å, but the groups are too far offset to 
be engaging in π-π stacking interactions. The dimer does contain three small 
windows intersecting the equator of the capsular assembly, potentially allowing the 
incorporation of guest species within the pore (figure 5.10). The internal and 
external void space was calculated as ca. 9700 Å3 using a 1.2 Å probe.34 Attempts to 
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encapsulate the small, flexible guest DME (dimethoxyethane) by taking advantage 
of H-atoms held in place on the benzimidazole backbone as potential hydrogen 
bonding sites were unsuccessful, and no evidence of DME encapsulation 
crystallographically, or in solution (1H NMR spectroscopy) was attained. 
Solution-state encapsulation of o-carborane and ferrocene was attempted but no 
evidence to suggest guest binding was obtained. 
The unit cell of 5.1 was extremely large (a = b = 23.5277(12), c = 77.681(4) Å), 
containing twelve discrete complexes. Attempts to solve the structure after indexing 
to a smaller unit cell were unsuccessful. Dimeric aggregates of 5.1 zig-zag along the 
crystallographic c-axis through complementary close-packing of Cp* and arene face 
units, leaving significant solvent-filled voids throughout the structure.
 
Figure 5.11 Unit cell of 5.1. 
Crystals were brittle, and when attempting to obtain SCXRD data, a number did 
break upon contact with the MiTeGen loop. Optical microscopy images of the 
crystals showed their rhombohedral shape, whilst the SEM images displayed lots of 
defects and cracks, attributed to exposure to the vacuum chamber prior to imaging 
(figure 5.12). 
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Figure 5.12 SEM (left) and optical microscopy (right) images of 5.1 crystals. 
Crystals of 5.2 suitable for diffraction analysis could be grown from the diffusion of 
pentane vapours into a dichloromethane solution of the complex. The structure was 
solved in the orthorhombic Pbca space group. And the asymmetric unit comprised a 
full complex molecule. The guaiacol group is of opposite orientation in the crystal 
structure of 5.2 compared to that of 5.1, and the methoxy group is aligned away 
from the Ir(III) centre (figure 5.13). The space filling model of 5.2 shows the 
ancillary ligands afford excellent steric protection of the metal centre.  
 
Figure 5.13 Left: asymmetric unit of 5.2. Ellipsoids are drawn at the 50% probability. Right: 
space-filling diagram of 5.2.  
Bond lengths and angles about the Ir(III) centre of 5.2 bore stark similarities to those 
in 5.1, with bond lengths being almost identical, and angles through Ir(III) varying 
by 2o at most (table 5.1). The Carene-O-C-NNHC torsion angles were also comparable, 
with that in 5.1 being slightly less than in 5.2. The methoxy group of the guiacol 
NHC wingtip in 5.2 is aligned away from the Ir(III) centre, as opposed to 5.1, where 
it aligns towards the metal centre. Complex 5.2 exhibited weak CH···π interactions 
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between a Cp* methyl group and the π-cloud of a neighbouring Cp* ligand at a 
CMe-Cp* centroid separation of 3.4 Å. 
Table 5.1 Selected bond lengths (Å) and angles (o) for 5.1 and 5.2 
 5.1 5.2 
Ir-CNHC 2.073(11) 2.027(4) 
Ir-Cl1 2.421(3) 2.4155(11) 
Ir-Cl2 2.422(3) 2.4084(11) 
Ir-Cp* centroid 1.810 (measured) 1.811 
Cl1-Ir-Cl2 85.92(12) 86.33(4) 
CNHC-Ir-Cl1 90.7(3) 92.44(13) 
CNHC-Ir-Cl2 91.2(3) 93.09(12) 
Cl1-Ir-Cp* centroid 125.07 124.14 
Cl2-Ir-Cp* centroid 122.65 122.53 
CNHC-Ir-Cp* centroid 129.13 127.31 
Carene-O-C-NNHC 168.9 174.1 
 
5.2.1 Catalytic evaluation of 5.1 and 5.2 
Complexes 5.1 and 5.2 were examined as catalysts in the TH of acetophenone, and 
their activity compared to the Ir(III) precursor, [Ir(Cp*)(Cl)2]2. Catalyst loading was 
measured by mol% Ir, because 5.2 contains one metal centre, the precursor two, and 
5.1 three. The reactions were also carried out in the absence of metal catalyst 
because the base-catalysed36 TH and disproportionation37 of ketones and alcohols 
are known pathways following a similar mechanism to the Meerwein-Pondorf-
Verley reaction, where the alkali metal cation templates the reaction. A fourfold 
increase in conversions was noted when employing Ir(III) catalysts, suggesting the 
Ir(III) complexes are catalytically active in the TH of acetophenone.. 
 
Scheme 5.3 Transfer hydrogenation of acetophenone using Ir(III) complexes as catalysts. 
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Table 5.2 Conversions for the transfer hydrogenation of acetophenone using 5.1-2 as catalysts, 
and control reactions. 
Complex Conversion 
(%) 
Transition metal and base-free 0(±0) 




Conversions are the average of 2 runs and were obtained using 1H NMR spectroscopy by 
comparing the methyl resonance of 1-phenylethanol and 1,4-dimethoxybenzene 
  as an internal standard. 
Conversions overall were low, with all three Ir(III) complexes displaying somewhat 
similar activities. 5.1 and 5.2 were expected to have lower conversions than the 
Ir(III) dimer, which is capable of splitting upon nucleophilic attack, affording an 
extra active site. Ir(III) is a kinetically inert metal, and complexes often display 
pronounced stability. 5.1 and 5.2 bear four strongly bound ligands in Cp*, an NHC 
and two chloride ligands, which are likely to exchange slowly in solution. 
Complexes 5.1 and 5.2 were similarly active, indicating that the three Ir(III) centres 
of 5.1 are behaving independently of one another. A typical inner-sphere mechanism 
is likely occurring for 5.1 and 5.2, with the methoxy group being a poor hydrogen 
acceptor. Kühn and co-workers have previously demonstrated that weaker NHC 
donors and increased bulk enhance TH catalysis, so such similar conversions 
observed between 5.1 and 5.2 were unexpected.18 Sarkar and co-workers have 
prepared a triply metallated disk-shaped ligand, which displayed enhanced activities 
compared to a monometallic analogue through π-π stacking interactions between 
NHC backbones.38 
A strategy employed to target more active catalysts was to abstract the halide 
ions and replace with more labile solvent molecules, which are easily displaced in 
catalytic transformations, affording an active site on the catalyst. This reaction was 
carried out in acetonitrile in the presence of Ag(I) salts (scheme 5.4). Such 
manipulations are widely used in Ir(III) chemistry, both with NHC ligands and also 
phenylpyridine derivatives for luminescent applications.39 Halide abstractions 
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involving 5.1 were unsuccessful, both when employing AgPF6 and the [BAr
F]¯ 
anion (BArF = tetrakis-[3,5-bis(trifluoromethyl)phenyl]borate, in order to enhance 
solubility in less polar solvents. An insoluble white solid precipitated after 24 h, and 
HRMS of the reaction mixture indicated no Ir was present. Crystals did grow from 
solution when employing AgPF6, but these proved to be [Ag(MeCN)4]PF6. This 
suggests that the halide abstraction may have partially occurred, but as the overall 
charge and degree of metathesis increases, the solubility of the system decreases. 
After the unsuccessful halide abstraction, altering the oxidation state of the Ir 
precursor could be an approach to catalyst optimisation. Ir(I) complexes are often 
stabilised by alkene ligands, which form labile interactions with metal ions, 
affording two active sites on the metal centre. Additionally, the oxidative addition of 
ligands at Ir(I) is facile, yielding Ir(III) complexes and facilitating a number of 
mechanistic processes for the same reaction. Ir(I)-NHC complexes are viable targets 
by applying similar methodology to the preparation of 5.1 and 5.2. 
 
Scheme 5.4 Attempted halide abstraction of 5.1. 
5.2.2 Cell-line studies of 5.1 and 5.2 
Previous work by McGowan and Sadler have shown Ir(III), Rh(III) and Ru(II) 
half-sandwich complexes to be effective anti-cancer agents in vitro.40-42 Liu and 
co-workers have recently demonstrated half-sandwich Ir(III)-NHC complexes as 
promising anti-cancer drugs, with IC50 values as low as 2.9 μM against a cervical 
cancer cell-line.43 In collaboration with Pablo Carames-Mendez of the McGowan 
group, complexes 5.1 and 5.2 were investigated in vitro against the pancreatic 
carcinoma Mia PaCa-2 using MTT-based assays. An IC50 value of < 20 μM is 
classed as highly active, 20-50 μM as moderately active, 50-100 μM as poorly active 
and > 100 μM inactive. 5.2 proved to be inactive against the pancreatic cancer 
cell-line, whilst 5.1 gave an IC50 value of 97.57 ± 4.20 μM, suggesting poor activity 
and overlapping with inactive drug molecules. Compounds 5.1 and 5.2 were also 
examined against healthy cells where a high IC50 value is desired, and both gave 
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values of > 100 μM, suggesting they are non-toxic. Hydrolysis of M-Cl bonds to 
form aqua species is a possible in vivo pathway for the activation of metallo-drugs, 
but Ir(III) complexes 5.1 and 5.2 may be too kinetically inert to be hydrolysed in 
hydrous media.44 The high barriers to activation may also explain the low catalytic 
activities observed for 5.1 and 5.2. 
5.3 Synthesis and characterisation of Ir(I) and Rh(I) complexes 
5.3.1 Preparation of Ir(I) complexes 
One pathway to potentially prepare more active catalysts would be the introduction 
of a more labile ligand, such as an alkene. In addition, decreasing oxidation state 
from Ir(III) to Ir(I) may allow for more favourable energetics in the oxidative 
addition steps during catalytic transformations. Alkene ligands are often used to 
stabilise low-valent transition metals. Their propensity as π-acids gives them 
excellent back-bonding properties, facilitating stabilisation of complexes of 
electron-rich metals such as Ir(I). Bis-ethene and bis-cyclooctene complexes derived 
from dimeric olefin-bearing precursors are known, but in many instances are not 
isolable, or are highly unstable.45-47 The chelate effect offered by 1,5-cyclooctadiene 
(COD) overcomes this, yielding often air-stable complexes. Iridium-COD 
complexes have a rich history in catalytic transformations, with Crabtree’s catalyst, 
[Ir(COD)(py)(PCy3)]PF6 being a much-documented hydrogenation catalyst.
3 
 Ir(I) complex 5.3, could be prepared following similar methodology to that 
for 5.1 and 5.2, with an alteration to solvents used (scheme 5.5). Ligand 4.3 was 
soluble in MeCN, whereas 5.3 had a high affinity for chlorinated solvents, and was 
barely soluble in MeCN, therefore a 1:1 mixture of MeCN and CHCl3 was applied. 
EDX analysis was also carried out on a sample of 5.3, which confirmed the absence 
of iodine, thus eliminating the possibility of halide mixing at Ir(I) as a competing 
reaction. The monometallic complex 1,5-cyclooctadiene chloro (1-methyl-3-((2-
methoxyphenoxy)methyl)benzimidazol-2-ylidene)iridium(I), 5.4 was also prepared. 
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Scheme 5.5 Synthesis of Ir(I) and Rh(I)-NHC complexes 5.3-5.6 
HRMS once again proved the most effective tool for characterising complex 
5.3, although there were discrepancies (Figure 5.14). The major peak observed was 
{M-3Cl}3+ with m/z = 580.5009 (calculated = 580.5100). Two other dominant peaks 
were noted, but were poor matches to the calculated m/z peaks despite bearing the 
same isotope pattern to that expected. A {M-Cl}+ was observed with m/z = 
1812.5251 (calculated 1812.4722) and m/z = 883.7722, five units from the 
calculated m/z of 888.2497 for the {M-2Cl}2+ fragment. A sister peak with m/z = 
888.2411 was adjacent to the dominant peak, and both displayed the characteristic 
isotope pattern simulated for these fragments. An imidazolium iodide ligand was 
employed alongside an iridium chloride precursor. If AgI was solubilised, halide 
exchange upon ionisation may offer an explanation to the poorer HRMS matches, 
although changes to isotope patterns would also occur.  
Three peaks were observed in the HRMS of 5.4, with the dominant peak at 
m/z = 569.1786 (calculated 569.1775) matching the {M-Cl} peak (figure 5.15). A 
peak at m/z = 1162.3563 best matches {M2-COD+MeCN+Na}
+ (calculated 
1162.2133). A third peak was also present with m/z = 837.2985 (calculated 
837.2986) which matched the rearrangement product {Ir(COD)(NHC)2}
+. Relative 
1H NMR integrals between NHC and COD eliminated this from being a side-
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product in the reaction. Herrmann and co-workers previously reported the transfer of 
NHC ligands between Rh(I) centres, which would be plausible for Ir(I) analogues.48 
Such rearrangement must be considered for Rh(I)-NHC complexes prepared. 
 
 
Figure 5.14 HRMS of 5.3. Inset: observed (top) vs simulated (bottom) isotope pattern for m/z 
580.5009, {M-3Cl}3+. 
 
Figure 5.15 HRMS of 5.4. Inset: observed (top) vs simulated (bottom) isotope pattern for m/z 
569.1786, {M-Cl}+. 
As anticipated, the 1H NMR spectrum of 5.3 was broad, but peaks did overlap 
with monometallic derivative 5.4 (figure 5.16). Furthermore, no imidazolium peaks 
were present downfield of 8 ppm, indicating the deprotonation of all imidazolium 
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groups. The 1H NMR spectrum of 5.4 revealed NCH2O methylene bridge separated 
by ca. 1 ppm which, whilst less than complex 5.3, is significant. The most upfield of 
these protons in both 5.3 and 5.4 displayed similar chemical shifts, indicating no 
further shielding of this group by the cavitand. Two broad peaks at 4.74 and 3.55 
ppm coupled with one another in the COSY NMR spectrum, consistent with the 
endo- and exo- protons of the CTV lower rim. The peak at 4.75 ppm appears at the 
same chemical shift as a COD resonance in monomer 5.4, which could explain the 
higher integral of this peak. A number of broad peaks in the 1H NMR spectra of both 
5.3 and 5.4 between 1.6 and 3 ppm coupled with one another, and were therefore 
assigned as COD protons. The N-methyl and methoxy resonances in 5.4 were 
observed at 4.19 and 3.89 ppm respectively, and peaks were observed at similar 
chemical shifts in 5.3. Surprisingly however, the methoxy resonance in 5.3 appeared 
to split into two peaks, with a second sharp peak at 3.65 ppm coupling to the same 
carbon atom. Neither of these peaks couple to one another in the COSY NMR 
spectrum (appendix), but they are both associated with the same carbon resonance in 
the HMQC spectrum (appendix), and 3J coupling from both peaks to the ipso-carbon 
of the CTV rim was observed in the HMBC spectrum. The reasoning behind such 
splitting remains unclear, but the absence of 2J coupling between these peaks may 
imply a break in C3-symmetry. 
 
Figure 5.16 1H NMR spectra (300 MHz, 293 K, CDCl3) of 5.3 (top, black trace) and 5.4 (bottom, 
red trace). 
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A 13C{1H} NMR spectrum could not be obtained for 5.3, therefore HMQC and 
HMBC spectroscopy were once again important tools (figure 5.17). Significantly, 
the N-methyl resonance (1H, 4.2 ppm) coupled with a single observed 13C peak at 
ca. 200 ppm in the HMBC spectrum, implying a single C3-symmetric NHC 
complex. The NHC carbene resonance is sensitive towards the Lewis acidity of a 
metal centre, which is dependent upon both the metal ion itself and the donor 
strength of co-ligands, shifting downfield when greater electron density is associated 
with the Lewis acidic metal.49, 50 Hence, it was unsurprising to see a near 30 ppm 
difference between carbenic chemical shifts in 5.1 and 5.3.  
 
Figure 5.17 HMBC NMR spectrum of 5.3. 
A 13C{1H} NMR spectrum was attainable for 5.4 (figure 5.18). Significantly, the 
carbenic carbon was located at 193.28 ppm, comparable to the position in the 
trimetallic complex 5.3, and once again was corroborated by HMBC analysis, where 
long range C-H coupling was observed between the carbenic carbon and both the 
NHC R-groups. The NCH2O methylene bridge was sited at 78.89 ppm and one of 
five CH2 groups present in 5.4 as confirmed by DEPT-135 NMR spectroscopy, 
which also included four COD-CH2 resonances. 
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Figure 5.18 13C{1H} NMR spectrum (75 MHz, 293 K, CDCl3) of 5.4. 
Complex 5.3 could not be crystallised despite repeated attempts from a range of 
vapour diffusion and slow-evaporations containing the limited number of solvents 
5.3 would dissolve in (DCM, CHCl3, DMF, DMSO). However, yellow single 
crystals of 5.4 suitable for diffraction could be grown from the diffusion of pentane 
into a dichloromethane solution. The structure was solved in the triclinic 𝑃1̅ space 
group, and the asymmetric unit comprised of two crystallographically distinct 
molecules of 5.4 (figure 5.19). 
 
Figure 5.19 Molecular structure of 5.4 (left) and asymmetric unit (right). Ellipsoids are drawn 
at the 50% probability. 
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Table 5.3 Selected bond lengths (Å) and angles (º) in 5.4. 
Ir1-Cl1 2.3519(10) Ir2-Cl2 2.3632(10) 
Ir1-C1 2.018(4) Ir2-C25 2.004(4) 
Ir1-C19 2.122(4) Ir2-C43 2.102(4) 
Ir1-C20 2.090(4) Ir2-C44 2.096(5) 
Ir1-C23 2.201(4) Ir2-C47 2.193(5) 
Ir1-C24 2.165(4) Ir2-C48 2.184(5) 
C1-Ir1-Cl1 87.63(11) C25-Ir2-Cl2 
 
86.21(12) 
C1-Ir1-C19 94.11(16) C25-Ir2-C43 92.71(17) 
C1-Ir1-C23 167.36(16) C25-Ir2-C44 94.81(18) 
C19-Ir1-Cl1 164.65(12) C25-Ir2-C48 158.14(19) 
C19-Ir1-C23 89.83(17) C44-Ir2-Cl2 158.19(14) 
C20-Ir1-Cl1 155.55(12) C44-Ir2-C48 94.2(2) 
C20-Ir1-C23 81.21(17) C47-Ir2-Cl2 91.60(14) 
C23-Ir1-Cl1 91.75(12) C48-Ir2-Cl2 92.73(15) 
 
Ir(I) centres in both equivalents of 5.5 display a pseudo square-planar geometry. The 
COD ligands in both equivalents are of slightly different orientations. COD ligand 
coordinated to Ir1 is slightly staggered when looking down the dz axis of Ir(I) 
centres, whereas Ir2 coordinates to a COD ligand which is eclipsed along a mirror 
plane. The Carene-O-C-NNHC torsion angles in both cases were of similar rotations in 
opposite orientations, measured at 73.33 and -78.15º. The COD ligands on both 
equivalents of 5.5 in the asymmetric unit were of slightly different orientations. C=C 
bond lengths on the COD ligands ranged between 1.395(7)-1.429(7) Å, implying 
appreciable back donation from the electron-rich Ir(I) centres into the alkene π* 
orbitals. Ir-CCOD bond lengths trans with respect to the NHC ligand were slightly 
longer than the Ir-C cis-COD lengths as a consequence of the strong trans influence 
of the carbene. 
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5.3.2 Preparation of isostructural Rh(I) complexes 
As a consequence of the lanthanide contraction, Rh(I) and Ir(I) complexes are 
chemically similar, so would be comparable to the parent Ir(I) complexes reported in 
this chapter. Iridium does not possess spin-active nuclei, whereas 103Rh is NMR 
active (I = ½) with 100% abundance, affording a potentially powerful spectroscopic 
handle. Whilst 13C{1H} NMR spectra were unlikely to be viable analytical tools for 
CTV-complexes, the carbenic carbon and four alkenyl COD carbons would appear 
as doublets in the 13C{1H} NMR spectra, and also heteronuclear 2D NMR 
experiments, due to Rh-C coupling interactions. 
Trimetallic Rh(I0 complex 5.5 and monometallic 5.6 were prepared 
following the same methodology employed for 5.3 and 5.4, albeit obtained in lower 
yields by employing [Rh(COD)(Cl)]2 as the precursor. The 
1H NMR spectrum of 
complex 5.5 (figure 5.20) was near-identical to 5.3. No peaks were observed beyond 
8 ppm, suggesting a single complex had been isolated, with no evidence of partial 
reactivity. The methoxy protons appeared at 3.6 and 3.8 ppm again, and COSY 
NMR spectroscopy revealed the splitting of the NCH2O methylene bridge to two 
inequivalent resonances at 6.1 and 7.3 ppm, and the CTV endo- and exo- protons 
were attributed to broad peaks at 3.5 and 4.4 ppm. The same splitting for methoxy 
resonances was observed in 5.5 as in trimetallic complex 5.3. This was not observed 
in 5.6, as was also the case for Ir(I) monomer 5.4.  
The major fingerprint in the NMR assignment of 5.5 came in the HMBC spectrum 
(figure 5.21). The N-methyl protons coupled to two peaks at ca. 198 ppm, which 
were attributed to the carbenic doublet. JRh-C was measured as ca. 80 Hz, which 
whilst wider than a typical Rh-C coupling constant,27 is an approximation because 
collection of 13C{1H} NMR data was impeded.  
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Figure 5.20 1H NMR spectra (300 MHz, 293 K, CDCl3) of 5.5 (top, black trace) and 5.6 (bottom, 
red trace). 
 
Figure 5.21 HMBC spectrum of 5.5. Inset: 3J coupling interaction between N-methyl protons 
and carbenic carbon. 
The 13C{1H} NMR spectrum of 5.6 revealed the carbenic carbon appeared at 198.29 
ppm, with a JRh-C of 51.0 Hz which is typical for a Rh-C coupling constant (figure 
5.22).27 Four further doublets were observed, which were attributed to the COD 
alkene carbons. 
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Figure 5.22 13C{1H} NMR spectrum (75 MHz, 293 K, CDCl3) of 5.6. Top inset: expansion of 
carbenic resonance. Lower inset: DEPT-135 spectrum. 
Kück and Peris reported a trimetallic Rh(I)-NHC complex fused onto the related 
TBTQ cavitand and observed two sets of carbenic resonances in the 13C{1H} NMR 
spectrum, with the complex displaying pseudo-C3v symmetry.
30 This was attributed 
to the lack of free rotation about the Rh-C bond caused by their steric repulsion from 
the tert-butyl wingtips. A lack of free rotation is evident in 5.5, but only one 
carbenic resonance was observed in the HMBC NMR spectrum, suggesting 
atropisomers about the Rh-C bond may not be significant in this case, and the 
restricted rotation may be about the NCH2O group. 
HRMS in the case of 5.5 bore similarities to Ir(I)-NHC complex 5.3, with the 
dominant peak being {M-3Cl}3+ with m/z = 491.1194 (calculated = 491.1200) 
(figure 5.23). A {M-2Cl}2+ peak was observed at m/z = 754.1630 (calculated 
754.1648). The 2+ peak at m/z = 639.1764 may be a consequence of ligand 
scrambling, with [{Rh(NHC)2(COD)}{Rh(NHC)(COD)}·H2O]
2+ bearing a 
calculated m/z of 640.1859.  
The HRMS of 5.6 was diagnostic, and the spectrum comprised of the 
analogous peaks observed when interpreting 5.4. The dominant peak was {M-Cl}+ 
with m/z = 479.1218 (calculated 479.1201), with the simulated isotope pattern 
displaying an excellent match to the observed data (figure 5.24). Similarly to 
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complex 5.4, ligand-scrambling was observed in the HRMS, with 
{Rh(NHC)2(COD)}
+, m/z = 747.2411 (calculated 747.2413) and 
{[Rh(NHC)3(Cl)]+Na+H2O}
+ m/z = 984.2436 (calculated = 984.2410) detected. 1H 
NMR spectroscopy suggested the mono-NHC complex had exclusively been 
prepared, and ligand scrambling was consequence of ionisation. 
 
Figure 5.23 HRMS of 5.5. Inset: Observed (top) vs simulated (bottom) isotope pattern of m/z 
491.1194, {M-3Cl}3+. 
 
Figure 5.24 HRMS of 5.6. Inset: Observed (top) vs simulated (bottom) isotope pattern for m/z 
479.1218, {M-Cl}+. 
Complex 5.6 could be crystallised from the diffusion of pentane into a 
dichloromethane solution of complex. The crystal structure was solved in the 
- 202 - 
triclinic 𝑃1 space group and the asymmetric unit was isostructural to complex 5.4, 
comprising of two crystallographically inequivalent complex molecules (figure 
5.25). Rh-CNHC bond lengths were measured as 2.004(3) and 2.018(3) Å, identical to 
the isostructural Ir(I)-complex 5.4. Complex 2 within the asymmetric unit (bearing 
Rh2) displayed π-π stacking interactions between guaiacol units of the same 
equivalency at separation of 3.92 Å and as expected for the d8 metal cation, both 
equivalents of complex within the asymmetric unit displayed pseudo-square-planar 
geometry. The trans-influence of the NHC ligand is again subtly displayed, with 
trans-Rh-alkene bonds being ca. 0.1 Å longer than the cis-Rh-alkene bond with 
respect to the NHC ligand. 
 
Figure 5.25 Left: Molecular structure of 5.6. Right: asymmetric unit. Ellipsoids are drawn at 
the 50% probability. 
Complexes 5.3 and 5.5 were intended to be investigated as catalysts in TH reactions, 
but only displayed solubility in solvents unsuitable for catalytic transformations such 
as DCM and DMSO, which are either base-sensitive, or contain groups which may 
competitively react with substrates.  
5.4 Ru(II)-NHC complex synthesis and characterisation 
One investigative line to optimise TH catalysis would be to move to Ru(II). The 
precursor [Ru(p-cymene)(Cl)2]2 is a common entry point to Ru(II) organometallic 
chemistry, being straightforward to prepare and also commercially available. 
Reactivity mirrors that of the Ir dimers, whereby addition of Lewis bases yields 
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monometallic adducts. The p-cymene ligand is a poorer π-donor ligand than Cp* 
and less strongly bound to Ru(II). In solution, the p-cymene ligand can be displaced 
much more readily.51 This may have implications in catalytic transformations. 
 
Scheme 5.6 Synthesis of Ru(II)-NHC complexes 5.7 and 5.8. 
Trimetallic Ru(II) complex 5.7 was prepared following the same methodology used 
throughout this chapter (scheme 5.6). The complex itself proved air-sensitive upon 
dissolution in hydrous, oxic solvents, and turned from orange to black within ca. 10 
mins. Hence, storage and handling in a glovebox was necessary, alongside the use of 
anhydrous, degassed solvents. As a solid, 5.7 appeared more stable, and could be 
handled as a solid for ca. one month before decomposing. The work-up process in 
isolating Ru(II) complex 5.7 involved removing MeCN in vacuo, before 
redissolution in DCM and filtering through two Celite™ plugs before removal of 
DCM in vacuo and the addition of diethyl ether as antisolvent. Promisingly, 5.7 
displayed much greater solubility than 5.3 and 5.5, opening up the possibility of 
employing the triruthenium complex as a catalyst in TH reactions.  
Monomer 5.8 was prepared following the same methodology and employing 
ligand 4.8 as a precursor. The monomer displayed greater air- and moisture-
sensitivity than 5.7 and exposure of solutions to air for a matter of seconds led to 
decomposition and an insoluble black solid precipitated. 
- 204 - 
HRMS provided an excellent tool for characterising Ru(II) complexes, and a 
single {M-3(Cl)}3+ molecular ion peak with m/z = 551.1033 was observed, 
excellently matching the simulated pattern predicted with m/z = 551.1037 (figure 
5.26) . 
 
Figure 5.26 HRMS of 5.7. Inset: Observed (top) vs simulated (bottom) isotope pattern for m/z 
551.1033, {M-3Cl}3+. 
Monomer 5.8 behaved similarly in the HRMS spectrum, and the spectrum was 
dominated by the anticipated {M-Cl}+ fragment, detected at m/z = 539.1048 (figure 
5.27). This matched the calculated mass of 539.1039, and the observed data 
displayed a good isotopic match to the simulated pattern. A second {M2-Cl}
+ 
fragment at m/z 1114.1769 (calculated 1114.1744) was also detected. 
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Figure 5.27 HRMS of 5.8. Inset: Observed (top) vs simulated (bottom) isotope pattern of m/z 
539.1048, {M-Cl}+. 
The 1H NMR spectrum of 5.7 followed the same pattern as 5.1, 5.3 and 5.5, and was 
extremely broad and difficult to assign (figure 5.28). 2D NMR spectroscopy was 
once again used as a tool to offer some insight into the behaviour of the complex. 
The sharper doublet at 4.94 ppm in the spectrum of 5.7 suggests a C3-symmetric 
complex, and is typical of the endo-proton of the CTV lower-rim. Otherwise, peaks 
observed in the 1H NMR spectrum of 5.7 overlap excellently with the much sharper 
resonances of the monomer 5.8. The N-methyl and methoxy resonances afforded 
NMR handles at 4.26 and 3.78 ppm respectively, overlapping with major peaks in 
the 1H NMR spectrum of 5.7. 
Arene resonances associated with the η6-p-cymene ring are shielded and 
appear between 5-6 ppm, characteristic of the upfield shift upon coordination due to 
withdrawal of electron density from the π-cloud. All four p-cymene aromatic 
protons in 5.8 were inequivalent, with three peaks observed in a 1:2:1 ratio. The two 
peaks integrating to one proton coupled to one another, whereas no coupling was 
observed to the larger integrating peak, suggesting these two protons are adjacent to 
one another and on the opposite side of the arene. The p-cymene methyl CH3 group 
resided at 2.04 ppm. The two methyl groups of the isopropyl moiety became 
inequivalent, and subtly split by 0.03 ppm, as well as by ca 2 ppm in the 13C{1H} 
NMR spectrum. This is caused by one pointing towards the metal centre and one 
pointing away. The C-H of the tertiary isopropyl proton was sited at 3.00 ppm. 
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Significantly, peaks in the 1H NMR spectrum of 5.7 corresponding to the p-cymene 
ring overlapped with those in 5.8.  
The NCH2O methylene bridge splits into two doublets, with a potential 
preagostic interaction again arising. COSY and HMQC NMR spectroscopy 
confirmed the two doublets are sited at 5.92 ppm and 7.35 ppm. Again, the absence 
of resonances beyond 8 ppm is indicative of the absence of imidazolium hydrogen. 
 
Figure 5.28 1H NMR spectra (300 MHz, 293 K, CDCl3) of 5.7 (top trace, black) and 5.8 (bottom 
trace, red). 
Similarly to trimetallic Ir(III), Ir(I) and Rh(I)-NHC complexes, a 13C{1H} NMR 
spectrum of 5.7 could not be obtained, even when running 8000 scans. The 13C{1H} 
NMR spectrum of 5.8 further suggested NHC coordination at Ru(II), and the 
carbenic carbon was located at 193.32 ppm (figure 5.29). 
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Figure 5.29 13C{1H} NMR spectrum (75 MHz, 293 K, CDCl3) of 5.8. 
2D NMR spectra of 5.7 were weak, even when dissolving ca. 30 mg of sample. The 
HMBC spectrum did not display all expected coupling, but the anticipated 3J 
coupling between N-methyl group at ca. 4.20 ppm and carbenic carbon at ca. 193 
ppm was observed (figure 5.30). This is chemically similar to the analogous peaks in 
complex 5.8. The HMQC spectrum of 5.7 displayed what appeared to be two 
doublets at 4.91 and 3.75 ppm coupling to the same carbon atom at ca. 40 ppm in the 
13C{1H} NMR spectrum, consistent with the endo- and exo protons of the CTV 
lower-rim, implying a C3-symmetric complex. The upfield doublet overlapped with 
the methoxy group, which coupled to a carbon atom in the HMQC spectrum at ca. 
56.4 ppm, which is a good match to the methoxy resonance of 5.8 at 55.81 ppm. 
 
Figure 5.30 HMBC spectrum of 5.7. 
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5.4.1 Catalytic examination of complexes 5.7 and 5.8  
Complexes 5.7 and 5.8 were tested in the TH of acetophenone, and as anticipated, 
displayed higher activities than the Ir(III) counterparts 5.1 and 5.2 (table 5.4).  
 
Scheme 5.7 Ru(II) catalysed TH of acetophenone 
Table 5.4 Conversions obtained for the TH of acetophenone catalysed by 5.7 and 5.8.  
 0.5 mol% Ru 0.25 mol% Ru 
Catalyst Conversion (%) Conversion (%) 
[Ru(p-cymene)(Cl)2]2 32(±2) 44(±2) 
5.7 >99(±1) 56(±2) 
5.8 70(±2) 61(±3) 
Conversions were the average of two runs, obtained by 1H NMR spectroscopy by comparing 
the methyl resonances of 1-phenylethanol and 1,4-dimethoxybenzene as an  
 internal standard. 
Complexes were compared to [Ru(p-cymene)(Cl)2]2 which surprisingly became less 
active when catalyst loading was increased, possibly indicating an aggregative 
deactivation pathway during catalysis. Nguyen and co-workers have studied catalyst 
deactivation of immobilised {IrCp*} catalysts in TH reactions, and discovered 
anionic [Ir(Cp*)(OR)3]
- species may be the cause of deactivation (R = iPr or tBu).52 
Such species would also be likely when employing [Ru(p-cymene)(Cl)2]2 as a 
catalyst. Coordination of a persistent NHC ligand at Ru(II) or Ir(III) would prevent 
deactivation of a catalyst via the formation of an ionic species. At 0.25 mol% Ru, 
both 5.7 and 5.8 were both similarly active, and displayed higher activities than the 
dimer. Upon increasing catalyst loading to 0.5 mol% Ru, 5.7 gave near-quantitative 
conversions after 1 h, whereas a conversion of 70% was observed employing 
monomer 5.8. This potentially implies that at low loading, each Ru(II) centre on 5.7 
behaves independently, following similar trends to those noted by Matt and Toupet’s 
Pd(II) calixarenyl-NHC complexes.53 Increased activities at higher loading of 5.7 
may be a consequence of intermolecular cooperative effects upon greater 
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concentrations of catalyst being present in solution. It is unlikely that intramolecular 
cooperativity plays a major role in this increased activity due to the rigidity of the 
complex observed using 1H NMR spectroscopy. X-ray crystallography could have 
given insights into how molecules interact with one another in the solid state, but 
single crystals suitable for diffraction could not be grown. 
 The increased conversion of acetophenone to 1-phenylethanol when 
increasing catalyst loading of 5.7 with respect to 5.8 may be indicative of 
intermolecular cooperativity. This has previously been reported by Peris and 
co-workers for planar multimetallated NHC complex through aggregation of 
catalysts by means of π-π stacking interactions between the polyaromatic backbone 
to complexes,54 but this has not been established for cavitand-based systems. One 
possible mechanism of intermolecular aggregation involving complex 5.7 are 
bowl-in-bowl stacking which is commonly observed crystallographically for ligands 
and also some M3L complexes.
55 Secondly, π-π stacking interactions between 
benzo-backbones of the NHC ligands would allow for metal-metal interactions 
between molecules of 5.7. This could be achieved in a similar fashion to that 
observed crystallographically when studying complex 5.1 in the solid state. 
Host-guest interactions between the CTV bowl and acetophenone are possible, 
however the similar conversions observed when employing 5.7 and 5.8 as catalysts 
at lower loading suggests this is not influential. 
A handful of bimetallic and trimetallic Ru(II) have been prepared. Domski and 
co-workers recently reported a bimetallic Ru(II)-NHC complex which displayed 
lower activities than the similar monometallic complexes in the TH of 
acetophenone.56 Barbasiewicz and co-workers prepared bimetallic Grubbs’ catalysts, 
with Ru(II) centres behaving independently of one another.57 A small number of 
bimetallic and trimetallic Ru(II)-phosphine complexes were reported displaying high 
activities in the TH of acetophenone, but were still lower than some monometallic 
catalysts.58, 59 
Whilst the arene exchange of p-cymene is a known pathway in 
organoruthenium chemistry, the substitution of an electron-rich p-cymene for an 
electron-deficient π-donor in acetophenone would be energetically unfavourable. To 
confirm this, isopropanol and CDCl3 solutions of 5.7 and acetophenone were heated 
to reflux, with no change in 1H NMR or mass spectra observed. Watanabe and 
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Nelson have both proposed η6-η4 ring-slippage of arenes as plausible inner-sphere 
pathways when employing Ru(II) piano-stool complexes as catalysts in TH 
reactions.60, 61 An inner-sphere mechanism is likely as the methoxy group is a poor 
hydrogen acceptor, but may be mechanistically significant as a hemilabile ligand to 
Ru, potentially via second-sphere coordination because of the steric effects of the 
CTV bowl in 5.7. Jiménez and co-workers have previously observed hemilabile 
assistance of methoxy groups on ligands at Ir(I) and Rh(I).62 
5.5 Conclusions and future work 
Eight new organometallic complexes were prepared, four affixed onto a CTV 
cavitand, and four monopodal analogues, which proved effective as catalytic 
comparatives and also for spectroscopic corroboration. HRMS proved a valuable 
assignment tool, particularly for the trimetallic complexes, whose full elucidation by 
NMR spectroscopy was precluded by extremely broad spectra caused by species 
being conformationally locked. In addition, microanalysis suggested that 
by-products were present, presumably AgI which proved extremely difficult to 
remove. Solubility issues arose with monovalent COD-complexes, which could not 
be investigated in catalytic reactions using chemically reasonable solvents. Ir(III) 
complexes proved poorly active in the TH of acetophenone, likely caused by the 
kinetically inert Ir(III) centres and strongly bound ligands yielding highly stable 
complexes. To overcome this, more reactive Ru(II)-NHC complexes were prepared, 
which proved excellent catalysts in the TH of acetophenone at low catalyst loading. 
Future work would revolve around expanding the substrate scope in the 
Ru(II)-catalysed TH reaction. Metal-catalysed TH reactions are an attractive 
alternative to carrying out hydrogenations using H2 gas at high pressure, but 
substrate scope can be limited. Quinolines and imines are suitable, but more 
challenging substrates in the TH reaction for the preparation of secondary amines.63 
Conversions are often lower, with higher catalyst loading and often extended 
reaction times required. In the case of imine reductions, coordination of the amine 
product to the metal may deactivate catalysts, therefore protection of the imine is 
often necessary prior to TH.64 Complex 5.7 has proven highly effective at catalysing 
the TH of acetophenone, and the rigid, extremely bulky ligands may inhibit such 
deactivation pathways from proceeding. 
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A further direction would be to prepare noble metal complexes that do not 
bear multihaptic or multidentate ligands. This would be most achievable for Ir(I) and 
Rh(I), and could be achieved by either removing the π-ligand post-synthetically, for 
example by treatment with carbon monoxide gas, or employing a new dimeric 
precursor, such as [Ir(C2H4)2Cl]2, or [Rh(CO)2Cl]2. Complexes bearing ethene or 
carbonyl ligands would be anticipated to display more flexibility than the trimetallic 
complexes introduced in this chapter, allowing for more straightforward assignment, 
whilst still being sufficiently labile to enhance catalytic activity. 
5.6 Experimental section 
Unless stated in the experimental section, chemicals were bought from commercial 
suppliers and used without further purification. All reactions were performed under 
an atmosphere of dry nitrogen using standard Schlenk and glovebox procedures, 
with solvents dried and degassed using the same methodology described in section 
2.9. All analytical techniques are also consistent with those described in section 2.9. 




Ligand 4.3 (102 mg, 0.08 mmol), [Ir(Cp*)(Cl)2]2 
(100 mg, 0.12 mmol), Ag2O (29 mg, 0.12 mmol) 
and several activated 4 Å molecular sieves were 
added to a flame dried Schlenk flask. MeCN (5 
mL) was added and the orange reaction mixture 
was heated to 70 ºC for 16 h in the absence of 
light, during which time Ag2O was digested and a pale yellow precipitate formed. 
Solvents were removed in vacuo and replaced with DCM (10 mL). The yellow-
orange solution was filtered through two Celite plugs, DCM reduced in volume to 1 
mL in vacuo, and diethyl ether added, precipitating 5.1 as an orange solid. Yield 101 




2+ , calculated 473.6236, 
643.1665, 982.2345. Full 1H NMR assignment was precluded by extremely broad 
spectra. FTIR υ (cm-1) 2916, 1508, 1370, 1264, 1023; Elemental analysis for 
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C81H92Cl6Ir3N6O6∙0.5(AgI) Calcd.: C 45.20, H 4.31, N 3.90 Found: C 45.60, H 4.21, 
N 4.26.  
 
Synthesis of η5-1,2,3,4,5-pentamethylcyclopentadienyl dichloro (1-methyl-3-((2-
methoxyphenoxy)methyl)benzimidazol-2-ylidene)iridium(III), 5.2 
Ligand 4.8 (25 mg, 0.06 mmol), [Ir(Cp*)(Cl)2]2 (26 mg, 0.03 
mmol), Ag2O (8 mg, 0.03 mmol) and several activated 4 Å 
molecular sieves were added to a flame dried Schlenk flask. 
MeCN (5 mL) was added and the red reaction mixture was 
heated to 70 ºC for 16 h in the absence of light, during which 
time Ag2O was digested and a pale yellow precipitate formed. Solvents were 
removed in vacuo and replaced with DCM (10 mL). The yellow-orange solution was 
filtered through two Celite plugs, DCM reduced in volume to 1 mL in vacuo, and 
diethyl ether added, precipitating 5.2 as an orange solid. Yield 29 mg, 0.04 mmol, 
69%. HRMS (ESI+) m/z= 631.1702 {C26H31ClIrN2O2}
+ Calcd. 631.1698; 1H NMR 
(400 MHz, CDCl3) δ (ppm) 7.42-7.27 (m, 4H, H
6, H7, H8. H11a), 7.23 (m, 1H, H9), 
7.09-7.01 (m, 2H, H13, H14), 6.97-6.93 (m, 2H, H15, H16), 5.88 (d, 1H, J = 9.7 Hz, 
H11b), 4.22 (s, 3H, H4), 3.77 (s, 3H, H18), 1.69 (s, 15H, H1) ;13C{1H} NMR (100 
MHz, CDCl3) δ (ppm) 173.05 (C
3), 150.23 (C17), 146.52 (C12), 136.12 (C5), 134.99 
(C10), 123.86 (C15), 123.31 (C14), 121.31 (C7,8), 116.66 (C16), 112.73 (C13), 112.07 
(C9), 110.47 (C6), 90.31 (C2), 77.71 (C11), 55.93 (C18), 35.88 (C4), 9.13 (C1); FTIR υ 
(cm-1) 2911, 1507, 1253, 1013, 759; Satisfactory elemental analysis could not be 
obtained, presumably due to solvent and AgI contamination Calculated for 
C26H31Cl2IrN2O2∙0.4(CH3CN)∙0.2(AgI) C 44.09, H 4.45, N, 4.60; Found: C 44.01, H 
3.76, N 4.86. 
 




Ligand 4.3 (50 mg, 0.04 mmol), [Ir(COD)(Cl)]2 (41 mg, 0.06 mmol), Ag2O (15 mg 
0.06 mmol) and several activated 4 Å molecular sieves were added to a flame dried 
Schlenk flask. MeCN (2.5 mL) and CHCl3 (2.5 mL) were added and the red reaction 
mixture was heated to 70 ºC for 16 h in the absence of light, during which time 
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Ag2O was digested and a pale yellow 
precipitate formed. MeCN was removed in 
vacuo and replaced with DCM (10 mL). The 
yellow solution was filtered through two 
Celite plugs, DCM reduced in volume to 1 
mL in vacuo, and diethyl ether added, 
precipitating 5.3 as a yellow solid which was isolated via vacuum filtration. Yield 49 
mg, 0.026 mmol, 66%. HRMS (ESI+) 580.5009 {C75H84Ir3N6O6}
3+, 1812.5251 
{C75H84Cl2Ir3N6O6}
+, calculated 580.5100, 1812.4722; Full 1H NMR assignment 
was precluded by extremely broad spectra. FTIR υ (cm-1) 2933, 1507, 1097, 1025, 
742; Elemental analysis for C75H84Cl3Ir3N6O6∙0.83(AgI) Calcd.: C 44.07, H 4.14, N 
4.11, Found: C 43.78, H 4.22, N 4.27.  
 
Synthesis of 1,5-cyclooctadiene chloro (1-methyl-3-((2-
methoxyphenoxy)methyl)benzimidazol-2-ylidene)iridium(I), 5.4  
Ligand 4.8 (50 mg, 0.12 mmol), [Ir(COD)(Cl)]2 (42 mg, 0.06 
mmol), Ag2O (15 mg, 0.06 mmol) and several activated 4 Å 
molecular sieves were added to a flame dried Schlenk flask. 
MeCN (5 mL) was added and the red reaction mixture was heated 
to 70 ºC for 16 h in the absence of light, during which time Ag2O was digested and a 
pale yellow precipitate formed. Solvents were removed in vacuo and replaced with 
DCM (10 mL). The yellow-orange solution was filtered through two Celite plugs, 
DCM reduced in volume to 1 mL in vacuo, and diethyl ether added, precipitating 5.4 





calculated 569.1775, 837.2986, 1162.2133; 1H NMR (300 MHz, CDCl3) δ (ppm) 
7.59–7.50 (m, 1H, H4), 7.34-7.27 (m, 3H, H5, H6, H7), 7.15 – 6.94 (m, H9a, H11, H13, 
H14), 6.89 (t, J = 7.6 Hz, 1H, H12), 6.10 (d, J = 9.3 Hz, 1H, H9b), 4.73 (dd, J = 11.7, 
5.2 Hz, 2H, COD-H), 4.19 (s, 3H, H2), 3.89 (s, 3H, H16), 3.14 – 3.02 (m, 2H, COD-
H), 2.36-2.10 (m, 3H, COD-H), 1.94 – 1.68 (m, 3H, COD-H), 1.52 (m, 2H, COD-
H); 13C{1H} NMR (75 MHz, CDCl3) δ 193.28 (C
1), 151.33 (C15), 145.76 (C10), 
135.93 (C3), 134.70 (C8), 124.68 (C17), 123.36 (C6), 123.26 (C5), 121.24 (C12), 
119.87 (C14), 112.66 (C11), 111.39 (C4), 109.64 (C7), 87.99 (COD-CH), 87.03 
(COD-CH), 78.89 (C9), 55.94 (C16), 53.36 (COD-CH), 53.11 (COD-CH), 34.68 
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(C2), 34.28 (COD-CH2), 33.12 (COD-CH2), 30.00 (COD-CH2), 29.05 (COD-CH2); 
FTIR υ (cm-1) 2975, 2913, 1507, 1373, 1256, 1017; Elemental analysis for 
C24H28ClIrN2O2∙0.3(AgI) Calcd.: C 42.73, H 4.18, N 4.15; Found: C 42.82, H 4.48, 
N 4.27.  
 




Ligand 4.3 (50 mg, 0.04 mmol), 
[Rh(COD)(Cl)]2 (30 mg, 0.06 mmol), Ag2O 
(14 mg, 0.06 mmol) and several activated 4 
Å molecular sieves were added to a flame 
dried Schlenk flask. MeCN (2.5 mL) and 
CHCl3 (2.5 mL) were added and the red 
reaction mixture was heated to 70 ºC for 16 h in the absence of light, during which 
time Ag2O was digested and a pale yellow precipitate formed. MeCN was removed 
in vacuo and replaced with DCM (10 mL). The yellow solution was filtered through 
two Celite plugs, DCM reduced in volume to 1 mL in vacuo, and diethyl ether 
added, precipitating 5.5 as a pale yellow solid, which was isolated via vacuum 
filtration. Yield 29 mg, 0.018 mmol, 48%. HRMS (ESI+) 491.1194 
{C75H84N6O6Rh3}
3+, 754.1630 {C75H84N6O6Rh3}
3+, calculated 491.1200, 754.1648; 
Full 1H NMR assignment was precluded by extremely broad spectra; FTIR υ (cm-1) 
2932, 1507, 1374, 1264, 1086; Elemental analysis for C75H84Cl3N6O6Rh3∙0.5(AgI) 
Calcd.: C 53.05, H 4.99, N 4.95; Found C 52.96, H 4.90, N 5.25.  
 
Synthesis of 1,5-cyclooctadiene chloro (1-methyl-3-((2-
methoxyphenoxy)methyl)benzimidazol-2-ylidene)iridium(I), 5.6  
Ligand 4.8 (50 mg, 0.12 mmol), [Rh(COD)(Cl)]2 (31 mg, 0.06 
mmol), Ag2O (15 mg 0.06 mmol) and several activated 4 Å 
molecular sieves were added to a flame dried Schlenk flask. 
MeCN (5 mL) was added and the orange reaction mixture was 
heated to 70 ºC for 16 h in the absence of light, during which time 
Ag2O was digested and a pale yellow precipitate formed. Solvents were removed in 
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vacuo and replaced with DCM (10 mL). The yellow-orange solution was filtered 
through two Celite plugs, DCM reduced in volume to 1 mL in vacuo, and diethyl 
ether added, precipitating 5.6 as a pale yellow solid. Yield 26 mg, 0.05 mmol, 42%. 




+, calculated 479.1201, 747.2413, 984.2410; 1H NMR (300 
MHz, CDCl3) δ (ppm) 7.48 (s, 1H, H
7), 7.31 – 7.20 (m, 4H, H4, H5, H6, H9a), 7.14 – 
6.96 (m, 3H, H11, H13, H14), 6.91 (td, J = 7.8, 1.5 Hz, 1H, H12), 6.18 (d, J = 9.4 Hz, 
1H, H9b), 5.12 (s, 2H, COD-H), 4.33 (s, 3H, H2), 3.90 (s, 3H, H16), 3.57-3.40 (m, 
2H, COD-H), 2.58 – 2.42 (m, 1H, COD-H), 2.42 – 2.22 (m, 2H, COD-H), 2.22 – 
1.92 (m, 4H, COD-H), 1.84 (s, 1H, COD-H); 13C{1H} NMR (75 MHz, CDCl3) δ 
(ppm) 198.29 (d, JRh-C = 51.0 Hz, C
1) , 151.36 (C15), 145.93 (C10), 135.80 (C3), 
134.71 (C8), 124.71 (C13), 123.21 (C6), 123.13 (C5), 121.27 (C11), 119.84 (C12), 
112.69 (C14), 111.09 (C7), 109.51 (C4), 100.97 (d, JRh-C = 6.6 Hz, COD-H), 100.30 
(d, JRh-C = 6.7 Hz, COD-H), 79.30 (C
9), 69.46 (d, JRh-C = 7.6 Hz, COD-H), 69.27 (d, 
JRh-C = 7.3 Hz, COD-H), 55.96 (C
16), 35.04 (C2), 33.55 (COD-H2), 32.59 (COD-H2), 
29.29 (COD-H2), 28.60 (COD-H2); FTIR υ (cm
-1) 2917, 1605, 1507, 1373, 1264, 
1085, 1024, 742; Elemental analysis for C24H28ClN2O2Rh∙0.17(AgI) Calcd.: C 
52.03, H, 5.09, N 5.06; Found C 52.24, H 5.03, N 5.43. 
 




Ligand 4.3 (50 mg, 0.04 mmol), 
[Ru(p-cymene)(Cl)2]2 (36 mg, 0.06 
mmol), Ag2O (14 mg 0.06 mmol) and 
several activated 4 Å molecular sieves 
were added to a flame dried Schlenk 
flask. MeCN (5 mL) was added and the 
red reaction mixture was heated to 70 ºC for 16 h in the absence of light, during 
which time Ag2O was digested and a pale yellow precipitate formed. Solvents were 
removed in vacuo and anhydrous DCM (10 mL) was added via cannula transfer. The 
orange solution was filtered through two Celite plugs, DCM reduced in volume to 1 
mL in vacuo, and diethyl ether added, precipitating 5.7 as an orange solid, which 
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was filtered via cannula filtration and dried in vacuo. Yield 55 mg, 0.03 mmol, 78%. 
HRMS (ESI+) 551.1033 {C81H90Cl3N6O6Ru3}
3+, calculated 551.1037. Full 1H NMR 
assignment was precluded by extremely broad spectra. FTIR υ (cm-1) 2961, 1508, 
1462, 1370, 1264, 1085, 744; Satisfactory elemental analysis could not be obtained 
presumably due to AgI and solvent contamination, alongside potential 
decomposition. C81H90Cl6N6O6Ru3∙1.35(AgI)∙(CH3CN) Calcd.: C 47.08, H 4.43, N 
4.63; Found C 46.57, H 3.94, N 4.91. 
 
Synthesis of η6-p-cymene dichloro (1-methyl-3-((2-
methoxyphenoxy)methyl)benzimidazol-2-ylidene)ruthenium(II), 5.8  
Ligand 4.8 (50 mg, 0.12 mmol), [Ru(p-cymene)(Cl)2]2 (39 mg, 
0.06 mmol), Ag2O (15 mg 0.06 mmol) and several activated 4 Å 
molecular sieves were added to a flame dried Schlenk flask. 
MeCN (5 mL) was added and the orange reaction mixture was 
heated to 70 ºC for 16 h in the absence of light, during which 
time Ag2O was digested and a pale yellow precipitate formed. Solvents were 
removed in vacuo and anhydrous DCM (10 mL) was added via cannula transfer. The 
orange solution was filtered through two Celite plugs, DCM reduced in volume to 1 
mL in vacuo, and diethyl ether added, precipitating 5.8 as an orange solid, which 
was filtered via cannula filtration and dried in vacuo. Yield 28 mg, 0.05 mmol, 41%. 
HRMS (ESI+) 539.1048 {C26H30ClN2O2Ru}
+, 1114.1769 {C52H60Cl3N4O4Ru2}
+, 
calculated 539.1039, 1114.1744; 1H NMR (300 MHz, CDCl3) δ (ppm) 7.42 – 7.27 
(m, 5H, H4, H5, H6, H7, H9a), 7.15 – 7.00 (m, 2H, H13, H14), 6.96 (t, 2H, J = 6.9 Hz, 
H11, H12), 5.94 (d, 1H, J = 10.4 Hz, H9b), 5.70 (d, 1H, J = 5.7 Hz, H21), 5.41 (d, 2H, 
J = 4.7 Hz, H24, H25), 5.17 (d, 1H, J = 5.0 Hz H20), 4.27 (s, 3H, H2), 3.79 (s, 3H, 
H16), 3.00 (hept J = 7.44, 7.44, 7.89, 7.89, 7.89, 7.89 Hz, 1H, H18), 2.09 (s, 3H, H23), 
1.29 (s, 3H, H17a), 1.26 (s, 3H, H17b); 13C{1H} NMR (75 MHz, CDCl3) δ (ppm) 
193.32 (C1), 150.96 (C15), 146.32 (C10), 136.15 (C3), 135.23 (C8), 123.68 
(Benzimidazole CH), 123.64 (Benzimidazole CH), 121.46 (C11), 118.53 (C13), 
112.70 (C12), 111.11 (Benzimidazole CH), 110.09 (Benzimidazole CH), 109.95 
(C19), 100.52 (C22), 87.49 (C21), 85.82 (C24), 84.27 (C25), 81.76 (C20), 78.73 (C9), 
55.81 (C16), 36.85 (C2), 30.96 (C18), 23.91 (C17a), 21.51 (C17b), 18.83 (C23); FTIR υ 
(cm-1) 2961, 1507, 1372, 1253, 1119, 969; Elemental analysis for 
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C26H30Cl2N2O2Ru∙0.2(AgI) Calcd.: C 50.25, H, 4.87, N, 4.51; Found: C 50.53, H 
4.56, N 4.67. 
 
General catalytic procedure 
Potassium tert-butoxide (14 mg, 0.1 mmol), catalyst and 1,4-dimethoxybenzene 
(69.1 mg, 0.5 mmol) were added to a Schlenk flask. Acetophenone (118 μL, 1 
mmol) and isopropanol (2.3 mL) were added and the solution heated to 80 ºC for 1 
h. An aliquot of the reaction mixture (0.1 mL) was added to CDCl3 (0.4 mL) and the 
conversion obtained by 1H NMR spectroscopy.  
5.7 Crystallographic remarks 
Crystals were mounted under inert oil on a MiTeGen tip and flash frozen using an 
OxfordCryosystems low temperature device. X-ray diffraction data were collected 
using CuK radiation (λ = 1.54184 Å) or MoK (λ = 0.71073 Å) using an Agilent 
Supernova dual-source diffractometer with Atlas S2 CCD detector and fine-focus 
sealed tube generator, or using synchrotron radiation (λ = 0.6889 Å) at Beamline I19 
at the Diamond light source. Data were corrected for Lorenztian and polarization 
effects and absorption corrections were applied using multi-scan methods. The 
structures were solved by direct methods using SHELXS-97 and refined by full-
matrix on F2 using SHELXL-97. Unless otherwise specified, all non-hydrogen 
atoms were refined as anisotropic, and hydrogen positions were included at 
geometrically estimated positions. 
5.7.1 Additional crystallographic details 
5.1  
Crystals did not diffract to high angles using MoKα radiation, and the SQUEEZE 
routine of PLATON was applied.34 
5.4 
The largest peak was a Fourier ripple 0.75 Å from Ir1. 
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Compound 5.1b 5.2a 5.4b 5.6b 
Formula C972H1116Cl72Ir36N72O72 C208H248Cl16Ir8N16O16 C96H114Cl4Ir4N8O8 C96H114Cl4N8O8Rh4 
Mr 24432.26 5333.04 2416.52 2059.36 
Crystal colour and shape Yellow, block Yellow, block Yellow, block Yellow, block 
Crystal size (mm) 0.07 x 0.08 x 0.10 0.03 x 0.04 x 0.07 0.07 x 0.08 x 0.11 0.05 x 0.07 x 0.12 
Crystal system Hexagonal (trigonal 
edges) 
Orthorhombic Triclinic Triclinic 
Space group 𝑅3𝑐 Pbca 𝑃1 𝑃1 
a (Å) 23.5277(12) 8.53799(19) 8.9535(3) 8.9560(5) 
b (Å) 23.5277(12) 20.0779(5) 12.9352(4) 12.8612(7) 
c (Å) 77.681(4) 29.0881(7) 20.3565(5) 20.3426(10) 
α (0) 90 90 91.617(2) 91.712(4) 
β (0) 90 90 102.372(2) 102.480(4) 
γ (0) 120 90 109.306(2) 109.169(5) 
V (Å3) 37239(4) 4986.4(2) 2160.78(11) 2148.0(2) 
Z 12 8 4 4 
T/K 120 120 120 120 
ρcalc (g.cm-3) 1.089 1.776 1.857 1.592 
θ range (0) 2.898- 20.815 3.038-74.271 2.825-30.7840 2.834-26.022 
No. data collected 26406 20650 25022 18664 
No. unique data 4338 5056 8751 8166 
Rint 0.0974 0.0579 0.0274 0.0346 
No. obs. Data (I > 2σ(I)) 3274 3817 7715 6812 
No. parameters 314 305 545 545 
No. restraints 75 0 0 0 
R1 (obs data) 0.0547 0.0322 0.0269 0.0350 
wR2 (all data) 0.1473 0.0766 0.0972 0.0825 
S 1.023 0.996 0.788 1.030 
Max. shift/esd 0.005 0.002 0.001 0.001 
Largest difference peak 
and hole/ (e Å3) 
1.924, -0.891 1.687, -1.127 1.715, -0.824 0.643, -0.703 
Table 5.5 Table of crystallographic data. a = CuKa radiation, b = MoKa radiation 
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Chapter 6  
Synthesis and catalytic assessment of trimetallic Pd(II) N-
heterocyclic carbene complexes 
This chapter focuses on the preparation of four Pd(II) N-heterocyclic carbene 
complexes, their characterisation and viability as catalysts in Suzuki-Miyaura 
cross-coupling reactions, with the intention of observing a supramolecular benefit to 
tethering three metal centres to one scaffold.  
6.1 Introduction  
Chapter 5 discussed the preparation of NHC complexes containing Ir, Ru and Rh. 
The four classes of complex prepared contained either a multihaptic π-donor, or 
bidentate COD ligand for square-planar Ir(I) and Rh(I) complexes, occupying 50% 
of the available coordination sites of the metal in question. The NHC and π-donating 
environments both exerted significant bulk on the systems and led to restricted 
rotation about a number of sites on the complexes, thus complicating NMR analysis. 
An obvious method to relieve some steric strain would be to prepare complexes not 
bearing multihaptic or chelating ligands.  
 Palladium N-heterocyclic carbene complexes are amongst the most 
established in the literature. A diverse array of NHC ligands have been observed 
coordinating to Pd(II), including monodentate NHCs,1 bis-NHCs,2, 3 chelating 
pyridyl-NHC ligands4, 5 amongst others. One particular class of complexes which 
have become synonymous with organometallic chemistry are the PEPPSI™ 
complexes pioneered by Organ and co-workers in the early 21st Century.6  
6.1.1 PEPPSI™ complexes 
PEPPSI™ complexes (Pyridine Enhanced Precatalyst Preparation Stabilisation and 
Initiation) have become one of the most widely encountered classes of NHC bearing 
species. This is to their ease of synthesis, which in a number of cases can be carried 
out in air. Reactions are often high yielding, with yields of >90% not uncommon for 
PEPPSI™-IMes (IMes = bis-mesitylimidazol-2-ylidene) or PEPPSI™-IPent (IPent 
= bis-2,6-diisopentylphenylimidazol-2-ylidene. Organ and co-workers demonstrated 
scalability when preparing PEPPSI™-IMes, and achieved a 93% yield carrying out 
its synthesis in a coffee mug, using 10 g of PdCl2.
6 
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Scheme 6.1 Organ’s synthesis of PEPPSI™-IMes6. 
The 3-chloropyridyl ligand behaves as a throwaway ligand, both stabilising the 
active Pd(0) catalyst, and being easily displaced during catalytic cycles. PEPPSI™ 
catalysts are remarkably robust (can be heated indefinitely in DMSO to 120 ºC 
without decomposition). The complexes have become key catalysts in academic and 
industrial laboratories, owing to their straightforward and scalable synthesis, 
functional-group tolerance and ability to catalyse an incredible substrate scope 
across a variety of C-C7-13 and C-N14-17 coupling reactions, including 
regioselective18 and enantioselective19 examples, when employing a chiral NHC 
ligand. Goldup and Larrosa have reported the highly selective polybutylation of 
polybromobenzenes when using one eq. butylzinc bromide in PEPPSI™-catalysed 
Negishi couplings, proposing that a minimum of two distinct Pd(0) species mediate 
the oxidative addition step.20 The first reacts under activation control, the typical 
reactivity observed when employing Pd(0) catalysts. The second arises from the 
reductive elimination step yielding ‘ultra-active’ Pd(0) species stabilised within a 
solvent cage, which exhaustively substitute the polybromobenzene under diffusion 
control. DFT calculations have suggested a PEPPSI™-IPr mediated reductive 
elimination product from ethylbenzene and ethylzinc bromide would be a 
Pd(0)-ZnBr2 adduct,
21 which if stabilised within a solvent cage could lead to 
exhaustive substitution. The PEPPSI™ complexes display selective 
polyfunctionalisations in a number of cross-coupling reactions in addition to the 
Negishi reaction, including the Kumada coupling and also to a lesser extent the 
Suzuki-Miyaura reaction.22 This suggests that polyfunctionalisation of 
polybromoarenes is a general property of PEPPSI™ complexes, rather than by the 
stabilisation of a Pd(0)-ZnBr2 adduct.  
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6.2 Synthesis of trimetallic trans-3-chloropyridyl complexes 
6.2.1 Preparation of trimetallic N-methyl Pd(II)-NHC 6.1 
By following the methodology introduced by Organ and co-workers in the 
preparation of PEPPSI™ complexes, imidazolium salt 4.3 could be deprotonated 
using potassium carbonate as the base and 3-chloropyridine as both solvent and 
ligand (scheme 6.2). Trimetallic complex 6.1 was isolated in good yield, and unlike 
the complexes introduced in Chapter 5, sharp, diagnostic NMR spectra were 
obtained. The preparation of 6.1 could be carried out in hydrous 3-chloropyridine 
under aerobic conditions, but yields dropped from 84% to 40%, therefore standard 
Schlenk procedures were applied. 
Scheme 6.2 Synthesis of complex 6.1. 
The disappearance of the NCHN proton in the 1H NMR spectrum associated with 
the benzimidazolium unit is indicative of a deprotonation taking place, and the 
formation of a Pd(II)-NHC complex (figure 6.1). The three chemical shifts 
appearing furthest downfield in the 1H NMR spectrum were all coupling to one 
another in the 1H-1H COSY NMR spectrum, and are attributed to protons on the 
3-chloropyridyl ligand. The two doublets assigned as H14 correspond to 
diastereotopic protons on the NCH2O methylene bridge. Both doublets assigned as 
H14 also couple to the same carbon environment in the HMQC spectrum. It can be 
conjectured that solution-state preagostic interactions were not observed in 6.1, as 
was seen with 5.1-5.8. The splitting at H14 is typical for a diastereotopic site, as 
opposed to the wider splitting noted in Ir(III) complexes caused by influence of the 
metal on a proton at this site. The endo- and exo- doublets associated with the CTV 
bowl were located at 4.44 and 3.41 ppm, again implying a C3-symmetric product.  
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Figure 6.1 1H NMR spectrum (300 MHz, 293 K, CDCl3) of complex 6.1. 
A peak at 161.69 ppm corresponded to the carbenic carbon in the 13C{1H} NMR 
spectrum (figure 6.2), and coupled to both the N-methyl (H7) and diastereotopic 
N-CH2-O (H
14) hydrogen atoms in the HMBC spectrum. A carbenic 13C{1H} 
resonance of ca. 160 ppm is typical for a Pd(II)-NHC trans to a pyridyl ligand.23 
HMQC spectroscopy confirmed the identities of both C14 and C21 at 79.20 and 35.76 
ppm.  
 
Figure 6.2 13C{1H} NMR spectrum (75 MHz, 293 K, CDCl3) of complex 6.1. Inset HMBC 
spectrum. 
The HRMS of 6.1 contained a single peak at m/z = 1794.5960 corresponding to the 
complex losing one iodide and three 3-chloropyridine ligands during the ionisation 
process, and the observed isotope pattern was an excellent match to the simulated 
- 226 - 
pattern (figure 6.3). The loss of 3-chloropyridine during electrospray ionisation was 
anticipated due to the strong trans-influence of NHC ligands. 
 
Figure 6.3 HRMS (ESI+) of complex 6.1. Inset: observed isotope pattern (top), simulated isotope 
pattern (bottom). 
Single crystals of composition 6.1·(CH2Cl2)0.5·(C5H14)2·(H2O)2 were grown from the 
diffusion of pentane vapours into a dichloromethane solution. The structure was 
determined by X-ray diffraction. The asymmetric unit comprised a molecule of 6.1, 
dichloromethane at half occupancy, water sites and two pentane solvent molecules. 
The diffuse nature of lattice solvent led to crystals desolvating within seconds of 
exposure to air, and the crystallographic data are of poor quality. One 
3-chloropyridyl ligand was disordered over two positions (figure 6.4), as was one 
pentane. 
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Figure 6.4 Left: Molecular structure of 6.1·(CH2Cl2)0.5·(C5H14)2·(H2O)2 (left). Ellipsoids are 
drawn at the 50% probability. Right: Space filling drawing of 6.1. 
The three metallated arms were external to the bowl, directed towards the base of 
the cavitand, with Carene-O-C-NNHC torsion angles between -66.9 and -67.2
o. The 
Pd-C bond lengths are between 1.931(13) and 1.943(12) Å, comparable with the 
bond length of 1.969(3) Å reported by Organ et al. for PEPPSI™-IPr.6 All three 
benzo-backbones of NHC ligands undertake π-π stacking interactions with 
neighbouring NHCs, at centroid-centroid distances of 3.68-3.72 Å (figure 6.5, left). 
A dimeric handshake (concept introduced in Section 2.2) was also observed between 
neighbouring complexes, whereby one 3-chloropyridyl ligand behaves as a guest 
species to an adjacent cavitand, as shown in figure 6.5 (right). This interaction is 
reciprocated; in this case, the meta-hydrogen atom of the 3-chloropyridyl ligand is 
directed towards the hydrophobic cavity, with a Cpy-centroid separation of 3.944 Å. 
Crystals grown were racemic, with the dimeric handshake undertaken by M and P 
isomers of complex 6.1. Distances between a calculated H atom of the NCH2O 
methylene bridge and Pd centres were between 2.8 and 2.9 Å, but were not aligned 
in the same manner as Ellman’s Rh complexes to suggest preagostic interactions.24 
The space-filling model shows significant exposure of Pd(II) above and below the 
equatorial plane of the metal cation, potentially enhancing catalytic activity.  
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Figure 6.5 Top left: π-π Stacking arrangements between enantiomers of 6. Top right: Dimeric 
handshake interaction. Opposite enantiomers are shown in red and blue. Bottom: 
packing diagram of 6.1·(CH2Cl2)0.5·(C5H14)2·(H2O)2. 
Orange needles of (6.1)2·(C4H8O2)6 also grew from the diffusion of diethyl ether 
vapours into a 1,4-dioxane solution of 6.1, and the structure was determined by 
X-ray diffraction. Crystals were of much better quality, and did not readily 
decompose when removed from the mother liquor. The asymmetric unit comprised 
of two crystallographically distinct 6.1 complexes and 7.5 dioxane positions, some 
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refined to 0.5 occupancy to a total of 6 dioxane molecules. As opposed to the 
pentane solvate, the metallated arms of the complex point upwards, crowning the 
cavitand (figure 6.6). It was anticipated that the significantly bulky NHC complexes 
linked to the CTV bowl would undergo steric clashes with one another. However, 
the metallated arms were observed both above and below the upper rim of the 
cavitand in two different crystal structures, suggesting there is a barrier to overcome 
restricted rotation observed heavily in Chapter 5. 
 
Figure 6.6 Asymmetric unit of (6.1)2· (C4H10O2)6. Ellipsoids are drawn at the 50% probability 
and H atoms omitted for clarity. 
The arene faces in the solid-state structure of 6.1 lay flat at the top of the complex, 
with the 3-chloropyridyl ligands slightly inclined towards the top of the complex. 
The orientation of metallated arms allows for both the NHC backbone and 
3-chloropyridine ligands to engage in π-π stacking interactions with neighbouring 
complexes. Contrary to 6.1·(CH2Cl2)0.5·(C5H14)2·(H2O)2, π-π stacking interactions 
are between NHC backbone and a 3-chloropyridyl moiety, rather than two NHC 
groups. Triple deckers of 3-chloropyridyl-NHC backbone-3-chloropyridyl form the 
buttress to this assembly, at separation of 3.673 and 3.649 Å. Pd-C bond lengths 
varied between 1.93-1.97 Å, which was comparable to the pentane solvate. The 
Carene-O-C-NNHC torsion angles of both complexes in the asymmetric unit were 
between -175.4 and -180.0o with near-planar alignment of this group. Three dioxane 
molecules were ordered and were constrained within a capsule-like assembly, 
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whereas other solvent molecules were refined at low occupancies, and rigid 
restraints were applied (figure 6.7, right). Both distinct molecules of 6.1 π-π stack 
with one another through the CTV bowl at separation of 3.6 Å. 
 
Figure 6.7 Top left:One equivalent of 6.1 with dioxane guest partaking in second-sphere 
coordination. Top right: and capsule-like assembly of (6.2)2 encapsulating three  
   dioxane molecules. Bottom: unit cell diagram. 
Inclusion of a dioxane guest within the cavity of CTV 6.1 was observed, with one 
C2H4 wall pointing towards the hydrophobic bowl and, potentially encouragingly for 
catalysis purposes, an interaction between dioxane oxygen and Pd(II) at a 
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second-sphere coordination distance of 4.5 Å (figure 6.7, left). This could 
potentially open a gateway towards a supramolecular influence upon site-selective 
cross-coupling reactions. 
6.2.2 Synthesis and characterisation of N-benzyl derivative 6.2 
Coordination of benzyl ligand 4.5 to Ir, Ru and Rh was not viable because of a 
considerable solubility mismatch; the ligand only proved soluble in the most 
coordinating of solvents, such as DMF and DMSO, and insoluble in acetonitrile. 
Ligand 4.5 was, however, soluble in 3-chloropyridine, which opened the possibility 
of preparing a Pd(II) NHC complex analogous to 6.1 (scheme 6.3). When aligned 
towards the metal, the benzylic arm would simultaneously add steric bulk to both 
sides of the NHC and impart a flexible site on an otherwise rigid system, a feature 
which has been shown to improve cross-coupling reactions when using Pd-
pyridyl-NHC crossover systems as catalysts in the Suzuki-Miyaura reaction.4 Using 
similar methodology applied to complex 6.1, the bulkier Pd(II) N-benzyl NHC 
complex 6.2 could also be prepared. The synthetic methodology was varied slightly 
to that used when preparing 6.1, with the necessary addition of potassium iodide to 
suppress halide mixing due to the benzimidazolium ligand bearing bromide anions 
rather than iodides. 
 
Scheme 6.3 Synthesis of complex 6.2. 
HRMS was diagnostic, with the main peak matching complex less one iodide ion 
and all three 3-chloropyridyl ligands at m/z = 2022.6935 (calculated 2022.6951), 
displaying an excellent match between simulated and observed isotope patterns, as 
shown in figure 6.8.  
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Figure 6.8 HRMS (ESI+) of 6.2. Inset: Observed (top) vs simulated (bottom) isotope pattern 
The complex also gave diagnostic 1H NMR data, and the issues associated with 
trimetallic complexes seen in Chapter 5 did not arise. Ligand 4.5 conveniently 
contained a single peak encompassing all benzylic aromatic groups (figure 6.9). This 
was not the case in complex 6.2, where a sharp spectrum comprising of many 
resonances was obtained. A number of peaks between 7 and 8 ppm were observed 
attributed to the N-benzyl aromatics, the CTG arene protons, the NHC 
benzo-backbone and meta-3-chloropyridyl proton. Similarly to complex 6.1, the loss 
of imidazolium proton was observed, and endo- and exo- protons of H26 at 4.53 and 
3.49 ppm confirmed the presence of a single species in solution. Two methylene 
bridges proximal to the divalent carbon underwent diastereotopic splitting. H18, 
associated with the NCH2O methylene bridge appeared further downfield by virtue 
of deshielding at this site, with doublets assigned as 6.67 and 6.52 ppm. The 
benzylic CH2 group (H
7) split into two doublets sited at 6.19 and 5.94 ppm.  
13C{1H} NMR spectroscopy was also carried out (figure 6.10), with full 
assignment complemented by DEPT-135, HMQC and HMBC experiments. DEPT-
135 NMR spectroscopy allowed for the elucidation of C7, C18 and C26, with recorded 
chemical shifts of 54.90, 79.64 and 35.97 ppm respectively. The carbenic carbon, 
C6, was assigned as 162.69 ppm and confirmed by HMBC spectroscopy, coupling to 
both N-substituents of the NHC.  
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Figure 6.9 1H NMR spectrum of 6.2 (300 MHz, 293 K, CDCl3). Inset: COSY NMR spectrum. 
 
Figure 6.10 13C{1H} NMR spectrum of 6.2 (75 MHz, 293 K, CDCl3). Inset: HMQC spectrum. 
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6.3 Guaiacol-derived Pd(II) NHC complexes 
6.3.1 Synthesis and characterisation of an N-methyl monometallic 
complex 
In a similar vein to Chapter 5, monometallic Pd(II) NHC complexes 3-chloropyridyl 
diiodo (1-methyl-3-((2-methoxyphenoxy)methyl)benzimidazol-2-ylidene)palladium, 
6.3 and 3-chloropyridyl diiodo (1-benzyl-3-((2-
methoxyphenoxy)methyl)benzimidazol-2-ylidene)palladium, 6.4 were synthesised 
to give new catalysts bearing a similar environment to the arene faces of the CTV 
core, with the intention of comparing monometallic and trimetallic complexes in 
catalytic transformations.  
 
Scheme 6.4 Synthesis of complex 6.3. 
The N-methyl monopalladium complex 6.3 was prepared in reasonable yield 
according to the same procedure as 6.1. The 1H NMR spectrum of 6.3 contained the 
NMR handle afforded by the N- and O-methyl resonances assigned as 4.20 and 3.96 
ppm. Peaks assigned as H-atoms proximal to the Pd(II) centre in both 6.1 and 6.3 
appeared at near-identical chemical shifts. H14 was marginally downfield in 6.3 
compared to 6.1, with this site perhaps being slightly deshielded compared to the 
cavitand complex. Diastereotopic splitting of H14 was not observed in the 1H NMR 
spectrum of 6.3, suggesting this hinge is flexible, in addition to preagostic 
interactions being absent. Whilst chemically similar, the main discrepancy in 1H 
NMR spectra lay with the guaiacol group. 6.1 bears two protons on each CTV face 
which are para with respect to one another, affording two singlets in the 1H NMR 
spectrum. Conversely, 6.3 contains four aromatic protons on its pendant guaiacol 
arm, all of which couple to one another, causing some convolution of the aromatic 
region in its 1H NMR spectrum. 
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Figure 6.11 1H NMR spectrum (300 MHz, 293 K, CDCl3) of complex 6.3. 
Carbon atoms were fully assigned using HMQC, HMBC and DEPT-135 NMR 
spectroscopy (see appendix). The 13C{1H} NMR spectrum of 6.3 (figure 6.12) bore 
similarities to 6.1, with chemical shifts proximal to Pd(II) being highly comparable. 
The carbenic carbon, C6 was sited at 161.36 ppm. The methylene bridge C14 was 
assigned as 79.38 ppm, and N-methyl resonance as 36.21 ppm. Complex 6.1 
depicted these relative environments as 161.69, 79.20 and 36.36 ppm respectively.  
 The anticipated {M-(I)-(3Clpy)}+ fragment dominated the mass spectrum 
(ESI)+ (figure 6.13) and displayed an excellent isotopic match to the simulated 
model. The fragment observed at  m/z = 1130.7631 was identified as a {6.3}2
+ 
fragment, with the loss of one iodide ion and two 3-chloropyridyl donors (calculated 
m/z = 1130.7626). 
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Figure 6.12 13C{1H} NMR spectrum (75 MHz, 293 K, CDCl3) of complex 6.3. Inset: HMBC 
spectrum. 
 
Figure 6.13 HRMS (ESI+) of complex 6.3. Inset: Observed (top) vs simulated (bottom isotope 
patterns for the main peak 
Single crystals suitable for diffraction were grown from the diffusion of pentane into 
a dichloromethane solution of 6.3. The structure was solved in the monoclinic P21/c 
space group, with the asymmetric unit comprising of one whole unit of 6.3, as 
shown in figure 6.14. 
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Figure 6.14 Asymmetric unit of 6.3. Ellipsoids are drawn at the 50% probability. 
The structure was highly ordered, with no anticipated positional disorder about the 
3-chloropyridyl ligand, selected bond lengths and angles are shown in table 6.1.  
Table 6.1 List of selected bond lengths (Å) and angles (º) for 6.3. 
Pd1-I1 2.61062(14) I1-Pd1-C1 88.13(4) 
Pd1-I2 2.61109(14) I2-Pd1-N3 92.02(4) 
Pd1-N3 2.1117(13) I2-Pd1-C1 87.73(4) 
Pd1 C1 1.9568(15) C1-Pd1-N3 173.37(6) 
I1-Pd1-I2 172.219(6) C10-O1-C9-N2 -169.837 
I1-Pd1-N3 92.85(4)   
 
Molecules of 6.3 interact with each other through π-π stacking interactions between 
neighbouring 3-chloropyridine ligands at separation of 3.68 Å. Guaiacol groups and 
the benzo-backbone of NHC ligands are within 3.5 Å of one another at their closest 
contacts, but are aligned incorrectly to engage in π-π stacking, and the bulk of both 
rings are separated by a distance of greater than 4 Å. C-H···π interactions were also 
noted between the 5-position of 3-chloropyridyl ring and the centroid of guaiacol 
pendants, at a C···centroid separation of 3.34 Å. 
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6.3.2 Preparation and characterisation of N-benzyl monomer 6.4 
The N-benzyl monomer, 6.4 was prepared following the same procedure to that of 
the CTV derivative 6.2 (scheme 6.5) and was isolated as a sticky solid. 
 
Scheme 6.5 Synthesis of complex 6.4 
The propensity of these complexes to ionise and form {M–I-(3Clpy)}+ fragments 
was again observed (figure 6.15), with a peak of m/z = 576.9599 dominating the 
HRMS. The observed isotope pattern displayed an excellent match to the simulated 
model. Furthermore, an additional two fragments were detected, firstly at m/z =  
449.0491, which corroborated with a bidentate Pd(II)-NHC fragment bearing no 
iodide ligands and a cyclometallated benzylic moiety (calculated m/z = 449.0476). 
1H NMR spectroscopy disproved the presence of this fragment in the bulk solution 
as a side-product, and no observed Pd-C peaks arising from cyclometallation in the 
13C{1H} NMR spectrum in their characteristic range of 150-160 ppm. Therefore, m/z 
= 449.0476 was attributed as a result of ionisation. The third peak present displayed 
an excellent match to K[Pd(NHC)I2]
+ with m/z = 742.8273 (calculated m/z = 
742.8281). 
The 1H NMR spectrum of 6.4 (figure 6.16) contains twelve aromatic 
resonances within a 1 ppm range. The diastereotopic NCH2O and N-benzyl CH2 
protons both appear as singlets at 6.72 and 6.03 ppm, without splitting as was 
observed in 6.1 and 6.2. Similarly to 6.1-6.3, the doublet and doublet of doublets at 
9.02 and 8.92 ppm were good matches to resonances on the 3-chloropyridyl ligand. 
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Figure 6.15 HRMS (ESI+) of complex 6.4. Inset: Observed (top) vs simulated (bottom) isotope 
patterns for the major peak in the spectrum 
 
Figure 6.16 1H NMR spectrum (300 MHz, 293 K, CDCl3) of 6.4. 
The 13C{1H} NMR spectrum of 6.4 (figure 6.17) showed similarities to 6.1-6.3, with 
the carbenic carbon C6 resonating at 162.57 ppm. The carbenic carbon was observed 
within a 1.5 ppm range for complexes 6.1-6.4, suggesting that fusing a Pd(II)-NHC 
complex with N-methyl or N-benzyl arms onto a rigid CTV bowl does not have a 
significant effect on the electronic factor of the NHC ligand. Two CH2 peaks were 
observed in the DEPT-135 spectrum, 79.99 and 55.01 ppm, which were assigned as 
C18 and C7 respectively.  
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Figure 6.17 13C{1H} NMR spectrum (75 MHz, 293 K, CDCl3) of 6.4. 
Single crystals of 6.4 could be grown from the diffusion of diethyl ether vapours 
into an acetonitrile solution of the complex. The X-ray data were collected by 
Edward Britton using synchrotron radiation. The structure was solved in the 
orthorhombic P21/n space group, and the asymmetric unit comprised two 
crystallographically distinct 6.4 molecules, which interact through π-π stacking 
arrangements between 3-chloropyridyl ligands and NHC benzo-backbones at a 
separation of 3.6 Å (figure 6.18). The NHC N-substituents of both 6.4 molecules are 
of different orientations, The NHC wingtips associated with complex 1 (containing 
Pd1) were both folded towards the same face of the complex, and the second 
complex contains N-substituents bent towards opposite faces of the ligand. The aryl 
groups on both substituents are aligned away from the Pd centres on both 
complexes. Chains grow throughout the crystal lattice by means of CH-π 
interactions between the methoxy group of the N-(2-methoxyphenoxymethyl) 
component of one complex (Pd1) and the N-benzyl substituent of the second 
complex, at a C···centroid separation of 3.53 Å. Bond lengths and angles about the 
Pd(II) centres are similar to one another, with differences of no more than 4º in bond 
angles when comparing the crystallographically distinct complex molecules. Both 
have considerably dissimilar Carene-O-C-NNHC torsion angles, with complex 1 being 
close to antiperiplanar, whilst complex 2 is much more strained, with a measured 
torsion angle of -71.943º. The N-benzyl arms were of similar orientations in both 
complex equivalents, and resided roughly perpendicular to the Pd-C bond. Selected 
bond lengths and angles are given in table 6.2. 
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Figure 6.18 Asymmetric unit of (6.4)2. Ellipsoids are drawn at the 50% probability. 
Table 6.2 Selected bond lengths (Å) and angles (º) from the crystal structure of (6.4)2. 
Pd1-I1 2.6099(8) Pd2-I3 2.6142(8) 
Pd1-I2 2.5983(8) Pd2-I4 2.5882(8) 
Pd1-N3 2.086(7) Pd2-N6 2.131(6) 
Pd1-C1 1.957(7) Pd2-C28 1.969(7) 
I1-Pd1-I2 172.32(3) I3-Pd2-I4 174.45(3) 
I1-Pd1-N3 91.36(18) I3-Pd2-N6 93.06(18) 
I1-Pd1-C1 88.4(2) I3-Pd2-C28 88.3(2) 
I2-Pd1-N3 92.52(18) I4-Pd2-N6 92.19(18) 
I2-Pd1-C1 87.8(2) I4-Pd2-C28 86.4(2) 
C1-Pd1-N3 179.6(3) C28-Pd2-N6 176.7(3) 
C16-O1-C15-N1 172.738 C43-O4-C42-N4 -71.943 
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Figure 6.19 Left: One equivalent of 6.4. Right: space-filling diagram of the asymmetric unit. 
The main intermolecular interaction driving crystallisation were the π-π stacking 
interactions between 3-chloropyridine and NHC benzo-backbone. Whilst the two 
aromatic wingtips did not partake in π-π stacking, the flexible groups aligned 
themselves into a closely packed structure, with guaiacol groups sandwiched 
perpendicularly between two 3-chloropyridine units at separations of ca. 3.9 and 
4.5 Å. 
6.4 Catalytic assessment of Pd(II) complexes 
6.4.1 Catalytic activity in the Suzuki-Miyaura reaction of phenylboronic 
acid and 4-bromotoluene 
Cross-coupling reactions are widespread, and applicable in many branches of 
synthetic chemistry as a facile method of C-C bond formation, replacing traditional 
procedures which used harsh conditions and organolithium reagents. Common 
coupling reactions involve those between aryl halides and alkenes (Heck),25 alkyne 
and aryl halides in the presence of a Cu(I) co-catalyst (Sonogashira),26 as well as 
Negishi27 and Kumada28, 29 couplings, which use more reactive organozinc or 
Grignard reagents as coupling substrates. The reactions have been mainstays in 
synthetic chemistry for almost half a century, and for their work on developing such 
significant reactions, Suzuki, Heck and Negishi were awarded the 2010 Nobel Prize 
in Chemistry.30 The active catalyst in cross-coupling reactions is typically a Pd(0) 
species, although the facile in situ reduction of much more stable Pd(II) complexes 
by reaction with an excess of boronic acid allows for straightforward reactivity.  
The Suzuki-Miyaura reaction was first reported in 1979 for the coupling 
between alkenyl halides and alkenyl boronic acids.31 Nowadays, the reaction is the 
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primary method for biaryl synthesis, and has become a mainstay in synthetic 
chemistry. Boronic acids are commercially available, or straightforward to prepare 
by reaction of a Grignard reagent with a trialkyl borate, which is hydrolysed to the 
boronic acid upon aqueous workup. Extensive development of this reaction has led 
to an assortment of catalysts being reported, with substrate scope also being 
extensive. The main components of the Suzuki reaction are an aryl halide or triflate, 
which can be coupled with a boronic acid, pinacolato boronate ester, or in the most 
resistant of cases, an aryl bismuth reagent.32-34 The base (shown as NaOH in scheme 
6.6) performs a number of roles, notably reacting with the boronic acid to yield a 
more nucleophilic boronate salt.35 The active catalyst is a Pd(0) species, and a 
battery of ligand classes have been used to stabilise such complexes, including 
phosphines and NHCs. 
The generally accepted mechanism for the Suzuki-Miyaura reaction (scheme 
6.6) involves first reducing the Pd(II) complex to Pd(0) where necessary, before the 
oxidative addition of aryl halide. Halide abstractions can occur when using alkali 
metal bases, replacing the halide with a more labile ligand. A transmetallation step 
then proceeds, where the labile ligand is substituted for the aryl of the boronic acid, 
producing a soluble borate salt as by-product. A cis-trans isomerisation reversibly 
ensues (irrelevant when cis-chelating or significantly bulky ligands are used), prior 
to the reductive elimination of biaryl component and the regeneration of a Pd(0) 
species. Deactivation pathways known include homocoupling (often involves two 
equivalents of boronic acid), and also colloidal Pd nanoparticle (also known as 
palladium black) aggregation which, depending on the nature of the nanoparticles, 
may or may not be catalytically active. 
Complexes 6.1-6.4 were all examined in the Suzuki-Miyaura reaction 
between 4-bromotoluene and phenylboronic acid (scheme 6.7). The effect of 
tethering three catalytic sites to a rigid cavitand to see whether supramolecular 
interactions enhance or hinder catalysis was assessed. 
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Scheme 6.6 Generally accepted mechanism for the Pd(0)-catalysed Suzuki-Miyaura reaction. 
 
Scheme 6.7 Suzuki-Miyaura reaction between 4-bromotoluene and phenylboronic acid. 
Table 6.3 Conversions and TONs for the Suzuki-Miyaura reaction between 4-bromotoluene 
and phenylboronic acid catalysed by 6.1-6.4. 
















- - 56 (±1) 110 (55) - - 
6.1 (CTV) 21 (±1) 84 (42) 24 (±1) 48 (24) 20 (±2) 20 (10) 
6.2 (CTV) 37 (±5) 148 (74) 41 (±3) 82 (41) 22 (±1) 22 (11) 
6.3 22 (±6) 88 (44) 23 (±2) 46 (23) 42 (±6) 42 (21) 
6.4 26 (±11) 104 (52) 32 (±2) 64 (32) 55 (±3) 55 (22.5) 
Conversions were obtained using 1H NMR spectroscopy, were the average of two runs and 
compared to 1,4-dimethoxybenzene as an internal standard. Turnover number 
 defined as moles of product/moles Pd. 
Monometallic complexes 6.3 and 6.4 showed increased conversions on increasing 
the catalyst loading. This is in contrast to the trimetallic complexes 6.1 and 6.2, 
which displayed similar conversions at 0.25, 0.5 and 1 mol% Pd loading. Turnover 
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numbers (TON) revealed a homeopathic effect in all four cases, where a decrease in 
catalyst loading leads to increased activities.36 Homeopathic effects in catalysis 
occur when low catalyst loading leads to higher performing results than when higher 
concentrations of catalysts are applied. This can be connected to nanoparticle 
formation at higher catalyst concentrations, where the active site of nanoparticles is 
poorly defined compared to a homogeneous catalyst. Turnover numbers in this 
chapter are defined as the moles of product formed per Pd centre. TON were slightly 
higher for 6.1 and 6.2 at lower catalyst loading compared to 6.3 and 6.4, although 
the presence of a N-benzyl component appeared to have a greater impact on 
catalysis rather than guaiacol vs CTV. Pd black was liberated in screens involving 
all four catalysts. The formation of Pd nanoparticles occurred within minutes when 
employing 6.3 or 6.4 as catalysts, whereas this was offset for ca. 1 h during 
reactions catalysed by 6.1 and 6.2, suggesting that whilst the cavitand may not 
enhance catalysis in this case, it may afford a stabilising effect to complexes. 
Turnover frequencies (TOF) also decreased significantly as catalyst loading 
increased, with values ranging from 74 h-1 for 6.2 at 0.25 mol% Pd loading to 10 h-1 
for 6.1 at 1 mol% Pd loading. TOF is defined as the turnover number per hour. CTV 
catalysts 6.1 and 6.2 were much more active at low loading, but became 
considerably less active than 6.3 and 6.4 when catalyst loading was increased. This 
could be due to nanoparticle formation, which may be poorly active or inactive at 
catalysing the cross-coupling of 4-bromotoluene and phenylboronic acid. TONs 
associated with 6.3 and 6.4 do not decrease significantly when increasing catalyst 
loading from 0.5 mol% to 1 mol%. Alongside the observation of rapid palladium 
black formation, the similar TONs between examinations could suggest the 
formation of catalytically active nanoparticles. All reactions at 0.5 mol% were 
compared to the commonly employed Pd(OAc)2 and PPh3 system, which was more 
active than all four reported complexes. A palladium-free screen gave no 
conversion. 
 The groups of Matt, Toupet and Brenner have studied catalytic efficacy of 
mononuclear calix[4]arene37 or resorcin[4]arene38 tethered Pd-NHC complexes and 
compared to a Pd(II) arene-wingtipped complex. Their results revealed similar 
activities between the more conventional complex and their cavitand derivative, 
suggesting the bowl does not behave as a receptor, and the cavitand is merely 
behaving as a bulky ligand, contrasting their previous findings when employing 
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phosphine analogues.39 This remains relatively consistent with the CTV derivatives, 
which generally do not enhance nor impede the coupling of 4-bromotoluene and 
phenylboronic acid. Matt’s resorcin[4]arene complexes bearing mono, bis and 
tetrakis NHC ligands all displayed similar activities, suggesting each Pd(II) centre 
behaves independently from others on the scaffold. 
 Contrasting behaviour is seen when comparing disk-shaped multimetallic 
complexes containing extended polyaromatic systems. Peris and co-workers have 
reported a number of multimetallic complexes which have a propensity to π-π stack 
with one another leading to much higher catalytic activities than in monometallic 
analogues (M= Pd, Au).40 Doping catalytic reactions with pyrene and 
hexafluorobenzene led to severely reduced conversions for multimetallic examples, 
implying that stacking arrangements leading to cooperativity between complexes are 
responsible for this increase.41 DFT studies revealed little communication between 
metals in the extended aromatic multimetallic complexes.42 
 A cross-coupling reaction that PEPPSI™ complexes are known to catalyse is 
the Buchwald-Hartwig amination reaction, historically between a secondary amine 
and an aryl halide, yielding a tertiary amine.43 Coupling a less bulky primary amine, 
or even ammonia are much more challenging due to the propensity of the amine to 
bind to the metal, however sterically encumbered catalysts can help remediate 
this.44, 45 With this in mind, complex 6.1 was tested in the cross-coupling between 
aniline and 4-bromotoluene at a reasonably high catalyst loading of 3 mol%. After 
24 h, a conversion of 9% was observed by 1H NMR spectroscopy. This conversion 
is considerably lower than a number of reported examples for what is a reasonably 
well-documented, but still challenging reaction.46 Therefore it was decided to remain 
with the Suzuki-Miyaura reaction and alter the substrates. 
6.4.2 Determining the nature of catalysis 
A number of Pd-catalysed reactions can be facilitated by nanoparticles, therefore it 
is critical to determine whether homogeneous or heterogeneous catalysis is 
occurring. In the Suzuki-Miyaura reaction between 4-bromotoluene and 
phenylboronic acid catalysed by complexes 6.1-6.4, a significant quantity of Pd 
black precipitated from reactions; for the trimetallic complexes this occurred from 
ca. 1 h onwards, whereas for the monometallic complexes it was almost immediate 
after reaching 80 oC. As detailed in section 6.5.1, a homeopathic effect was 
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observed, where lower catalyst loading led to elevated activity.36 This can be an 
indication of inhomogeneity, whereby a higher concentration of catalyst being 
present induces aggregation, and the formation of inactive nanoparticles. One 
method of qualitatively determining the nature of the active catalyst is the mercury 
drop test.47 The precatalyst is reduced to its Pd(0) form, before the addition of 150-
300 eq. elemental Hg. Any colloidal Pd(0) amalgamates with the Hg, leaving only 
mononuclear (or trinuclear in the case of 6.1 and 6.2) catalyst in solution. In the case 
of a positive mercury drop test, biaryl is detected in the reaction which suggests that 
homogeneous catalysis is occurring as the colloidal Pd(0) is absent. If no product is 
detected, the reaction is therefore thought to be catalysed in a heterogeneous 
manner. Palladium nanoparticle formation has been monitored using UV-vis 
spectroscopy, but monitoring their formation during a reaction under inert 
conditions may be challenging.48  
For complexes 6.1-6.4 at 0.5 mol% Pd, identical conditions to the previous 
screens (table 6.3, scheme 6.7) were carried out, with the addition of Hg. 1H NMR 
spectra after 2 h revealed the presence of 4-phenyltoluene in all four examples, 
albeit in heavily reduced conversions of ca. 10%, suggesting a level of 
homogeneous catalysis is ongoing. The reduced activities in mercury drop tests can 
be caused by catalytically active nanoparticles rendered inactive by amalgamation, 
so only gives a qualitative indication that heterogeneous catalysis is contributory 
towards the overall reaction. De Vries suggested the formation of Pd nanoparticles 
via soluble Pd clusters is reversible, so equilibration between states could also be an 
important factor.36 
6.4.3 Towards regioselective Suzuki-Miyaura reactions 
Second-sphere coordination of a guest 1,4-dioxane to a Pd(II) centre in the crystal 
structure of (6.1)2·(C4H8O2)6 was observed. Should this be extended to heteroarenes 
such as pyridyl substrates bearing more than one halide, regioselectivity mediated by 
confinement could allow for a different product distribution for reactions catalysed 
by trimetallic complexes compared to the monometallic counterparts. Reactivity 
between 4-bromotoluene and phenylboronic acid was sluggish, therefore an 
electron-rich boronic acid was selected alongside a more electron-deficient pyridyl 
substrate. 
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The reaction of 2,5-dibromopyridine and 4-methoxyphenylboronic acid was 
selected because of the potential for regioselective catalysis. This particular 
cross-coupling reaction has been examined for regioselectivity in previous studies, 
with regioselectivity at the 2-position dominating (scheme 6.8). In order to 
preferentially cross-couple at the 5-position, a more reactive halide has to be 
employed. Rao has employed 2-bromo-5-iodopyridine and 2-iodo-5-bromopyridine 
to afford site-selectivity.33 An established number of regioselective reactions using 
the 2,5-dibromopyridine substrate have been reported, including Suzuki,33, 49, 50 
Sonogashira51, 52 and Stille coupling.53 In all cases, regioselectivity was observed at 
the anticipated electron-deficient 2-position. Studies by Handy and co-workers led 
to the monosubstitution at the 2-position in modest yield, however, under some 
conditions hydrodehalogenation of the 5-bromo substrate dominated proceedings, so 
could be a potential pathway to further byproducts.54 
Scheme 6.8 The Suzuki-Miyaura reaction between 2,5-dibromopyridine and 
4-methoxybenzeneboronic acid, and potential products. 
Using a supramolecular approach to regioselective catalysis in this particular 
reaction is undocumented, although a number of cases stem from Fujita’s pioneering 
Diels-Alder reactions within an octahedral cage.55 
Cid and co-workers proposed Pd(II) binuclear complexes as reaction 
intermediates in the Suzuki-Miyaura reaction, and upon reacting Pd(PPh3)4 with 
2,4-dibromopyridine, oxidative addition at the 2-position yielded a dinuclear 
complex, which equilibrated with a mononuclear species, observing a clear pathway 
for o-coupling to dominate (figure 6.20).56 The same intermediates would be 
anticipated in the cross-coupling of 2,5-dibromopyridine with boronic acids.  
 
Figure 6.20 Cid's bimetallic species isolated from the reaction of 2,4-dibromopyridine and 
[Pd(PPh3)4]54. 
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Reactions catalysed by 6.1-6.4 were compared to a Pd(OAc)2 and PPh3 catalyst 
system. The cross-coupling reaction catalysed by Pd(OAc)2 and PPh3 was highly 
regioselective, with biaryl a being the major product (table 6.4). When using 6.1-6.4 
as preformed catalysts, observed conversions were lower and there was no 
indication of regioselectivity. Considerable quantities of b were observed in the 1H 
NMR spectra alongside traces of c. A palladium-free screen gave no conversion. 
Table 6.4 Conversion and ratios of products observed for the Suzuki-Miyaura reaction between 
2,5-dibromopyridine and 4-methoxybenzeneboronic acid. 
Catalyst Net Conversion 
(%) 
TON Ratio a:b:c 
Pd(OAc)2, PPh3 83 (±3) 166 70:5:5 
6.1 (CTV) 59 (±3) 118 31:23:7 
6.2 (CTV) 51 (±2) 102 26:20:5 
6.3 56 (±2) 112 29:18:6 
6.4 46 (±2) 92 24:18:4 
Conversions and ratios were interpreted by 1H NMR spectroscopy compared to the OMe 
resonance of 1,4-dimethoxybenzene internal standard (3.78 ppm) and are the  
 average  of two runs. Methoxy groups of a, b and c all overlapped at ca. 3.85 ppm. The 
6-pyridyl resonance (a, 8.68 ppm; b, 8.54 ppm; c, 8.87 ppm).32 
Whilst the four NHC complexes all displayed poor levels of regioselectivity in this 
particular reaction, 6.1 and 6.2 were slightly more active when compared to 6.3 and 
6.4 respectively. Net conversions were also greater than when screening the 
synthesis of 4-phenyltoluene. In a reverse manner to the previous Suzuki-Miyaura 
reactions, N-methyl complexes were more active than their N-benzyl counterparts. 
The fact that ratios of each product were similar in all four screens suggests 
encapsulation of a guest substrate is not influential in this example. Much greater 
activity at the 5-position was observed when compared to the control reaction, 
which was unexpected considering this position is less favourable. Electronic factors 
including the presence of directing groups can influence regioselective 
transformations, however, the bulky NHC wingtips of 6.1-6.4 may hinder 
intermediates similar to Cid’s from forming, propagating the less favourable 
cross-coupling reaction at the 5-position. A similar stoichiometric study was carried 
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out with complex 6.1 and 2,4-dibromopyridine in the presence of excess Cs2CO3, 
but only the precatalyst and 2,4-dibromopyridine were observed. It is worth noting 
that Cid used a Pd(0) precursor, whereas 6.1 would require reducing prior to the 
oxidative addition of 2,4-dibromopyridine. PEPPSI™ complexes are known to be 
reduced by an excess of boronic acid prior to catalysis, which could initiate a 
catalytic cycle so was not attempted.57 
The aryl halide substrate was changed to 2,4-dibromopyridine, which bears 
two electronically similar bromide substituents. A handful of regioselective 
transformations of 2,4-dibromopyridine have been documented, with most 
Pd-catalysed examples favouring o-substitution of the pyridyl ring.52, 33, 50 Very few 
examples of preferential p-coupling when using 2,4-dibromopyridine have been 
reported. Rao and co-workers reported Suzuki-Miyaura reactions between 
2,4-dibromopyridine and triarylbismuth reagents, whereby p-substitution was 
favoured in a 5:1 ratio, with significant bis-substituted product also forming.32 
Regioselectivity at the 4-position has otherwise been achieved employing 
2-bromo-4-iodopyridine.49, 58 If 6.1-6.4 did display a lower affinity towards 
o-substitution as postulated for the cross-coupling of 2,5-dibromopyridine with 
4-methoxyphenylboronic acid, the strongly ortho-para directing pyridine may afford 
an additional driving force for reactivity at the 4-position of 2,4-dibromopyridine, 
which could well direct regioselectivity at this site. 
Scheme 6.9 Suzuki-Miyaura reaction between 2,4-dibromopyridine and 4-
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Table 6.5 Conversions and product ratios obtained for the Suzuki-Miyaura reaction between 
2,4-dibromopyridine and 4-methoxybenzeneboronic acid (1.2 eq.) catalysed by 6.1-6.4 









TON Ratio d:e:f 
Pd(OAc)2, 
PPh3 
N/A  N/A 79 (±4) 158 25:33:21 
6.1 (CTV) 44 (±1) 176 2:19:23 68 (±3) 136 3:32:33 
6.2 (CTV) 41 (±3) 164 2:17:22 59 (±4) 118 4:27:29 
6.3 39 (±1) 156 2:16:21 58 (±2) 116 3:27:28 
6.4 46 (±1) 184 3:20:24 53 (±2) 106 4:26:24 
Conversions are monitored by 1H NMR spectroscopy relative to 1,4-dimethoxybenzene as an 
internal standard and are the average of two runs. The 6-pyridyl resonances (d, 8.43 
ppm; e, 8.35 ppm; f, 8.67 ppm)56 were compared to the methoxy resonance of 1,4-
dimethoxybenzene. 
As predicted, complexes 6.1-6.4 all displayed a preference towards e and f (scheme 
6.9 and table 6.5), with trace quantities of 2-(4-methoxyphenyl)pyridine, d, being 
observed. The fact that all four complexes are displaying the preference towards e 
and f eliminates cooperative effects between Pd sites on 6.1 and 6.2. The CTV 
cavitand is merely behaving as a bulky ligand, which happens to tether three 
independent catalytically active metal centres to the same scaffold. After reducing 
the loading to 0.25 mol% Pd, conversions did diminish to 40-50%, and all catalysts 
were similarly active. The reaction was compared to the control reaction using 
Pd(OAc)2 and PPh3 as precatalyst components, which gave a total conversion higher 
than complex 6.1, although no regioselectivity was observed. A Pd-free screen gave 
no conversion. At lower catalyst loading, a slightly higher quantity of triaryl c was 
observed in all cases, compared to a marginally greater ratio of e at 0.5 mol% Pd. In 
all cases, TONs and hence TOFs were higher at lower catalyst loading, suggesting a 
homeopathic effect. All reactions remained pale yellow in colour, with no 
blackening to suggest Pd(0) formation. 
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Both e and f were detected in similar quantities, which led to reactions being 
profiled in order to determine the ordering of cross-coupling reactions. This could be 
via pathways including o-substituted d being formed first before being digested to 
yield f, or e simply dominating, followed by the subsequent o-coupling, yielding f. 
Interestingly, catalytic transformations occurred on a very fast timescale, with a 
screen involving 6.1 already reaching a total 32% conversion after 120 s, with a 
1:12:19 ratio of d:e:f. After 20 mins, the conversions reach a level of 95% of the 
final screen, with ratios of products being similar to those observed after 2 h, 
suggesting a slow cessation of catalysis. The fast turnovers after 120 s at 80 oC led 
to the order of coupling being unclear, and whilst a higher ratio of c was present at 
this moment, the trace of a observed shed no light on reaction chronology. One 
method employed was to reduce the temperature to 50 oC to decelerate reactivity, to 
hopefully shed light on the coupling order (figures 6.21 and 6.22).  


















Time (min)  
Figure 6.21 Profile of the Suzuki-Miyaura reaction between 2,4-dibromopyridine and 
4-methoxyphenylboronic acid catalysed by complex 6.1. 2,4-Dibromopyridine 
 (blue trace), product d, 2-aryl (green), product e, 4-aryl(red), product f,  
 bis-aryl (black). 
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Time (min)  
Figure 6.22 Profile of the Suzuki-Miyaura reaction between 2,4-dibromopyridine and 
4-methoxyphenylboronic acid catalysed by 6.3. 2,4-Dibromopyridine (blue trace), 
product d, 2-aryl (green), product e, 4-aryl (red), product f, bis-aryl (black). 
Complexes 6.1 and 6.3 were selected, with aliquots taken every twenty minutes up 
to 2 h, and an additional aliquot taken after 60 s. Both 6.1 and 6.3 displayed similar 
behaviours throughout the 2 h reactions, with 6.1 faring slightly better. An initial 
spike in catalysis was observed at 50 oC, albeit considerably lower than after 2 mins 
at 80 ºC, before a smoothing of gradients. The net conversion after 2 h when 
employing 6.1 was also ca. 20% lower at 50 ºC than at 80 ºC. Most reactivity in the 
formation of products e (2-bromo-4-(p-methoxyphenyl)pyridine) and f occurs within 
the first 20 mins, with a gradual increase until cessation of the reaction. The 
formation of e and f appeared at a similar rate (figures 6.21 and 6.22), whereas 
product d was observed at a low, relatively constant level throughout the reaction, 
indicating the syntheses of e and f may be of similar favourabilities.  
Goldup and Larrosa found that PEPPSI™ complexes catalyse the 
polyfunctionalisation of polyhaloarenes in the Negishi, Kumada, and to a lesser 
extent Suzuki-Miyaura coupling reaction with high selectivities.20 The authors 
suggested that alongside the ‘normal’ activation-controlled Pd(0) active catalyst, a 
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second species of Pd(0) catalyses the polyfunctionalisation of polyhaloarenes 
exhaustively substituting the polyhaloarene through diffusion controlled oxidative 
addition within a solvent cage. When monitoring the Suzuki-Miyaura reaction 
between 2,4-dibromopyridine and 1.2 eq. of 4-methoxybenzeneboronic acid 
catalysed by 6.1-6.4, concentrations of both e and f remained relatively constant 
with respect to one another, which in this case could imply both an ‘activation’ 
pathway to prepare e and ‘diffusion-controlled’ pathway forming f were occurring at 
similar rates. The significantly high quantities of f detected early in catalytic 
examinations may also be evidence of exhaustive substitution occurring during this 
particular reaction. 
6.5 Conclusions and future work 
Four complexes have been prepared, structurally authenticated and assessed as 
catalysts in two Suzuki-Miyaura reactions. Lower activities than anticipated were 
observed for the coupling of 4-bromotoluene and phenylboronic acid, but a positive 
mercury drop test in all cases indicates that both homogeneous and heterogeneous 
catalysis are occurring. The CTG complexes fared better than monomers at low 
loadings, displaying a homeopathic Pd effect. Benzyl-NHC complexes proved 
superior to the methyl analogues, and in terms of turnover numbers, the trimetallic 
complexes outperformed the monometallic counterparts. A second Suzuki-Miyaura 
reaction was carried out between 2,5-dibromopyridine and 4-methoxyphenylboronic 
acid. Higher turnovers and conversions were observed, but the desired 
regioselectivity for trimetallic complexes was not observed, with a highly elevated 
proportion of the less-favoured 5-substituted product being present. Unusual 
regioselectivity towards 4-substitution in the Suzuki-Miyaura reaction of 
2,4-dibromopyridine and 4-methoxyphenylboronic acid was observed, implying the 
anticipated o-substitution on the pyridyl ring was unfavourable. Complexes 6.1-6.4 
displayed similar activities in all reactions tested, and therefore the behaviours of 
monometallic vs trimetallic complexes cannot be described as dichotomous. This 
aligns with Matt’s studies using flexible calix[4]arene-NHC complexes, who 
described a similar effect where the bulk of the cavitand did not influence activity of 
catalysts in the same manner as the analogous phosphine complexes.37, 39 
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The substrate scope for regioselective transformations could also be expanded to the 
quinoline family. Furthermore, alternative cross-coupling reactions could be 
pursued. 
Future work in this section could focus on expanding the Pd(II)-NHC 
complexes on a CTV scaffold by investigating the effect of altering the trans-ligand. 
Complexes in this chapter only focus on the trans-3-chloropyridyl series. Altering 
the ligand could lead to subtle changes in catalytic behaviours, for example, Navarro 
and co-workers have prepared trans-triethylamine Pd(II) complexes which are 
active catalysts in room-temperature Buchwald-Hartwig aminations.59, 60 
Furthermore, ditopic ligands such as DABCO and pyrazine,61 in addition to tritopic 
derivatives,62 are attracting attention as the transoid ligand of Pd(II) mono-NHC 
complexes. Employment of such ligands in the place of 3-chloropyridine could lead 
to the assembly of [M6L2] or higher-order cages with linkers between metal centres, 
which could both be catalytically active, and provide an approach to preparing more 
soluble metallo-supramolecular assemblies based on the CTV scaffold. 
6.6 Experimental section 
Unless stated in the experimental section, chemicals were bought from commercial 
suppliers and used without further purification. Unless stated, all reactions were 
carried out under aerobic conditions. Reactions performed under an atmosphere of 
dry nitrogen were carried out using standard Schlenk and Glovebox procedures, with 
solvents dried and degassed using the same methodology described in Section 2.9. 
All analytical techniques are also consistent with those described in Section 2.9. 
 




Palladium(II) iodide (100 mg, 0.28 mmol), potassium carbonate (192 mg, 1.40 
mmol) and 4.3 (113 mg, 0.09 mmol) were dissolved in 3-chloropyridine (3 mL) and 
the reaction mixture degassed. The orange suspension was stirred at 80 ºC under an 
N2 atmosphere for 24 h. Water (10 mL) and DCM (10 mL) were added. The organic 
layer was separated, and washed with water (3 x 5 mL) before being dried over 
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MgSO4. Solvents were removed 
in vacuo, and the residue 
triturated in pentane (5 mL). 
The resulting solid was filtered, 
affording 6.1 as an orange solid. 
Yield 171 mg, 0.08 mmol, 84%. 




1794.5962; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.05 (d, 3H, J = 2.2 Hz, H
1), 8.95 
(dd, 3H, J = 5.4, 1.1 Hz, H3), 7.77-7.72 (m, 3H, H2), 7.34-7.27 (m, 6H, H5, H9), 7.20 
(s, 3H, H17), 7.10 (t, 3H, J = 7.7 Hz, H10), 6.98 (d, 3H, J = 8.2 Hz, H12), 6.79 (s, 3H, 
H20), 6.73 (t, 3H, J = 7.8 Hz, H11), 6.61 (d, 3H, J = 10.2 Hz, H14), 6.40 (d, 3H, J = 
10.2 Hz, H14), 4.44 (d, 3H, J = 13.8 Hz, endo-H21), 4.23 (s, 9H, H7), 3.83 (s, 9H, 
H22), 3.41 (d, 3H, J = 13.8 Hz, exo-H21); 13C{1H} NMR (75 MHz, CDCl3) δ (ppm) 
161.69 (C6), 152.88 (C1), 151.92 (C13), 149.97 (C16), 143.99 (C15), 138.10 (C2), 
136.55 (C18), 134.96 (C8), 134.68 (C13), 132.54 (C4), 132.07 (C19), 125.04 (C5), 
123.54 (C10), 123.41 (C11), 123.36 (C17), 114.19 (C20), 111.15 (C12), 109.78 (C9), 
79.20 (C14), 57.07 (C22), 36.36 (C7), 35.76 (C21); FTIR ν (cm-1) 1506, 1461, 1264, 
743; m.p 165-167 oC (dec.); Elemental analysis for C66H60Cl3I6N9O6Pd3 Calcd.: 
C 35.04, H 2.67, N 5.57; Found C 35.15, H 2.80, N 5.30. 
 




Palladium(II) iodide (41 mg, 0.11 mmol), potassium carbonate (79 mg, 0.57 mmol), 
potassium iodide (95 mg, 0.57 mmol) and 4.5 (50 mg, 0.04 mmol) were dissolved in 
3-chloropyridine (3 mL) and the reaction mixture degassed. The orange suspension 
was stirred at 80 ºC under an N2 atmosphere for 24 h. Water (10 mL) and DCM (10 
mL) were added. The organic layer was separated, and washed with water (3 x 5 
mL) before being dried over MgSO4. Solvents were removed in vacuo, and the 
residue triturated in pentane (5 mL). The resulting solid was filtered, affording 6.2 as 
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a yellow-orange solid. Yield 70 
mg, 0.028 mmol, 70%. HRMS 
(ESI+) 2022.6935 Calcd. for {M-
(I)-3(3-Clpy):C69H60I5N6O6Pd3}
+; 
1H NMR (300 MHz, CDCl3) δ 
(ppm) 9.01, (d, 3H, J = 2.3 Hz 
H5), 8.89 (dd, 3H, J = 5.5, 1.4 Hz, 
H1), 7.70 (tdd, 3H, J = 8.5, 2.4, 
1.3 Hz, H3), 7.63 – 7.57 (m, 6H, 
H9), 7.42 – 7.28 (m, 18H, H2, H10, 
H11, H13, H21), 7.21 (d, 6H, J = 8.2 
Hz, H14), 6.94 (d, 3H, J = 6.3 Hz H15), 6.91 (s, 3H, H24), 6.84 (ddd, 3H, J = 8.3, 6.1, 
2.3 Hz, H16), 6.67 (d, 3H, J = 10.0 Hz, H18), 6.52 (d, 3H, J = 9.9 Hz, H18), 6.19 (d, 
3H, J = 15.7 Hz, H7), 5.94 (d, 3H, J = 15.8 Hz, H7) 4.53 (d, 3H J = 13.8 Hz, endo-
H26), 3.84 (s, 9H, H25), 3.49 (d, 3H, J = 13.5 Hz, exo-H26); 13C{1H} NMR (75 MHz, 
CDCl3) δ (ppm) 162.69 (C
6), 152.90 (C5), 151.94 (C1), 150.17 (C20), 144.07 (C19), 
138.06 (C3), 136.60 (C22), 135.24 (C17), 134.47 (C12), 134.41 (C8), 132.52 (C4), 
132.15 (C23), 129.00 (C10, C11), 128.49 (C9), 125.01 (C2), 124.47 (C13), 123.51 (C16, 
C21), 114.45 (C24), 111.50 (C15), 111.46 (C14), 79.64 (C18), 57.12 (C25), 54.90 (C7), 
35.97 (C26); FTIR ν (cm-1) 1414, 1356, 1266, 1028, 742; Elemental analysis for 
C84H72Cl3I6N9O6Pd3 Calcd.: C 40.51, H 2.91, N 5.06; Found C 40.55, H 2.86, N 
5.04. 
 
Synthesis of 3-chloropyridyl diiodo (1-methyl-3-((2-
methoxyphenoxy)methyl)benzimidazol-2-ylidene)palladium(II), 6.3 
Ligand 4.8 (40 mg, 0.12 mmol), palladium(II) iodide (44 
mg, 0.12 mmol) and potassium carbonate (85 mg, 0.6 
mmol) were dissolved in anhydrous, degassed 
3-chloropyridine (2 mL). The reaction mixture was 
heated to 80 ºC under an N2 atmosphere for 24 h and 
turned dark brown. Water (20 mL) was added and the 
product was extracted into dichloromethane (3 x 20 mL), and the solvents separated. 
The organic layer was washed with water (3 x 20 mL), and organic solvents dried 
over MgSO4, and then removed in vacuo. The orange residue was triturated in 
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hexane, and the resultant orange solid filtered. The title compound was isolated as 
an orange solid. Yield 44.3 mg, 0.05 mmol, 50%. HRMS (ESI+) 500.9284, 
1130.7631, Calcd. for {M-(I)-(3Clpy): C16H16IN2O2Pd}
+ 500.9286, {2M-(I)-
2(3Clpy): C32H32I3N4O4Pd2}
+ 1130.7626; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.07 
(d, 1H, J = 2.3 Hz, H1), 8.97 (dd, 1H, J = 5.4, 1.4 Hz, H5), 7.76 (dt, 1H, J = 8.2, 1.8 
Hz, H3), 7.64-7.54 (m, 1H, H9), 7.41-7.19 (m, 5H, H4, H10, H11, H12, H19), 7.07 (td, 
1H, J = 7.8, 1.7 Hz, H17), 6.97 (dd, 1H, J = 8.2, 1.6 Hz, H16), 6.82 (td, 1H, J = 7.6, 
1.6 Hz, H18), 6.65 (s, 2H, H14), 4.20 (s, 3H, H7), 3.96 (s, 3H, H21); 13C{1H} NMR 
(126 MHz, CDCl3) δ (ppm) 161.36 (C
6), 152.72 (C1), 151.72 (C5), 151.29 (C20), 
145.11 (C15), 137.76 (C3), 135.28 (C8), 134.52 (C13), 132.32 (C2), 124.83 (C4), 
124.77 (C17), 124.69 (C11), 123.43 (C10), 121.40 (C19), 121.18 (C18), 112.69 (C16), 
111.70 (C9), 109.75 (C12), 79.38 (C14), 55.88 (C21), 36.21 (C7); FTIR ν (cm-1) 2160, 
1497, 1413, 1258, 742; m.p. 145oC (dec.); Elemental analysis for C21H20ClI2N3O2Pd 
Calcd.: C 33.99, H 2.72, N 5.66; Found C 33.87, H 2.64, N 5.62. 
 
Synthesis of 3-chloropyridyl diiodo (1-methyl-3-((2-
methoxyphenoxy)methyl)benzimidazol-2-ylidene)palladium(II), 6.4 
Ligand 4.9 (40 mg, 0.09 mmol), palladium(II) iodide (34 
mg, 0.09 mmol), potassium iodide (78 mg, 0.47 mmol) and 
potassium carbonate (65 mg, 0.47 mmol) were dissolved in 
anhydrous, degassed 3-chloropyridine (2 mL). The reaction 
mixture was stirred at 80 ºC under an N2 atmosphere for 24 
h. Water (20 mL) was added and the product was extracted 
into dichloromethane (3 x 20 mL), and the solvents separated. The organic layer was 
washed with water (3 x 20 mL), and organic solvents dried over MgSO4, and then 
removed in vacuo. The orange residue was triturated in hexane, and the resultant 
orange solid filtered. The title compound was isolated as an orange solid. Yield 42 
mg, 0.05 mmol, 57%. HRMS (ESI+) 449.0471, 576.9599, 742.8273, Calcd. for {M-
2(I)-H-(3Clpy)}: 449.0476, {M-(I)-(3Clpy): C22H20IN2O2Pd}
+ 576.9599 {M+K-
(3Clpy): C22H20I2KN2O2Pd}+ 742.8281; 1H NMR (300 MHz, CDCl3) δ (ppm) 9.02 
(d, 1H, J = 2.3 Hz, H1), 8.92 (dd, 1H, J = 5.5, 1.3 Hz, H5), 7.73 (ddd, 1H, J = 8.2, 
2.4, 1.3 Hz, H3), 7.63 (d, 1H, J = 8.1 Hz, H13), 7.56 (dd, 2H J = 7.5, 2.0 Hz, H10), 
7.42 – 7.27 (m, 5H, H4, H9, H11, H23), 7.20 (td, 1H, J = 8.3, 7.8, 1.2 Hz, H15), 7.14 – 
7.04 (m, 2H, H14, H22), 6.99 (dd, 1H, J = 8.2, 1.6 Hz, H20) 6.94 (d, 1H, J = 8.9 Hz, 
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H16), 6.87 (td, 1H, J = 7.7, 1.6 Hz, H21), 6.72 (s, 2H, H18), 6.03 (s, 2H, H7), 3.96 (s, 
3H, H25); 13C{1H} NMR (75 MHz, CDCl3) δ (ppm) 162.57 (C
6), 152.95 (C1), 151.96 
(C5), 151.54 (C24), 145.39 (C19), 137.98 (C3), 135.26 (C17), 134.86 (C12), 134.42 
(C8), 132.51 (C2), 128.98 (C9), 128.42 (C10), 128.39 (C11), 125.07 (C22), 124.90 (C4), 
123.69 (C14), 123.60 (C15), 121.55 (C23), 121.46 (C21), 112.92 (C20), 112.05 (C13), 
111.72 (C16), 79.99 (C18), 56.13 (C25), 55.01 (C7); FTIR ν (cm-1) 1504, 1252, 1212, 
1026, 745; Elemental analysis for C27H24ClI2N3O2Pd Calcd. C 39.64, H 2.96, N 
5.14; Found C 39.55, H 2.89, N 5.07. 
 
General catalytic procedure 
Aryl bromide (1 mmol), boronic acid (1.2 mmol), caesium carbonate (625 mg, 2 
mmol), catalyst (0.25-1 mol% Pd)and 1,4-dimethoxybenzene (69.1 mg, 0.5 mmol) 
were added to a Schlenk flask or carousel tube and dried in vacuo for 10 mins. 1,4-
Dioxane (2.5 mL) and degassed water (2.5 mL) were added, and the reaction heated 
to 80 ºC for 2 h. An aliquot of the reaction mixture (0.1 mL) was added to CDCl3 
(0.4 mL) and the conversion obtained by 1H NMR spectroscopy. 
6.7 Supplementary crystallographic information 
Crystals were mounted under inert oil on a MiTeGen tip and flash frozen using an 
OxfordCryosystems low temperature device. X-ray diffraction data were collected 
using CuK radiation (λ = 1.54184 Å) or MoK (λ = 0.71073 Å) using an Agilent 
Supernova dual-source diffractometer with Atlas S2 CCD detector and fine-focus 
sealed tube generator, or using synchrotron radiation (λ = 0.6889 Å) at Beamline I19 
at the Diamond light source. Data were corrected for Lorenztian and polarization 
effects and absorption corrections were applied using multi-scan methods. The 
structures were solved by direct methods using SHELXS-97 and refined by full-
matrix on F2 using SHELXL-97.47 Unless otherwise specified, all non-hydrogen 
atoms were refined as anisotropic, and hydrogen positions were included at 
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6.7.1 Additional crystallographic details 
6.1·(CH2Cl2)0.5·(C5H14)2·H2O2 
Crystal data were of poor quality because crystals rapidly decomposed upon contact 
with air. One 3-chloropyridyl group was disordered over two positions of 0.75 and 
0.25 occupancies, the lower occupancy position was refined as isotropic. All solvent 
molecules were refined as isotropic and hydrogen positions of the water molecule 
omitted. One pentane solvent molecule was disordered over two positions. 
 
(6.1)2·7.5(C4H8O2) 
One 3-chloropyridine ligand was disordered over two positions, each of 0.5 
occupancy and C-Cl bonds restrained to be chemically reasonable. The AFIX 
command of SHELX was applied to restrain both disordered pyridine rings. 4.5 
dioxane molecules were refined as isotropic, bond lengths and angles were 
restrained to be chemically reasonable. Rigid restraints were applied to both 6.1 
molecules using the RIGU command of SHELX. The largest peak was a Fourier 
ripple 0.95 Å from I3. 
(6.4)2  
The largest residual electron density was 0.95 Å from I2 and is likely a Fourier 
ripple. 
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C153H170Cl8I12N18O17Pd6 C313H334Cl12I24N36O48Pd12 C21H20ClI2N3O2Pd 
C54H48Cl2I4N6O4Pd2 
Mr 4929.86 5006.91 742.05 1636.28 
Crystal size 0.06 x 0.08 x 0.11 0.07 x 0.06 x 0.05 0.05 x 0.02 x 0.02 0.09 x 0.01 x 0.01 
Crystal system Triclinic Triclinic Monoclinic Monoclinic 
Space group 𝑃1̅ 𝑃1̅ P21/c P21/n 
a (Å) 15.6946(6) 18.4409(5) 13.617 11.02430(10) 
b (Å) 15.8484(8) 21.9443(8) 10.995 14.5623(2) 
c (Å) 21.6110(10) 23.7505(8) 15.82040(10) 35.8034(5) 
α (0) 104.839(4) 99.360(3) 90 90 
β (0) 111.072(4) 97.234(3) 93.46 98.4410(10) 
γ (0) 98.298(3) 103.156(3) 90 90 
V (Å3) 4679.2(4) 9100.5(5) 2364.260(15) 5685.58(12) 
Z 2 2 4 4 
ρcalc (g.cm
-3) 1.767 1.827 2.085 1.912 
θ range (0) 3.115-54.242 3.116-74.228 1.452-29.998 1.115- 25.502 
No. data collected 16063 71312 40488 74794 
No. unique data 9748 34313 7553 11597 
Rint 0.0356 0.0929 0.0391 0.0869 
No. obs. Data (I > 
2σ(I)) 
7663 18012 7258 7865 
No. parameters 934 1931 273 651 
No. restraints 17 57 0 0 
R1 (obs data) 0.0533 0.0804 0.0181 0.0520 
wR2 (all data) 0.1506 0.2329 0.0444 0.1566 
S 1.026 1.018 0.912 1.035 
Max. shift/esd 0.001 0.001 0.002 0.002 
Largest difference 
peak and hole/ (e 
Å3) 
2.018, -1.120 2.824, -1.459 0.677, -0.481 1.952, -1.269 
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